LOREAL Document de Reference 2011

REGISTRATION
DOCUMENT
2012
ANNUAL FINANCIAL REPORT
Table of
contents
Presentation of the Group
1.1.
1.2.
1.3.
1.4.
1.5.
Mission
History
Business activities and strategy
International and cosmetics market
Research and innovation: excellence,
to meet the needs of all markets*
1.6. Operations
1.7. Investment policy
1.8. Risk factors*
Corporate governance
2.1. Summary of the principles
2.2. The Boards composition and the way in which
the Boards work is prepared and organised
2.3. Remuneration of the members of the Board
of Directors and the corporate officers
2.4. Summary of trading by Directors and corporate
officers in LOral shares in 2012
2.5. Internal
Control and
Risk
Manageme
nt
procedures
(Report of
the
Chairman of
the
Board of Directors on Internal Control)
2.6. Statutory
Auditors report,
prepared in
accordance with
article L. 225-235
of the French
Commercial Code on the report prepared by
the Chairman of the Board of Directors
2.7. Statutory Auditors Special Report on regulated
agreements and commitments with third parties
Page
5.7. Other information relating to the financial

statements of LOral parent company
5.8. Five-year financial summary
5.9. Investments (main changes including
shareholding threshold changes)
5.10. Statutory Auditors Report on the financial
statements
179
180
181
182
social, environmental
6 Corporate
and societal responsibility
185
*
6.1.
6.2.
6.3.
6.4.
Social information
Environmental information
Societal information
Table of concordance in respect of social,
environnemental and societal matters
6.5. Attestation of completeness and limited
assurance report of the Statutory Auditors
on selected social, environmental and other
sustainable development information
market information
7 Stock
and share capital
7.1.
7.2.
7.3.
7.4.
7.5.
7.6.
3
4
187
200
207
214
216
219
Information relating to the Company

Information concerning the share capital*
Shareholder structure*
Long-Term Incentive Plans*
The LOral share / LOral share market
Information policy
Key figures and comments

on the 2012 financial year
3.1. The Groups business activities in 2012*
3.2. Financial highlights
3.3. Recent events and prospects
2012 Consolidated financial

statements*
4.1. Compared consolidated income statements
4.2. Consolidated statements of net profit and gains
and losses recognised directly in equity
4.3. Compared consolidated balance sheets
4.4. Consolidated statements of changes in equity
4.5. Compared consolidated statements
of cash flows
4.6. Notes to the consolidated financial statements
4.7. Consolidated companies
at December 31st, 2012
4.8. Statutory Auditors Report on the consolidated
financial statements
2012 Parent company

financial statements*
5.1.
5.2.
5.3.
5.4.
5.5.
Compared income statements

Compared balance sheets
Changes in shareholders equity
Statements of cash flows
Notes to the parent company financial
statements
5.6. Table of subsidiaries and holdings
220
222
224
228
235
240
77
78
84
93
95
96
97
98
99
100
101
148
153
155
156
157
158
159
160
175
9
Annual General Meeting
243
8.1. Draft resolutions and Report of the Board of Directors to the

Annual General Meeting
to be held on April 26th, 2013

(as at February 11th, 2013)
245
8.2. Statutory Auditors Special Report on
the authorisation for the free granting of existing
shares and/or shares to be issued to employees
and corporate officers of the Company
254
8.3. Statutory Auditors Special Report on the share
capital increase reserved for employees
of the Company
255
Appendix
9.1. Statutory Auditors
9.2. Historical financial information included
by reference
9.3. Person responsible for the Registration
Document and the Annual Financial Report
9.4. Declaration by the person responsible
for the Registration Document
and the Annual Financial Report
9.5. Registration Document table of concordance
9.6. Annual Financial Report table of concordance
9.7. Table of concordance with the AMF Tables
on the remuneration of corporate officers
9.8. Table of concordance of the Management
Report
257
258
258
259
259
260
262
262
263
Detailed chapter contents can be found at the beginning of each chapter.

*
This information forms an integral part of the Annual Financial Report as provided for in
the article L. 451-1-2 of the French Monetary and Financial Code.
2012
REGISTRATION DOCUMENT
Annual Financial Report
In application of Article 212-13 of the General Regulation of the Autorit

des Marchs Financiers (AMF), this Registration Document was filed with
the AMF on March 18th, 2013.
This Registration Document may be used in connection with a financial
transaction if it is accompanied by an information memorandum approved
by the AMF. The document has been prepared by the issuer and its
signatories incur liability in this regard.
This is a free translation into English of the LOral 2012 Registration Document issued in
the French language and is provided solely for the convenience of English speaking
readers. In case of discrepancy the French version prevails.
PEFC/10311316
management system.
www.pefc-france.org
This document was printed in France on
chlorine-free and PEFC certified paper
produced from sustainably managed
forests.This document is printed in
compliance with ISO 14001: 2004 for an
environment
This label recognises the most

transparent Registration
Documents according to the
criteria of the Annual Transparency
Ranking.
2012 has been another year

of strong performance by
LOral.
The Group has continued to
demonstrate its ability to outperform the
market and strengthen its worldwide
leadership of the beauty sector.
REGISTRATION DOCUMENT LORAL 2012
Message from the Chairman and Chief Executive Officer

Balance of
power
2012 has been another year of strong performance by LOral.

The Group has continued to demonstrate its ability to outperform
the market and strengthen its worldwide leadership of the beauty
sector.
A very good vintage for innovations

This year was a very good vintage for innovations in our Group,
which, by creating the finest products in all channels and
categories, has revived the product offer and driven the market
forward. Innovation is at the heart of our profession. It is the quality
The quality of our results is also underpinned by the very high

standards of governance which we strive to raise year after year.
The freedom and independence which this brings to the Board
of Directors guarantees the balance of power with General
Management.The Board holds the resources it needs to deal freely
with the questions at hand and in particular to approve, monitor
and ensure the implementation of the Companys strategic
orientations, while overseeing the good management thereof.
The balance of power within the Board of Directors is guaranteed
by clearly defining the individual remits of the Chairman and
Chief Executive officer on the one hand, and on the other, the
13 board members who have complete freedom of judgement.
and performance of our products that enables us to attract

and win ever-growing numbers of
consumers, and ensure their loyalty.
2012 was also a year of renewal for
some of our major brands, such as
PROGRESS IN
Lancme,Vichy, Garnier and The Body
Shop. Meanwhile, LOral enriched its
ADAPTING LORAL
brand cataloguewith acquisitions
such as Cadum in France, Vogue in
Colombia and Urban Decay in the
United Statesto further intensify its
A YEAR OF GREAT
TO A RAPIDLY
CHANGING WORLD
coverage of the beauty market.
At the Annual General Meeting, the

Board will propose the appointment
of Mrs Virginie Morgon as new Board
Director. Mrs Morgon is an Executive
Board Member of Eurazeo, one of the
leading investment companies listed

in Europe. All the directors have been
provided with appropriate resources,
within the framework of a code of
operation, with carefully structured
specialist committees whose remits have been broadened. The

Board greatly appreciates the quality of the contributions made by
the four Committees, whose work is increasingly thorough. LOrals
streamlined governance mode simplifies decision-making, which
Accelerated international development

In geographic terms, LOral has built up its position,
en in the
most difficult markets, such as Western Europe and
e United
States, where we have achieved record market share gains. In
North America, the Group grew roughly twice as fast as the market,
driven by the aim of matching our market share level in Western
Europe, where we continue to strengthen our position,
hile also
improving our profitability. At the same time, LOral
as taken
internationalisation to the next level. 2012 marked a
ajor step
forward, as the New Markets have become, for the first ime ever,
the Groups number one sales zone, representing some 40% of
total cosmetics sales.
Strong value creation

2012 was also a year of strong value creation and rowth in
financial results, with our sales growth attaining double-digit
figures. Operating profit and net profit reached record levels, nd
there was a spectacular increase in cash flow. These results
illustrate the strength & efficiency of the LOral business model.
Thanks to the solidity and quality of our results and the
Companys very favourable prospects, the Board of Directors
will propose a further substantial dividend increase of +15% to
2.30 euros at the next Annual General Meeting.
is crucial in the beauty sector, where innovation and adaptation

are fundamental requirements.
REGISTRATION DOCUMENTT LORAL 2012
Preparing LOral for

tomorrows challenges
The Board of Directors actively supports the changes now taking
place in the company. In relation to this, 2012 has been a year of
great progress in adapting LOral to a rapidly changing world, and
sucessfully preparing the Group for tomorrow. Research & Innovation
has undergone a spectacular upgrade with the inauguration of the
largest Hair Research Centre in the world at Saint-Ouen, in France
and a fifth regional research hub at Mumbai, in India, which is
essential to our universalisation strategy. Not only have production
facilities been modernised, two new plants have been added, in
Indonesia and Mexico, to support the conquest of the New
Markets.The digital revolution has continued unwaveringly, with
growth in digital communication and rapid advances in e-commerce.
Digital communication is both a lever for sales growth and a way of
strengthening brand-consumer relationships. Finally, the LOral
Group has continued to make optimum use of growth drivers (media,
etc.), which represent a major economic opportunity for the coming
years.
Targeting sustainable, responsible

and inclusive growth
Transforming the company also means redefining its position and its
role in relation to the social, economic and environmental issues it
faces. This is why we have integrated the principles of sustainable
development into our business model to make societal responsibility
in 2012, more than 70% of the Groups employees yet again

answered an opinion survey conducted by the Group worldwide.
The survey reflects the progress made over the last four years,
but also identifies areas for further improvement, in order to
meet the concerns and expectations of each of our employees.
We also want to build growth that fosters inclusiveness and
generosity. Through the programmes of the LOral Foundation,
our philanthropic initiatives and our Solidarity Sourcing project,
which encourages social inclusion through purchasing, we are
strengthening our commitment to sharing our success with the
communities around us every day. Our commitment to societal
and environmental responsibility has led to several awards from
ratings agencies, which are a tribute to our efforts and our
achievements in these areas.
Confidence in the future

We have confidence in the buoyancy of our profession and our
market. Beauty is an essential, timeless and universal need.
Cosmetics is both a supply-led market driven by innovation, and
a demand-led market, bolstered by the rise of middle classes all
over the world.This makes it a structurally dynamic market, and
so it will remain in the future.
We also believe in our universalisation growth strategy, which
embodies our essential missionto offer women and men all over
WE HAVE CONFIDENCE
IN THE BUOYANCY
OF OUR PROFESSION
a priority and build growth that is sustainable,
AND OUR MARKET

the world the
best in beauty, in terms of quality, efficacy and safety,
responsible and inclusive.

In 2012, we continued to progress
in all fields of social responsibility
in which it is our duty as a leading
company to excel in: social and
ethical matters, diversity and
environmental issues.
We have continued our efforts in
innovation and sustainable production in order to guarantee an
ever-increasing responsible growth. LOral has thus reduced its
CO2 emissions by nearly 39% since 2005, even though the
Groups growth has risen substantially over this period.
LOral and its subsidiaries throughout the world are committed to
making sure that the social and economic performance of the Group
go hand in hand. This goal is now part of a worldwide reporting
system which allows us to orientate our action plans in the future and
to measure our progress year by year. Furthermore
while respecting their differences

and provides an objective that
motivates the whole company: to
conquer a billion new consumers
over the next 10 years.
Finally, we have faith in LOrals
fundamental strengths. Its Research
& Innovation, the most powerful in
the industry. Its ability to constantly invent high-quality products

that boast cutting-edge performance and ensure complete
consumer satisfaction. Its unique catalogue of brands, the
richest and most comprehensive in the industry. The strength of
its business model, which creates value and generates cash
flow, and of our very solid financial situation. And above all, we
believe in our talented and committed teams, who all share the
culture, spirit and values of LOral.
The great LOral adventure continues, the future is in our hands.
M. Jean-Paul Agon
Chairman and Chief Executive Officer
1
PRESENTATION
OF THE GROUP
excellence, to
meet the needs
of all markets *
1.5.1. Research, in the Groups
genes
1.1. Mission
1.5.2. One step ahead in active

principles
1.2. History
1.3. Business
activities
strategy
and
1.3.1. The foundations of

a winning strategy
1.3.2. An organisation
that
serves
the
Groups
development
1.4. Internatio
nal
and
cosmetics
market
1.4.1. A historical
presence
in
developed
markets
1.4.2. Rapid
development
outside Western
Europe
1.4.3. A
com
mitm
ent
to
shar
ed
and
susta
inabl
e
grow
th
1.4.4. Immense
development
potential
1.5. Research
and
innovation:
1.5.3. Setting
technological
decisive
advantage
up
new
platforms: a
competitive
1.5.4. A permanent
commitment to
predicting the
harmlessness and
efficacy of products
1.5.5. Two
cutting
investments
edge
1.5.6. Research in tune with the

market
1.6. Operations
1.6.1. From sourcing to delivery, continuous

improvement of industrial efficiency
1.6.2. A well-oiled industrial model
7
7
1.6.3.
Continuous
improvement
and optimisation of production
1.6.4. Long-term partnerships with suppliers
1.6.5. LOral and

its
partners:
working
together to innovate
17
10
1.6.6. Strong commitments with regard to

social responsibility and safety
17
10
1.6.7. Environmental protection at the heart

of production
18
11
20
1.8. Risk factors *
20
11
11
14
14
14
14
14
15
15
1.8.1. Business risks
20
1.8.2. Legal risks
23
1.8.3. Industrial and environmental risks
24
1.8.4. Counterparty risk

1.8.5. Customer risk
25
25
1.8.6. Liquidity risk
25
1.8.7. Financial and market risks
25
1.8.8. Insurance
27
PRESENTATION
OF THE GROUP
Mission
1.1. Mission
Beauty for all

For more than a century, LOral has devoted itself solely to one business: beauty. It
is a business rich in meaning, as it enables all individuals to express
their personalities, gain self-confidence and open up to others.
Beauty is a language.
LOral has set itself the mission of offering all women and men worldwide the best
of cosmetics innovation in terms of quality, efficacy and safety. It pursues this goal
by meeting the infinite diversity of beauty needs and desires all over the world.
Beauty is universal.
Since its creation by a researcher, the Group has been pushing
back the frontiers of knowledge. Its unique Research arm enables
it to continually explore new territories and invent the products of
the future, while drawing inspiration from beauty rituals the world
over.
Beauty is a science.
Providing access to products that enhance well-being, mobilising its innovative
strength to preserve the beauty of the planet and supporting local communities are
exacting challenges, which are a source of inspiration and creativity for LOral.
Beauty is a commitment.
By drawing on the diversity of its teams, and the richness and
the complementarity of its brand portfolio, LOral has made
the universalisation of beauty its project for the years to come.
LOral, offering beauty for all.
PRESENTATION OF THE GROUP

History
1909
Creation of Socit Franaise des Teintures

Inoffensives pour Cheveux by Eugne Schueller.
1929
Imdia, the first quick oxidation hair colour.
1935
Ambre solaire, the first sun protection oil with

filtering.
1954
Cosmair is named as LOrals agent in the United

States.
1957
Launch of Elnett hair lacquer.
1963
LOral enters the Paris Stock Market.
1964
Acquisition of Lancme.
1965
Acquisition of Laboratoires Garnier.
1970
Acquisition of Biotherm.
1973
Acquisition of Gemey, an open door to the

consumer make-up market.
1979
The first model of a reconstructed epidermis from

LOral Research.
1981
Creation of Laboratoires dermatologiques

Galderma.
1989
Acquisition of La Roche-Posay.
1993
Acquisition of Redken 5th avenue in the United

States.
1.3. Business
activities and
strategy
1.3.1.
THE
FOU
NDA
TIO
NS
OF
A
WIN
NIN
G
STR
ATE
GY
1.3.1.1. A
growth market:
an immense
potential
The world cosmetics
market
is
worth
approximately
180
billion euros in net
manufacturer prices.
Over the last fifteen
years, its average
annual growth is
estimated
at
approximately 4.3%.
This market, which
has
experienced
strong,
regular
growth,
is
also
particularly solid and
resilient: at the peak
of
the
world
economic crisis in
2008-2009,
it
continued
to
progress by nearly
+3% in 2008 and
+1% in 2009 before
picking up again in
2010.This
market
grew
+4.6% in 2011 and

+4.6% in 2012 (1).
Because the world
will always need
beauty, the world
cosmetics market
has
a
glowing
future. Under the
combined effects of
population growth,
urbanisation,
progress
in
infrastructure and
growth in world
GDP, the population
with
access
to
modern cosmetics
could grow by 50%
over the next twenty
(1)
years, boosted by
the rapid rise of the
urban middle class
in the New Markets.
1.3.1.2. One
Purpose:
beauty for
everyone
For more than a
century, LOral has
been pushing back
the boundaries of
science to invent
beauty and to offer
men and women all
over the world the
best of cosmetics in
terms of quality,
Source: LOral estimates of worldwide

cosmetics market based on net manufacturer
prices excluding soap, toothpaste, razors and
blades. Excluding currency fluctuations.
PRESENTATION
OF
GROUP
Business activities
andTHE
strategy
1.3.2.
efficacy and safety. Giving everyone access to beauty by offering

products in harmony with their needs, culture and expectations
in their infinite diversity. This is the true meaning of our activity.
THE GROUPS DEVELOPMENT

1.3.2.1. LOral S.A.
1.3.1.3. Research and Innovation: inventing

the future of beauty
LOral parent company acts as a holding company and has

a role of strategic, scientific and industrial coordination of the
Group on a global basis. The role of most of the subsidiaries
involves the marketing of the products produced by the Groups
plants. LOral parent company wholly owns the capital of the vast
majority of its subsidiaries. In parallel, LOral parent company,
which has its head office in France, performs a sales activity that
is specific to this market
LOral places research and innovation at the centre of its

development model. With 22 research and 17 evaluation centres
on all continents, the Group has developed more than 130
molecules during the last 40 years. 3,817 researchers play their
part in developing new formulas and filed 611 patents in 2012.
LOral is now entering the era of universalisation and beauty for
everyone. The exploration of new scientific and technological
territories is being enriched by this global dimension: with its indepth knowledge of skin and hair in all latitudes, LOral research
creates cosmetics products adapted to the worlds diversity.
1.3.2.2. Branches and Divisions

The Cosmetics Branch, which represents most of the Groups
activities (nearly 93% of its consolidated sales in 2012), is made
up of 4 Operational Divisions which each correspond to a specific
1.3.1.4. The portfolio of cosmetics brands:

offering the best of beauty in each
distribution channel
marketing channel:
the Professional Products Division markets products used
but also sold in hair salons. Privileged partner of hairdressers
all around the world, it supports them in every facet of their
development and offers them high-level training. Its portfolio
of differentiated brands meets the needs of all types of salon.
Professional Products Division brands: LOral Professionnel,
Redken, Krastase and Matrix;
With 27 international brands with diverse cultural backgrounds

present in all distribution channels, LOral is able to meet the
aspirations of all consumers whatever their origins, beauty habits
or revenue levels. The LOral teams design new products in all
areas of cosmetics: hair care, hair colour, skin care, make-up
and perfumes.
the Consumer Products Division offers the best in cosmetic

innovations at accessible prices in all mass-market retail
channels (hypermarkets, supermarkets, drugstores and
traditional stores) on every continent. Consumer Products
Division brands: LOral Paris, Garnier, Maybelline, Softsheen
Carson and Essie;
1.3.1.5. The internationalisation of development:

attracting a billion new consumers
Present in 130 countries, the Group has shown its ability over the
first 100 years of its existence to attract nearly 1 billion consumers,
representing around 15% of the population of the planet. With
accelerating globalisation, LOrals mission is being enlarged:
based on its international positions and its power of innovation,
the Groups ambition is to conquer nearly a billion new consumers
over the next 10 to 15 years.
1.3.1.6. A commitment to responsible,

shared and sustainable growth
With a particularly robust balance sheet and a solid financial
situation, the Group can look forward to the future with confidence.
Supported by loyal shareholders, vigilant governance and stable
management, LOral has always targeted constant, sustainable
growth. Based on a solid business model, LOral is also a
company which strives to be exemplary, exacting in limiting its
footprint on the planet, and increasingly creative in inventing new
models of sustainable consumption.
AN ORGANISATION THAT SERVES
LOral Luxury brings together a unique set of prestigious

brands. These brands are sold through selective distribution,
broken down between department stores, perfumeries, travel
retail outlets, but also its own stores and through e-commerce
websites. LOral Luxury Division brands: Lancme, Giorgio
Armani,Yves Saint Laurent, Biotherm, Kiehls, Ralph Lauren, Shu
Uemura, Cacharel, Helena Rubinstein, Diesel, Clarisonic and
Viktor & Rolf;
the Active Cosmetics Division distributes its products worldwide

in healthcare products distribution channels, primarily through
pharmacies, drugstores, medispas and, in some countries,
dermatologists. Its unique portfolio of brands, which meets all
the needs of consumers in terms of health-beauty, and its
privileged partnership with healthcare professionals have made
this Division the worlds No. 1 in dermocosmetics. Active
Cosmetics Division brands: Vichy, La Roche-Posay,
SkinCeuticals, Innov and Roger & Gallet.
The Body Shop Branch represents approximately 4% of consolidated

sales in 2012. Founded in 1976 in the United Kingdom by Dame Anita
Roddick, The Body Shop is known for its ethical commitment and its
products with natural ingredients. More than 87% of its products contain
ingredients from its Community Fair Trade programme. With a presence
in 65 countries, the brand
distributes
its
products
and
expresses
its
values through a
network
of
exclusive stores
but
also
complementary
distribution
channels:
Internet
sales
and
airport
shops.
The
Dermatology
Branch
which
represents
approximately
3%
of
consolidated
Group
sales
(share
attributable
to
LOral),
consists
Busin
ess
activit
ies
and
strate
gy
of Galderma, a joint venture set up by LOral and Nestl over

30 years ago. After posting regular growth for many years, the
Galderma laboratory crossed the threshold of one billion euros
in sales in 2010, confirming its place as one of the leaders in
dermatology.
(1)
Cosmetics Branch
The Body Shop
Professional Products
Division
Consumer Products
Division
L'Oral
Luxe
Active Cosmetics
Division
(1)
Almost all subsidiaries are directly attached to

L'Oral parent company with a holding or control
percentage equal to or close to 100%. The
detailed list of these subsidiaries is set out in the
notes to the consolidated and parent company
financial statements on pages 148 to 152 and
175 to 178.
and
Finance
Division,
in
charge of the
Groups financial
policy,
controlling and
consolidation,
information
systems
and
legal and tax coordination;
1.3.2.3.
Support
Divisions
Several specialist
Divisions provide
their expertise and
support to the
Branches and
Operational
Divisions:
the
Research
and Innovation
Division,
in
charge
of
fundamental and
applied
research;
the Operations
Division,
in
charge
of
coordination of
production and
the
supply
chain;
the
Human
Resources
Division,
in
charge
of
recruitment,
training
and
talent
development
policies and coordination
of
social policy;
the
Administration
the
Communication,
Sustainability
and
Public
Affairs Division,
in charge of coordination
of
corporate
communication,
co-ordination of
communication
by
the
Operational
Divisions
and
brands
and
Sustainable
Development.
The
Strategic
Marketing
department
provides
the
operational
Divisions
and
Zones
with
support to help
them
identify
and implement
new marketing
developments,
particularly
in
the
area
of
digital
communications
.
1.3.2.4.
Geographic
zones
The
Groups
international
development
has
naturally meant that
LOral has had to
adapt
its
organisation to the
need to co-ordinate
the establishment
and development of
its brands on every
continent.
Thus,
various
geographical zones
have been created,
each
with
operational
responsibility for the
subsidiaries in the
countries
of
its
region:
Western Europe
Zone;
North
Zone;
America
Asia,
Zone;
Pacific
Latin
Zone;
America
Eastern Europe
Zone;
Africa,
Middle
East Zone.
PRESENTATION
THE GROUP
International and OF
cosmetics
market
1.3.2.5. Executive Committee

Members of LOrals Executive Committee
First name/Last name
Position
Jean-Paul Agon

Executive Vice-President
Research and Innovation
Operations
President
LOral Luxe
President
Consumer Products Division
President
Active Cosmetics Division
Strategic Marketing Department
Administration & Finance
Latin America Zone
Communication, Sustainability and Public Affairs
North America Zone
Africa-Middle East Zone
Human Resources and Advisor to the Chairman
President
Professional Products Division
Asia, Pacific Zone
Laurent Attal
Jean-Philippe Blanpain
Nicolas Hieronimus
Jean-Jacques Lebel
Brigitte Liberman
Marc Menesguen
Christian Mulliez
Alexandre Popoff
Sara Ravella
Frdric Roz
Geoff Skingsley
Jrme Tixier
An Verhulst-Santos
Jochen Zaumseil
1.4. International and cosmetics market

1.4.1.
HISTORICAL
PRESENCE IN DEVELOPED
MARKETS
LOral is present in 130 countries in all 5 continents. Founded in
France in 1909, the Group developed rapidly in Western Europe. In
2012, it made nearly 36% of its cosmetics sales in this territory in
which the Group is long established.
In the first half of the 20th century, LOral gained a foothold in North
America. Initially, the Group entrusted distribution
10
companies with distributing its products, these companies being

united in 1953 around an exclusive agent, Cosmair. Following the
companys takeover in 1994, it ensured the Groups development
on the North American continent with the status of subsidiary.The
acquisition of brands like Maybelline (1996), Matrix and Kiehls
(2000), or more recently Clarisonic and Urban Decay (20112012)
have firmly anchored the Group in North America. In 2012, its sales
on that continent increased by 7.2% like-for-like to reach 25% of
world sales.

regions of the world.
1.4.2.
RA
P
I
D
D
E
V
E
L
O
P
M
E
N
T
O
U
T
S
I
D
E
W
E
S
T
E
R
N
E
U
R
O
P
E
Beginning in the
1970s, the Latin
America
Zone
developed with a
multi-divisional
organisation that
the Group has
reproduced
in
the other major
Present in Japan for

nearly 50 years, the
LOral Group has
developed
its
presence
in
that
country by choosing
the brands to be given
priority
for
this
extremely
specific
market: Krastase in
hair salons, Lancme
in Luxury products and
Maybelline and LOral
Paris in mass-market
products.
The 1990s witnessed
the opening up of New
Markets with the fall of
the Berlin wall which
gave
the
brands
access to the markets
in Eastern European
countries.
LOral was among the
first foreign groups to
obtain an authorisation
from
the
Indian
government in 1994
for the creation of a
wholly-owned
subsidiary.
In 1997, the Group
created a large multidivisional zone in Asia
and
opened
new
subsidiaries,
particularly in China
where LOral holds
100% of the capital of
its entity.
Africa and the Middle
East where the Group
had a weak presence
is a new frontier for
development in the
New
Markets:
the
number of subsidiaries
in that region has
increased from 7 to 12
over the last four
years.
The mid 2000s was
the turning point: the
strong acceleration of
the development of
New
Markets
is
leading to a shift of the
point of gravity in the
economic world.
In all, the percentage
of cosmetics sales
generated
by
the
Group in the New
Markets was 15.5% in
1995, 27.1% in 2006
and 39.4% in 2012.
This
progress
is
expected to continue.
1.4.3.
A
C
O
M
M
I
T
M
E
N
T
T
O
S
H
A
R
E
D
A
N
D
S
U
S
T
A
I
N
A
B
L
E
G
R
O
W
T
H
Anxious
to
protect the future
and
to
lay
the
foundations for lasting
growth, the Group is
striving to develop its
presence in the New
Markets by applying
the fundamental rules
of a good corporate
citizen:
the
products
offered
to
consumers
meet
the highest quality
standards;
sidia
Intern
ries;
ationa
l and all production centres comply with the sam
cosm
reduction in environmental footprint. Socia
etics
marke
out at suppliers of factories;
t
each
t
h
e
G
r
o
u
p
s
c
o
m
m
i
t
m
e
n
t
s
i
n
s
o
c
i
a
l
m
a
t
t
e
r
s
a
r
e
t
h
e
s
a
m
e
i
n
a
l
l
i
t
s
s
u
b
subs
idiar
y
parti
cipat
es,
as
far
as
its
reso
urce
s
per
mit,
in
the
large
corp
orat
e
phila
nthr
opy
prog
ram
mes
of
the
LOr
al
Fou
ndati
on
such
as
For
Wo
men
In
Scie
nce,
Hair
dres
sers
agai
nst
AID
S
and
Bea
uty
for a
Bett
er
Life.
Th
is
gl
ob
al
ap
pr
oa
ch
is
in
lin
e
w
i
t
h
t
h
e
G
r
o
u
p
s
a
m
b
i
t
i
o
n
a
s
pi
ng
to
m
ak
e
th
e
w
orl
d
m
or
e
be
au
tif
ul.
1.4.4.
IM
M
E
N
S
E
t
h
e
D
E
V
E
L
O
P
M
E
N
T
w
o
r
l
d
l
e
a
d
e
r
i
n
P
O
T
E
N
T
I
A
L
c
o
s
m
e
t
i
c
p
r
o
d
u
c
t
s
:
h
e
l
Be
sid
es
th
e
m
ajo
r
co
un
t
r
i
e
s
k
n
o
w
n
a
s
t
h
e
B
R
I
M
C
c
o
u
n
t
r
i
e
s
(
B
r
a
z
i
l
,
R
u
s
s
i
a
,
I
n
d
i
a
,
M
e
x
i
c
o
a
n
d
C
h
i
na
),
L
Or
al
ha
s
no
ta
bly
ide
ntif
ied
a
m
on
g
its
gr
ow
th
m
ar
ket
s
th
e
foll
ow
ing
co
un
tri
es:
Po
lan
d,
Uk
rai
ne
,
Ar
ge
nti
na
,
Co
lo
m
bia
,
In
do
ne
sia
,
Th
ail
an
d,
Vi
et
na
m,
Ph
ilip
pin
es,
Tu
rk
ey,
Eg
ypt
,
Sa
udi
Ar
a
b
i
a
,
P
a
k
i
s
t
a
n
,
K
a
z
a
k
h
s
t
a
n
,
S
o
u
t
h
A
f
r
i
c
a
a
n
d
N
i
g
e
r
i
a
.
I
n
m
a
n
y
o
f
t
h
e
s
e
c
o
un
tri
es
,
th
e
co
ns
u
m
pti
on
of
co
s
m
eti
cs
pr
od
uc
ts
pe
r
in
ha
bit
an
t
is
10
to
20
ti
m
es
lo
w
er
th
an
in
m
at
ur
e
co
un
tri
es
.
Se
ve
ral
te
ns
of
mi
llio
ns
of
in
ha
bit
an
ts
ha
ve
ac
ce
ss
ev
er
y
ye
ar
to
l
e
v
e
l
s
o
f
r
e
v
e
n
u
e
s
w
h
i
c
h
m
a
k
e
t
h
e
m
p
a
r
t
o
f
t
h
e
m
i
d
d
l
e
c
l
a
s
s
e
s
a
n
d
a
l
l
o
w
th
e
m
to
co
ns
u
m
e
m
od
er
n
co
s
m
eti
cs
pr
od
uc
ts.
Th
e
m
ar
ke
tin
g
te
a
m
s,
in
pa
rti
cu
lar
in
lar
ge
co
un
tri
es
,
pa
y
he
ed
to
th
es
e
ne
w
co
ns
u
m
er
s.
Th
e
la
bo
rat
ori
es
on
all
co
nti
ne
nt
s
s
t
u
d
y
t
h
e
i
r
s
p
e
c
i
f
i
c
i
t
i
e
s
.
T
h
e
G
r
o
u
p
s
i
n
n
o
v
a
t
i
o
n
p
o
l
i
c
y
i
s
b
a
s
e
d
o
n
th
e
ac
ce
ssi
bili
ty
an
d
ad
ap
tat
io
n
of
pr
od
uc
ts
to
th
e
be
au
ty
ha
bit
s
an
d
rit
ua
ls
of
all
m
en
an
d
w
o
m
en
in
th
eir
inf
ini
te
di
ve
rsi
ty.
Th
es
e
for
m
th
e
ba
sis
for
th
e
un
iv
er
sa
lis
ati
on
of
be
au
ty.
11
PRESENTATION
THE GROUP
International and OF
cosmetics
market
NORTH AMERICA
WESTERN EUROPE
25% OF GROUP COSMETICS

SALES
35.6% OF GROUP COSMETICS

SALES
+7.2% Sales growth in 2012 (1)
+4.4% Market growth in 2012

Sales: 5,211 M
(2)
Stable market in 2012 (2)

Sales: 7,400 M
Operating profit: 18.4%

(% of sales)
Operating profit: 21.3%

(% of sales)
LATIN AMERICA
AFRICA, MIDDLE EAST
EASTERN EUROPE
8.8% OF GROUP
COSMETICS SALES
3.3% OF GROUP
COSMETICS SALES
6.7% OF GROUP
COSMETICS SALES
+10.4% Sales growth in 2012
(1)
+10.2% Market growth in 2012 (2)

Sales: 1,827 M
+14.7% Sales growth in 2012
(1)

Sales: 683 M
ASIA,
PACIFIC
20.6% OF
GROUP
+3.9% Sales growth in 2012 COSMETICS
+3.0% Market growth in 2012SALES
Sales: 1,405 M+9.6% Sales growth in
2012 (1)
+5.9% Market growth in

2012 (2)
Sales: 4,287
M
NEW MARKETS
39.4% OF GROUP COSMETICS SALES
Sale
s: 8,202 M
Operating
profit: 18.5%
(% of sales)
(1)
Like-for-like.
(2)
Source: LOral estimates of worldwide cosmetics market based on net manufacturer prices excluding soap, toothpaste, razors
and blades. Excluding currency fluctuations.
12

International and cosmetics market
Worldwide cosmetics market from 2003 to 2012
(1)
(Annual growth rate as %)
+4.9% +5.0%
+4.0%
+4.6%
+4.6%
+4.2%
+3.8%
+3.4%
+2.9%
+1.0%
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
The worldwide cosmetics market represents

approximately 180 billion euros, and in 2012 it grew
by an estimated +4.6% (1). It is a particularly robust
market, which is steadily expanding, while proving
very resilient when economic conditions are at their
most difficult. The cosmetics consumers behaviour
has not changed since the crisis. There has been no
devaluation, banalisation or massification of the
market. On the contrary, consumers aspirations for
quality are higher than ever, and they are always
eager for technology and new ideas. The cosmetics
market remains a supply-led market, driven by
innovation, and consumers are always looking for
quality, performance and perceived results.
Breakdown of the world cosmetics market in 2012 (1)

(As %)
By geographic zone
By product category
Asia, Pacific
34.1%
Western Europe
21.8%
Africa,
Middle East
3.7%
North
America
Eastern Europe
7.1%
21.2%
Latin America
12.1%
Haircare
Skincare
33.8%
24.3%
Oral
cosmetics
1.4%
Make-up
16.4%
Toiletries,
deodorants
11.2%
Perfumes
12.9%
Main worldwide players (2)

(In billions of US dollars)
For the worldwide cosmetics market, 2012, like 2011, was boosted by
luxury products. With +6.3% growth, the selective market maintains a rapid
pace of growth; carried by Asia, North America and the Travel Retail sector,
it made a 25% contribution to worldwide growth (1). Mass-market retail
channels, with growth of +4.7%, have accelerated as compared to 2011
and contribute 53% to growth in the world cosmetics market.
From a geographic viewpoint, the New Markets continue to attain
increasing levels of growth: excluding Japan, they represented 77% of
worldwide market growth this year (1), primarily due to Asia Pacific, but also
with the contribution of Latin America, up by +10.2%.
28.33
20.70
18.58
9.44
8.53
Procter
LOral & Gamble Unilever
Este
Lauder
Shiseido
Competitive positions and market share held by the Groups Divisions and brands mentioned in this report are based on studies,
panels and polls obtained from specialised organisations and companies, or, in the absence of comprehensive studies, are the
result of estimates made by LOral on the basis of available statistical data.
(1)
Source: LOral estimates of worldwide cosmetics market based on net manufacturer prices excluding soap, toothpaste, razors and blades. Excluding
currency fluctuations.
(2)
Source: Beautys Top 100 WWD, August 2012, 2011 sales.
13
PRESENTATION
OF THEexcellence,
GROUPto meet the needs of all markets
Research and innovation:
1.5.
Research
and
innovation:
excellence, to meet the needs of all
markets
1.5.1. RESEARCH,
IN THE GROUPS
GENES
Over a century ago, a scientist called Eugne
Schueller founded LOral by launching a major
innovation: a harmless hair dye. Research
immediately became one of the components of the
Groups DNA and very quickly one of the keys to
its success. By always keeping one step ahead in
this area, LOral has integrated research into a
Sustainable Development process.The ingredients
used and the work carried out respect consumers,
the environment and biodiversity.
Today, to engage in the conquest of a billion new
consumers, the Group has rethought its innovation
model and increased its investments. With a
budget of 791 million euros in 2012, up by 9.7%
as compared to the previous year, LOrals
research teams innovate to meet beauty
aspirations all over the world in their infinite
diversity.
1.5.2.
ONE STEP AHEAD IN ACTIVE

PRINCIPLES
LOrals Fundamental Research Department was

set up in 1963. Its conviction: knowledge of skin
and hair enables LOrals researchers to think up
new concepts which lead to the synthesis of new
molecules.The Group subsequently multiplied the
number of patent filings (611 in 2012) and
developed a large number of active principles, the
main ones being at the source of the Groups
flagship products.
This capacity to implement long-term research
programmes now enables LOral to remain
ahead of its competitors.
Among these major molecules, it is possible to
cite Ionene G, launched in 1978 in hair colour with
Majirel to ensure real respect of the integrity of
hair; Mexoryl SX, a sun filter launched in 1993 in
the Vichy Capital Soleil range; Pro-Xylane, which,
launched for the first time in 2006, became part of
the Lancme Absolue BX range to treat deep
wrinkles; and more recently, LR2412, used in
Lancme Visionnaire, a star product launched in
2011, which reduces wrinkles while offering a
more even skin tone and, finally, Stemoxydine
launched in 2012 in the Vichy Neogenic product
1.5.3. SETTING UP
NEW
TECHNOLOGICAL
PLATFORMS: A
DECISIVE
COMPETITIVE
ADVANTAGE
LOrals research team makes breakthrough
innovations for all Divisions, all brands, and all
product categories. The Group creates formulas
with textures which enhance the efficacy of active
ingredients. For example, in 2009, LOral
Professionnel launched the INOA hair colouring
range with the ODS (Oil Delivery System), which
makes it possible to avoid ammonia in the
oxidation colouring.The ODS is now a
technological platform rolled out in the hair
products businesses. The teams have thus
developed the second-generation ODS which led
to Garniers home hair colour OLIA in 2012.
1.5.4. A
PERMANENT
COMMITMENT
TO
PREDICTING
THE
HARMLESSNESS AND EFFICACY
OF
PRODUCTS
range which favours follicular regrowth.
The harmlessness and efficacy of LOrals

technological innovations are essential. To meet
these requirements, the research team embarked
in the 1980s on developing alternative methods to
animal testing for the evaluation of the safety of its
products.
Thanks to these models, LOral was able to put

an end to animal testing for finished products in
1989, i.e. 14 years before it was required by law in
Europe. In three decades, the Group has created
genuine expertise in the field of reconstructed
tissues. Up until now, twelve reconstructed skin
and cornea models have been developed.
Much progress has been made thanks to tissue

engineering, which made it possible to reconstruct
the first human epidermis in 1983 and then the
first complete skin (epidermis and dermis) in 1996.
These models are fabulous tools to predict the

safety and efficacy of products and make it
possible to reduce the time-to-market.
Research and innovation budget
Research employees
Number of patents
( million, including 50% of Galderma

research expenses)
(including 50% of Galderma

research employees)
(cosmetics and dermatological

research)
2010
2011
2012
14
665
721
791
2010
2011
2012
3,420
3,676
3,817
2010
2011
2012
612
613
611

Research and innovation: excellence, to meet the needs of all markets
1.5.5.
TWO
C
U
T
TI
N
G
E
D
G
E
IN
V
E
S
T
M
E
N
T
S
1.5.5.1. The
world
production
centre
for
reconstructe
d biological
tissues
In 2011, LOral inaugurated its
global predictive evaluation
centre in Gerland (Lyon,
France). Dedicated to the
predictive evaluation of the
safety
and
efficacy
of
ingredients and products, this
centre is the first cosmetics
industry
site
to
produce
reconstructed biological tissues
(around 130,000 units per
year).
The Groups performances, in
terms of predictive evaluation,
also
benefit
from
the
considerable
amount
of
historical data that LOral has
developed over the 100 years
of exclusive innovations in
cosmetics.The Group currently
has a large database on
several tens of thousands of
molecules.Thanks
to
a
computer modelling system, the
cross-comparing of all this data makes it

possible to predict the efficacy and safety
of the ingredients and the products,
increasing the reliability and improving the
cost of the formulas.
All the
necessary
skills for
the
developme
nt of high
performing
products
are
brought
together in
the centre:
major
technologies and
offer consumers
products
that
respond to the
diversity of their
expectations;
an
instrumental,
expert,
sensory
evaluation which
accompanies
future
products
from design to
launch, thanks to
a whole range of
competencies at
the onservice
applied Research grouped together
the same of
floor to
performance
create innovative prototypes and yield a regular flow of
perceived by the
consumer;
innovations for our markets;
develop
ment
teams
working
together
by
major
product
categori
es
to
create
effective
formula
e based
on
key expertise in
the
fields
of
physics
and
chemistry
or
formulation,
automation
and
modelling
processes;
all the essential

support and back
office functions to
support all the
centres activities.
1.5.5.2. The Global Hair

Research Centre
In 2012, LOral inaugurated its
Global Hair Research Centre in
Saint-Ouen (France). This 25,000
square metre building, representing
an investment of 100 million euros,
hosts 500 people responsible for
developing,
formulating
and
evaluating products in the three main
categories of hair products (hair
colouring, hair care and styling).
The centre houses the international
divisions of these businesses which
define global innovation strategies
throughout the world and coordinate
the global portfolio of new products.
But it is also the regional centre for
Europe along the same lines as the
five other regional centres in Brazil,
North America, Japan, China and
India.
1.5.6.
RES
E
A
R
C
H
I
N
T
U
N
E
W
I
T
H
T
H
E
M
A
R
K
E
T
All stages of research which lead up

to the launch of an innovative
product are connected to the market.
There is a veritable interaction
between research and marketing.
This approach is closely related to
the Groups development strategy in
the New Markets. Consumers in
India are not the same as those in
China or in Europe. Their cosmetic
needs and aspirations differ. To pay
heed to the needs of its customers in

their diversity, LOral has created a
Consumer
&
Market
Insights
Department in the Innovation
Department to build up a global
consumer data bank per product
category and per major region of the
world.The cosmetic needs and
expectations of consumers all over
the world in 15 priority markets for
the Group are identified through
these studies.
15
PRESENTATION
OF THE GROUP
Operations
Research sites worldwide

c
e
n
t
r
e
s
Local research
and adaptation of
products
3 Global centres
(France)
5 Regional hubs
2
2
R
e
s
e
a
r
c
h
c
e
n
t
r
e
s
1
7
E
v
a
l
u
a
t
i
o
n
To adapt to consumers all

over the world, LOrals
research teams are present
in all geographic zones
through its 22 cosmetics
and
dermatological
research centres and 17
evaluation
centres.The
research
centres
are
grouped together in 3 global
centres
in
France
(Advanced Research, Hair
mtiers
and
Cosmetic
mtiers) and 5 regional
hubs: the United States,
China, Japan, Brazil and
India. In symbiosis with the
local environment, these
regional
hubs
identify
needs, scientific expertise
and cosmetic practices. The
richness of their science

ecosystem
promotes
cooperation
and
partnerships
for
excellence.The
data
collected then enable the
researchers to develop
new products that are
perfectly in tune with
needs. The innovations
developed will then be
shared with the other
research centres in a
coordinated manner, and
needs identified in one
country may subsequently
lead to success on a
global scale.
1.6.
Operatio
ns
1.6.1.
F
ROM
SOUR
CING
TO
DELIV
ERY,
CONT
INUO
US
IMPR
OVEM
ENT
OF
INDU
STRIA
L
EFFIC
IENCY
LOral offers Men and
Women worldwide the
best
of
cosmetics.
Operations
develop,
produce on an industrial
scale and distribute the
products corresponding to
this
offering,
by
guaranteeing the
most effective and the

most responsible solutions
and those most suited to
the specific natures of our
brands and markets.
The Operations Division
comprises seven areas of
expertise with regard to
industrial production and
logistics:
procurement,
packaging,
production,
quality,
supply
chain,
environment, health and
safety,
and
real
estate.Three
support
functions complete the
Divisions
resources:
Information
Systems,
Finance
and
Human
Resources.
16
1.6.2.
A
W
E
L
L
O
I
L
E
D
I
N
D
U
S
T
R
I
A
L
M
O
D
E
L
With locations all
over the world,
the
Groups
factories
produce 88% of
cosmetics units
sold. This choice
of essentially inhouse
production offers
a guarantee of
quality,
traceability and
corporate social
responsibility,
which reduces
risks. Plants are
generally
dedicated to the
production
of
one Operational
Division
and
specialised
in
major industrial
technologies
located close to
the markets that they

serve. The rotation of
brands
on
the
packaging lines is
furthermore assisted
by
an
increased
standardisation
of
industrial processes.
This industrial model
helps
to
improve
output year on year
and
guarantees
continuous activity on
each site.
1.6.3.
CON
T
I
N
U
O
U
S
I
M
P
R
O
V
E
M
E
N
T
A
N
D
O
P
T
I
M
I
S
A
T
I
O
N
OF
PROD
UCTIO
N
LOral has set itself the
target of continually
improving output and
optimising
production
costs.This ambition is
accompanied by a
demanding quality
system
that
extends
from
design
to
customer,
and
which aims to
guarantee
the
integrity of the
formulation
of
products all over
the world and
ensures
compliance with
social
and
environmental
responsibility
standards
on
each production
site in accordance
with
national
regulations.
In 2008, LOral
launched
a
global
programme
to
improve
the
efficiency of its
production
facilities called
Operational
Excellence.
Based on a set
of best practices,
this programme
is shared by all
sites.
This
triggered sharing
of the support
and procurement
functions in the
major
geographic
zones. Efficiency
has
been
improved while
the specificities
of each region
have
been
maintained.This
productive,
highly
responsive
organisation
model
is
particularly
adapted
to
LOrals
objective
of
accelerated
growth in the
New Markets.
1.6.4.
LO
N
G
T
E
R
M
P
A
R
T
N
E
R
S
H
I
P
S
W
I
T
H
S
U
P
P
L
I
E
R
S
LOrals
industrial
success can also be
accounted for by the
Groups
exacting
standards in the choice
of its suppliers and the
sustainable
relationships that it
sets up with them. The
Group organised its
first World Suppliers
Day in 2012 in order to
share
the
Groups
vision and strategy with
LOrals most strategic
suppliers. Durable links
with suppliers also
require
the
development of local
procurement in strong
growth zones. In 2010,
the Group initiated the
wall-to-wall
programme
which
consists in setting up a
production unit for
packaging
items
operated by a supplier
within the plant itself.
This partnership
develops
responsiveness
and
industrial
flexibility, while
reducing
(1) European
ratings agency.
Operations
th
e
tra
ns
po
rta
tio
n
of
pa
ck
ag
in
g
ite
m
s
an
d
th
e
ge
ne
rat
io
n
of
w
as
te
rel
at
ed
to
th
eir
pa
ck
ag
in
g.
It
is
ai
m
ed
at
pl
an
ts
wit
h
hi
gh
ly
specialised technologies
that produce very large
volumes
and for
have
ongoing needs
external
resources.
1.6.5.
L
O
R
A
L
A
N
D
I
T
S
P
A
R
T
N
E
R
S
:
W
O
R
K
I
N
G
T
O
G
E
T
H
E
R
T
O
I
N
N
O
V
A
T
E
P
a
c
k
a
g
i
n
g
i
s
a
m
ajo
r
en
vir
on
m
en
tal
an
d
ind
ust
rial
ch
all
en
ge
for
th
e
Op
er
ati
on
s
Di
vis
ion
.
Th
e
Gr
ou
p
re
sp
on
de
d
to
thi
s
ch
all
en
ge
in
20
10
by
cr
ea
tin
g
a
pa
ck
agi
ng
fai
r
cal
led
C
he
rry
Pa
ck
.
Int
er
na
tio
nal
su
ppl
ier
s
a
r
e
a
b
l
e
t
o
p
r
o
p
o
s
e
t
h
e
i
r
l
a
t
e
s
t
i
n
n
o
v
a
t
i
o
n
s
a
t
t
h
i
s
e
v
e
n
t
o
n
a
n
e
x
c
l
u
s
ive
ba
sis
.
At
th
e
en
d
of
th
e
tw
o
da
ys
of
pr
es
en
tati
on
,
pr
oje
cts
ar
e
sel
ect
ed
by
th
e
br
an
ds
an
d
th
e
Re
se
ar
ch
&
In
no
vat
ion
Di
vis
ion
.
Th
is
ev
en
t,
wh
ich
tak
es
pla
ce
ab
ou
t
on
ce
ev
er
y
18
m
on
ths
.
d
e
m
o
n
s
t
r
a
t
e
s
L
O
r
a
l
s
i
n
t
e
n
t
i
o
n
t
o
r
e
i
n
f
o
r
c
e
i
t
s
l
i
n
k
s
w
i
t
h
i
t
s
s
u
p
p
l
i
e
r
s
by
ga
m
bli
ng
on
col
lab
or
ati
ve
int
elli
ge
nc
e.
Ex
ter
nal
inn
ov
ati
on
is
als
o
bo
ost
ed
thr
ou
gh
pa
rtn
er
shi
ps
wit
h
hig
hly
cr
ea
tiv
e
an
d
inn
ov
ati
ve
sc
ho
ols
.
1.6.6.
ST
R
O
N
G
C
O
M
M
I
T
M
E
N
T
S
W
I
T
H
R
E
G
A
R
D
T
O
S
O
C
I
A
L
R
E
S
P
O
N
S
I
B
I
L
I
T
Y
A
N
D
S
A
F
E
T
Y
Th
e
Op
era
tio
ns
Div
isi
on,
lik
e
the
Gr
ou
p
as
a
wh
ole
,
pla
ys
a
pre
do
mi
na
nt
rol
e
in
the
fiel
d
of
so
cia
l
res
po
nsi
bili
ty
an
d
saf
ety
.
Th
rou
gh
its
B
uy
&
Ca
re
pro
gra
m
me
,
L
Or
al
inc
ite
s
its
su
ppl
ier
s
to
be
mo
r
e
r
e
s
p
o
n
s
i
b
l
e
a
n
d
c
a
r
r
i
e
s
o
u
t
r
i
g
o
r
o
u
s
m
o
n
i
t
o
r
i
n
g
o
f
t
h
e
i
r
c
o
m
m
i
t
m
e
n
t
s
t
hro
ug
ha
lar
ge
nu
mb
er
of
so
cia
l
au
dit
s
car
rie
d
out
on
su
ppl
ier
s
thr
ou
gh
out
the
wo
rld.
Sin
ce
the
pro
gra
m
me
wa
s
put
in
pla
ce,
clo
se
to
4,4
00
so
cia
l
au
dit
s
ha
ve
be
en
car
rie
d
out
in
3,7
00
of
the
Gr
ou
ps
su
ppl
ier
s
sit
es.
Th
e
o
b
j
e
c
t
i
v
e
i
s
n
o
t
t
o
i
m
p
o
s
e
s
a
n
c
t
i
o
n
s
o
n
s
u
p
p
l
i
e
r
s
b
u
t
t
o
h
e
l
p
t
h
e
m
t
o
im
pro
ve
the
ir
saf
ety
sta
nd
ard
s
an
d
the
ir
en
vir
on
me
nta
l
an
d
so
cia
l
per
for
ma
nc
es.
Th
e
Gr
ou
p
rec
eiv
ed
a
pri
ze
fro
m
VI
GE
O
(1)
in
20
12
for
the
pre
ve
nti
on
of
so
cia
l
du
mp
ing
in
the
su
ppl
y
ch
ain
.
In
cr
ea
tin
g
t
h
e
S
o
l
i
d
a
r
i
t
y
S
o
u
r
c
i
n
g
p
r
o
g
r
a
m
m
e
,
t
h
e
G
r
o
u
p
t
o
o
k
t
h
e
i
n
i
t
i
a
t
i
v
e
o
f
u
s
i
ng
lo
ca
l
su
pp
lie
rs
w
ho
m
ak
e
co
m
mi
tm
en
ts
in
fa
vo
ur
of
mi
no
riti
es
:
di
sa
bl
ed
w
or
ke
rs
or
w
or
ke
rs
fro
m
de
pri
ve
d
co
m
m
un
iti
es
. It
m
ay
al
so
in
vo
lv
e
ve
ry
s
m
all
su
pp
lie
rs
or
fai
r
tra
de
p
l
a
y
e
r
s
t
h
a
t
L
O
r
a
l
c
a
l
l
s
o
n
t
o
c
o
n
t
r
i
b
u
t
e
w
i
t
h
t
h
e
h
e
l
p
o
f
i
t
s
s
u
p
p
l
i
e
rs.
Th
is
pr
og
ra
m
m
e
w
as
off
ici
all
y
la
un
ch
ed
in
20
12
to
th
e
Gr
ou
p
s
su
pp
lie
rs
in
or
de
r
to
en
co
ur
ag
e
th
e
m
to
de
ve
lo
p
th
e
sa
m
e
ap
pr
oa
ch
wit
h
th
eir
o
w
n
su
pp
lie
rs.
Wi
th
re
ga
rd
t
o
s
a
f
e
t
y
,
t
h
e
O
p
e
r
a
t
i
o
n
s
D
i
v
i
s
i
o
n
p
a
y
s
p
a
r
t
i
c
u
l
a
r
a
t
t
e
n
t
i
o
n
t
o
e
m
p
l
o
ye
es
w
ho
w
or
k
on
pr
od
uc
tio
n
sit
es
.
Th
ey
ar
e
tra
in
ed
in
co
m
pli
an
ce
wit
h
sa
fet
y
rul
es
an
d
ob
se
rv
e
a
sa
fet
y
mi
nu
te
ev
er
y
da
y
in
or
de
r
to
pr
ev
en
t
an
d
av
oi
d
ac
ci
de
nt
s.
17
PRESENTATION
OF THE GROUP
Operations
1.6.7.
ENVIRONMENTAL
PRODUCTION
Throughout the whole of the production chain,
innovative measures with regard to Sustainable
Development are implemented all over the world, from
projects with regard to efficient everyday use of
resources to breakthrough projects. Many initiatives
that are most suited to the local ecosystem are being
introduced at the Groups sites (geothermal energy in
Vichy, photovoltaic panels in Mexico, biomethanation
in Belgium, phytorestoration in Mourenx (France), and
so on).
PROTECTION
AT
THE
HEART
OF
All these initiatives respond to the three goals that the

Group has set itself for the 2005-2015 period for its
factories
and
distribution
centres:
reducing
greenhouse gas emissions by 50%, reducing waste
generated per finished good by 50% and reducing
water consumption per finished good by 50% (see
section 6.2. on pages 200 et seq.).
Furthermore, the environmental impacts related to
packaging, transport and buildings are also taken into
consideration.
42 industrial sites worldwide

EUROPE
NORTH AMERICA
LATIN AMERICA
AFRICA, MIDDLE EAST
ASIA, PACIFIC
Active Cosmetics:
2 factories
Professional Products:
3 factories
L'Oral Luxury :
5 factories
Consumer Products:
24 factories
Raw Materials:
3 factories
Devices:
1 factory
Dermatology:
4 factories
18

Operations
Producing
and
consuming
locally
particularly in the New Markets, accounts for th

geographical breakdown of this Divisions facto
in order to support the conquest of another billi
in the emerging markets, the Group started up

R
us
si
a
in
20
10
.
In
20
12
,
tw
o
ne
w
fa
ct
ori
es
op
en
ed
in
In
do
ne
si
a
an
d
M
ex
ic
o.
In
20
13
, a
ne
w
pl
an
t
wil
l
be
op
en
ed
in
Eg
yp
t.
The
Groups
factories
are
spread out all
over the world in
order to fulfil a
very
simple
objective:
to
reduce as far as
possible
the
distance
between
consumers and
the
production
zones.
The
Groups
42
factories
are
located in areas
enabling a rapid
supply of all the
countries
in
which the Group
is present. The
strong growth of
products in the
Consumer
Products
Division,
Cosmetics investments
(production and supply chain commitments,
millions)
326
235
331
Comparable an
purchasing price
(index base 100: year N-1

95.4
99.
2010
2011
2012
2010
Cosmetics branch production and

sales by geographic zone in 2012
PRODUCT
ION
New Markets
32.6%
Western Europe
45.0%
North America
22.4%
SALES
New Markets
39.4%
Western Europe
35.6%
North America
25.0%
19
201
PRESENTATION
Investment policyOF THE GROUP

LOrals investment policy
responds to long-term
objectives.
LOral is an industrial
company whose
development is governed
by two types of investment
in particular:
1.
2.
scientific investments
and investments in
equipment which are
explained at length in
several sections of
this document (see,
in particular, section
1.5. on pages 14 et
seq. and section 1.6.
on pages 16 et seq.);
marketing
investments
which
are made on an
ongoing basis and
are inherent to the
Groups
activities,
particularly in the
cosmetics
industry.
Indeed, in order to
win
new
market
share,
thorough
research has to be
conducted all over
the
world,
and
advertising
and
promotional
expenses need to be
modulated depending
on the familiarity of
the brands and their
competitive position;
finally, investments in
point-of sale (POS)
advertising materials
ensure
optimal
presence
for
our
brands in points of
sale.
For reasons relating to

strategy and competition,
LOral cannot therefore
provide any systematic
information
on
future
investments.
1.8. Risk
factors
In 2012, the Groups

investments amounted to
955 million euros; i.e.
4.3% of its sales, a very
similar percentage to the
levels before the financial
crisis.
This
evolution
reflects
the
constant
efforts made by the
Group, in particular in the
fields of improvement of
industrial efficiency, the
performance of research
teams and enhancement
of the value of brands.
The 955 million euros that
were invested in 2012 can
be broken down as
follows:
production
and
physical
distribution
represent
approximately 34% of
total investments;
marketing investments,
including moulds, POS
advertising materials
and stores account for
41%;
the
remainder
concerns
Research
and the head offices in
different countries;
IT investments spread
over
all
these
categories represented
15%
of
total
investments
(See note 12 on page

122, note 14 on page 125
and note 26 on page 145
of the chapter on the
Consolidated
Financial
Statements).
The Group operates in a

changing
environment.
Like any company, it is
necessarily exposed to
risks which, if they were to
materialise, could have a
negative impact on its
business activities, its

financial situation and its
assets.This
chapter
presents the main risks to
which the Group considers
that it is exposed: those
specific to the business
activities of LOral, then
the legal, industrial and
environmental risks, and
finally the risks of an
economic and financial
nature.
Faced with these risks,
LOral has set up an
Internal Control system to
prevent and control them
better.
The
Internal
Control
and
risk
management procedures
are thus described in
section 2.5., as provided
for by Article L. 225.37 of
the French Commercial
Code (cf. pages 66 et
seq.).
However, it is not possible
to guarantee total absence
of risk. Furthermore, other
risks of which the Group is
not currently aware or
which it does not consider
as material at the date of
this report could have a
negative effect.
20
Risks which the Group

considers it is exposed to:
1.8.1. Business risks

1.8.2. Legal risks
1.8.3. Industrial and environmental risks
1.8.4. Counterparty risk
1.8.5. Customer risk
1.8.6. Liquidity risk
1.8.7. Financial and market risks
1.8.1. BU
SINESS
RISKS
1.8.1.1. Image
and reputation
The Companys reputation
and its brand image may
be compromised at any
time in a globalised world
where
information
is
disseminated rapidly. No
company is safe from an
undesirable event whether
this involves the use or
misuse of a product or
reprehensible
individual
conduct. The circulation in
the media of detrimental
information,
whether
founded or not, which has
been facilitated by the
introduction
of
new
technologies
and
development of the social
networks, could also affect
the Companys reputation
and its brand image.
page 20
page 23
page 24
page 25
page 25
page 25
page 25

Risk factors
In order to reduce
the risks that may
arise from events
of
this
kind,
LOral has set up
a
crisis
management
procedure, whose
global task is to
prevent, manage
and
limit
the
consequences of
undesirable
events on the
Company.
The
Group
crisis
management
officer
reports
directly to the
Chief
Executive
Officer.
Furthermore, the
deployment of the
Code of Business
Ethics throughout
the whole Group
aims at reinforcing
the spreading of
the rules of good
conduct
which
ensure LOrals
integrity
and
strengthen
its
ethics.The
purpose of these
rules of good
conduct
is
to
guide actions and
behaviour, inspire
choices and make
sure
that
the
Groups
values
are reflected in
the everyday acts
of each employee.
In
addition,
LOral
has
implemented
a
charter of good
practices for use
of social media by
its employees.
1.8.1.4.
Seasonal
nature of the
business
The pace of sales may, in certain cases, and fo

be linked to climate conditions, such as for exa
products. The products and brands sought afte
as gifts are reliant on a strong concentration of

en
d
an
d
du
rin
g
ho
lid
ay
pe
rio
ds
.
Th
is
is
th
e
ca
se
in
pa
rti
cu
lar
for
fra
gr
an
ce
s
an
d
Th
e
Bo
dy
Sh
op
pr
od
uc
ts.
An
y
m
aj
or
di
sr
up
tio
n
in
eit
he
r
of
th
es
e
f
a
c
t
o
r
s
c
o
u
l
d
a
f
f
e
c
t
L
O
r
a
l
s
s
a
l
e
s
.
L
O
r
a
l
e
n
d
e
a
v
o
u
r
s
t
o
m
i
t
i
g
a
t
e
t
h
es
e
ris
ks
thr
ou
gh
th
e
di
ve
rsi
ty
an
d
en
ric
h
m
en
t
of
its
pr
od
uc
t
off
eri
ng
s
an
d
by
arr
an
gi
ng
pr
od
uc
t
la
un
ch
es
an
d
sp
ec
ial
pr
od
uc
t
pr
o
m
oti
on
al
ev
en
ts
thr
ou
gh
ou
t
th
e
en
tir
e
ye
ar.
1.8.1.2.
Product
quality and
safety
Consumer safety is
an absolute priority
for
LOral.The
International Safety
Assessment
Department
specifically evaluates
the safety of raw
materials
and
finished products. It
establishes
the
toxicological profile of
the ingredients which
are used and the
tolerance
of
the
formulas before they
are launched on the
market.
LOral goes one

step further in the
safety evaluation by
monitoring
the
potential
adverse
effects that may
arise when the
product
is
marketed.This
makes it possible to
take the appropriate
corrective
measures,
where
necessary.
Faced with the
questions that civil
society may ask
regarding
certain
substances
and
their effects on
health
and
the
environment,
LOrals
position
may be summed up
in three points:
vigilance
with
regard to any
new
scientific
data;
cooperation with
the
relevant
authorities;
precautions
leading
to
substitution
of
ingredients
in
the event of a
proven risk or a
strongly
suspected risk.
1.8.1.3 R
espo
nsibl
e
Com
muni
catio
n
LOral
provides
consumers
with
innovative products,
and the success of
these products is
based
on
their
quality
and
performance. The
resulting
benefits
are highlighted in
our
communications. In
spite of all the care
we
take
to
guarantee
the
accuracy
and
fairness
of
the
claims made in
these
communications,
there is always a
possibility that they
may be challenged
by the authorities,
organisations
or
consumers.
In order to reduce
the
risk
of
challenges of this
kind being made,
the
International
Product
Communication
Evaluation
Department makes
sure
of
the
conformity
of
product
communications
before they are put
on the market.The
Groups Code of
Business
Ethics
sets
out
the
fundamental
principles
of
responsible
communication and
LOral has made a
commitment
to
implement
the
Cosmetics Europe
Charter
on
responsible
advertising
and
marketing
communication, to
which the key global
cosmetics industry
players in Europe
adhere.
1.8.1.5.
Geo
g
r
a
p
h
i
c
p
r
e
s
e
n
c
e
a
n
d
e
c
o
n
o
m
i
c
a
n
d
p
o
li
ti
c
a
LOral
has
subsidiaries in 69
countries, with 64%
of its sales being
generated outside
Western
Europe.
Global growth in the
cosmetics markets
has led LOral to
develop its activities
in countries of the
New
Markets
Zone,
which
represent over 39%
of its cosmetic sales
in
2012.
The
breakdown
and
changes in LOrals
sales are given in
paragraph 1.4.4. on
pages 11 et seq.
Besides the
currency risks
mentioned in
chapter 4 in note
24.1.
Hedging
of
currency risk on
pages 140 to 142
and in paragraph
1.8.7.2. on page
26,
political
or
economic
disturbances
in
countries where the
Group generates a
significant portion
of its sales could
have an impact on
its
business
activities.
However, its global
presence helps to
maintain a balance
in
sales
and
enables results to
be offset between
countries
and
geographic regions.
In periods of major
economic
slowdown or in
sovereign
debt
crisis situations in
certain
countries,
growth
in
the
Groups sales may
however
be
affected.
l
e
n
v
i
r
o
n
m
e
n
t
1.8.1.6.
Distribution
network
To sell its products,
LOral
uses
independent
distribution
channels, except for
a limited number of
stores which are
owned
by
the
Company.
The
concentration
or
disappearance
of
distribution chains
and changes in the
regulations
with
regard to selective
distribution
could
have an impact on
the development of
the Groups brands
in the country or
countries
concerned.
The presence of the
Groups brands in
all
types
of
distribution
networks helps to
attenuate
any
potential negative
effect.
1.8.1.7.
Competition
Due to its size and
the positioning of its
brands, LOral is
subject to constant
pressure from local
and
international
competitors in all
countries.
21
PRESENTATION
OF THE GROUP
Risk factors
This competition is healthy; it leads our teams, all over the world,
to always do their best to serve the interests of consumers and
the Groups brands. In the context of a constant struggle to
obtain the best positions and launch the most attractive and
most effective product ranges, with an optimal price/quality
ratio, winning market share, improving operating profitability and
thereby ensuring growth are a permanent challenge.
The day-to-day management of activities which notably include

purchasing, production and distribution, invoicing, reporting and
consolidation operations as well as exchanges of internal data
and access to internal information relies on the proper functioning
of all the technical infrastructures and IT applications. The risk of
a malfunction or breakdown in these systems for exogenous or
endogenous reasons (including intrusions, malicious acts, etc.)
1.8.1.8 Innovation and consumer expectations
cannot be precluded.
The development of innovative products and their adaptation

to market requirements is an ongoing priority for the Group. If
the Group fails to anticipate or interpret changes in consumer
behaviour and new trends, its sales could be affected.
In order to minimise the impact that this type of occurrence could

have, the Information Systems Department has introduced strict
rules with regard to data back-ups, protection and access to
confidential data and security with regard to both computer
hardware and software applications. In order to adapt to
the evolution of new communication methods, LOral has
introduced an Information and Communication Technologies
Charter. These measures are described in paragraph 2.5.2.4. on
page 68 (Control activities The measures recommended by
the Group).
The Consumer & Market Insights Department, which is part of the

Innovation Division, constantly watches for changes in consumers
cosmetic expectations by product category and major regions of
the world. This work enables the Groups researchers to develop
new products that are in line with market needs as mentioned in
1.5.6. Research in tune with the market on page 15.
1.8.1.9. External growth transactions

Within the scope of its development strategy, LOral has made,
and may have occasion to make acquisitions or sign licence
agreements.
Implementation of this strategy nevertheless requires that LOral is
able to find development opportunities at an acceptable cost and
under acceptable conditions.
The Group has introduced a process for the upstream oversight of
these transactions which includes:
the setting-up of multidisciplinary teams for the preparation of

projects and due diligence work; and
a review by the Strategy and Sustainable Development

Committee of the Board of Directors, then by the Board of
Directors, of the opportunities for acquisitions or for equity
investment for a significant amount or falling outside the scope
of the Groups usual business activities, and the conditions for
their implementation.
These operations may have a negative impact on the Groups

results if the Group does not succeed in integrating the activities of
the companies that have been purchased, their personnel, their
products and their technologies under the anticipated conditions, in
achieving the expected synergies and in handling liabilities which
have not been anticipated at the time of completion of the
transaction and for which LOral has little or no protection from the
seller.
Acquisitions that have been decided by the Board of Directors are
regularly monitored by the Board of Directors which is informed of
the conditions of integration and the performances achieved.
22
1.8.1.10. Information systems
1.8.1.11.Risks related to Human

Resources management
One of the keys to the success of LOral lies in the talent of its staff.
Should LOral not succeed in identifying, attracting, keeping and
training competent employees who behave responsibly, the
development of its activities and its results could be affected.
The Group therefore develops a motivating, engaging professional
environment, and encourages the attachment to its values, including
those put forward by the Code of Business Ethics. LOrals Human
Resources policy is moreover described in paragraph 2.5.2.1. The
Internal Control organisation and environment on pages 66 et seq. and
in paragraph 6.1.1. The LOral Groups Human Resources policy on
page 187.
1.8.1.12. Risk of an Internal Control failure

LOral has set up an Internal Control system which, even though it
is adequate, can only provide a reasonable assurance and not an
absolute guarantee of achievement of the Companys objectives
due to the inherent limitations of any control.Thus, the Group
cannot rule out the risk of an Internal Control failure that may
expose it to an act of fraud in particular.
Deployment to all the Management Committees of the Groups
subsidiaries of a programme to raise awareness of the risk of fraud
(presenting the main operational scenarios that could be
envisaged, the alert systems and the existing procedures and
controls) is intended to reduce the Groups exposure to this risk. In
addition, the Group is preparing a corruption prevention guide
which will complete the commitments and principles set out in
LOrals Code of Business Ethics and which are described in
paragraph 6.3.4. Ethical practices, pages 211 et seq.

Risk factors
1.8.2.
LEGA
L
RI
S
K
S
1.8.2.1.
Intel
l
e
c
t
u
a
l
p
r
o
p
e
r
t
y
:
t
r
a
d
e
m
a
r
k
s
a
n
d
m
o
d
e
l
LOral is the owner of

the major intangible
assets on behalf of the
Groups companies, to
which it grants licences
in exchange for the
payment of royalties.
Thus, LOral is the
owner of most of its
brands, which are a
strategic asset for the
Group, in particular the
major
international
brands described in
paragraph
1.3.2.2.
Branches
and
Divisions on page 8,
with the exception of a
few brands for which
LOral has obtained a
license and most of
which are currently
used
by
LOral
Luxury, primarily the
Giorgio Armani, Yves
Saint Laurent, Ralph
Lauren,
Cacharel,
Viktor & Rolf and
Diesel brands.
The trademark name,
the
products
themselves and the
models
may
be
infringed
or
counterfeited
by
economic
players
wishing to illegally and
illegitimately claim the
benefits
of
their
reputation.
Special care is given to
the protection of the
trademarks and models
belonging to LOral,
and is entrusted to a
special section of the
Groups
Legal
Department, which has
responsibility
for
registering trademarks
in all countries.This
department also keeps
a close watch on the
market and launches
the necessary action
against infringers and
counterfeiters.
The LOral Group is

also an active member
of the organisations
who
have
set
themselves the task of
combating
counterfeiting
and
promoting
good
commercial practice.
This is the case, in
particular,
of
the
French
Manufacturers
association
(namely Union
des Fabricants),
the International
Chamber
of
Commerce and
Business
Europe.
Before
any
trademark and
model
registration, prior
rights searches
are conducted.
In light of the
large number of
countries
in
which
the
products
are
sold and the
multiple potential
prior rights that
may exist in
each of these
countries,
we
cannot rule out
the
possibility
that third parties
may claim prior
rights
with
regard to certain
LOral
trademarks and
models.
This
is
a
potential
risk
which has to be
cited in order to
be
exhaustive
even though the
likelihood of its
occurrence
is
low due to the
care taken when
conducting prior
rights searches.
1.8.2.2.
Industrial
property:
patents
Research
and
innovation
are
the
historic
pillars
of
LOrals
development.
The dedication
of
LOrals
research teams
has made it one
of the leading
industrial patent
filers in its field
for many years.
In order to protect
the Group against
the risk of another
company claiming
one of its molecules, a

production process or
packaging, LOral has
set
up
a
specific
structure,
the
International
Industrial
Property Department as
part of the Research and
Innovation Division; this
department
is
responsible for filing the
Groups
patents,
exploiting them and
defending them on a
worldwide
basis.
However, it cannot be
excluded
that
third
parties could contest the
validity of certain patents
held by the Group.
is
re
pr
es
en
1.8.2.3.
te
d,
Changes in
L
the
Or
regulations
a
LOral is subject to the llaws which apply to all companies and
pl beyond reproach. LOral asks its
strives to adopt an attitude
ay the regulations of the countries
subsidiaries to comply with
s
in which the Company operates. Being an active member of
an
p
ac
r
tiv
o
e
f
rol
e
e
s
in
s
th
i
e
o
on
n
go
a
in
l
g
di
a
al
s
og
s
ue
o
wit
c
h
i
th
a
e
t
na
i
tio
o
na
n
l
s
or
re
gi
i
on
n
al
au
t
th
h
ori
e
tie
s
in
c
ch
o
ar
u
ge
n
of
t
th
r
e
i
sp
e
ec
s
ific
re
w
gu
h
lat
e
io
r
ns
e
go
ve
i
rni
t
ng
s
th
e
pr
i
od
n
uc
d
ts
u
in
s
its
t
in
r
du
y
s
t
r
i
a
l
s
e
c
t
o
r
i
n
o
r
d
e
r
t
o
p
r
e
v
e
n
t
o
r
a
c
c
o
m
p
a
n
y
a
n
y
r
i
s
k
s
t
h
a
t
m
a
y
r
e
s
u
l
t
fro
m
ch
an
ge
s
in
re
gu
lat
io
ns
.
Th
e
Eu
ro
pe
an
R
EA
C
H
re
gul
ati
on
s
(R
egi
str
ati
on
,
Ev
alu
ati
on
an
d
Au
th
ori
sat
ion
of
Ch
e
mi
cal
s)
th
at
ca
m
e
int
o
for
ce
in
Ju
ne
20
07
ar
e
ai
m
ed
at
inc
re
asi
ng
hu
m
a
n
a
n
d
e
n
v
i
r
o
n
m
e
n
t
a
l
s
a
f
e
t
y
o
f
c
h
e
m
i
c
a
l
s
b
y
r
e
q
u
i
r
i
n
g
a
l
l
u
s
e
r
c
o
m
p
a
n
i
e
s
to
pr
ov
e
th
at
th
ey
ha
ve
im
ple
m
en
te
d
ap
pr
op
ria
te
ris
k
m
an
ag
e
m
en
t
m
ea
su
re
s.
L
Or
al
pla
ys
an
act
ive
rol
e
in
thi
s
pr
oc
es
s
for
th
e
su
bst
an
ce
s
m
an
uf
act
ur
ed
or
im
po
rte
d
by
its
Eu
ro
pe
an
leg
a
l
e
n
t
i
t
i
e
s
c
o
n
c
e
r
n
e
d
.
W
i
t
h
i
n
t
h
e
f
r
a
m
e
w
o
r
k
o
f
n
a
t
i
o
n
a
l
a
n
d
E
u
r
o
p
e
a
n
a
s
s
o
c
iati
on
s,
L
Or
al
co
ntr
ibu
tes
to
th
e
an
aly
sis
an
d
dr
afti
ng
of
pr
act
ica
l
gui
de
s
for
im
ple
m
en
tati
on
of
th
es
e
re
gul
ati
on
s.
L
Or
al
is
als
o
su
bje
ct
in
Eu
ro
pe
to
th
e
7th
a
m
en
d
m
en
t
to
th
e
Eu
ro
pe
an
Co
s
m
e
t
i
c
s
D
i
r
e
c
t
i
v
e
o
n
a
n
i
m
a
l
t
e
s
t
i
n
g
o
f
c
o
s
m
e
t
i
c
i
n
g
r
e
d
i
e
n
t
s
.
A
n
a
c
t
i
o
n
p
l
a
n
ha
s
be
en
dr
aw
n
up
at
L
Or
al
in
or
de
r
to
im
pr
ov
e
th
e
co
nc
ep
tio
n
an
d
th
e
m
et
ho
ds
of
ev
alu
ati
on
of
th
e
saf
ety
of
ra
w
m
at
eri
als
.T
his
pla
n
is
su
bje
ct
to
an
ac
cel
er
at
ed
im
ple
m
en
tati
on
in
or
de
r
t
o
p
r
e
p
a
r
e
i
n
t
h
e
b
e
s
t
w
a
y
p
o
s
s
i
b
l
e
f
o
r
t
h
e
a
p
p
l
i
c
a
t
i
o
n
o
f
t
h
e
s
e
r
e
g
u
l
a
tio
ns
wh
ich
is
sc
he
dul
ed
for
20
13
.
Wi
th
re
ga
rd
to
tes
ts
on
fini
sh
ed
pr
od
uct
s,
L
Or
al
pu
t
an
en
d
to
ani
m
al
tes
tin
g
in
19
89
th
an
ks
to
th
e
us
e
of
alt
er
na
tiv
e/
pr
edi
cti
ve
m
et
ho
ds
as
de
scr
ibe
d
in
pa
ra
gr
a
p
h
1
.
5
.
4
.
A
p
e
r
m
a
n
e
n
t
c
o
m
m
i
t
m
e
n
t
t
o
p
r
e
d
i
c
t
i
n
g
t
h
e
h
a
r
m
l
e
s
s
n
e
s
s
a
n
d
e
f
f
i
c
ac
y
of
pr
od
uc
ts
on
pa
ge
14
.
1.8.2.4. Other
legal risks and
litigation
In
th
e
or
di
na
ry
co
ur
se
of
its
bu
si
ne
ss
,
th
e
Gr
ou
p
is
in
vo
lv
ed
in
le
ga
l
ac
tio
ns
an
d
is
su
bj
ec
t
to
ta
x
as
se
ss
m
en
ts,
cu
st
o
m
s
co
ntr
ol
s
a
n
d
a
d
m
i
n
i
s
t
r
a
t
i
v
e
a
u
d
i
t
s
.
I
t
i
s
a
l
s
o
t
h
e
s
u
b
j
e
c
t
o
f
p
r
o
c
e
e
d
i
n
g
s
i
n
i
t
i
a
t
e
d
by
na
tio
na
l
co
m
pe
titi
on
au
th
ori
tie
s,
in
pa
rti
cu
lar
in
Eu
ro
pe
an
co
un
tri
es
(s
ee
no
te
22
Pr
ov
isi
on
s
fo
r
lia
bil
iti
es
an
d
ch
ar
ge
s
on
pa
ge
13
7
in
ch
ap
ter
4).
In
or
de
r
to
be
tte
r
pr
ev
en
t
thi
s
r
i
s
k
,
t
h
e
G
r
o
u
p
s
L
e
g
a
l
D
e
p
a
r
t
m
e
n
t
h
a
s
i
n
t
r
o
d
u
c
e
d
a
t
r
a
i
n
i
n
g
s
e
s
s
i
o
n
o
n
c
o
m
pe
titi
on
la
w
for
th
e
e
m
pl
oy
ee
s
co
nc
er
ne
d.
In
20
11
, it
al
so
di
str
ib
ut
ed
an
et
hi
ca
l
an
d
le
ga
l
gu
id
e
on
th
e
co
nd
iti
on
s
of
fai
r
co
m
pe
titi
on
,
ca
lle
d
T
he
w
ay
w
e
co
m
pe
te
.
A
p
r
o
v
i
s
i
o
n
i
s
s
e
t
a
s
i
d
e
i
n
t
h
e
p
a
r
e
n
t
c
o
m
p
a
n
y
a
n
d
c
o
n
s
o
l
i
d
a
t
e
d
f
i
n
a
n
c
i
a
l
st
at
e
m
en
ts
w
he
ne
ve
r
th
e
Gr
ou
p
ha
s
an
ob
lig
ati
on
to
w
ar
ds
an
ot
he
r
pa
rty
an
d
wil
l
ha
ve
to
fa
ce
a
pr
ob
ab
le
ou
tfl
o
w
of
ec
on
o
mi
c
re
so
ur
ce
s
w
ho
se
co
st
ca
n
be
rel
ia
bl
y
es
ti
m
a
t
e
d
.
W
e
c
o
n
s
i
d
e
r
t
h
a
t
t
h
e
r
e
i
s
c
u
r
r
e
n
t
l
y
n
o
e
x
c
e
p
t
i
o
n
a
l
e
v
e
n
t
n
o
r
a
n
y
g
o
ve
rn
m
en
tal
pr
oc
ed
ur
e,
le
ga
l
or
ar
bit
rat
io
n
pr
oc
ee
di
ng
w
hi
ch
ha
s
re
ce
ntl
y
m
at
eri
all
y
aff
ec
te
d,
or
is
se
rio
us
ly
lik
el
y
to
m
at
eri
all
y
aff
ec
t,
th
e
fin
an
ci
al
sit
ua
tio
n,
as
se
ts
or
op
er
ati
o
n
s
o
f
t
h
e
C
o
m
pa
ny
an
d
th
e
L
Or
a
l
Gr
ou
p.
23
PRESENTATION
OF THE GROUP
Risk factors
1.8.3.
INDUSTRIAL AND
ENVIRONMENTAL RISKS
In order to improve the efficiency and productivity of its industrial

processes, LOral carries out most of its production in 42 factories,
each specialising in a specific type of technology.
1.8.3.1. Production and supply Chain

Products must be made available on the market on the scheduled
dates to meet time to market and customer demand, in order
to enable new product ranges to be referenced by distribution
in a cosmetics market that requires companies to be more and
more responsive.
Therefore, a major stoppage of activity in a factory or a distribution
centre could have an adverse effect on the achievement of
commercial objectives.
In order to prevent this risk, business continuity plans exist for each
operational site.They aim at anticipating the unavailability of part
of the Group supply chain as far as possible and at restarting
activities as quickly as possible.
1.8.3.2. Supplier dependence

LOral is dependent on its external suppliers for the delivery of
materials (raw materials and packaging items) that are essential
for the manufacture of finished products, which may therefore
suffer disruption as the result of a default by an important supplier.
In order to prevent these risks, LOral has prepared business
continuity plans for production which aim notably at looking for
replacement solutions (for example: supplier back-up, availability
of several moulds for strategic products).
1.8.3.3. Environment and safety

The cosmetics industry has a limited environmental risk profile.
However, as is the case for any production, distribution, research
and general administration operation, LOral is exposed to safety
and environmental issues (relating, for example to the use of
certain raw materials, the use of machines or electrical equipment
in production or storage areas, handling operations liable to cause
accidents involving bodily injury, waste water treatment etc.). The
main risk faced in the Groups industrial sites is fire due to the
inflammable materials used in products (alcohol, propellant gases,
powders, oxidants and solvents) and the storage of combustible
products and chemicals.
To ensure that the Group complies with its commitment to protect
the environment and improve occupational health and industrial
safety conditions, and to achieve concrete targets, a rigorous
Environment, Health and Safety (EHS) policy has been
implemented throughout the Group for many years. It was updated
in 2010 as described in paragraph 6.2. Environmental Information
on pages 200 et seq.
24
The Operations Division issues Internal Rules providing for

the principles of LOrals EHS policy. An EHS representative is
appointed at each site. Training programmes are systematically
organised. EHS performance indicators are collected monthly
from all production sites, all distribution centres and all research
centres.The collection is carried out on a quarterly basis for most
of the administrative sites.
The fire risk is dealt with in the framework of very strict fire prevention
standards (National Fire Protection Association standards).
LOral Group operates 116 manufacturing sites, of which two are
classified as Seveso high threshold and are therefore subject to
strict regulations through the European Union Seveso Directive
on the prevention of major accident hazards due to the storage
of chemicals or inflammable products.
1.8.3.4. EHS risk map and audits

Within the scope of this EHS policy, for the industrial sites, the SHAP
(Safety Hazard Assessment Procedure) is a hazard prevention
programme based on the assessment of risks by employees at
grassroots level under the responsibility of the Site Manager.This
programme contributes to identifying the dangers overall and
for each workstation and assessing the corresponding risks.The
SHAP method thus makes it possible to prepare a risk mapping
for the sites, to evaluate the level of risks and to put in place
the necessary means of control. It is supported by dialogue
between persons in charge, thus contributing to a significant
collective improvement in risk management. This approach is
constantly evolving and is updated regularly depending on
changes at sites and experience on the ground. EHS audits
are conducted every three or four years in each factory and
distribution centre. The site risk map is reviewed within the
scope of this audit. In 2012, an EHS risk audit was carried out at
11 factories and 14 distribution centres.
1.8.3.5. Constant concern for

the safety of employees
Preservation of employee health and safety is one of LOrals
priorities and is an integral part of the EHS policy and the Groups
human and social policy. It rests on the evaluation and prevention
of professional risks in the Company as described in detail in
paragraph 6.1.2.4. Health and Safety on page 195. Nevertheless,
the risk of accidents at the workplace or occupational diseases
cannot be entirely ruled out.
The Group implements the necessary means to ensure that it is in
compliance with the legal provisions and the regulations relating to
health and safety in the various countries where it operates. The
Group is also vigilant about the general safety of its employees in
the countries where they work.
An International business travel assistance programme provides
our employees with health and safety information on the countries
they are visiting.
RISK
1.8.3.6.
Natural
disasters
The
Groups
presence
at
more than 300
sites (excluding
our own shops
and the sales
outlets of our
distributor
customers)
throughout the
world exposes it
to risks with
regard to natural
disasters,
climate
uncertainties or
earthquakes,
which
could
have a negative
impact on its
activities.
In 2010, the Real
Estate
Department
classified
countries
according
to
their seismic risk
and launched a
campaign
to
assess
the
vulnerability of
the
most
exposed sites. At
the same time,
the Information
Systems
Department
initiated
a
procedure
to
ensure that the
seismic risk is
taken
into
consideration in
the IT continuity
plans of the most
exposed
countries.
1.8.4.
COU
N
T
E
R
P
A
R
T
Y
The Group enters into

financial relations in
priority
with
international
banks
and
insurance
companies given the
best ratings by the
three main specialised
rating agencies.
When
the
Group
makes
financial
investments, in the
form of either bank
deposits or marketable
securities (see note 19
Cash
and
cash
equivalents on page
127 in chapter 4), it
gives priority to shortterm
transferable
instruments from firstrate
financial
institutions.
The Group therefore
considers
that
its
exposure
to
the
counterparty risk is
weak (see note 24.4.
Counterparty risk on
page 143 in chapter 4).
Risk factors
ns
T
h
e
L
O
r
a
l
G
r
o
u
p
s
l
i
q
u
i
d
i
t
y
r
i
s
k
i
s
m
a
n
a
g
e
d
w
i
t
h
t
h
e
p
r
i
m
a
r
y
a
i
m
o
f
uri
ng
co
nti
nu
ed
fin
an
ci
ng
an
d
op
ti
mi
si
ng
th
e
fin
an
ci
al
co
st
of
de
bt.
To this effect, the Group has unused confirmed
several first-rate banks totalling 2,550 million.

th
an
1
ye
ar
for
2
50
mi
lli
on
an
d
ra
ng
in
g
fro
m
1
to
4
ye
ar
s
for
2
,3
00
mi
lli
on
(s
ee
no
te
23
.9.
C
on
fir
m
ed
Cr
ed
it
l
i
n
e
s
o
n
p
a
g
e
1
4
0
i
n
c
h
a
p
t
e
r
4
)
.
T
h
e
s
e
c
r
e
d
i
t
l
i
n
e
s
a
r
e
n
o
t
s
u
b
j
e
c
t
t
o
a
n
y
co
nd
iti
on
ali
ty
cl
au
se
ba
se
d
on
fin
an
ci
al
cri
ter
ia.
Fu
rth
er
m
or
e,
th
e
Gr
ou
p
us
es
th
e
fin
an
ci
al
m
ar
ke
ts,
on
a
ve
ry
re
gu
lar
ba
si
s,
to
m
ee
t
liq
ui
dit
y
ne
ed
s
thr
ou
gh
th
e
us
e
of
sh
ort
ter
m
p
a
p
e
r
s
i
n
F
r
a
n
c
e
a
n
d
s
h
o
r
t
t
e
r
m
c
o
m
m
e
r
c
i
a
l
p
a
p
e
r
i
n
t
h
e
U
n
i
t
e
d
S
t
a
t
e
s
.
N
on
e
of
th
es
e
de
bt
s
co
nt
ai
ns
an
ea
rly
re
pa
y
m
en
t
cl
au
se
lin
ke
d
to
co
m
pli
an
ce
wi
th
fin
an
ci
al
rat
io
s
(c
ov
en
an
ts)
(s
ee
no
te
s
23
.1.
D
eb
t
by
ty
pe
an
d
23
.2.
D
eb
t
by
m
at
uri
ty
da
te
o
n
p
a
g
e
1
3
9
a
n
d
n
o
t
e
2
4
.
5
.
L
i
q
u
i
d
i
t
y
r
i
s
k
o
n
p
a
g
e
1
4
3
i
n
c
h
a
p
t
e
r
4
)
.
T
h
e
L
Or
a
l
Gr
ou
p
be
ne
fit
s
fro
m
th
e
fol
lo
wi
ng
sh
ort
ter
m
cr
ed
it
rat
in
gs
:
A-1+, awarded in
June 2012 by
Standard & Poors;
Prime 1, awarded in
June 2012 by Moodys;
and
F1+, awarded in
June 2012 by
FitchRatings.
Th
es
e
rat
in
gs
ar
e
un
ch
an
ge
d
co
m
pa
re
d
to
th
os
e
as
si
gn
ed
in
20
11
.
1.8.5. C
UST
OM
ER
RIS
K
The customer risk
may result from
non-collection
of
receivables due to
cash
problems
encountered
by
customers or due to
the disappearance
of customers.
However, this risk is
limited by Group
policy which is to
take out customer
insurance
cover
inasmuch as this is
permitted by local
conditions.The risk
associated
with
credit insurance is
mentioned below in
paragraph
1.8.8.
Insurance on page
27.
Furthermore, due to
the large number and
variety of distribution
channels
at
worldwide level, the
likelihood
of
occurrence
of
significant
damage
on the scale of the
Group
remains
limited.
The
10
largest
customers/distributor
s represent around
19% of the Groups
sales. The amount
considered as posing
a
risk
of
noncollection for which a
provision for liability
is therefore booked is
set out in note 17
Trade
accounts
receivable on page
127 in chapter 4. It
does not exceed 2%
of gross accounts
receivable.
1.8.6. L
IQUI
DIT
Y
RIS
K
The
Groups
Financial Services
Department
centralises all the
subsidiaries
financing
needs
and
also
negotiations
with
financial institutions
in order to have
better
command
over
financing
conditions.
Any
transactions
that
may be carried out
directly
by
subsidiaries
are
closely supervised.
1.8.7. F
INA
NCI
AL
AND
MA
RKE
T
RIS
KS
Financial
risks
include interest rate
risk, currency risk,
the risk relating to
the impairment of
intangible
assets,
equity risk, risks
with regard to the
assets
hedging
employee
commitments, the
risk
relating
to
changes
in
tax
regulations and the
core
commodity
risk.
1.8.7.1.
Interest rate
risk
For the requirements
of its development
and
its
capital
expenditure
policy,
LOral
uses
borrowings
and
short-term
papers.The
Group
mainly refinances at
floating rates, as
mentioned
23.4.
in
note
Breakdown of fixed
rate and floating
rate debt on page
140 in chapter 4.
Other details with
regard to debt and
interest rates are
also provided in
notes
23.5.
Effective
interest
rates,
23.6.
Average
debt
interest rates and
23.7. Fair value of
borrowings
and
debts on page 140
in chapter 4.
None
of
these
debts contains an
early
repayment
clause linked to
compliance
with
financial
ratios
(covenants).
In order to limit the
negative impact of
interest
rate
variations,
the
Group has a nonspeculative interest
rate management
policy
using
derivatives,
as
described in notes
24.2. Hedging of
interest rate risk
and
24.3.
Sensitivity
to
changes in interest
rates on pages 142
and 143 in chapter
4.
25
PRESENTATION
OF THE GROUP
Risk factors
1.8.7.2. Currency risk

Due to its international presence, LOral is naturally exposed
to currency variations. The fluctuations between the main
currencies may therefore have an impact on the Groups results,
at the time of translation into Euro of the non-Euro financial
statements of subsidiaries, and may therefore make it difficult to
compare performances between two financial years. In addition,
commercial flows involving the purchase and sale of items
and products are carried out between subsidiaries in different
countries. Procurement by subsidiaries is mainly made in the
currency of the suppliers country.
In order to limit currency risk, the Group adopts a conservative
approach of hedging at year-end a significant portion of annual
requirements for the following year through forward purchases or
sales contracts or through options. Requirements are established
for the following year on the basis of the operating budgets of
each subsidiary.These requirements are then reviewed regularly
throughout the year in progress. In order to benefit from better
visibility of the flows generated, currency risk management is
centralised with the Treasury Department at head office (Financial
Services Department) which uses a specific tool for centralising
the subsidiaries requirements by currency (FX report).
The system of foreign exchange risk hedging is presented to the
Audit Committee. The hedging methodology and the values
involved are described in note 24.1. Hedging of currency risk on
pages 140 to 142 in chapter 4.
The breakdown of consolidated sales for 2012 by currency is
specified in section 3.2. Financial Highlights on page 84.
Significant changes in the monetary environment could have
an impact on the Groups results and on its shareholders equity.
The analysis of sensitivity to currency fluctuations and the
impact on equity are set out in detail in note 20.4. Items directly
recognised in equity on page 132 in chapter 4. Finally, the impact
of foreign exchange gains and losses on the income statement
is described in note 6 Foreign exchange gains and losses on
pages 113 and 114 in chapter 4.
1.8.7.3. Risk relating to the impairment

of intangible assets
As stated in paragraph 1.8.2. above relating to legal risks, LOrals
brands are a strategic asset for the Group.
As described in note 1.15 Intangible assets on page 104 in chapter 4,
goodwill and brands with an indefinite life span are not subject to
depreciation but to periodic impairment tests which are carried out at
least once a year. Where the recoverable value of the brand is lower
than its net book value, an impairment loss is recognised. Similarly, any
variance between the recoverable value of each Cash-Generating Unit
and the net book value of the assets including goodwill would lead to an
impairment loss in respect of the asset, recorded in the income
statement. The amounts for the last 3 financial years are provided in
note 7 Other operational income and expenses on page 114 in chapter
4.
26
The data and assumptions used in the impairment tests for

the Cash-Generating Units with significant goodwill and nondepreciable brands are described in note 13 Impairment tests
on intangible assets on page 124 in chapter 4.
1.8.7.4. Equity risk

LOral does not invest its cash in shares. For LOral, the main
equity risk lies in the 8.91% stake that it holds as of December 31st,
2012 in the capital of Sanofi, for an amount described in note 15
Non-current financial assets on page 126 in chapter 4.
If the Sanofi share price were to fall below the initial share price
significantly or on a prolonged basis, this would potentially expose
LOral to impairing its assets through the income statement
as explained in note 24.6. Shareholding risk on page 143 in
chapter 4.
1.8.7.5. Risks with regard to the assets hedging

employee commitments
The assets used as financial hedges for employee commitments
are, by nature, exposed to the fluctuations on the markets on
which such assets are invested.
Pursuant to the provisions of the Charter on the Management
of assets dedicated to the hedging of the Groups employee
commitments, the allocation by category of assets is subject
to limits aimed in particular at reducing volatility risks and
correlation risks between these different categories of assets. A
Supervisory Committee for the pension and benefit schemes
offered by the Groups subsidiaries, ensures that these principles
are implemented and monitored, as described in chapter 6
Benefit and Pension schemes and other benefits on page 191.
However, a large, lasting fall in the financial markets could have
an impact on the value of the portfolios set up (see note 21
Post-employment benefits, termination benefits and other longterm employee benefits on pages 133 et seq. in chapter 4).
Furthermore, the Group adopts a conservative policy for
the choice of insurers and custodians for these assets (see
counterparty risk in paragraph 1.8.4.).
1.8.7.6. Risk relating to the

change in tax regulations
The Group is exposed to risks of an increase in existing taxes, the
introduction of new taxes, or double taxation concerning in
particular corporate income tax, customs duties, and import taxes,
the repatriation of dividends or social levies, which could have an
adverse impact on the Companys results.
1.8.7.7. Core commodity risk

The production of cosmetics depends on the purchase of raw
materials, at fluctuating prices. These raw materials or components
enter into the composition of products or their packaging. The main
core raw materials are polyethylene,
1.8.8.1. The
Groups overall
insurance policy
polypropylene,
aluminium and
vegetable
oils
and their byproducts.
An
exceptionally
large increase in
the
price
of
these
raw
materials
or
energy prices on
the world market
could have a
direct effect on
the
manufacturing
cost
of
the
cosmetics. It is
nevertheless
estimated
that
the impact of this
rise on gross
margin
would
remain limited.
In
order
to
anticipate
the
effect of these
fluctuations and
as a preventive
measure,
LOral
negotiates price
indices with its
main suppliers of
raw
materials
and packaging
items.The Group
therefore does
not use hedging.
Also, in order to
offset
market
volatility, LOral
makes ongoing
efforts
by
carrying
out
purchase actions
and actions to
improve
industrial
productivity.
Furthermore, the
pooling
of
responsibility for
purchases has
made it possible
to
reinforce
these measures.
The objective of the

Groups
policy
on
insurance is to protect
the Groups assets
and property from the
occurrence
of
identified material risks
that could adversely
affect
it.This
risk
transfer
forms
an
integral part of the
Groups
risk
management process.
This policy is applied
at two levels:
at parent company
level, the Group
has
negotiated
worldwide
insurance
programmes
to
cover its main risks
after reviewing the
cover available;
in a local context,
subsidiaries have
to
purchase
insurance cover to
meet their local
regulatory
obligations
and
supplement
the
Groups worldwide
programmes
for
any specific risks.
The financial solvency

of the insurers chosen is
an important criterion in
the Groups insurer
selection process. Each
insurance programme
subscribed by the Group
involves
the
participation of a pool of
insurers. Overall, the
main global insurance
companies are involved
in one or more of these
Group programmes.
1.8.8.2.
Integrated
worldwide
programmes
Third party liability
1.8.8.
INSU
R
A
N
C
E
The Group has had an

integrated
global
programme covering
all its subsidiaries for
several years. This
programme covers the
financial
consequences of the
third party liability of
Group entities.
In particular, it
covers operating
liability, including
sudden
and
accidental
environmental
pollution,
product liability
and
product
recall costs.
Claim
activity
under
this
programme has
historically been
low, which shows
the
extremely
high
quality
requirements
and
safety
standards
applied by the
Group
in
managing
its
operations and
Risk factors
in designing and manufacturing its products. T

safety of consumers and employees is a const
levels of Group operations.
Directors liability
Gr
ou
p
co
m
pa
ni
es
be
ne
fit
fro
m
a
Di
re
ct
or
s
an
d
off
ic
er
s
lia
bili
ty
in
su
ra
nc
e
pr
og
ra
m
m
e.
Property damage
and interruption of
operations
Th
e
Gr
ou
p
ha
s
set
up
an
int
eg
rat
ed
glo
bal
pr
og
ra
m
m
e
to
c
o
v
e
r
a
l
l
t
h
e
p
r
o
p
e
r
t
y
(
f
i
x
e
d
a
s
s
e
t
s
a
n
d
i
n
v
e
n
t
o
r
i
e
s
)
o
f
i
t
s
s
u
b
s
i
d
i
a
r
i
e
s
.
Th
is
pr
og
ra
m
m
e
als
o
co
ve
rs
op
er
ati
ng
los
se
s
dir
ect
ly
re
sul
tin
g
fro
m
an
ins
ur
ed
pr
op
ert
y
los
s
or
da
m
ag
e.
Th
e
lev
el
of
ins
ur
an
ce
co
ve
r
ha
s
be
en
sel
ect
ed
to
co
ve
r
th
e
m
axi
m
u
m
re
as
o
n
a
b
l
y
f
o
r
e
s
e
e
a
b
l
e
l
o
s
s
,
t
a
k
i
n
g
i
n
t
o
a
c
c
o
u
n
t
t
h
e
s
c
a
l
e
o
f
t
h
e
p
r
e
v
e
n
t
i
o
n
an
d
pr
ot
ect
ion
m
ea
su
re
s
im
ple
m
en
te
d
at
th
e
Gr
ou
ps
m
an
uf
act
uri
ng
sit
es
to
ge
th
er
wit
h
th
e
bu
sin
es
s
co
nti
nui
ty
pla
ns.
As
th
e
ca
pa
cit
y
of
th
e
ins
ur
an
ce
m
ar
ket
is
lim
ite
d
for
ce
rta
in
typ
es
o
f
e
v
e
n
t
s
,
t
h
i
s
p
r
o
g
r
a
m
m
e
i
n
c
l
u
d
e
s
a
g
g
r
e
g
a
t
e
s
u
b
l
i
m
i
t
s
,
p
a
r
t
i
c
u
l
a
r
l
y
i
n
t
he
ev
en
t
of
na
tur
al
dis
ast
er
s.
Th
is
pr
og
ra
m
m
e
inc
lud
es
th
e
pe
rfo
rm
an
ce,
by
th
e
ins
ur
er
s
en
gin
ee
rs,
of
los
s
pr
ev
en
tio
n
au
dit
s
for
th
e
Gr
ou
ps
loc
ati
on
s.
Th
es
e
au
dit
s
for
m
pa
rt
of
th
e
Gr
ou
s
g
e
n
e
r
a
l
s
a
f
e
t
y
m
a
n
a
g
e
m
e
n
t
s
y
s
t
e
m
.
Transport
T
h
e
G
r
o
u
p
h
a
s
s
e
t
u
p
p
r
o
g
r
a
m
m
e
to
co
ver
the
tra
ns
por
tati
on
of
all
its
pro
du
cts
.
All
su
bsi
dia
rie
s
su
bs
cri
be
to
thi
s
pro
gra
m
me
,
wh
ich
en
sur
es
opt
im
um
tra
ns
por
t
ins
ura
nc
e
for
all
flo
ws
of
go
od
s.
Customer credit
risk
Su
bs
idi
ari
es
ar
e
en
co
ur
ag
ed
t
o
p
u
r
c
h
a
s
e
c
r
e
d
i
t
i
n
s
u
r
a
n
c
e
,
w
i
t
h
t
h
e
a
s
s
i
s
t
a
n
c
e
o
f
h
e
a
d
o
f
f
i
c
e
a
n
d
u
n
d
e
r
ter
m
s
an
d
co
nd
iti
on
s
ne
go
tia
te
d
by
it,
in
ad
dit
io
n
to
th
eir
o
w
n
cr
ed
it
m
an
ag
e
m
en
t
pr
oc
ed
ur
es
,
pr
ov
id
ed
th
at
su
ch
co
ve
r
is
co
m
pa
tib
le
wit
h
th
eir
le
ve
l
of
co
m
m
er
ci
al
ac
t
i
v
i
t
y
a
n
d
i
s
a
v
a
i
l
a
b
l
e
u
n
d
e
r
f
i
n
a
n
c
i
a
l
l
y
a
c
c
e
p
t
a
b
l
e
c
o
n
d
i
t
i
o
n
s
.
I
n
a
p
e
r
i
od
of
m
aj
or
ec
on
o
mi
c
sl
o
w
do
w
n,
a
re
du
cti
on
of
co
m
mi
tm
en
ts
by
m
aj
or
in
su
ra
nc
e
co
m
pa
ni
es
co
ul
d
be
no
te
d
on
th
e
cr
ed
it
in
su
ra
nc
e
m
ar
ke
t
as
th
ey
m
ay
de
ci
de
to
re
du
ce
th
e
i
r
c
o
v
e
r
o
f
a
m
o
u
n
t
s
r
e
c
e
i
v
a
b
l
e
i
n
c
e
r
t
a
i
n
c
o
u
n
t
r
i
e
s
.
T
h
e
i
n
s
u
r
a
n
c
e
p
o
l
i
c
ie
s
pu
t
in
pl
ac
e
in
th
es
e
co
un
tri
es
co
ul
d
be
aff
ec
te
d
by
thi
s
tre
nd
.
Self-insurance
Th
ro
ug
h
its
rei
ns
ur
an
ce
su
bs
idi
ar
y,
th
e
Gr
ou
p
ca
rri
es
ris
k
ret
en
tio
n
le
ve
ls
th
at
ar
e
no
t
m
at
eri
al
at
co
n
s
o
l
i
d
a
t
e
d
l
e
v
e
l
,
a
n
d
t
h
e
s
e
a
r
e
a
p
p
l
i
c
a
b
l
e
o
v
e
r
a
n
d
a
b
ov
e
lo
ca
l
de
du
cti
bl
e
a
m
ou
nt
s
un
de
r
th
e
D
a
m
ag
e
an
d
Tr
an
sp
ort
pr
og
ra
m
m
es
w
hi
ch
ar
e
ab
so
rb
ed
by
th
e
su
bs
idi
ari
es
in
su
re
d.
27
28
2
CORPORATE
GOVERNANCE
*
2.1. Summary of
the principles
2.2. The
Boards
composi
tion and
the way
in which
the
Boards
work
is
prepared
and
organised
2.2.1. Composition of
the
Board
of
Directors
2.2.2. The
ways in
which the
Boards
work is
prepared
and
organised
(includes
the internal
rules
of the Board of
Directors
page
53)
2.2.3. Specific
terms and
conditions
of
participatio
n by
shareholde
rs in the
Annual
General
Meeting
2.2.4. Principles and rules

adopted
by the Board of Directors
to determine the
remuneration and benefits
of all kinds granted to the
corporate officers
30 2
.
4
.
S
u
m
m
a
r
y
o
f
t
r
a
d
i
n
g
b
y
Di
re
ct
or
s
a
n
d
c
or
p
or
at
e
officers in LOral shares

in 2012
31 2.5.
Internal
Control and Risk
32 Manage
ment
procedu
res
(Report
of the
Chairma
n of the
Board of
Director
s on
Internal
66
Control)
48
59
59
66
2.5.1. Definition and objectives of Internal

Control
66
2.5.2. Components of the system
66
2.5.3. The players
69
2.5.4. Internal Control system relating

to the preparation and processing of
financial and accounting information
70
2.6.
2.3. Remuneration
of
the
members of
the Board of
Directors
Stat
utor
y
Audi
tors
repo
rt,
prep
ared
in
acco
rdan
ce
and
the
corporate
officers
2.3.1. Remun
eration of
the
members
of
the
Board of
Directors
2.3.2. Remun
eration of
the
Chairman
and Chief
Executive
Officer
60 with
article
L. 225235 of
the
French
Comme
rcial
Code
on
2.3.3. Stock
options
granted to the
Chairman
and
Chief
Executive
Officer
2.3.4. Stock
options
exercised during
the
financial
year by the
Chairman and
Chief
Executive
Officer
60 the
repo
rt
prep
ared
by
the
Chai
rma
n of
the
Boar
d of
61
Directors
62 2.7.
Statu
tory
Audi
tors
Spec
ial
Repo
rt on
regul
ated
73
63
agreements and commitments

with third parties
74
2.3.5. Conditional shares (ACAs) granted to
CORPORATE
GOVERNANCE
Summary of the
principles
This chapter describes the way in which the Board of Directors work is prepared
and organised and includes, in particular, a summary of the principles of
organisation guaranteeing a balance of powers ( 2.2). It includes the complete
text of the Internal Rules of the Board of Directors ( 2.2.2.3). All components of
the remuneration of Directors and corporate officers are mentioned ( 2.3.) as well
as the trading by Directors and corporate officers in LOral shares in 2012 ( 2.4).
The internal control procedures implemented by the Company are also described
( 2.5). The Statutory Auditors Reports related to Corporate Governance, namely
their report on the report prepared by the Chairman ( 2.6) and that
on regulated agreements and commitments ( 2.7), are included here.
2.1. Summary of the principles

AFEP-MEDEF CODE:
THE REFERENCE CODE
The Board of Directors considers that the recommendations of
the AFEP-MEDEF Code of Corporate Governance for listed
companies of April 2010 fall within the Companys approach to
corporate governance. Accordingly, this is the code referred to by
the Company to prepare this Corporate Governance chapter,
approved by the Board at its meeting on Monday, February 11th,
2013. The AFEP-MEDEF Code can be consulted over the
Internet at the following address: http://www.medef.com/.
In accordance with Article L. 225-37 of the French Commercial
Code, this chapter on Corporate Governance includes the report
of the Chairman on the Boards composition and on the ways in
which the Boards work is prepared and organised (section 2.2)
as well as on the Internal Control procedures implemented by the
Company (section 2.5).
Under the terms of Article L. 225-37, paragraph 6, of the French
Commercial Code, the Chairman is required to present a
supplementary report, attached to the Management Report:
[ ] The Chairman of the Board of Directors gives an account,
in a report attached to the report mentioned in Articles L. 225100, L. 225-102, L. 225-102-1 and L. 233-26, of the Boards
composition and of the application of the principle of balanced
representation of men and women on the Board, of the ways
in which the Boards work is prepared and organised, and on
the Internal Control and risk management procedures put in
place by the Company, describing in particular those of its
procedures that relate to the preparation and processing of
accounting and financial information for the parent company
financial statements and, where applicable, for the
consolidated financial statements. Without prejudice to the
provisions of
30
Article L. 225-56, the report also indicates any limitations that

the Board of Directors imposes on the powers of the Chief
Executive Officer.
This same article of the French Commercial Code states that:
Where a Company voluntarily
governance drawn up by
businesses, the report [] also
have not been applied and
application []
refers to a code of corporate

organisations representing
specifies the provisions which
the reasons for this non-
The report provided for in this Article also describes the specific
terms and conditions of participation by shareholders in the
General Meeting or refers to the provisions of the Articles of
Association which set out such terms and conditions.
This report furthermore describes the principles and rules

adopted by the Board of Directors to determine the
remuneration and benefits of all kinds granted to the
corporate officers [].
In accordance with Article L. 255-37, paragraph 9, of the French
Commercial Code, it is specified that the information provided for
in Article L. 225-100-3 of the French Commercial Code is
published on page 220 of chapter 7.
In application of this same Article, the Board of Directors of LOral
approved this chapter at its meeting on February 11th, 2013.
In accordance with the recommendations made by the Autorit

des Marchs Financiers (French financial markets authority), this
chapter identifies in a summary table (on page 65) those
provisions of the AFEP-MEDEF Code which were not applied and
explains the reasons for that choice pursuant to Article L. 225-37
of the French Commercial Code.
CORPORATE GOVERNANCE
The Boards composition and the way in which the Boards work is prepared and organised
2.2. The Boards composition and the way in

which the Boards work is prepared and
organised
Enriched by the experience and diversity of its members, the Board of Directors is demonstrating its unity and
strong commitment to the LOral corporate project: universalisation and beauty for all. It is fully assuming its role of
validating the Companys strategic goals, while opening up new ways of further improving governance.
(Jean-Paul Agon, Chairman & CEO of LOral)
THE BALANCE OF POWERS AT LORAL IN

A BOARD OF DIRECTORS THAT IS
INDEPENDENT, STRONGLY COMMITTED
AND VIGILANT
The organisation of LOrals Board of Directors is adapted to the Companys
specificities and constant progress is always sought.
In 2006, the duties of Chairman of the Board of Directors were separated

from those of Chief Executive Officer, at the time when Sir Lindsay OwenJones had announced that he wanted to hand over some of his
responsibilities to devote some time to the position of Chairman of the
Board of Directors.This separation of the duties, which lasted for five years,
made it possible to completely ensure a smooth transition with Jean-Paul
Agon, appointed as Chief Executive Officer.
In 2011, LOrals Board of Directors decided that the duties of Chairman
of the Board of Directors would be reunified with those of Chief Executive
Officer and appointed Mr. Jean-Paul Agon to this office.
The Board of Directors considers that the unification of the duties is
particularly adapted to the specificities of LOral: a stable and loyal
shareholder base, clear identification of its businesses, gradual, steady
development of its international activities and top-quality financial and
economic performances. An extreme loyalty that has always existed
among its senior managers and executive officers, who have precise
knowledge of the business. Furthermore, the C ompany has to be
responsive, firstly in a business sector in which decisions have to be taken
quickly in a highly competitive international environment, and secondly in
the beauty sector which requires strong, coherent communication at all
times (see section 2.2.1.1. on page 32).
Within this general framework, the modus operandi of the Board of
Directors has been subject to particular attention so that the Board is in a
position to fully carry out its role and the balance of powers on the Board is
ensured. At the end of 2012, like in 2011, at the time of the evaluation of
their work and their relations with the general management, the Directors
noted that the organisation that has been put in place works well.
Decision-making processes are clear, as is the division of powers.
31
The balance of powers

The balance of powers on the Board is ensured through a very precise
definition and sharing of the tasks to be carried out by everyone, with, on
the one hand, the Chairman and CEO and, on the other, thirteen Directors
who are free to exercise their judgment. All the Directors receive
information on an ongoing basis and have suitable means, within the
framework of a code of operation, with well-structured, specialised
committees and remits that have been added to since their creation.
Well-informed, independent Directors

LOrals Directors are informed on an ongoing basis of all the aspects of
the state of the C ompanys business and its performances.
Beyond the presence of strongly committed Directors with complementary
experience (financial, industrial or business expertise, etc.), some of whom
carry the memory of the Companys history, as they have longstanding indepth knowledge of the Company and its environment, the Directors are all
assiduous in attending meetings and vigilant. The Boards work is carried
out and deliberations are made perfectly independently of the operational
commitments by the General Management (see section 2.2.1.2. on page
33).
A Board of Directors has a wide array of means

The Board has the means to enable it to handle the questions that concern
it with complete freedom questions and particularly when this involves
determining the Companys strategic orientations, ensuring and monitoring
their implementation and overseeing the good management thereof. The
General Management communicates transparently and has the support of
the Board of Directors in the strategic choices that it proposes and which
are finally decided by the Board. The Chairman conducts the Boards work
to build this cohesion without which General Management and its
Executive Committee would not be able to commit themselves completely
and ensure the Companys development with complete confidence and
tranquillity. It is naturally in the interest of all the shareholders but
CORPORATE
GOVERNANCE
The Boards
composition and the way in which the Boards work is prepared and organised
also of all the stakeholders for the Chairman to lead the

debates and encourage discussions on the Board of
Directors. It can hold meetings at any time depending
on topical issues that may arise (see section 2.2.2.1.1.
on page 48).
A Board of Directors whose action is fully

organised
The Board acts in all circumstances in the Companys
corporate interests. This mission is reinforced
inasmuch as the Board has adopted a code of
operation defining rules with regard to conduct and
formally providing for the conditions in which it will be
given the means it needs to fully perform its role, for
example, by deciding to handle any issue with regard to
the good running of the Company, within the framework
of the law.
Thus, LOrals Board of Directors has adopted Internal
Rules which it updates from time to time, both with regard
to the formal aspects of its missions and with regard to the
rights and obligations of the Directors (knowledge of the
regulatory provisions and compliance with them, respect of
the Companys interests, a duty of diligence, confidentiality
and secrecy, responsibility in the field of insider trading,
etc.), in the light of the findings of the evaluation of its work
and within the scope of good corporate governance
practices that it has put in place.The complete text of the
Internal Rules, which were last updated in February 2011,
is published in this present Registration Document on
pages 53 et seq. It may be amended by the Board in light
of the changes in the laws and regulations, but also in its
own modus operandi.
Finally, a Director formally reports potential conflicts of

interest which might concern him/her and, in any event,
in this case he/she does not take part in the voting in
this respect (see section 2.2.1.2. on pages 33 and 46).
Well-structured, specialised Board

Committees, whose remits have been
added to
In 2011, additions were made to the remits of the
Boards Committees, with a greater number of
Directors serving on these committees and more
opportunities to meet with high-level managers. Only
the Strategy and Sustainable Development Committee
is chaired by the Chairman and CEO, who does not
serve on any other committee.
They include independent Directors, who represent half
of the members of the Audit Committee and the
Remuneration Committee and include the Chairman of
each committee. These committees are completely free
to define their respective agendas. They report
regularly on their work to the Board of Directors,
prepare for its meetings and make proposals to it.
Within the scope of the review of its own work at the
end of 2012, the Board once again appreciated the
quality of the contribution made by its committees in
relation with the decisions that it takes, in an
increasingly detailed manner (see section 2.2.2.1.2. on
page 49).
The Board periodically

evaluates the quality
ofitsorganisation andits work
Within the framework of the annual evaluation of its modus
operandi, on the basis of the best corporate governance
practices, the Directors set themselves new targets for
improvement of the quality of their organisation and their
deliberations every year, for example by enlarging the
agenda for their meetings and those of their
committees.They seek to adopt the best possible modus
operandi and ensure that they have all the necessary
assets to successfully perform their tasks, with complete
freedom.
2.2.1. COMPOSITION
OF THE BOARD OF
DIRECTORS
The composition of the Board of LOral, the rules it
applies to its work, its modus operandi, and the work
that it has carried out in the year, evaluated on an
annual basis by the Directors, as well as the decisions
made, are dealt within this chapter. The Board wishes
to point out that it carries out its work above all on a
collective basis, in accordance with ethical principles
and in compliance with the legal provisions, regulations
and recommendations.
The Board of Directors comprises 14 members: the
Chairman and Chief Executive Officer, the Honorary
Chairman, six Directors appointed by the majority
shareholders, three of whom are appointed by Mrs.
Bettencourts family group and three by Nestl (the two
Vice-Chairmen of the Board being chosen from among
these members) and six independent Directors: Ms.
Annette Roux, Mr. Charles-Henri Filippi, Mr. Xavier
Fontanet, Mr. Bernard Kasriel, Mr. Marc Ladreit de
Lacharrire and Mr. Louis Schweitzer.
Four elected employee representatives also attend

Board meetings and have a consultative vote.
The allocation of LOrals share capital at December 31 st,
2012 is shown in this Registration Document in section
7.3.2. on page 225.
2.2.1.1. Method of General Management

chosen
At its meeting on Thursday, February 10 th, 2011, the
Board of Directors decided that the duties of Chairman
of the Board of Directors would be reunified with those
of Chief Executive Officer and entrusted Mr. Jean-Paul
Agon with such duties. This transfer of responsibilities
has been effective since March 18 th, 2011. Sir Lindsay
Owen-Jones, who continues to be a Director of LOral,
has been appointed as Honorary Chairman.
The separation of the duties of Chairman of the Board
of Directors from those of Chief Executive Officer from
2006 to 2011 made it possible to ensure a smooth
transition between Sir Lindsay Owen-Jones and Mr.
Jean-Paul Agon. In 2011, the Board of Directors
considered that the environment was favourable to
reunifying these duties. This governance model is
32
indeed specifically adapted to the

specificities of LOral and its shareholder
structure: a stable and loyal shareholder
base, clear identification of its businesses,
gradual, steady development of its
international activities, and top-quality
financial and economic performances.
LOral has always had senior managers
and executive officers who are loyal to the
C ompany and have precise knowledge of
the business. Furthermore, the C ompany
has to be responsive, firstly in a business
sector in which decisions have to be
taken quickly in a highly competitive
international environment, and secondly
in the beauty sector which requires
strong, coherent communication at all
times.
At the end of 2012, at the time

firstly of the evaluation of their
work (see section 2.2.2.2. on page
53), and secondly of that of their
relations with the Companys
executives,
the
Directors
confirmed that this organisation
operated in a balanced manner.
2.2.1.2. Corporate officers

The 14 Directors of LOral, who are strongly committed and
responsible, exercise complete freedom of judgment, both in
terms of independence and gender parity. The composition
of the Board of Directors is therefore in compliance with the
recommendations of the AFEP-MEDEF Code of Corporate
Governance.
List of offices and directorships held by Directors and corporate officers at December
31st, 2012
Jean-Paul Agon
French.
Age: 56.
He joined LOral in 1978. Following an international career as General Manager of the
Consumer Products Division in Greece and of LOral Paris in France, International
Managing Director of Biotherm, General Manager of LOral Germany, Executive VicePresident of the Asia Zone, President and CEO of LOral USA, Jean-Paul Agon was
appointed as Deputy Chief Executive Officer of LOral in 2005 and then Chief Executive
Officer in April 2006 and finally Chairman and CEO in 2011. A Director of LOral since
2006, he is also Chairman of the LOral Corporate Foundation and Chairman of the
Strategy and Sustainable Development Committee. Jean-Paul Agon is also a Director of
Air Liquide.
Expi
ry
date
of
term
of
offic
e:
201
4
Director since 2006

Chairman of the Strategy and Sustainable Development Committee
Professional address: LOral 41 rue Martre 92117 Clichy Cedex France
Holds 31,500 LOral shares
Other corporate offices and directorships held
French company
LAir Liquide S.A.*
Director
Foreign companies
Galderma Pharma S.A. (Switzerland)**
Director
LOral USA Inc. (United States)
Director
Other
LOral Corporate Foundation

Corporate offices and directorships over the last five years that have expired
Foreign companies
Chairman of the Board of Directors

[since April 24th, 2012]
Director
Expiry
term o
Galderma Pharma S.A. (Switzerland)

The Body Shop International PLC (United Kingdom)
*
*
Listed company.
50% owned by LOral.
33
Chairman of the Board

Vice-Chairman and Director
Ap
Marc
CORPORATE
GOVERNANCE
The Boards composition
and the way in which the Boards work is prepared and organised
Franoise Bettencourt Meyers

French.
Age: 59.
The daughter of Mrs. Liliane Bettencourt, who is herself the daughter of the founder of LOral, Eugne Schueller,
she has been the Chairwoman of the family-owned holding company since January 31 st, 2012 and is the
Chairwoman of the Bettencourt Schueller Foundation. Franoise Bettencourt Meyers has been a Director of LOral
since 1997 and a member of the Strategy and Sustainable Development Committee since April 2012.
Expiry date of term of office: 2013
Director since 1997

Member of the Strategy and Sustainable Development Committee
Professional address: Tthys 27-29 rue des Poissonniers 92200 Neuilly sur Seine France
Holds 283 LOral shares in absolute ownership and 76,441,389 shares in bare ownership
French companies
Tthys SAS
Chairwoman [since January 31st,2012]

Chairwoman of the Supervisory Board
Financire de lArcouest SAS
Chairwoman
Socit Immobilire Sebor SAS
Chairwoman
Other
Bettencourt Schueller Foundation
Chairwoman of the Board of Directors

Expiry date of
term of office
French company
Clymne SAS
34
Chairwoman
June 28th, 2012
Peter Brabeck-Letmathe
Austrian.
Age: 68.
His main position outside LOral is that of Chairman of the Board of Directors of Nestl. Peter BrabeckLetmathe has been a Director of LOral and Vice-Chairman of the Board of Directors since 1997. He has
been a member of the Strategy and Sustainable Development Committee, the Appointments and
Governance Committee and the Human Resources and Remuneration Committee since 2007.

Director since 1997
Vice-Chairman of the Board of Directors
Member of the Appointments and Governance Committee
Member of the Human Resources and Remuneration Committee
Professional address: Nestl Avenue Nestl, 55 CH 1800 Vevey Switzerland
Main corporate office held outside LOral
Nestl S.A. (Switzerland)*

Foreign companies
Credit Suisse Group (Switzerland)*
Vice-Chairman of the Board Directors

Director
Delta Topco Limited (Jersey)
Exxon Mobil (USA)*
Director
Nestl Health Science S.A. in Lutry (Switzerland)
Director and Chairman of the Board

Member of the Steering
Committee
Nestl Institute of Health Science S.A. in Ecublens (Switzerland)

Others
World Economic Forum (Switzerland)
European Industrialists Round Table (Belgium)
Member of the Foundation Board

Member of the Executive Committee
Chairman of the Working Group on
External Economic Relations
Expiry date of
term of office
Foreign company
Roche Holding S.A. (Switzerland)
Director
March 2010
Others
Uprona Ltd (Canada)
Director and Chairman

February 2011
Chairman of IBC [Internat. Business
Council]
November 2010
World Economic Forum (Switzerland)

ECR Europe (Belgium)
Cereal Partners Worldwide (Switzerland)
*
Listed company.
35
Co-Chairman of the Executive Board

Co-Chairman of the Supervisory
Board
May 2008
April 2008
CORPORATE
GOVERNANCE
Paul Bulcke
Belgian.
Age: 58.
He joined Nestl in 1979, and has been its Chief Executive Officer since 2008. Paul Bulcke has been
a Director of LOral since 2012, a member of the Strategy and Sustainable Development Committee
since April 2012 and is a Board member of Roche Holding in Switzerland.
Director since 2012

Main corporate offices held outside LOral
Chief Executive Officer
Nestl Health Science S.A. in Lutry (Switzerland)
Director
Nestl Institute of Health Science S.A. in Ecublens (Switzerland)
Member of the Steering committee

Foreign companies
Cereal Partners Worldwide (Switzerland)
Co-Chairman of the Supervisory Board
Roche Holding Ltd (Switzerland)*
Director
Other
The Consumer Goods Forum (France)
Director and Co-Chairman of

the Governance Committee
Expiry date of
term of office
Foreign company
Alcon Inc. (Switzerland)
*
36
Listed company.
Director
August 2010
Charles-Henri Filippi
French.
Age: 60.
He spent his career in particular within the HSBC Group, in which he was notably Chairman and Chief Executive Officer
of HSBC France from 2004 to 2007 and Chairman of the Board of Directors in 2007 and 2008. Charles-Henri Filippi
has been a Director of LOral since 2007 and is also a Board member of France Telecom, a member of the Supervisory
Board of Euris and a non-voting member of the Board of Directors of Nexity. He is currently the Chairman of Citigroup
for France. It is noted that Citigroup does not have, and has never had, a significant position with regard to LOrals
banking transactions. Nevertheless, Charles-Henri Filippi is aware that he is under the obligation of notifying the LOral
Board of Directors of all situations constituting a conflict of interest, even if such conflict is only potential, and that
he must refrain from participating in the corresponding decisions. Furthermore, at Citigroup, he will not take part in
the work that is liable to concern LOral. Charles-Henri Filippi is an independent Director, with no conflicts of interest,
available and competent.
Chairman of the LOral Audit Committee from May 23rd, 2008 to February 12th, 2013, a member of the Audit Committee,
Mr. Filippi harmoniously and effectively supplements the Boards expertise in the field of finance. He has also been a
member of the Human Resources and Remuneration Committee since April 2011.
Director since 2007
Member of the Audit Committee and Chairman of the Audit Committee until February 12th, 2013
Professional address: Citigroup France 1-5 rue Paul-Czanne 75008 Paris
Citigroup France
Chairman

French companies
Euris
Member of the Supervisory

Board
Femu Qui SA
Member of the Supervisory Board
France Telecom*
Nexity*
Director
Non-voting member of the Board
of Directors
Piasa S.A.
Director
Others
ADIE (Association pour le Droit lInitiative Economique)
Director
Association des Amis de lOpra-Comique
Chairman
Centre National dArt et de Culture Georges Pompidou
Director
Expiry date of
term of office
French companies
Viveris Reim SA

Board
Octagones (parent company) and Alfina (Subsidiary)
Chairman
CVC Capital Partners (CVC)
Senior Advisor
December 2010
HSBC France

Director
Member of the Executive
Commission
December 2008
HSBC Bank plc (United Kingdom)
Director
December 2008
HSBC Private Banking Holdings S.A. (Suisse)
Director
Other
Association des Amis du Festival dAutomne Paris
Director
Altadis
July 2012
May 2012
February 2008
Foreign companies
Listed company.
37
September 2009
CORPORATE
GOVERNANCE
Xavier Fontanet
French.
Age: 64.
He is a former Chairman and Chief Executive Officer (1996-2009) and former Chairman of the Board of
Directors of Essilor (2010- 2012), member of the Supervisory Board of Schneider Electric, and he has been
a Director of LOral since 2002 and Chairman of the Appointments and Governance Committee since 2011.
Director since 2002

Chairman of the Appointments and Governance Committee
Professional address: Essilor 147 rue de Paris 94227 Charenton Cedex France
Essilor International S.A.*
Director

French company
Schneider Electric SA*
Member of the Supervisory Board
Other
Association Nationale des Socits par Actions
Permanent representative of
Essilor International and member
of the Board of Directors
Expiry date of
term of office
French companies
Crdit Agricole S.A.
Essilor International S.A.
Director
of Directors
Director
Chairman and Chief Executive
Officer
Foreign companies
Essilor Amico (L.L.C) (United Arab Emirates)
Nikon and Essilor International Joint Research Center Co. Ltd
Nikon Essilor Co. Ltd (Japan)
EOA Holding Co. Inc. (United States)
Essilor India PVT Ltd (India)
Essilor Manufacturing India PVT Ltd (India)
Transitions Optical Holding B.V. (Netherlands)
Transitions Optical Inc. (United States)
Shanghai Essilor Optical Company Ltd (China)
Director
Chairman and Director
Director
Chairman-Director
Director
Director
Director
Director
Director
Essilor of America Inc. (United States)
Director
Essilor International S.A.

Fonds Stratgiques dInvestissement S.A.
38
Listed company.
May 2012
January 2012
June 2011
January 2010
December 2011
December 2011
December 2011
October 2010
June 2010
June 2010
May 2010
May 2010
April 2010
March 2010
Bernard Kasriel
French.
Age: 66.
He is a former Chief Executive Officer of Lafarge. He has been a Director of LOral since 2004 and is
Chairman of the Human Resources and Remuneration Committee and member of the Strategy and
Sustainable Development Committee. He is also a Board member of Arkema and Nucor (United States).

Director since 2004
Chairman of the Human Resources and Remuneration Committee
Professional address: 1 rue Saint-James 92200 Neuilly-sur-Seine France
French company
Arkema S.A.*
Director
Foreign company
Nucor (United States)*
Director
Expiry date of
term of office
French companies
LBO France
Partner
Lafarge S.A.
LBO France
*
September 2011
Director
Member of the Management
Board
May 2010
January 2010
Listed company.
Christiane Kuehne
Swiss.
Age: 57.
Head of the Food Strategic Business Unit at Nestl which she joined in 1977. Christiane Kuehne has
been a member of LOrals Board of Directors and the Audit Committee since April 2012.
Director since 2012

Member of the Audit Committee
Head of Food Strategic
Business Unit

None
None
*
Listed company.
39
CORPORATE
GOVERNANCE
Marc Ladreit de Lacharrire

French.
Age: 72.
A member of the Institut de France and with LOral from 1976 to 1991, Marc Ladreit de Lacharrire has been a
Director of LOral since 1984, Chairman and Chief Executive Officer of Fimalac, Chairman of Fitch (United
States), and a Board member of Casino, Lucien Barrire and Renault. His professional experience
and his freedom of judgment, combined with a good knowledge of the Company, make a big
contribution to the discussions and decisions of the Board. His length of office is an asset for the
Board. It contributes to putting LOrals main strategic options into perspective.
Director since 1984

Professional address: Fimalac 97 rue de Lille 75007 Paris France
F. Marc de Lacharrire (Fimalac)

Officer

French companies
Agence France Museums
Casino*
Director
Gilbert Coullier Productions SAS
Director
Groupe Lucien Barrire

Groupe Marc de Lacharrire
Director
Chairman of the Management
Board
Renault S.A.*
Director
Renault s.a.s.
Director
Socit Fermire du Casino Municipal de Cannes SFCMC
Director [since March 15th, 2012]
Foreign companies
Fimalac Participations Sarl (Luxembourg)
Managing Director
Fitch Group (United States)
Chairman
Other
Comit National des Conseillers du Commerce Extrieur de la France
Honorary Chairman
Conseil Artistique des Muses Nationaux
Member
Fonds de dotation Abbaye de Lubilhac
Chairman
Fondation dEntreprise Culture et Diversit
Member
Fondation des Sciences Politiques
Member
Institut de France
Member
Muse des Arts Dcoratifs
Member
Expiry date of
term of office
40
French company
Fimalac Participations
Managing Director
Foreign companies
Fitch Ratings (United States)
Algorithmics (Canada)
Chairman
Director
Others
Director
Member
Banque de France
Member of the Consultative

Council
Listed company.
September 2010
2012
2009
2012
May 2010
2008
Jean-Pierre Meyers
French.
Age: 64.
He has been a Director of LOral since 1987, Vice-Chairman of the Board of Directors since 1994, member
of the Strategy and Sustainable Development Committee, the Audit Committee, the Appointments and
Governance Committee and the Human Resources and Remuneration Committee. He is Vice- Chairman of
the Supervisory Board and Chief Executive Officer of the family-owned company Tthys, a Board member
of Nestl and Vice-Chairman of the Bettencourt Schueller Foundation.

Director since 1987
Vice-Chairman of the Board of Directors
Member of the Audit Committee
Member of the Appointments and Governance Committee
Professional address: Tthys 27-29 rue des Poissonniers 92200 Neuilly-sur-Seine France
French company
Vice-Chairman of the Supervisory
Board
Tthys SAS
Foreign company
Nestl S.A.(Switzerland)*
Director
Other
Vice-Chairman of the Board of
Directors
Expiry date of
term of office
French company
Clymne SAS
*
Listed company.
41
June 28th, 2012
CORPORATE
GOVERNANCE
Jean-Victor Meyers
French.
Age: 26.
He studied economics and management at universities in France and the United States. In the context of his
professional experience, and over the last few years, he has spent several months in LOral Divisions, in
France and other countries. He has been a member of the Supervisory Board of the family holding company
Tthys since January 2011 and was co-opted to LOrals Board of Directors at its meeting on February 13 th,
2012. This co-optation was ratified by the Annual General Meeting on April 17 th, 2012.
Director since 2012

Professional address: Tthys 27-29 rue des Poissonniers 92200 Neuilly-sur-Seine
French companies
Tthys SAS
Exemplaire SAS
None
42

Board
Chairman
Sir Lindsay Owen-Jones

British.
Age: 67.
He joined the LOral Group in 1969. After a career in France, Chief Executive Officer of LOral in Italy from
1978 to 1981, President (CEO) of LOral USA from 1981 to 1984, he was appointed as a Director and Chief
Executive Officer of LOral in 1984 then Chairman and Chief Executive Officer in 1988. Honorary Chairman
of LOral since March 18th, 2011, Sir Lindsay Owen-Jones is a Board member of Ferrari (Italy).

Director since 1984
Honorary Chairman
Professional address: LOral 41 rue Martre 92117 Clichy cedex France
Holds 2,998,095 LOral shares
French company
Alba Plus SASU
Chairman
Foreign company
Director
[Amministratore]
Ferrari S.p.A. (Italy)
Expiry date
of term
French companies
Sanofi
Director
of Directors
Vice-Chairman of the Board
of Directors
March 2011
LOral U.K. Ltd (United Kingdom)
Chairman & Director
March 2011
LOral USA Inc. (United States)
Chairman & Director
March 2011
LOral S.A.
LAir Liquide S.A.
May 2012
May 2009
Foreign companies
Other
of Directors
Director
43
April 2012
CORPORATE
GOVERNANCE
Annette Roux
French.
Age: 70.
Chairperson and Managing Director of Bnteau from 1976 to 2005, then Vice-Chairperson of the
Supervisory Board, Annette Roux has been a member of LOrals Board of Directors since 2007. She
is also Chairperson of the Bnteau Corporate Foundation.
Director since 2007

Professional address: Les Embruns 16 boulevard de la Mer 85800 Saint-Gilles-Croix-de-Vie France
Bnteau S.A.(1) (2)
Vice-Chairperson
of the Supervisory Board

French companies
Beri 21 S.A.
Chairperson
of the Supervisory Board
BH S.A.S. (2)
Director
Construction Navale Bordeaux S.A.S(2)
Director
OHara S.A.
(2)
SPBI S.A.(2)
Director
Director
Foreign company
Bnteau Espaa(2)
Director
Other
Bnteau Corporate Foundation
Chairperson
Expiry date of
term of office
French company
Beri 3000 S.A.
Chairperson and Chief

Executive Officer
August 2010
Other
Fdration des Industries Nautiques
(1)
(2)
44
Company listed on compartment B of Eurolist.

Companies controlled by Beri 21 S.A.
Chairperson
March 2009
Louis Schweitzer
French.
Age: 70.
Chairman and Chief Executive Officer of Renault from 1992 to 2005, Chairman of the Board of Directors until 2009,
Louis Schweitzer has been a Director of LOral since 2005, a member of the Strategy and Sustainable Development
Committee and the Audit Committee since 2011 and Chairman of the Audit Committee since February 12 th, 2013.
He is also a member of the Advisory Committees of Allianz AG (Germany) and Bosch (Germany).
Director since 2005
Member of the Audit Committee and Chairman of the Audit Committee since February 12th, 2013
Professional address: Renault Bt. Pierre Dreyfus 37 avenue Pierre Lefaucheux 92109 Boulogne-Billancourt Cedex France
French companies
BNP Paribas*
Veolia Environnement*
Foreign companies
Allianz AG (Germany)*
Bosch (Germany)
Others
Comit des Salons
Festival dAvignon
Fondation Nationale des Sciences Politiques
Initiative France
Maison de la Culture MC93
Muse du Quai Branly
Socit des Amis du Muse du Quai Branly
French Institute of International Relations
French companies
Veolia Environnement
Le Monde (lMPA, lMSA, SEM)
Renault
Electricit de France
Foreign companies
AstraZeneca (United Kingdom)
AB Volvo (Sweden)
Philips (The Netherlands)
Others
Institut Franais des Relations Internationales
Haute Autorit de Lutte contre les Discriminations et pour lEgalit
Le Cercle de lOrchestre de Paris
Muse du Louvre
Banque de France
*
Listed company.
45
Director
Lead Director [since May 16th, 2012]
Member of the Advisory
Committee
Member of the Advisory
Committee
Chairman
Chairman
Member of the Board
Chairman
Chairman
Director
Chairman
Vice-President [since April 2012]
Expiry date of
term of office
Vice-Chairman of the Board
May 2012
Chairman of the Supervisory Board December 2010
April 2009
Director
April 2008
Director
Vice-Chairman of the Supervisory
Board
Member of the Board
Chairman
Member of the Board
Member of the Consultative Council
June 2012
April 2012
April 2008
April 2011
March 2010
June 2008
May 2008
CORPORATE
GOVERNANCE
The Boards
not have held any of these positions during the
previous five years;
EXPERIENCED DIRECTORS WHO COMPLEMENT ONE

ANOTHER
LOrals Directors come from different backgrounds;

they complement one another due to their different
professional experience, their skills and their
nationalities. They have good knowledge of the
Company. The Directors are present, active and
strongly committed. These are all assets which
contribute to the quality of the Boards deliberations in
the context of the decisions that it is called on to make.
REPRESENTATION OF WOMEN AND MEN THAT
COMPLIES WITH THE PROVISIONS OF THE FRENCH
LAW OF JANUARY 27TH, 2011
Out of a total of 14 Directors, three women have seats

on LOrals Board of Directors.The Board is thus in
advance of the French Law of January 27 th, 2011
relating to the balanced representation of men and
women, which provides for a proportion of 20% of
women to be reached by 2014. The Board is doing
everything it can to appoint more female Directors.
The Appointments and Governance Committee
initiated a selection process and made proposals to the
Board of Directors in 2012.A female candidate will be
proposed to the Annual General Meeting on April 26 th,
2013, which will thereby lead to an increase in the
proportion of women on the Board.
In any event, in 2017, the composition of the Board will
be in compliance with French law which requires
balanced representation of men and women, namely a
proportion of 40% of Directors of the same gender.
INDEPENDENT DIRECTORS
The balance of powers on the Board is ensured
through a very precise definition and sharing of the
tasks to be carried out by everyone, with, on the one
hand, the Chairman and CEO and, on the other,
thirteen Directors who are free to exercise their
judgment. All the Directors receive information on an
ongoing basis and have suitable means, within the
framework of the Internal Rules of the Board of
Directors, with well-structured, specialised committees
and remits that have been added to since their
creation.
The directors have a duty of vigilance and have
complete freedom of judgement, which enables them in
particular to participate, in total independence, in the
decisions and work of the Board, and, where
appropriate, of its Review Committees.
At the end of 2012, the Board of Directors reviewed the
situation of each of its members on a case-by-case basis,
in particular in light of the independence criteria provided
for in the AFEP-MEDEF Code. A member of the Board is
considered as independent when he/she does not maintain
any relationship of any kind with the Company, its group or
its General Management which may interfere with his/her
freedom of judgment.
In this spirit, the criteria which guide the Board in

determining whether a member can qualify as
independent are the following criteria specified by the
AFEP-MEDEF Code:
the member must not be an employee or corporate

officer of the Company, an employee or director of
its parent company or a company which it
consolidates in its financial statements, and must
the member must not be a corporate officer of a

company in which the Company directly or
indirectly holds the office
into perspective.
of director or in which an employee designated as

such or a corporate officer of the Company (either
currently or having performed such duties within the
last five years) holds an office as director;
the member must not be a customer, supplier,

investment banker or financial banker:
which is important for the Company or its group,

or
for which the Company or its group represents a

significant portion of activities;
the member must not have any close family links
with a corporate officer;
the member must not have been the Companys
auditor over the five previous years.
The Board failed to adopt one of the criteria specified

by the AFEP-MEDEF Code as it considers that the fact
that a member has performed a term of office for over
12 years does not lead to such member losing his
independent status.
Thus, although Mr. Ladreit de Lacharrire has been a
Director of LOral for over 12 years, his professional
experience and his freedom of judgment, combined
with good knowledge of the Company, make a big
contribution to the discussions and decisions of the
Board. His length of office is an asset for the Board. It
contributes to putting LOrals main strategic options
46
Indeed, the quality of a director is also measured by

his experience, his skills, his authority and his good
knowledge of the Company, which are all assets which
make it possible to conduct a long-term strategy.
Out of the 14 members of the Board of Directors, six
Directors qualify as independent: Ms. Annette Roux,
Mr. Charles-Henri Filippi, Mr. Xavier Fontanet, Mr.
Bernard Kasriel, Mr. Marc Ladreit de Lacharrire and
Mr. Louis Schweitzer.
It is furthermore specified that a review was carried out
of the financial flows that took place in 2012 between
LOral and the companies in which the six
independent Directors also hold an office. It appears
from this that the nature of these business
relationships is not significant.
The proportion of independent Directors is thus equal to at
least one-third and in line with the recommendations of the
AFEP-MEDEF Code. Under these conditions, the Boards
tasks are carried out with the necessary objectiveness and
independence and all the Directors take account of the
interests of all the shareholders.
RESPONSIBLE DIRECTORS
Handling of conflicts of interest
Within the scope of the law and the rights and
obligations of the Directors as defined in the Internal
Rules of the Board of Directors of LOral and in
accordance with the AFEP-MEDEF Code, the
Directors are subject to compliance with the rules in
force with regard to conflicts of interest and stock
market ethics.
presence of six independent Directors on the Board of
Directors. See also paragraph 7.3.5. on page 226
which concerns agreements relating to shares in the
Companys capital.
Thus, the Directors are under the
obligation of notifying the Board of all
situations constituting a conflict of
interest, even if such conflict is only
potential, and must refrain from
participating
in
the
corresponding
deliberations. In this regard, on the basis
of the declarations made by each
Director, the Board has not identified any
conflict of interests. The information
pursuant to Annex I of European
Regulation No. 809/2004 set out hereafter
contains additional details in this respect.
Information relating to
corporate officers pursuant to
Annex I of European Regulation
No. 809/2004 (see table of
concordance of the
Registration Document in section
9.5. Page 260)
FAMILY RELATIONSHIPS EXISTING
BETWEEN THE CORPORATE OFFICERS
OR DIRECTORS (ARTICLE 14.1 OF THE
ANNEX)
Mrs. Franoise Bettencourt Meyers is Mrs.

Liliane Bettencourts daughter and Mr.
Jean-Pierre Meyers wife. Mr. Jean-Victor
Meyers,
Mrs.
Liliane
Bettencourts
grandson, is the son of Mrs. Franoise
Bettencourt Meyers and Mr. Jean-Pierre
Meyers.
NO CONVICTION OR INCRIMINATION
OF THE CORPORATE OFFICERS AND
DIRECTORS (ARTICLE 14.1 OF THE
ANNEX)
To the Companys knowledge, over the

last five years, the corporate officers and
Directors have not been convicted for
fraud, associated with a bankruptcy,
receivership or liquidation, or the subject
of any official public incrimination or
sanction imposed by statutory or
regulatory
authorities
(including
designated professional bodies) or a
decision by a court disqualifying them
from acting as a member of an
administrative,
management
or
supervisory body or from acting in the
management or conduct of the business
of any issuer.
POTENTIAL CONFLICTS OF INTEREST
BETWEEN THE DUTIES
OF THE CORPORATE OFFICERS AND
DIRECTORS WITH REGARD TO LORAL,
AND THEIR PRIVATE INTERESTS AND/OR
OTHER DUTIES (ARTICLES 14.2 AND 18.3
OF THE ANNEX)
Paragraph 2.2.1.2. on pages 33 et seq.

reviews the situation of each of the
Directors with regard to the independence
criteria provided for in the AFEP-MEDEF
Code.The method of organisation and
modus operandi adopted by the Board
would allow it, where applicable, to
prevent any wrongful exercise of control
by a shareholder, in particular due to the
INFORMATION ON SERVICES CONTRACTS WITH

MEMBERS OF THE ADMINISTRATIVE BODIES (ARTICLE
16.2 OF THE ANNEX)
No corporate officers or Directors have a service

contract with LOral or any of its subsidiaries providing
for the granting of benefits upon termination of such
contract.
Stock market ethics
The Board took cognizance of the rules to be applied to
prevent insider trading, in particular regarding the
periods during which it is prohibited to trade in shares.
It decided to amend its Internal Rules accordingly and
issued recommendations to General
inside information.
Lastly, Directors are required to
notify the Autorit des Marchs
Financiers of each transaction
carried out by them or their close
relatives and friends relating to
LOral shares. The Company
reminds them regularly of this
obligation (see Summary of trading
by Directors and corporate officers
in LOral shares in 2012 in section
2.4. on page 66).
Management
to
update
LOrals
Stock Market Code of
Ethics
and
the
Fundamentals
of
Internal Control.
On the basis of the
legal
provisions,
regulations
and
recommendations,
this code points out
that
inside
information must only
be passed on and
used for professional
purposes.
CORPORATE
OFFICES AND
DIRECTORSHIPS
HELD BY
CORPORATE
OFFICERS AND
DIRECTORS
The Board of Directors complies

with the
AFEP-MEDEF Code of
Inside information is precise information of a non-public
nature,
Corporate
which
which, if made public, could have a significant influence
on the Governance
provides
share price. Such inside information may, in particular,
fall that
into the staggering of the
terms
of office must be organised
one of three main categories: strategic, linked to the
definition
in order linked
to avoid renewal all at
and application of the Groups growth strategy; recurring,
onceofand
favour the harmonious
to the annual schedule for production and publication
annual
renewal
of
the
Directors.
and interim financial
statements, regular
releases or periodic
meetings devoted to
financial information;
exceptional, linked to
a
specific
programme, project
or
financial
transaction.
END OF MRS. LILIANE

BETTENCOURTS TENURE
AS DIRECTOR IN 2012
In
February
2012,
the
Appointments and Governance
Committee placed on record the
end of Mrs. Liliane Bettencourts
tenure as Director and proposed to
the Board, which accepted, the cooptation on the Board of her
grandson, Mr. Jean-Victor Meyers.
The Board of Directors expressed
its profound gratitude to Mrs.
Bettencourt
for
her
active
participation
in
the
Boards
meetings and for the great interest
she has always shown in the
Boards work and that of its
committees.
The Stock Market

Code of Ethics states
that any person in
possession of inside
information
must
proceed with the
greatest
caution
when trading in or
enabling others to
trade
in
LOral
shares,
and
emphasises that any
misconduct in this
area may result in
criminal proceedings.
The Internal Rules of
the Board point out
specifically that a
Director, who has
permanent
insider
status, is requested
to refrain from trading
in LOral shares
precisely in certain
periods and when
he/she has access to
Mrs. Bettencourts loyalty and her

personal support for LOrals
business affairs, her taste for
entrepreneurship, her curiosity for
everything new or modern within
the scope of our businesses, are
not only exceptional, they show her
formidable attachment to this
Company and her desire for it to
enjoy lasting success, in a
changing world. Her unfailing
support
for
the
groups
management, its development and
international success was precious
and exemplary.
47
CORPORATE
GOVERNANCE
The Boards
RENEWAL OF TENURES AS DIRECTORS IN 2012

The Annual General Meeting held on April 17th, 2012
renewed the tenures of Mr. Bernard Kasriel and Mr.
Jean-Pierre Meyers for a term of four years.
APPOINTMENTS OF DIRECTORS IN 2012
The proposal by the Appointments and Governance
Committee to appoint Mr. Jean-Victor Meyers as a
Director of LOral was unanimously acclaimed by the
Board which stressed, on this occasion, the extent to
which the Bettencourt familys strong attachment to
LOral is a considerable asset to ensure its
harmonious development.The Annual General Meeting
on April 17th, 2012 proceeded with the appointment of
Mr. Jean-Victor Meyers as a Director for a term of four
years.
Mr. Werner Bauer and Mr. Francisco Castaer Basco
did not want their tenure to be renewed at the end of
the Annual General Meeting on April 17th, 2012. The
Board of Directors thanked them for their active
participation in all the work of the Board and its
committees over the last few years.
On the proposal of the Appointments and Governance
Committee, the Board of Directors proposed the
appointment of two new Directors, Ms. Christiane
Kuehne and Mr. Paul Bulcke to the Annual General
Meeting on April 17th, 2012. The Annual General
Meeting on April 17th, 2012 appointed them as
Directors for a term of four years.
TENURES AS DIRECTOR THAT ARE DUE TO EXPIRE IN
2013
The tenures as Director of Mrs. Franoise Bettencourt

Meyers, Mr. Peter Brabeck-Letmathe and Mr. Louis
Schweitzer are due to expire at the close of the Annual
General Meeting on Friday, April 26th, 2013. The
renewal of their tenures will be put to the vote of the
shareholders on that occasion.
APPOINTMENT OF A NEW DIRECTOR IN 2013
Once again in 2012, the Appointments and Governance
Committee looked at the changes in its composition in
order to make sure that its composition in 2017 would
be in line with the French Law of January 27 th, 2011
requiring the balanced representation of men and
women, namely a proportion of 40% of Directors of the
same gender. The Board of Directors is already in
advance of this law which provides for a proportion of
20% of women to be reached by 2014 and is doing
everything it can to gradually appoint more female
Directors. In 2012, female representation on the Board
was 21.4%. With the help of the Appointments and
Governance Committee, which has implemented a
selection process in order to prepare the future
proposals which will be presented to the Annual
General Meeting when the time comes, the Board
wishes to increase the representation of women on the
Board as from 2013.
The appointment of Ms. Virginie Morgon will be
proposed to the Annual General Meeting on April 26 th,
2013.
Ms. Virginie Morgon

Age: 43. She worked for 16 years at Lazard, in
particular as an investment banker in New York and
London at the start of her career in 1991 and as a
with Eurazeo, one of the top listed investment

companies in Europe, she is a member of the
Executive Board and was appointed as Chief
Investment Officer in December 2012. She is a
Board member of Accor and Edenred* and a
member of their Audit Committees. Virginie Morgon
is a member of the Board of Directors of the
Womens Forum for the Economy & Society.
Virginie Morgon has concrete experience of the
corporate world as an investor and will provide
LOrals Board of Directors with complementary
experience and skills in this area.
This appointment of Ms. Virginie Morgon as an
independent Director for a term of four years would lead to
an increase in the number of Directors to 15 and the
number of women on the Board to 4, thus leading to a
percentage of representation of women of 26.7% as
opposed to 21.4% in 2012, and the number of independent
Directors to 7, thus giving a percentage of independent
Directors of 46.7% as compared with 42.9% in 2012.
senior partner in Paris from 2001 to 2007. She

advised a large number of French and international
groups on mergers and acquisitions. Since 2008
2.2.2. THE WAYS IN WHICH

THE BOARDS WORK IS
PREPARED
AND
ORGANISED
2.2.2.1.
General information
on Board and Committee

meetings in 2012
COMMITTED DIRECTORS
The preparation and holding of Board meetings and
meetings of its committees require increasing
availability and a significant investment by the
Directors.This has led to an increase in the time
devoted to Committee and Board meetings, and as the
Board of Directors wished in 2011, more Directors
have been involved in the Committees work
throughout the year.
2.2.2.1.1. The activities of the Board of

Directors
* Until March 6th, 2013.
48
The Board constantly strives to apply a modus

operandi that strictly complies with legal requirements,
and is also conducive to good corporate governance.
Appointed by shareholders, the Directors control the
economic and financial management of the Group and
participate in determining its strategy. They review and
approve the main lines of action adopted by the
General Management, which implements them.
The Boards work is based on Internal Rules (published
in paragraph 2.2.2.3. on pages 53 et seq.) designed to
supplement the legal, regulatory and statutory rules
upheld by the Board as a whole and by each Director
individually.The Internal Rules define the modus
operandi of the Board, in the interest of the Company
and all its shareholders, as well as that of its
committees made up of Directors to which it gives
preparatory assignments with regard to its work. These
Internal Rules may be amended by the Board of
Directors to reflect the changes in the laws and
regulations, but also those made in its own modus
operandi. In this case, the new Internal Rules are made
public as soon as possible, initially via LOrals
website.
AND THE COMPANYS COMMITMENTS
ASSIDUOUS ATTENDANCE AT
MEETINGS BY DIRECTORS
In 2012, the Board, with 14 Directors in
office throughout the year, met 7 times (as
opposed to 5 times in 2011). Some
Directors, who were either at the
beginning or the end of their tenures, were
only in office for part of the year. Of the 7
meetings held, 2 extraordinary meetings
were called to examine the organisation of
the Board and an acquisition project.
No variable amounts of attendance fees
were paid for these short meetings, in
accordance with the wishes expressed by all
the Board members.The average attendance
rate was 87.8% in 2012.
Allocation of the attendance fees, which is

made on the basis of attendance by each
Director at Board meetings and presence
on the various Board Committees, is
described in the paragraph 2.3.1. of this
chapter dedicated to Remuneration of the
members of the Board of Directors on
pages 60 et seq.
THE BOARDS WORK FOCUSED ON
BUSINESS ACTIVITIES, STRATEGY
AND THE COMPANYS
ENVIRONMENTAL, SOCIAL AND
SOCIETAL RESPONSIBILITY
COMMITMENTS
In 2012, the Board of Directors carried out
a great deal of work analysing the
components of strategy and following the
business activities in the presence of
several
senior
managers.The
presentation at a Board meeting by a
senior manager gives the Directors the
opportunity to take stock, in an ever more
detailed manner, of an aspect that
characterises its business and its
organisation, enabling them to forge an
opinion and to make their decisions in full
knowledge of the facts.
In this way, in 2012 for example, in the
presence of senior managers, the Board
reviewed and decided on certain acquisition
projects, dealt with issues relating to the
development of the Professional Products
Division and the Consumer Products Division
in France, the strategic orientations for
LOral Luxury, LOrals policy and practices
in the field of Ethics and the evolution of
Digital methods in the Group with regard to
communication and marketing.
Furthermore, as attested to by the

preparatory work of its committees (see
below), the Board examines all the other
aspects of strategy, the Groups economic
and financial management, Human
Resources
and
the
Companys
commitments in the environmental, social
and societal fields.
PROVISION OF INFORMATION TO THE
BOARD ON THE FINANCIAL
SITUATION, THE CASH SITUATION
The financial situation and the cash situation are reviewed

at least twice a year at a Board meeting, at the time of
closing of the annual financial statements and the review of
the interim financial statements or at any other time if
necessary. The balance sheet structure remains solid and
the Group is not in debt.
The Companys commitments are reviewed within the
framework of the annual renewal of the authorisations
given to the Chairman and Chief Executive Officer and the
delegations he makes.
their economic and financial

consequences,
acquisition
opportunities,
and
financial
transactions liable to significantly
change
the
balance
sheet
structure. The committee also
makes sure that the Companys
commitments with regard to
Sustainable Development have
been duly taken into consideration,
in light of the issues specific to the
Groups business activities and its
objectives. Within this framework,
the committee looks at the means
and resources put in place and
reports on them to the Board.
2.2.2.1.2. The activities of the

Board Committees
The
Boards
discussions
and
decisions
are
assisted by the work
performed
by
its
Review Committees,
which report to it after
each
of
their
meetings.
The
committees
were
again
given
responsibility by the
Board for preparing
its deliberations in
2012.
The
membership of these
committees,
their
remits and their work
in 2012 are described
in detail in this
chapter.
In 2012, two new Directors, Mrs.

Franoise Bettencourt Meyers and
Mr. Paul Bulcke joined the
committee, after the end of the
tenures as Director of Mrs. Liliane
Bettencourt and Mr. Francisco
Castaer Basco.
Composition of the Committee
The Boards Committees act strictly within

the framework of the
remits given to them by the Board. They prepare
actively
for its
and make proposals but
they do not
have work
any decision-
making powers.Their
remits are set out in
the Internal Rules of
the
Board
of
Directors (published
in paragraph 2.2.2.3.
on pages 53 et seq.).
THE STRATEGY AND SUSTAINABLE

DEVELOPMENT COMMITTEE
This
committee
clarifies, through its
analyses,
the
strategic orientations
submitted
to
the
Board of Directors
and monitors the
implementation and
progress
of
significant operations
that are under way. It
ensures that the main
financial balances are
preserved. Within this
framework,
the
committee
reviews
the main strategic
lines of development,
options and projects
presented by the
General
Management,
and
The committee, which consists of

seven Directors, is chaired by the
Officer (Mr. Jean-Paul Agon). It is
also composed of two members of
the Bettencourt family (Mrs.
Franoise Bettencourt Meyers and
Mr. Jean-Pierre Meyers), two
members from Nestl (Mr. Peter
Brabeck-Letmathe and Mr. Paul
Bulcke) and two independent
Directors (Mr. Bernard Kasriel and
Mr. Louis Schweitzer). All these
Directors participate in Committee
meetings with complete freedom of
judgment and in the interest of all
the shareholders.
The committee met five times in
2012, with an attendance rate of
91.4%.
The Committees work
As in the past, at each of its
meetings in 2012, the committee
examined the performance of the
latest product launches, analysed
business activities in terms of sales
and income, and discussed the
prospects
and
development
opportunities of the Group and its
Divisions within the scope of
changes
in
markets
and
competition.
Approach to strategy
At the end of the year, in light of all
the performances for the financial
year, it was confirmed that the
Groups development
49
CORPORATE
GOVERNANCE
The Boards
strategy rested in particular on major innovations within

the framework of progress in research and increasingly
international business.
Acquisitions
In 2012, another Director, Ms. Christiane Kuehne, was

appointed to the committee, thus maintaining the
number of Committee members at four, following the
end of Mr. Francisco Castaer Bascos tenure as
Director in 2012.
Throughout the year, acquisition projects were

reviewed by the committee before some of them were
presented to the Board for its decision. Thus, the Board
of Directors authorised the General Management to
enter into strategic acquisitions in 2012. LOral thus
confirmed the acquisition of Cadum in France in April,
the signature of a contract with a view to the acquisition
of the Vogue make-up brand in Colombia in October
and the signature of an agreement for the acquisition of
the Urban Decay make-up brand in the United States
in November.
Sustainable Development
In 2012, the committee reviewed the Sustainable
Development Report firstly in the form of an informative
summary published with the Activity Report and the
Registration Document, and secondly in the form of a
complete website dedicated in particular to professionals
such as investors, analysts, rating agencies or journalists,
etc. The principle of reporting, making it possible to
measure and monitor the performance of the corporate
social, environmental and societal responsibility policies at
LOral, is based on the indicators and the Global
Reporting Initiative (GRI) expert guidance which are
published in full.
In November 2012, LOral was designated by Vigo,

Europes leading analysis and social rating agency, as
the leading company in social responsibility in France.
Cosmetics claims
The committee was informed of the performance
studies in support of the cosmetics claims of the
products sold by the Group. Communication is above
all fair and since and there must be nothing to mislead
the consumer.
The committee reported to the Board on all its work.
THE AUDIT COMMITTEE
The main remit of the Audit Committee involves, in
accordance with the ordinance of December 8th, 2008
and in line with the recommendations made by the AMF
on July 22nd, 2010, monitoring the process for
preparation of financial information, the effectiveness of
the Internal Control and risk management systems, the
statutory audit of the annual and consolidated financial
statements by the Statutory Auditors and finally the
Statutory Auditors independence.
Furthermore, if, in the course of its work, the committee
detects a substantial risk, which in its view is not
adequately dealt with, it warns the Chairman of the Board
accordingly.The committee can also, in agreement with the
General Management, consult other people who may be
able to help it carry out its duties, particularly managers
with economic and financial responsibilities and those in
charge of processing financial information.
The Chairman and Chief Executive Officer is not a

member of the Audit Committee.
From May 23rd, 2008 to February 12th, 2013, the

committee was chaired by Mr. Charles-Henri Filippi, an
independent Director who had recognised financial
expertise. It is also composed of Mr. Jean-Pierre
Meyers, a member of the committee since its creation
in 1999, and Mr. Louis Schweitzer, an independent
Director, appointed as a member of the committee in
2011 and who chairs it since February 12th, 2013. Mr.
Filippi is currently the Chairman of Citigroup for France.
It is noted that Citigroup does not have, and has never
had, a significant position with regard to LOrals
banking transactions. Nevertheless, Charles-Henri
Filippi is aware that he is under the obligation of
notifying the LOral Board of Directors of all situations
constituting a conflict of interest, even if such conflict is
only potential, and that he must refrain from
participating
in
the
corresponding
decisions.
Furthermore, at Citigroup, he will not take part in the
work that is liable to concern LOral. Charles-Henri
Filippi is an independent Director, with no conflicts of
interest, available and competent.
The Directors who are members of the Audit Committee
have the necessary qualifications due to their professional
experience and their good knowledge of the Groups
accounting and financial procedures which are presented
to them on a regular basis. They participate actively in
Committee meetings, with complete freedom of judgment
and in the interest of all the shareholders.
The provision of the AFEP-MEDEF Code that

recommends that two-thirds of the Directors should be
independent has not been adopted inasmuch as the
Company is controlled by two main shareholders.
However, the Board of Directors decided to change the
composition of this committee by appointing another
independent Director, Mr. Louis Schweitzer, to the
committee in 2011 so that half its members are
independent.
The Audit Committee met four times in 2012, in the
presence of all its members. On several occasions, it
interviewed the Vice-President of the Administration
and Finance Division and the senior managers in
charge of the areas in which the Committee reviews
activities, in particular within the scope of the
processes related to risk management and control.
The Statutory Auditors attend meetings. The
committee did not consider it appropriate to use
outside experts.
50
Statutory Auditors
management.
Quality of the results

The committee examines in depth all the
aspects of the Groups annual and interim
results, and the main items on the
Companys balance sheet.
Time frame for provision of documents
Within the scope of the publication of the
annual and interim results, the Audit
Committees meeting relating to the review
of these financial statements is held on a
date close to that of their presentation to the
Board of Directors. But it should be noted
that the Board and its committees are
regularly given the appropriate information to
carry out their supervisory assignment, in
this field in particular. Furthermore, the
corresponding documents are systematically
sent to them prior to the meetings.
Internal Audit and Internal Control

activities
Within the scope of more extensive
control of the data making up the financial
statements, the committee looked at the
Internal Audit Departments activities and
noted that the quality of the organisation
and the results of the assignments were
being constantly improved. The findings
make it possibly to enhance the quality of
the standards, the procedures and the
tools for processing and secure treatment
of information.
In relation with Internal Control, the
committee is informed of the risk map
showing the risks identified on the basis
of an in-depth process of identification
and analysis within the regulatory
framework and within the scope of the
recommendations made by the AMF. The
committee noted that risks are taken into
consideration at operational level, which
is controlled, and that there is a process
for a regular review of risks by the
Executive Committee.
Finally, the committee was informed of the
deployment of a programme to raise
awareness of fraud risk (with the main
operational scenarios that may be
envisaged, the alert procedures and the
existing procedures and controls) which is
aimed at reducing the Groups exposure
to this risk.
Legal risks
The committee is regularly informed of the
legal risks and the potential litigation and
major events liable to have a significant
impact on LOrals financial position and
its assets and liabilities. No major event or
litigation of this kind was noted by the
committee in 2012.
Statutory Auditors opinions
Within the scope of the auditing of the
accounts by the Statutory Auditors, the
committee regularly asked for their
comments and their opinions. Like it does
every year, the committee met with the
outside
the
presence
of

THE APPOINTMENTS AND GOVERNANCE
COMMITTEE
The main remits of the Appointments
and Governance Committee involve
assisting in the decisions made by
the Board with regard to the
conditions of performance of General
Management and the status of the
executive officers, making proposals
to the Board for the choice of
Directors,
discussing
the
classification
of
independent
Directors which is reviewed by the
Board every year before the
publication of the Annual Financial
Report, issuing an opinion on the
proposals of the Chairman of the
Board for the appointment of the
Chief Executive Officer, making sure
that
the
Code
of
Corporate
Governance to which the Company
refers is properly applied, ensuring
the implementation of a procedure for
the preparation of succession plans
for the executive officers in the event
of an unforeseen vacancy and
conducting the reflection process with
regard to the committees that are in
charge of preparing the Boards work
and preparing for the Boards
decisions with regard to the updating
of its Internal Rules.
One of the main

tasks of Research &
Innovation at LOral
is to guarantee the
safety of all products,
without
any
compromise,
and
complete control over
the design quality of
these products. This
is a longstanding
commitment
by
Research
and
Innovation at LOral
with
respect
to
consumers,
professionals
in
Beauty
trades,
distributors
and
employees.
Industrial and environmental risks
In 2012, a meeting was
devoted to industrial
and
environmental
risks, in the presence
of the Executive VicePresident Operations,
the Global Executive Vice-President,
Environment,
Health and
Director of Quality.
2 Safety and the
The priorities are the

quality of products,
impact
on
the
environment,
the
reduction of CO2
emissions, oversight
of
purchases,
monitoring
of
financial
problems,
measurement of lack
of capacity, the social
responsibility
of
suppliers, continuity
of
production,
traceability in the
field of distribution
and
information
systems.

Three Directors are members of
this
committee:
Mr.
Xavier
Fontanet, an independent Director
and Chairman of the committee,
Mr. Jean-Pierre Meyers and Mr.
Peter Brabeck-Letmathe. These
Directors actively participate in
Committee
meetings,
with
complete freedom of judgment and
in the interest of all the
shareholders. The provision of the
AFEP-MEDEF
Code
that
recommends that a majority of the
Directors should be independent
has not been adopted inasmuch as
the Company is controlled by two
main shareholders.
Information Systems Security

The principles adopted by the Group in relation
with Information Systems Security were
presented to the committee, which noted that
LOrals development was taking place through
a solid, durable and innovative infrastructure, in a
secure environment, with costs under control.
Product quality and safety
In 2012, a meeting was devoted to product
quality and safety, in the presence of the
Executive Vice-President, Research & Innovation
and the Global Head - Worldwide Safety
Evaluation & Regulatory Affairs.
51
In 2012, the committee met four times in the

presence of all its members.The Chairman and
Chief Executive Officer can attend Committee
meetings except with regard to any matters on
the agenda that concern him directly.
Unification of duties
The committee examined certain aspects of the
organisation and modus operandi of the Board of
Directors.
In 2011, the committee had recommended to the
Board that it reunify the duties of Chairman with
those of Chief Executive Officer, as all the
conditions were once again met to revert to
reunified duties, a governance model which is
specifically
CORPORATE
GOVERNANCE
The Boards
adapted to LOral and its shareholder structure. In this

chapter of the Registration Document (see pages 31et
seq), the measures put in place to ensure the balance of
powers on the Board of Directors have been described to
show the specific nature and also the effectiveness of the
organisation put in place.
Review of the independence of the Directors

proposes to the Board of Directors every year to
examine on a case-by-case basis the situation of each
of the Directors with regard to their independence
according to the criteria set out in the AFEP-MEDEF
Code.
Renewal of tenures of Directors and
appointment of a Director in 2012
As mentioned in paragraph 2.2.1.2., the committee
made proposals to the Board of Directors for renewals
of tenures and appointments of new Directors
inasmuch as some Directors wanted to end their terms
of office.
Balanced representation of men and women
The Appointments and Governance Committee once
again examined in 2012 the changes in the
composition of the Board in order to be in line, in 2017,
with the French Law of January 27 th, 2011 requiring the
balanced representation of men and women, namely a
proportion of 40% of Directors of the same gender.
Appointment of a new Director in 2013
The Appointments and Governance Committee looked
at the profile of a female candidate for office as a new
Director in 2013 which was approved by the Board of
Directors. The proposed appointment of Ms. Virginie
Morgon is put to the Annual General Meeting on Friday
April 26th, 2013.
Renewal of tenures as Director in 2013
As the tenures as Director of Franoise Bettencourt
Meyers, Peter Brabeck-Letmathe and Louis Schweitzer
are due to expire in 2013, the renewal of their tenures
for a term of four years was proposed to the Board of
Directors, and with the Boards agreement, is being
submitted to the Annual General Meeting.
Continuity of General Management
The committee continued with its work which it begun a
long time ago, reflecting on and proposing the
conditions in which the continuity of LOrals General
Management would be ensured if the Chief Executive
Officer is unable to act.
THE HUMAN RESOURCES AND REMUNERATION
COMMITTEE
The main remits of the Human Resources and

Remuneration Committee are in particular to make
proposals with regard to the remuneration of the
Chairman of the Board of Directors and that of the
Chief Executive Officer, the total amount of the
attendance fees to be submitted for approval to the
Annual General Meeting and the method of distribution
of such fees, and the implementation of long-term
incentive plans such as for example, stock option plans
or plans for free grants of shares.
The committees role has been enlarged to include all the

components of the Human Resources policy such as, for
example, labour relations, recruitment, diversity, talent
management and fostering employee loyalty. The
committee also makes sure that the rules of ethical
conduct, as set out in a Code of Conduct, and the Groups
strong values, such as respect and integrity, are widely
disseminated, known and put into practice.
Four Directors are members of the committee: Mr.

Bernard Kasriel, an independent Director and
Chairman of the committee, Mr. Jean-Pierre Meyers,
Mr. Peter Brabeck-Letmathe and Mr. Charles-Henri
Filippi. These Directors actively participate in
Committee meetings, with complete freedom of
judgment and in the interest of all the shareholders.
The provision of the AFEP-MEDEF Code which
recommends that a majority of the Directors should be
independent has not been adopted inasmuch as the
Company is controlled by two main shareholders.
However, the Board of Directors decided to have the
composition of this committee evolve by appointing an
additional independent Director as a member in 2011,
such that half its members are independent.
In 2012, the committee met four times with an
attendance rate of 93.8%.
The Chairman and Chief Executive Officer can attend
Committee meetings except with regard to any matters
on the agenda that concern him directly.
Remuneration of the corporate officers and
Directors and the conditional grant of
shares to employees
The committee made new proposals to the Board with
regard to the remuneration of the corporate officers,
particularly after the appointment of a Chairman and
Chief Executive Officer (see section 2.3. on page 60)
and proposed to the Board to make a conditional grant
of shares.
Attendance fees
In light of the changes in the remits and work of the
committees, the committee asked the Board to approve
the rules for the allocation of attendance fees, then
proposed the amounts allocated in respect of the 2012
financial year in light of the actual presence of
Directors at Board meetings and on a prorated basis
according to their membership of one or more
committees. For 2012, two short extraordinary Board
meetings were called and were held by telephone for
some of the members. The Board did not want the
Directors to receive the variable portion of attendance
fees for these meetings.
Conditional grant of shares to employees
The committee made proposals to the Board for
changes in the long-term incentives offered to
employees. It wants to make conditional grants of
shares the only instrument in its incentive policy, for all
beneficiaries including the Chairman and Chief
Executive Officer, consequently without any stock
options also being granted.
52
The grants are made after the closing of the

annual financial statements. They associate
those who have made big contributions with
the future evolution of the Groups results
and help to instil a Group spirit by fostering
the loyalty of employees.Vesting of the free
shares depends on the fulfilment of
performance conditions.They align the
interests of beneficiaries with those of the
shareholders, secure employee loyalty and
are a medium- to long-term source of
motivation thanks to long vesting periods
and strict performance conditions in line with
the Groups economic objectives, calculated
over several years.
The vesting period

beneficiaries plus
holding period for
and/ or French
security purposes.
is 4 years for all the

an additional 2-year
French tax residents
residents for social
The free share grants are subject to

performance obligations that the Board
records at the end of the vesting period.
At the time of closing of the annual
financial statements, the Board of
Directors
notes
the
performances
achieved over a period of three full
financial years, i.e. over a long period.
Recognising this performance makes it
possible to set the exact number of
shares which will become the property of
each of the beneficiaries of the free grant
of shares at the date on which the fouryear vesting period comes to an end.
In February 2013, the Board reviewed the
performances for financial years 2012,
2011 and 2010 and recorded that the
performances under the plan for the free
grant of shares of March 2009 had been
achieved.
Human Resources
The committee examined the Groups
resources in terms of talent of both men
and women, at the various brands and in
different countries. The Group has a highquality pool of talent to build LOrals
future success.
Ethics
Following the presentation made in 2011
to the committee, it requested that
LOrals ethical values, integrity, respect,
excellence, courage and transparency be
presented and validated by the Board in
2012. It was stressed that Ethics go
beyond legal obligations and covers
individual and collective discretionary
conduct and decisions, guided by these
values. LOral develops a culture
encouraging ethical behaviour, within the
framework of a widely disseminated
policy, and with significant means devoted
to it.
The committee reported to the Board on
all its work.
This evaluation is carried out within

the framework of the AFEPMEDEF Code, to which the Board
refers
and
market
recommendations like those of the
AMF. On the basis of the summary
of prior individual interviews
between the Director and the
Secretary of the Board of Directors,
such interviews being conducted
on the basis of a guide which sets
out the principles provided for in
the
code
and
the
recommendations,
the
Board
considers the avenues of progress
that still remain open and, at the
end of the discussion that takes
place, adopts the improvement
measures
that
it
considers
appropriate.
The Directors again exercised their complete freedom of
judgment in 2012. This freedom of judgment allowed them to
participate, in total independence,
in the work and collective decisions
of the Board, and, where
applicable,
in
conducting
preparatory work and making
proposals through the Board
Committees.
The Board considered that the
quality of its meetings has
continued to improve, in light of
what were considered as avenues
of progress following the selfevaluation carried out at the end of
2011, particularly with regard to the
strategic challenges faced by the
Group which are regularly debated
and discussed, in the presence of
the senior managers who are
members
of
the
Executive
Committee.
Once again this year, the approach to
strategy was examined in detail in the
course of the Boards work in light of
the development of the brands, the
countries and the markets on which
the Group operates. Thus, the day
spent on strategy at LOral Luxury
was
particularly
appreciated.
Furthermore, the Board made a more
in-depth analysis of performance, in
light in particular of competitors and
the a posteriori review of the
acquisitions made it possible to
monitor the due and proper
application of the decisions made.
In 2012, the Board once again

appreciated the pace, frequency
and format of the information
provided to it in connection with
business activities in general and
the main events in the life of the
Group. Making documentation
available prior to Board or
Committee
meetings,
in
compliance with the requirements
of confidentiality and
the time constraints
with
which
the
Company is faced,
favours the quality of
the debates.
topics to be included on the

agenda for meetings in 2013,
principally in relation with the areas
for development of the Group and
Research
&
Innovation,
the
comparison of strategy with that of
competitors and Human Resources
worldwide.
The Directors made

new proposals of
2.2.2.2. Self-evaluation by the Board

of Directors
Every year, the Board reviews its composition, its
organisation and its modus operandi, in particular
in order to verify that, firstly, under these
conditions, the agenda for its work duly covers
the scope of its assignments and that important
questions have been appropriately prepared for
and discussed and, secondly, to assess the
contribution made by each member to the
Boards work.
53
2.2.2.3. Complete text

of the Internal Rules
of the Board of
Directors
At the beginning of 2011, the Board decided to
update its Internal Rules in order to add to the
remits of two of its committees, give a reminder
of the need to strictly respect the confidentiality
of the information that it is called on to handle
and specify that Board members are prohibited
from trading in the Companys shares during
certain specific periods.
CORPORATE
GOVERNANCE
The Boards
Preamble
These Rules are applicable to all present and future
Directors, and are intended to complement the legal,
regulatory and statutory rules in order to state
accurately the modus operandi of the Board of
Directors and its Review Committees, in the best
interests of the Company and of its shareholders.
LOrals Board of Directors refers to the principles of
corporate governance as presented by the AFEPMEDEF Code.
1.
Duties and authority of the

Board of Directors
1.1. BOARD OF DIRECTORS

The Board of Directors determines the Companys
business strategy and oversees the implementation
thereof.
Subject to the powers expressly conferred during
General Shareholders Meetings and within the limit of
the Companys purpose, the Board deals with all
matters regarding the smooth running of the Company
and settles issues concerning the Company by virtue of
its decisions.
The Board of Directors is a collegial body which
collectively represents all the shareholders and which
is required to act in all circumstances in the interest of
the Company.
The Board of Directors carries out the controls and
verifications it considers appropriate.
The Companys Chairman or Chief Executive Officer
must provide each Director with all of the documents
and information required to carry out his/her duties.
The Board of Directors may entrust one or more of its
members or third parties with special assignments or
projects with a view, inter alia, to examining one or
more specific topics.
It can decide to set up committees responsible for
examining matters submitted by the Board or its
Chairman for their opinion.
The Directors of the Company:
provide their expertise and professional experience;
are required to act with due care and attention, and

have complete freedom of judgement.
This freedom of judgement enables them in particular

to participate, in total independence, in the decisions
and work of the Board, and, where appropriate, of its
Review Committees.
In principle, it is agreed by the Board members that all
Directors will tender their resignation to the Board prior
to the Annual General Meeting following their 73 rd
birthday and that they will no longer apply for renewal
of their tenure if this rule does not enable them to
perform their office for at least two years.
In any event, in accordance with French law and the
Articles of Association, the total number of Directors
who are over 70 years of age may not exceed one third
of the Directors in office.
The staggering of the terms of office is organised in

order to avoid renewal of too many Directors all at
once and favour the harmonious renewal of the
Directors.
1.2. CHAIRMAN OF THE BOARD OF DIRECTORS
The Board of Directors must elect a Chairman from
among its members.
The Chairman of the Board of Directors organises and
oversees the Boards work and reports thereon to the
Shareholders Annual General Meeting.
The Chairman is actively involved in defining the
Companys growth strategy and encourages and
strengthens, inter alia, links between the Company and
the main market players.
The Chairman oversees the work of the Companys
bodies responsible for corporate governance and
ensures, in particular, that the Directors are able to
perform their duties. He may ask for any document or
information that is likely to assist the Board of Directors
in preparing for its meetings.
The Chairman of the Board of Directors must use his
best efforts to promote the values and image of the
Company at all times. The Chairman expresses his
views in that capacity.
He is provided with the material resources required to
perform his duties.
1.3. FORM OF GENERAL MANAGEMENT
The Board of Directors determines the form of the
Companys General Management.
General Management of the Company is carried out,
under his responsibility, by either the Chairman of the
Board of Directors or by another individual appointed
by the Board of Directors with the position of Chief
Executive Officer.
The Board of Directors chooses one of these two forms of
General Management upon the appointment or renewal of
the tenure of the Chairman of the Board or the Chief
Executive Officer.
The Board of Directors consistently aims to ensure the

ongoing and continued implementation by the General
Management of the strategic orientations defined by
the Board.
To this end, the Board entrusts its Chairman with the
task of developing and maintaining an ongoing,
trusting relationship between the Board of Directors
and the Chief Executive Officer.
1.4. POWERS OF GENERAL MANAGEMENT
The Chief Executive Officer, who may be the Chairman
of the Board of Directors or another individual, is
vested with the broadest powers to act in all
circumstances in the name of the Company. He must
exercise these powers within the limit of the
Companys purpose subject to the powers expressly
granted by French law to Shareholders Meetings and
the Board of Directors.
However, transactions which may materially impact the
scope of consolidation of the Company, in particular,
transactions involving an amount in excess of

150,000,000, and all new transactions which are outside
54
the normal course of business, must be submitted to the

Board. In any event, the Board of Directors
the best interest of the Company, and at least 5 times
per year.
must be informed of the conclusion and

implementation of all transactions.
The Chief Executive Officer represents
the Company in its dealings with third
parties.
Upon a proposal by the Chief Executive
Officer, the Board of Directors may
appoint one or more individuals
responsible for assisting the Chief
Executive Officer, who will hold the
corporate office of Deputy Chief Executive
Officer(s).
2.
Modus operandi
Board of Directors
of
the
2.1. CONVENING THE BOARD

The Board is convened by any
appropriate means, and may even be
convened verbally. Notices convening a
meeting may be transmitted by the Board
Secretary.
Except
in
special
circumstances notices convening a
meeting are sent in writing at least eight
days before each meeting.The notices
specify the venue of the meeting, which
may be the registered head office or any
other venue.
2.2. INFORMING DIRECTORS
All the documents that are necessary to
inform the Directors about the agenda
and about any questions submitted to the
Board for review are enclosed with the
notice convening the meeting or are sent
or provided to them within a reasonable
period of time, prior to the meeting.
With regard to the decisions to be taken, the
Director must ensure that he has at his
disposal the information he considers
essential for the Board or the Review
Committees to carry out their work
satisfactorily. If this is not the case, or if he
considers it is not the case, he must request
that the situation is rectified. His requests
should be made to the Chairman of the
Board, who is required to ensure that the
Directors are in a position to fulfil their
mission.
The Company provides its Directors with

useful information at any time in the life of
the Company between Board meetings, if
this is required due to the importance or
urgent nature of the information. This
ongoing information process also includes
all relevant information, including criticism,
with regard to the Company, and in
particular press articles and financial
analysis reports.
The Board is regularly given the
opportunity to meet the Companys main
senior managers.
2.3. BOARD MEETINGS
The Board meets as often as required in
The dates of the Board meetings for the following year

are set no later than the beginning of the summer,
except in the case of Extraordinary Meetings.
2.4. PARTICIPATION
VIDEOCONFERENCE
BY
OR
TELECOMMUNICATION
FACILITIES
In accordance with the legal and regulatory provisions

and with Article 9 paragraph 2 of the Articles of
Association, Directors who take part in Board meetings
by means of videoconference or telecommunication
facilities are deemed to be present for the purpose of
calculating the quorum and the majority.
participating in the Board meeting by means of videoconference

or telecommunication facilities will initial an attendance sheet
on his own behalf and, where applicable, on behalf of the
Director that he represents. The Board Secretary will attach the
attendance sheet to the attendance register, and will gather
wherever possible any items constituting material evidence of
the meeting held by videoconference or telecommunication
facilities.
However, these
facilities may not be
used when the Board
is deliberating on any
of the following
points:
3.
Review Committees
If the Board of Directors sets up

any Review Committees, the
Board will appoint the members of
these committees and determine
their duties and responsibilities.
the closing of the

parent company
financial
statements
and
the consolidated
financial
statements;
The committees act within the

remit granted to them by the Board
and therefore have no decisionmaking power.
the preparation of
the Management
Report, including
the
Group
Management
Report;
The Board may entrust the

Chairman of the committee or one
or more of its members with a
special assignment or project to
carry out specific research or study
future possibilities.
the technical characteristics of the videoconference facilities
must enable the uninterrupted broadcasting ofThe
the debates;
designated individual will
report on this work to the
carried out
before the deliberations begin, a check must be
committee
concerned such that the
to ensure the absence of all third parties, microphones and
committee may deliberate on this
all other items that could compromise the confidential nature
work and in turn report thereon to
of the deliberations.
2.5.
MINUTES
In relation with the performance of
The draft minutes of the previous Board meeting their
are sent duties,
or
the
Review
provided to all Directors at the latest on the day on
which the may contact the
Committees
following meeting is convened.
Companys main senior managers
after informing the Chairman of the
The minutes of the meeting also mention the participation
Board ofofDirectors and provided
Directors by means of videoconference or telecommunication
that they report to the Board in this
facilities.The minutes also indicate whether any technical
respect. incidents
occurred during a meeting held by means of videoconference
or telecommunication facilities, if such incidents disrupted
the
The committees
may in no event
course of the meeting.
take over the powers of the
General Management as set out in
For each site other than the venue of the meeting,
the Director
paragraph
1.4. of these rules.
55
CORPORATE
GOVERNANCE
The Boards
3.1.
AUDIT COMMITTEE
3.1.1. Remit
The Audit Committee, acting under the exclusive,
collective responsibility of the members of the Board of
Directors, is responsible for monitoring issues relating
to the preparation and control of accounting and
financial information.
The Audit Committee must make sure that the General
Management has at its disposal the means to enable it
to identify and manage the economic, financial and
legal risks facing the Group inside and outside France
in carrying out its normal and exceptional operations.
This is in order to avoid the possibility of any
impairment of the value of the Companys assets.
Without prejudice to the areas of authority of the Board of
Directors, this committee is responsible in particular for
monitoring:
a)
the process for preparation of financial information;
b)
the effectiveness of the Internal Control and risk

management systems;
c)
the statutory audit of the annual and, where

applicable, the consolidated accounts by the
Statutory Auditors;
d)
the Statutory Auditors independence.
It makes a recommendation with regard to the

Statutory Auditors proposed to the Annual General
Meeting for appointment.
This audit enables the committee to issue
recommendations, if necessary, concerning the
improvement of existing procedures and the possible
setting up of new procedures.
The Audit Committee can be consulted for all questions
relating to procedures for controlling risks of an
unusual nature, particularly when the Board or the
General Management considers it appropriate to
submit such questions to it.
3.1.2. Work organisation
The Audit Committee is composed of at least three
members, who are non-executive Directors of the
Company.
The Chairman of the Audit Committee issues
guidelines for the committees work each year, based
on his judgement concerning the importance of the
specific types of risk faced, in agreement with the
General Management and the Board.
The committee meets when convened by its Chairman,
each time the Chairman or Board considers this
appropriate, and at least three times per year.
The agenda of the meetings is set by the Chairman of
the committee, in relation with the Board if the latter
initiated the convening of the meeting. The agenda is
sent to the committee members before the meeting,
together with the information which is useful for their
debates.
The secretarial work of the committee is performed by
the Board Secretary.
To carry out its mission, and if it considers it
appropriate, the Audit Committee consults the Statutory

Auditors and the senior managers of the Company, in
particular those responsible for preparing the financial
statements and for the Internal Audit, outside the
presence of General Management.
information, and provide it with the documents required

by law every year.
It reviews the principles and methods, the programme

and the objectives and the general conclusions of the
operational control missions of the Internal Audit
Department.
The Statutory Auditors inform the Audit Committee of:
1)
2)
their general work programme implemented as

well as the various sampling tests they have
carried out;
the changes which they consider should be made
to the financial statements to be closed off or
other accounting documents, making any
appropriate observations on the valuation
methods used to prepare them;
3)
the irregularities and inaccuracies they may have

discovered;
4)
the conclusions resulting from the above

observations and rectifications with regard to the
results for the period compared to those for the
previous period.
The Statutory Auditors also assess, with the Audit

Committee, the risks with regard to their independence
and the protective measures taken to mitigate these
risks.
They inform the committee of significant Internal
Control weaknesses, with regard to the procedures for
preparation and processing of accounting and financial
56
The committee can also, in agreement with the

General Management, consult other people who may
be able to help it carry out its mission, particularly
executives with economic and financial responsibilities,
and those in charge of processing information.
3.1.3. Activity Report
The Audit Committee regularly reports to the Board on
the performance of its missions and takes note of the
Boards observations.
The committee informs the Board without delay of any
difficulty encountered.
In its report, the Audit Committee makes the
recommendations it considers appropriate with regard
to:
the suitability of the various procedures and of the

system as a whole in terms of achieving the
objective of managing information and risk;
the effective application of the procedures in place,

and where appropriate the means implemented to
achieve this aim.
It also formulates in its report all recommendations and

proposals aimed at improving the effectiveness of the
various procedures and the overall system, or at adapting
them to a new situation.
If during its work the committee detects a substantial

risk which in its view is not adequately taken into
account, it warns the Chairman of the Board
accordingly.
3.2.
APPOINTMENTS AND
GOVERNANCE COMMITTEE
3.2.1. Remit
The main missions of the Appointments
and Governance Committee, within the
context of the work of the Board of
Directors, are to:
enlighten the decisions made by the

Board with regard to the conditions of
performance of General Management
and the status of the corporate
officers;
make proposals to the Board for the

choice of Directors;
discuss the status of independent

director which is reviewed by the
Board every year prior to publication of
the Annual Report;
issue an opinion on proposals made

by the Chairman of the Board of
Directors for appointment of the Chief
Executive Officer;
ensure the application of the corporate

governance code to which the
Company refers;
ensure the implementation of a

procedure for the preparation of
succession plans for the corporate
officers in the event of an unforeseen
vacancy;
conduct the reflection process with

regard to the committees that are in
charge of preparing the Boards work;
prepare for the decisions by the Board

with regard to updating its Internal
Rules.

The Appointments and Governance
Committee is composed of at least three
members,
who
are
non-executive
Directors of the Company.
The committee meets when convened by
its Chairman, each time the Chairman or
Board considers this appropriate.
The agenda of the meetings is set by the
Chairman of the committee, in relation
with the Board if the latter initiated the
convening of the meeting.
The committee may meet at any time it
considers to be appropriate, for example
to assess the performance of the
Companys senior managers.
The Chairman of the Board is associated
with its work, except with regard to all the
topics concerning him personally.
Within this framework, the main

missions of the Human Resources
and Remuneration Committee,
within the context of the work of
the Board of Directors, are to make
proposals with regard to the
following in particular:
the fixed and variable remuneration of the Chairman
of the
Board and any other benefits he receives;
the fixed and variable remuneration of the Chief Executive
Officer and any other benefits he receives (pension,
termination indemnities, etc.);
the total amount of attendance

fees to be submitted to the
Annual General Meeting and
the method of distribution of
such fees;
the implementation of long-term

incentive plans, such as for
example, those that could
provide for the distribution of
stock options or for free grants
of shares.
The committee also examines:
all the other components of the

Human Resources policy such
as,
for
example,
labour
relations, recruitment, diversity,
talent
management
and
fostering employee loyalty;
the rules of ethical conduct, as

set out in a code of Conduct,
and the Groups strong values,
such as respect and integrity,
that
must
be
widely
disseminated, known and put
into practice.

The Human Resources and
Remuneration
Committee
is
composed of at least three
members, who are non-executive
Directors of the Company.
The committee meets when
convened by its Chairman, each
time the Chairman or Board
considers this appropriate, and at
least three times per year. The
agenda of the meetings is set by
the Chairman of the committee, in
relation with the Board if the latter
initiated the convening of the
meeting.
The committee may meet at any
time it considers to be appropriate,
for example to assess the
performance of the Companys
senior managers.
The Chairman of the Board is
associated with its

work, except with
regard to all the
topics
concerning
him personally.

The committee must regularly
report on its work to the Board and
makes proposals to the Board.
The committee must regularly report on its work

to the Board and makes proposals to the Board.
3.3. THE HUMAN RESOURCES
AND
REMUNERATION
COMMITTEE
3.3.1. Remit
The Board of Directors freely determines the
remuneration of the Chairman, the Chief
Executive Officer and the Deputy Chief
Executive Officers.
57
3.4. THE
STRATEGY
AND
SUSTAINABLE
DEVELOPMENT COMMITTEE
3.4.1. Remit
The remit of the Strategy and Sustainable
Development Committee is to throw light,
through its analyses and debates, on the
Groups strategic orientations as submitted to the
Board of Directors and to monitor the
implementation and advancement of significant
operations in progress.
CORPORATE
GOVERNANCE
The Boards
The Directors are under the obligation of notifying the
Board of all situations constituting a conflict of interest,
even if such conflict is only potential, and must refrain
from participating in the corresponding deliberations.
The committee examines:
the main strategic lines of development, options

and projects presented by the General
Management, and their economic and financial
consequences;
opportunities for acquisitions or investments which

involve significant amounts or which represent a
departure from the Groups usual business
operations, and the conditions relating to their
implementation;
financial transactions liable to significantly change

the balance sheet structure;
the Companys commitments with regard to

Sustainable Development, in light of the issues
specific to the Groups business activities and its
objectives, and the means and resources put in
place.
More generally, the committee debates all questions

considered essential for the future strategy of the
Group and for preserving its main financial balances.
The Strategy and Sustainable Development Committee
is composed of six LOral Directors. It is chaired by
the Chairman of the Board of Directors.
It meets when convened by the Chairman of the
committee whenever he or the Board considers this
appropriate, and no less than six times annually.
The agenda of the meetings is set by the Chairman of
the committee, in conjunction with the Board of
Directors if the Board initiates the meeting.
The Strategy and Sustainable Development Committee
reports on its work to the Board whenever necessary,
and at least once a year.
4.
Rights and obligations of Directors
4.1. AWARENESS OF AND COMPLIANCE

WITH REGULATORY TEXTS
Each of the members of the Board declares that he is
aware of:
the Companys Articles of Association;
the legal and regulatory texts that govern Socits

Anonymes with a Board of Directors under French
law, especially: the rules on limiting the number of
directorships held, the rules relating to agreements
and transactions concluded between the Director
and the Company;
the definition of the powers of the Board of

Directors; and
the rules relating to the holding and use of

privileged information, which are set out hereafter in
point 4.6.
4.2. RESPECT FOR THE INTERESTS OF THE
COMPANY
The Directors are required to act in all circumstances in

the interest of the Company and all its shareholders.
Outside the Company, only collegial expression is

possible, particularly in the form of releases intended to
provide the markets with information.
4.3. OBLIGATION OF DILIGENCE

The Director must devote the necessary time and
attention to his duties.
He must limit the number of offices held so as to
ensure his availability.
Each Board member undertakes to be diligent:
by attending all Board meetings, where necessary

by means of videoconference or telecommunication
facilities, except in the case of a major impediment;
by attending, wherever possible,

Shareholders General Meetings;
by attending the meetings of the

Committees of which he is a member.
all
the
Review
4.4. TRAINING OF DIRECTORS

Each Director may benefit, on his appointment or
throughout his directorship, from the training
programmes which he deems necessary for the
exercise of his office.
The training programmes are organised and provided
by the Company, and are at its expense.
4.5. OBLIGATION
OF
CONFIDENTIALITY
RESERVE
AND
The Directors undertake not to express themselves

individually other than in the internal deliberations of
the Board on questions raised at Board meetings.
58
With regard to information not in the public domain to

which the Director has access as a result of his duties,
the Director must consider himself to be bound by strict
professional confidentiality, which is more demanding
than the mere obligation of discretion stipulated in
Article L. 225-37, paragraph 5, of the French
Commercial Code. The obligation of discretion applies
to all persons called on to attend Board meetings, and
covers all information of a confidential nature and all
information presented as confidential by the Chairman
of the Board. Beyond this legal obligation and to
ensure the quality of the discussions of the Board of
Directors, the Board has set a rule that all the
information given to Board members and the opinions
they express have to be kept strictly confidential.
4.6.
RULES GOVERNING INSIDER TRADING
4.6.1. Principles
Privileged information must only be used by the
Director in the exercise of his office. Such information
must in no case be communicated to a third party other
than in the exercise of the Directors duties, and for
any other purpose or any other activity than those for
which it is held.
It is the duty of all Directors to refrain from trading in,
having others trade in, and enabling others to trade in
the securities of the Company on the basis of this
information until such time as the information has been
made public.
It is the personal responsibility of each Director to
determine whether the information he holds is
privileged or not, and accordingly whether he may or
may not use or transmit any of
the information, and whether he may or

may not trade or enable trading in the
Companys securities.
4.6.2. Periods of abstention

During the period preceding the
publication of any privileged information to
which Directors have access, in their
capacity of insiders, Directors must by law
refrain from all trading in LOral
securities.
Furthermore, it is prohibited for them, in
accordance
with
the
AMFs
recommendations, to trade in the
Companys shares over the following
periods:
a minimum of 30 calendar days before

the date of publication of the press
release on the annual and half-year
results;
an additional share for Review

Committee members, which
amount is doubled for the
committees Chairman.
The Board of Directors may award

the Directors special remuneration
for
specific
assignments
or
projects entrusted to them.
6.
Annual review of the Boards modus

operandi
Once a year the Board carries out a formal review of its modus
operandi, and where appropriate takes all steps considered
appropriate to improve it. The Board informs the shareholders
accordingly in the Annual Report.
7.
Amendments to the Internal Rules
These Rules may be amended by a decision of the

Board.
a minimum of 15 calendar days before

the date of publication of the press
release
on
quarterly
financial
information.
4.6.3. Insider trading

The Director has been informed of the
provisions in force relating to the holding
of privileged information and insider
trading: Article L. 465-1 of the French
Monetary and Financial Code and Articles
621-1 et seq. of the General Regulations
of
the
French
financial
markets
supervisory authority (AMF).
4.6.4. Obligation of declaring trading
in the securities of the Company
In accordance with the applicable regulations,
the Directors and individuals closely related to
them, as defined by decree, must inform the AMF
of all acquisitions, sales, subscriptions or
exchanges involving the Companys financial
instruments and of transactions involving related
instruments where the cumulative amount of
such transactions is higher than 5,000 for the
calendar year in progress.
The Directors and individuals closely related to
them must submit their declaration to the AMF by
e-mail
([email protected])
within five trading days following completion of
the transaction.
These individuals must simultaneously provide a
copy of this notice to the Secretary of the
Companys Board of Directors.
The declarations are then posted on the AMFs
website and are mentioned in an annual
summary set out in the Companys Management
Report.
4.7. HOLDING OF A MINIMUM NUMBER
OF SHARES Each Director owns at least
1,000 shares in the Company.
2.2.3.
SPECIFI
C TERMS
AND
CONDITIONS
OF
PARTICIPATI
ON BY
SHAREHOLD
ERS
IN THE ANNUAL GENERAL

MEETING
It is to be noted, in accordance with Article 12 of
the Companys Articles of Association, that the
terms and conditions of participation by the
shareholders in Annual General Meetings are
those provided for by the regulations in force,
and that any shareholder may, if the Board of
Directors so decides when calling the Annual
General Meeting, participate in the meeting by
videoconference or by any telecommunication or
remote transmission means including the
Internet, under the conditions provided for by the
applicable regulations at the time of their use.
Where applicable, this decision is communicated
in the meeting notice published in the Bulletin
des Annonces Lgales et Obligatoires
(B.A.L.O.), the official French gazette.
In 2012, the shareholders updated the
Companys Articles of Association in application
of the new regulations, whose purpose is to
simplify the participation by shareholders in
Annual General Meetings.A reference to the
irrevocable nature of proxy forms was thus
removed and a reference to the use of
communication and electronic signatures was
inserted.
registered is the responsibility of the Director.
The decision as to whether or not all or some of

the shares held by the Director should be
5.
Remuneration of the corporate

officers
The Directors receive attendance fees in the

amount approved by the vote at the Ordinary
General Meeting, and which are allocated as
decided by the Board.
The attendance fees are divided between the
Directors as follows:
an equal share allocated to each Director,

comprising a fixed part and a part that varies
according to the degree of regularity in
attending meetings;
2.2.4.
PRINCIPL
ES AND RULES
ADOPTED BY
THE BOARD
OF DIRECTORS TO
DETERMINE THE
REMUNERATION
AND BENEFITS OF
ALL KINDS
GRANTED TO THE
CORPORATE
OFFICERS
The Board refers to the recommendations of the
AFEP-MEDEF Code for the determination of the
remuneration and benefits granted to the
corporate officers.
59
CORPORATE
GOVERNANCE
Remuneration
of the members of the Board of Directors and the corporate offi cers
The Board of Directors constantly wishes to incite

the General Management both to maximise
performance for each financial year and to ensure
that the performance is repeated and remains
steady year after year.
remuneration, ensuring the overall balance of that

remuneration. It is particularly attentive to the
performance assessment criteria and whether
they are in line with the Groups development
objectives.
To ensure that the corporate officers appointed by

the Board are offered remuneration and long-term
incentive instruments that will attract them,
motivate them, and foster their loyalty, the Board
is guided in its reflections by two clear principles:
Based on this approach, and in light of this data,

the Human Resources and Remuneration
Committee makes its proposals to the Board,
which deliberates and makes a collective decision
with regard to each proposal.
cash remuneration must be modulated in

accordance with responsibilities actually
exercised, and must be competitive. It must
also depend, for the determination of the
variable part, partly on the Companys
performance, and on the role played in this
performance by each of the corporate officers,
and partly on qualitative management criteria;
Conditional grants of shares (ACAs), which
have replaced stock options since 2012, are
made to these corporate officers in order to
give them an interest in the long-term
development of the Companys value and its
share price on the stock market, due to their
contribution to this valuation.
In assessing these different components of

remuneration, reference is made to the situation
of executive officers in large international
companies with the position of world leaders and
operating on similar markets. The Human
Resources and Remuneration Committee studies
each component of
At the beginning of the year, the committee

proposes to the Board:
the amount of the variable remuneration

relating to the previous financial year after a
review of each qualitative and quantitative
performance criterion in light of the final
results for the year. For reasons of
confidentiality, the level of performance
achieved is measured precisely by the Board
but cannot be made public;
for the current financial year, the amount of the

fixed remuneration to be paid, and definition of
the objective (value and criteria) determining
the variable remuneration.
The Human Resources and Remuneration

Committee makes proposals for the conditional
grant of shares (ACAs) to the corporate officers
appointed by the Board.
2.3. Remuneration of the members of

the Board of Directors and the
corporate officers
2.3.1. REMUNERATION
OF
THE MEMBERS OF
THE BOARD OF
DIRECTORS
The provisions adopted by the Board in this
regard in September 2003, at the time when the
Board published its Internal Rules for the first
time, are as follows:
The Directors receive attendance fees in the
amount approved by the vote at the Ordinary
General Meeting, and which are allocated as
decided by the Board.
The attendance fees are divided between the
Directors as follow:
an equal share allocated to each Director,

comprising a fixed part and a part that varies
according to the degree of regularity in
attending meetings;
an additional share for Review Committee

members.
In 2012, the Board adopted for a full year: a fixed

annual sum of 30,000; an amount of 5,000 for
each Board meeting which the Director attends; an
amount of 15,000 for each Director who is a
member of the Strategy and Sustainable
Development Committee
and an additional amount of 15,000 for the

Chairman of this committee; an amount of
10,000 for each Director who is a member of the
Human Resources and Remuneration Committee
and the Appointments and Governance
Committee and an additional amount of 10,000
for the Chairman of each of these Committees;
an amount of 25,000 for each Director who is a
member of the Audit Committee and an additional
amount of 25,000 for its Chairman. The Audit
Committees remit is indeed particularly exacting
and requires continued attention and a significant
commitment.
60
A total amount of 1,069,000, which falls within

the total overall amount of 1,300,000 voted by
the Annual General Meeting in 2011, was
distributed to the Directors at the beginning of
2013 in respect of the 2012 financial year, for a
total of seven meetings, i.e. two more than for
2011.
Out of the 7 meetings held in 2012, 2
extraordinary meetings were called to review the
Boards organisation and an acquisition project.
These short meetings were not remunerated in
terms of the variable portion of attendance fees,
according to the Boards wishes.
The attendance rate at Board of Directors
meetings in 2012 is 87.8% on average.
Remuneration of the members of the Board of Directors and the corporate offi cers
Amounts of attendance fees

In euros
2012
(total 7 meetings and
17 Committee meetings)
2011
(total 5 meetings and
17 Committee meetings)
85,000
11,000
64,000
80,000
43,000
23,250
79,000
50,000
55,000
90,000
-------95,000
115,000
75,000
90,000
62,750
50,000
115,000
55,000
55,000
50,000
95,000
110,000
65,000
100,000
-------55,000
115,000
-------61,000
45,000
76,500
Mr. Jean-Paul Agon

Mr. Werner Bauer*
Mrs. Franoise Bettencourt Meyers
Mr. Peter Brabeck-Letmathe
Mr. Paul Bulcke*
Mr. Francisco Castaer Basco*
Mr. Charles-Henri Filippi
Mr. Xavier Fontanet
Mr. Bernard Kasriel
Ms. Christiane Kuehne*
Mr. Marc Ladreit de Lacharrire
Mr. Jean-Pierre Meyers
Mr. Jean-Victor Meyers*
Ms. Annette Roux
Mr. Louis Schweitzer
*
Directors whose term of office began or ended during the 2012 financial year.
Mr. Jean-Paul Agon, Chairman and Chief Executive Officer, does not receive any attendance fees in the LOral Group other than those
referred to above.
2.3.2.
THE
REMUNERATION OF
CHAIRMAN
AND
the main competitors, operating profit plus advertising and

promotion expenses, net earnings per share and cash flow as
compared to 2011;
CHIEF
EXECUTIVE OFFICER
2012:
With regard to the fixed remuneration of Mr. Jean-Paul Agon for 2012, it is to
be noted that at its meeting on February 13 th, 2012 and on the proposal of
the Human Resources and Remuneration Committee, the Board of Directors
had set such remuneration at a gross amount of 2,100,000 on an annual
basis, an amount that was unchanged as compared to 2011.
With regard to the variable part of Mr. Jean-Paul Agons remuneration

for 2012, the Human Resources and Remuneration Committee
examined the conditions of achievement of the objectives giving rise to
the allocation of such amount.
It is specified that the target objective was 2,100,000, as the Board of
Directors had set the same target objective of a variable part of
remuneration that could represent a maximum of 100% of the fixed
remuneration.
The performance assessment criteria had been set as follows:
half based on quantitative objectives relating to the Companys

performance: growth in comparable sales as compared to the
budget, market share as compared to
61
half on the basis of an assessment of the qualitative aspects of

management: the appropriateness of strategic choices, the quality of
leadership and management, the impact of communication, actions
to help society and addressing the specific priorities for the year.
On the proposal of the Human Resources and Remuneration
Committee, the Board decided, at its meeting on February 11th,
2013, to allocate to Mr. Jean-Paul Agon a variable amount of
remuneration 1,785,000 in respect of 2012, i.e. 85% of the target
objective.
Furthermore, at its meeting on April 17 th, 2012, the Board of Directors

granted 50,000 shares (via a Conditional Grant of Shares) to Mr. JeanPaul Agon. The final vesting of these shares is subject to fulfilment of
performance conditions, half based on growth in cosmetics sales as
compared to a panel of competitors and half based on growth in the
Groups consolidated operating profit, and calculated over a period of 3
full financial years.
CORPORATE
RemunerationGOVERNANCE
The table summarising the remuneration of the Chairman and Chief Executive Officer is as follows:
Mr. Jean-Paul Agon

In euros
Fixed remuneration
Variable remuneration (1)
Exceptional remuneration
Attendance fees(2)
Benefits in kind
TOTAL
(1)
(2)
2012
Amounts due
Amounts paid
2,100,000
1,785,000
85,000
3,970,000
2,100,000
1,785,000
79,000
3,964,000
2011
Amounts due
2,100,000
1,785,000
79,000
3,964,000
Amounts paid
2,100,000
1,680,000
55,000
3,835,000
The variable remuneration for year N is paid in year N+1.

Attendance fees for year N are paid in year N+1.
The summary table showing the remuneration, stock options and performance shares awarded to the Chairman and Chief Executive
Officer is as follows:
Mr. Jean-Paul Agon

In euros
Remuneration due in respect of the financial year

Valuation of stock options granted during the financial year
Valuation of performance shares awarded during the financial year
TOTAL
(1)
With regard to the fixed remuneration of Mr. Jean-Paul Agon for

2013, at its meeting on February 11th, 2013, and on the proposal
of the Human Resources and Remuneration Committee, the
Board of Directors set the gross amount of such remuneration at
2,100,000 on an annual basis.
impact of communication, actions to help society and

addressing the specific priorities for the year.
With regard to the variable part of Mr. Jean-Paul Agons

remuneration for 2013, on the proposal of the Human
Resources and Remuneration Committee, the Board of
Directors once again set the target objective of a variable
amount that could represent a maximum of 100% of the fixed
remuneration.
It also decided to maintain the performance assessment criteria
adopted in 2012 considering that these criteria were both
demanding and balanced from a quantative and qualitative
standpoint. Setting the same criteria once again thus falls within
the scope of the policy defined by the Board of Directors with
respect to remuneration: maximising performance year after
year but also encouraging regular performance.
Summary of the performance criteria for the variable amount of
remuneration for 2013:
62
2011
3,964,000
3,716,000(1)
0
7,680,000
Fair value estimated under IFRS used for the preparation of the Companys consolidated financial statements.
NB: The 2011 figure takes into account the waiver by Mr. Jean-Paul Agon of 200,000 stock options allocated under the April 22 nd, 2011 Plan.
2013:
2012
3,970,000
0
3,853,500(1)
7,823,500
half based on quantitative objectives relating to the

Companys performance: growth in comparable sales as
compared to the budget, market share as compared to the
main competitors, operating profit plus advertising and
promotion expenses, net earnings per share and cash flow
as compared to 2012;
half on the basis of an assessment of the qualitative aspects
of management: the appropriateness of strategic choices,
the quality of leadership and management, the
The Annual General Meeting of April 26th, 2013 will be asked to

renew the authorisation for the conditional grant of shares which
expires in 2013. On the basis of this authorisation, the Board of
Directors could decide, in 2013, on a Conditional Grant of
Shares (ACAs) to the Chairman and Chief Executive Officer, in
accordance with the principles and rules adopted to determine
the remuneration and benefits of all kinds granted to the
corporate officers.
2.3.3. STOCK OPTIONS

GRANTED TO THE CHAIRMAN
AND CHIEF EXECUTIVE
OFFICER
See details of the stock option plans in paragraph 7.4.2. Stock
option plans for the subscription and purchase of LOral parent
company shares pages 229 et seq.
No stock options for the subscription or purchase of shares

were granted in 2012 to the Chairman and Chief Executive
Officer.
In fact, the Board of Directors decided in 2012 to replace the grants

of stock options for the subscription or purchase of shares by ACAs
(Conditional Grant of Shares).
In accordance with this policy, the Board of Directors has not
proposed to the Annual General Meeting of April 26 th, 2013 the
renewal of the authorisation to grant stock options for the
subscription or purchase of shares.
Remuneration of the members of the Board of Directors and the corporate offi cers
Stock options granted to the Chairman and Chief Executive Officer which can still be exercised at December 31st, 2012:
The stock options granted by the Board of Directors to Mr. Jean-Paul Agon since his appointment as a corporate officer, and which can
still be exercised at December 31st, 2012, are as follows:
Date of grant
12.01.2006
11.30.2007
03.25.2009
04.27.2010
04.22.2011 (1)
(1)
Number
of options
granted
Number of
options not yet
exercised
1st possible
date of
exercise
Date of expiry
Subscription
price (in )
500,000
350,000
400,000
200,000
500,000
350,000
400,000
200,000
12.02.2011
12.01.2012
04.28.2015
04.23.2016
12.01.2016
11.30.2017
04.27.2020
04.22.2021
78.06 (S)
91.66 (S)
80.03 (S)
83.19 (S)
The Board of Directors allocated 400,000 stock options to Mr. Jean-Paul Agon on April 22 nd, 2011. Mr. Jean-Paul Agon waived 200,000 of these
stock options. He therefore benefits from 200,000 stock options under the Plan decided by the Board of Directors on April 22 nd, 2011.
Mr. Jean-Paul Agon, as a corporate officer, will retain a number of shares

corresponding to 50% of the balance of the shares resulting from the
exercise of the stock options, in registered form, until the termination of
his duties as Chairman and Chief Executive Officer of LOral.
The balance of the shares resulting from the exercise of the stock options
should be understood to mean the total number of shares resulting from
the exercise of stock options minus the number of shares that have to be
sold to finance the exercise of the stock options in question and, where
applicable, the payment of any immediate or deferred taxes, social levies
and costs relating to the exercise of these stock options as applicable at
the date of exercise of the options.
If the number of shares thus determined that must be retained until the
termination of Mr. Jean-Paul Agons duties as Chairman and Chief
Executive Officer is not a whole number of shares, this number of shares
would be rounded down to the nearest lower whole number of shares.
Mr. Jean-Paul Agon has undertaken not to enter into any risk hedging
transactions.
2.3.4. STOCK OPTIONS EXERCISED

DURING THE FINANCIAL YEAR BY
THE CHAIRMAN AND CHIEF
EXECUTIVE OFFICER
Mr. Jean-Paul Agon did not exercise any stock options in 2012.
2.3.5.
CONDITIONAL SHARES (ACAs)
GRANTED TO THE CHAIRMAN AND
CHIEF EXECUTIVE OFFICER
See details of the ACAs plans in paragraph 7.4.3. Plans for the conditional
grant of shares (ACAs) pages 232 et seq.
Within the scope of the authorisation of the Ordinary and Extraordinary General
Meeting of April 22nd, 2011, the Board of Directors decided, on April 17 th, 2012,
on the proposal of the Human Resources and Remuneration Committee, to
make a conditional grant of 50,000 shares (ACAs) to Mr. Jean-Paul Agon,
63
The final vesting of these shares is subject to fulfilment of performance

conditions which will be recorded at the end of a vesting period of 4 years
as from the date of grant.
Half of the number of shares that finally vests will depend on growth in
comparable cosmetics sales as compared to those of a panel of competitors,
such panel consisting of Procter & Gamble, Unilever, Este Lauder, Shiseido,
Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao, Revlon and Elizabeth
Arden; the other half will depend on the growth in LOrals consolidated
operating profit calculated over a period of three full financial years.
Mr. Jean-Paul Agon will retain 50% of the free shares that will be
definitively granted to him at the end of the vesting period in registered
form until the termination of his duties as Chairman and Chief Executive
Officer of LOral.
In light of the significant level of the holding obligations imposed on
LOrals Chairman and Chief Executive Officer at the time of the exercise
of stock options for the subscription of shares and the final vesting of
shares, the Board of Directors decided not to require Mr. Jean-Paul Agon
to purchase an additional quantity of shares of the Company when the
shares granted become available, as recommended by the AFEP-MEDEF
Code.
Furthermore, Mr. Jean-Paul Agon has undertaken not to enter into any risk
hedging transactions.
2.3.6.
COMMITMENTS MADE WITH
REGARD TO THE CHAIRMAN AND CHIEF
EXECUTIVE OFFICER
The Code of Corporate Governance for listed companies, prepared jointly
by the AFEP and the MEDEF, to which LOral refers, recommends that
companies should put an end to the practice of combining an employment
contract with a corporate office (point 19) although it does not impose this
as a mandatory requirement. LOrals Board of Directors shares the
objectives of this recommendation which aims at avoiding the possibility of
concurrently obtaining benefits both from the employment contract and the
corporate office and at prohibiting any interference with the possibility of
removing corporate officers ad nutum. The Board of Directors has formally
provided for the methods of application of the objectives of the
recommendation, as adapted to the professional context in the LOral
Group.
CORPORATE
GOVERNANCE
Remuneration
The Boards intention is to use the treatment set

out below for Mr. Jean-Paul Agon and, in future,
for any new corporate officer appointed who has
over 15 years length of service in the Group at
the time of appointment.
LOrals ongoing policy has been to appoint
employees who have completely succeeded in the
various stages of their careers in the Group as
corporate officers.This is how Mr. Jean-Paul Agon,
then Deputy Chief Executive Officer, was
appointed as Chief Executive Officer of LOral in
April 2006, following a brilliant career spanning 27
years within the Group.
The Board of Directors noted that if, in
accordance
with
the
AFEP-MEDEF
recommendation,
Mr.
Jean-Paul
Agons
employment contract with LOral was to be
terminated, Mr. Agon would lose the status he
acquired as a result of the twenty-seven years he
spent working for the Group as an employee.
The Board did not want Mr. Jean-Paul Agon, who
accepted the office of Chief Executive Officer after
27 years working with LOral, to be deprived of
the benefits to which he would have continued to
be entitled had he remained an employee.
The Board of Directors considered that the
objective pursued by the AFEP-MEDEF
recommendation can be fully achieved by
maintaining the suspension of the employment
contract and clearly separating out the benefits
related to the employment contract on the one
hand from those relating to his corporate office on
the other.
The Board of Directors has decided to eliminate
all right to any indemnity in the event of
termination of the corporate office.
In the event of departure, and depending on the
reasons, Mr. Jean-Paul Agon would only be paid
the dismissal indemnities, except in the event of
gross misconduct or gross negligence, or
retirement indemnities due in the event of
voluntary retirement or compulsory retirement on
the C ompanys initiative pursuant to the
employment contract that has been suspended.
These indemnities, which are attached solely to
termination of the employment contract and in
strict application of the National Collective
Bargaining Agreement for the Chemical Industries
and the company-level agreements applicable to
all LOral senior managers, are due in any event
pursuant to public policy rules of employment
law.They are not subject to any conditions other
than those provided for by the National Collective
Bargaining Agreement for the Chemical Industries
or the above-mentioned
company-level agreements. The same applies to

the non-competition clause and the related
financial consideration.
Remuneration in respect of the corporate office
will in no event be taken into consideration for
calculation of the indemnities due pursuant to the
collective bargaining agreement and the
company-level agreements applicable to all
LOral senior managers.
Mr. Jean-Paul Agon will continue to benefit from
the defined benefit pension scheme currently
applicable to the Groups senior managers, as
described in the paragraph Employee Benefit and
pension schemes and other benefits on page
191.
The reference remuneration to be used to
calculate all the rights attached to the
employment contract and in particular to compute
the pension under the above-mentioned defined
benefit scheme, is based on the amount of
remuneration at the date of suspension of the
employment contract in 2006, namely fixed
remuneration of 1,500,000 and variable
remuneration of 1,250,000.
This reference remuneration is reviewed every
year by applying the revaluation coefficient in
respect of salaries and pension contributions
published by the French State pension fund. As of
January 1st, 2013, the fixed remuneration
amounts to 1,650,000 and variable remuneration
to 1,375,000.
The length of service applied will take into
consideration his entire career, including the
years during which he was Chief Executive
Officer and Chairman and Chief Executive Officer.
Mr. Jean-Paul Agon will continue to be entitled to
benefit from the additional social protection schemes
and in particular the employee benefit and healthcare
schemes available to the Companys employees due
to the fact that he will be treated as a senior manager
throughout the entire period of his corporate office.
The above provisions are subject to the

procedure applicable to regulated agreements
and commitments; this commitment was
approved by the Annual General Meeting on April
27th, 2010 making a decision with regard to the
Special Report prepared by the Statutory
Auditors.
They remain unchanged within the scope of the
appointment of Mr. Jean-Paul Agon as Chairman
and Chief Executive Officer as from March 18th,
2011.
The table set out below, presented in the form recommended by the AMF, clearly shows that there are no
concurrent benefits under the suspended employment contract and the corporate office.
Mr. Jean-Paul Agon (1)
Employment
contract (2)
Yes
No
Supplementary
pension scheme (3)
Yes
No
Indemnities or benefits
due or which may
become due as a result Indemnities relating
of termination or change to a non-competition
of duties(4)
clause (5)
Yes
No
Yes
No
X
(1)
(2)
(3)
Mr. Agon has been a Director since April 25 th, 2006, the date on which he was appointed as Chief Executive
Officer. His tenure was renewed at the Annual General Meeting on April 27 th, 2010. Mr. Agon has been Chairman
and Chief Executive Officer since March 18th, 2011.
Mr. Agons employment contract is suspended throughout the entire length of his corporate office.
Pursuant to his employment contract, Mr. Agon is entitled to benefit from the Garantie de Retraite des Membres du Comit de
Conjoncture (Pension Cover of
the Members of the Comit de Conjoncture) as described on page 191. This defined benefit pension scheme provides that the
building up of rights to benefits is conditional on the beneficiary ending his career in the Company; the financing of this scheme by
LOral cannot be broken down individually by employee.
(4)
(5)
64
No indemnity is due in respect of termination of the corporate office. In respect of the employment contract,
pursuant to the provisions of the National Collective Bargaining Agreement for the Chemical Industries, in the
event of dismissal, except in the case of gross misconduct or gross negligence, the dismissal indemnity would be
capped, in light of Mr. Agons length of service, at 20 months reference remuneration.
In respect of the employment contract, pursuant to the provisions of the National Collective Bargaining Agreement
for the Chemical Industries, in the event of termination of the employment contract, the indemnity due in
consideration of the non-competition clause would be payable every month for two years on the basis of 2/3 of the
monthly reference fixed remuneration unless Mr. Agon were to be released from application of the clause.
SUMMARY TABLE OF THE RECOMMENDATIONS OF THE AFEP-MEDEF CODE

WHICH HAVE NOT BEEN APPLIED
Recommendations of the AFEP-MEDEF Code
(hereinafter the Code)
Independence criteria for the directors (point 8.4 of the Code):
Criterion providing that in order to be considered as independent
a director must not have been a director for more than twelve years.
LOrals practices and justifications

(see section on Corporate officers on page 46)
The Board failed to adopt one of the criteria specified by the AFEP-MEDEF
Code as it considers that the fact that a member has performed a term of
office for over 12 years does not lead to such member losing his independent
status.
Thus, although Mr. Ladreit de Lacharrire has been a Director of LOral for
over 12 years, his professional experience and his freedom of judgment,
combined with good knowledge of the Company, make a big contribution to
the discussions and decisions of the Board. His length of office is
an asset for the Board. It contributes to putting LOrals main
strategic options into perspective.
Indeed, the quality of a director is also measured by his experience,

his skills, his authority and his good knowledge of the Company, which
are all assets which make it possible to conduct a long-term strategy.
Proportion of independent members on the Committees (points
14.1, 15.1 and 16.1 of the Code):
The proportion of independent Directors on the Accounts Committee

must be at least two-thirds.
The Selection or Appointments Committee and the Remuneration Committee
must be composed of a majority of independent Directors.
Period for review of the accounts by the Audit Committee

(point 14.2.1 of the Code):
The time periods for review of the accounts by the Audit Committee must be
sufficient (at least two days before their review by the Board).
The executive officers employment contract (point 19 of the Code):

It is recommended, though not required, that when a senior manager or
executive becomes a corporate officer of the Company,
his/her employment contract with theCompany or another company of the
group should be terminated by agreed termination
or by resignation.
Performance shares (point 20.2.3 of the Code)

In accordance with the terms and conditions set by the Board and
made public at the time of the grant thereof, make the performance
shares granted to the executive officers conditional on the purchase
of a defined quantity of shares when the shares granted become
available.
*
(see the section on The activities of the Board Committees on pages 50, 51
and 52)
This requirement was not complied with concerning these three Committees
inasmuch as the Company is controlled by two main shareholders.
However, for the Audit Committee and the Human Resources and
Remuneration Committee, the Board of Directors decided to have the
composition of these Committees evolve by appointing an additional
independent Director as a member in 2011, such that half their members are
independent.)
(see section on The activities of the Board Committees on page 51)
Within the scope of the publication of the annual and interim results, the Audit
Committees meeting relating to the review of the financial statements is held on a date
close to that of their presentation to the Board of Directors. But it should be noted that
the Board and its Committees are regularly given the appropriate information to carry out
their supervisory assignment, in this field in particular. Furthermore, the corresponding
documents are systematically sent to them prior to the meetings.
(see pages 63 et seq.)

The Board of Directors considered that the objective pursued by this recommendation
can be fully achieved by maintaining the suspension of the employment contract and
clearly separating out the benefits related to the employment contract on the one hand
from those relating to his corporate office on the other. Furthermore, the Board of
Directors has decided to eliminate all right to any indemnity in the event of termination of
the corporate office. This position of the Board applies to the current office of Mr. JeanPaul Agon and, in future, to any new corporate officer appointed who has over 15 years
length of service in the Group at the time of appointment. LOrals ongoing policy has
been to appoint employees who have completely succeeded in the various stages of
their careers in the Group as corporate officers. This is how Mr. Jean-Paul Agon, then
Deputy Chief Executive Officer, was appointed as Chief Executive Officer of LOral in
April 2006, following a brilliant career spanning 27 years within the Group. The Board of
Directors noted that if, in accordance with the AFEP MEDEF recommendation, Mr. JeanPaul Agons employment contract with LOral was to be terminated, Mr. Agon would
lose the status he acquired as a result of the twenty-seven years he spent working for
the Group as an employee. See the position of the AMF*.
(see page 63)

In light of the significant level of the holding obligations imposed on LOrals Chairman
and Chief Executive Officer at the time of the exercise of stock options for the
subscription of shares and the final vesting of shares, the Board of Directors decided not
to require Mr. Agon to purchase an additional quantity of shares of the Company when
the shares granted become available, as recommended by the AFEP-MEDEF Code.
Extract from the AMF 2012 report on corporate governance and executive compensation considering that in this case this requirement was met: The AMF states that it
considers that a company complies with the code when it explains the maintenance of a senior executives employment contract in light of his length of service as an
employee in the Company and his personal situation. (page 72).
65
CORPORATE
GOVERNANCE
Summary of trading
by Directors and corporate offi cers in LOral shares in 2012
2.4. Summary of trading by Directors and

corporate officers in LOral shares in 2012
(Article 223-26 of the General Regulation of the Autorit des Marchs Financiers)
Person concerned
Fonds de dotation Abbaye de Lubilhac, a
legal entity related to Marc Ladreit de
Lacharrire, Director
Date of the
transaction
Nature of the
transaction
Unit price
Total amount
January 12th, 2012

February 28th, 2012
April 17th, 2012
June 7th, 2012
July 2nd, 2012
Sir Lindsay Owen-Jones, Director
Individual related to Sir Lindsay Owen-Jones,
Director
Sale
81.50
Sale
85.12
Sale
92.74
Sale
90.88
Sale
91.96
June 7th, 2012
June 7th, 2012
149,960.00
70,646.53
201,709.50
90,884.90
170,583.32
Sale
90.90
2,809,670.00
Sale
90.64
1,456,028.00
2.5. Internal Control and Risk Management

procedures (Report of the Chairman of the
Board of Directors on Internal Control)
At the request of the Chairman and Chief Executive Officer, the
Administration and Finance Division compiled the information
contained in this report based on the different types of work carried
out by departments working on Internal Control and management
of the Groups risks and which aims at covering the main
operational, legal, industrial, environmental, economic and financial
risks described in section 1.8. on pages 20 to 27.
For the preparation and drafting of this report and the definition of
Internal Control, LOral used the Reference Framework
recommended by the French financial markets authority (the
Autorit des Marchs Financiers) on July 22nd, 2010.
2.5.1.
DEFINITION
OBJECTIVES
OF
AND
INTERNAL
CONTROL
In LOral, Internal Control is a system that applies to the Company
and its consolidated subsidiaries (the Group) and aims at
ensuring that:
economic and financial targets are achieved in compliance with

the laws and regulations in force;
the orientations set by General Management are followed;
the Groups assets are valued and protected;
the Groups financial and accounting information is reliable and

provides true and fair statements.
66
By contributing to preventing and managing the risks to which the

Group is exposed, the purpose of the Internal Control system is to
enable the Groups industrial and economic development to take
place in a steady and sustainable manner in a control environment
appropriate for the Groups businesses. However, no absolute
guarantee can be given that these objectives will be met.
2.5.2. COMPONENTS
SYSTEM
OF
THE
2.5.2.1. The
Internal
Control
organisation and environment
The control environment, which is critical to the Internal Control
system,good risk management and the application of procedures,
is based on people, behaviour and the organisational structure. In
LOral, it forms part of a culture of rigour and commitment
communicated by senior management and is also in line with the
Groups strategic choices.
The Groups values

LOral has built up its business on the basis of strong ethical
values that have guided its development and contributed to
establishing its reputation: Integrity, Respect, Excellence, Courage
and Transparency.
Internal Control and Risk Management procedures
(Report of the Chairman of the Board of Directors on Internal Control)
specific training programme every year.
LOrals Code of Business

Ethics exists in 43 versions (35
different languages) and is also
published in Braille in French
and English. Issued to all
employees
throughout
the
world, it provides insight into
how these values need to be
reflected in the behaviour and
actions of its employees
through simple rules and a
description
of
concrete
situations to which they may be
exposed. Five supplements to
the Code of Business Ethics
have since 2010, covered
certain aspects in more detail.
Respect for these values is
integrated in the appraisal
system for all the employees
through
two
ethical
competencies: Acts/ Leads with
Human Sensitivity and Obtains
results with integrity.
The SVP, Chief Ethics Officer,

who reports directly to the
Officer, is in charge of ensuring
compliance with the Code of
Business Ethics. The Chief
Ethics Officer has a dedicated
budget and team access to all
the information and documents
concerning
the
Groups
activities and can call upon all
the
Groups
teams
and
resources to carry out his
mission. Employees have a
dedicated intranet site which
provides additional information
on
ethics.
Employee
awareness
is
raised
in
particular during an annual
Ethics Day. On Ethics Day in
2012, each Country Manager
discussed ethics with his/her
employees. Around 22,000
employees took part in this
dialogue and over 2,600
questions
were
asked
worldwide.
Moreover,
employees are able to refer
matters to the Chief Ethics
Officer through the LOral
Ethics Open Talk site which
offers a secure reporting
mechanism.
The
network
of
Ethics
Correspondents, whose role is
in particular to assist the
Country Managers in ensuring
compliance with the Code of
Business Ethics, is continuing
to
expand
and
offers
employees in 58 countries a
local contact. The Ethics
Correspondents
follow
a
The ethics training campaign is

continuing. A module on ethics is
included in the Discovery induction
programme for new managers. Ethics
modules have also been incorporated
into 14 corporate and job-specific training
programmes.
Finally, a practical tool for ethical risk
assessment and analysis has been made
available to the Groups entities. An annual
reporting system makes it possible to
monitor implementation of the ethics
program. Country visits and the inclusion of
ethical
questions
in
internal
audit
assignments complete the programme.
Responsibilities with regard to

Internal Control
The Group is organised into worldwide
Divisions and geographical zones, which
are
fully
responsible,
with
the
management of each country, business
unit or industrial entity, for the
achievement of the objectives defined by
the General Management with regard to
Internal Control. The Functional Divisions
bring their expertise to all operational
employees.
Worldwide responsibilities for Internal
Control of the activities of their division or
department are entrusted to each of the
members
of
the
Management
Committee. A system of delegation of
authority is in place and continues to
strengthen. The powers of the legal
representatives of Group companies and
of their delegatees are limited and
controlled in accordance with the
provisions of the Legal Charter.
Centres
offer
technical training and
personal
development
programmes,
including
helping
employees
with
integration
or
management; such
programmes
are
tailored to different
job
profiles
and
aimed at providing
mastery of different
skills in all areas of
activity.
Specialists
in financial
control,
informatio
n systems,
Human
Resources
or
industrial
and
logistics
techniques
provide
support to
operationa
l
employees
at
all
levels
of
the
organisatio
n,
which
makes it
easier to
diffuse
best
practices
of Internal
Control.
Information systems
Human Resources policy

The quality
and skills
of
male
and
female
employees
are
key
componen
ts of the
Internal
Control
system.
Human
Resources
policy
within
LOral is
defined by
the
constant
search for
excellence in recruitment and by the
development
of talent
the
Group, so as to
ensurewithin
that it has
the required level of skills in
all areas.
These
activities
also form
part of the
Groups
diversity
policy,
which
seeks
to
value and
respect
difference
throughout
the
organisatio
n.
Manageme
nt
Developm
ent
Strategic choices in
terms of systems are
determined by the
Group
Information
Systems
Division,
which is responsible
in
particular
for
implementation of a
single
ERP
(Enterprise Resource
Planning),
management
software application
used by the great
majority
of
commercial
subsidiaries,
and
which
issues
instructions
regarding
systems
security.The
worldwide roll-out of
this
integrated
software
package
also contributes to
strengthening
the
reliability and the
security
of
the
process
of
production
of
information, notably
accounting
and
financial information.
In pursuit of the
same objective, the
deployment of an
integrated production
and
management
solution
in
the
Groups
industrial
entities is continuing.
The
procedu
res and
standar
ds
governi
ng the
activitie
s
Each
Functional
Division
has
responsibility, in its
own specific field, for
defining
the
principles
and
standards
applicable
to all the
entities. In
order
to
make
it
easier for
employees
to take on
board all
these
principles
and
standards,
the
key
points
have been
summarise
d in the
Fundame
ntals
of
Internal
Control.
This guide
is
a
reference
framework
for
the
Groups
operational
activities,
and
is
presented
in the form
of
an
information
sheet for
each area.
Each
information
sheet
refers
to
the
detailed
Charters,
Codes and
standards
of
the
Group.
The
information
sheets are regularly
updated,
supplemented,
validated
by
the
experts in each area
of expertise
and
presented to the
Group Management
Committee.A
questionnaire
per
operational function
is
proposed
to
subsidiaries so that
they can make an
assessment
with
regard to their entity,
make
their
own
diagnosis with regard
to Internal Control
and determine the
areas
of
improvement within
their own scope of
activity.
A
management
standard with regard
to segregation of
duties
was
distributed
to
all
entities in 2010. It
defines the main
rules to be observed
in the fields of sales,
purchasing, logistics,
finance,
human
resources
and
information systems
management.
The
application of these
rules is aimed at
better prevention of
the risks of fraud and
reducing
the
probability that errors
(whether intentional
or not) may remain
undetected.
67
CORPORATE
GOVERNANCE
Internal Control
and Risk Management procedures
2.5.2.2. Communication of information inside

the Group
Sharing of information
The brochure Fundamentals of Internal Control has been
circulated individually to the Managing Directors and Finance
Directors in charge of all the consolidated subsidiaries,
including
the
industrial
entities.
Furthermore,
the
Fundamentals, self-diagnosis questionnaires, charters and
standards, together with the information related to the
organisation, changes and instructions from the Functional
Divisions are made permanently available to the subsidiaries
on the Groups intranet sites.
The other means of internal communication
In the area of Human Resources, the requirements related

to personnel management specify the documents to be
provided to employees, the way to book and report
headcount and personnel charges, the procedures for
recruitment, training and appraisal and the rules to be
observed in the field of payroll management.
In the area of purchasing, the Purchasing Code of Ethics

was updated in 2011:The way we buyis the practical and
ethical guide providing guidelines for each employee in
relationships with the Groups suppliers. The standard for
Management of suppliers and tender procedures specify
the conditions for competitive tendering and for the
registration of the main suppliers. The general terms of
purchase are used as the framework for transactions with
suppliers. The Purchase Commitments and Order
Management standard is aimed at facilitating and
strengthening control of the spending and investments of
Group entities.
In the area of safety and quality, procedures relating to the

protection of persons, property and data set out the
principles for covering industrial and logistical risks relating
to organisation and safety. Production quality standards
define rules governing the quality of products, for all stages
from creation to production and distribution. Almost all the
factories are ISO 9001-certified as far as their production is
concerned, ISO 14001-certified for their environmental
policy and OHSAS 1800-certified (or equivalent
certification) for their safety policy.
In the area of the supply Chain, the main assignments

consist in defining and applying the sales planning process,
customer demand management, development and control
of customer service, particularly through management of
physical order fulfilment, application of the general terms of
sale, the follow-up of orders, management of customer
returns and customer disputes as well as accounts
receivable collection procedures. Measures are also
recommended for the management of distribution centres
and inventories, subcontracting, product traceability,
business continuity plan and transport.
In the field of Information Systems, the Group has an

Information Systems Security Policy. Based on the international
ISO 27001 standard, this policy covers the main topics of
Information Systems security, describing the general principles
to be applied for each of them. It enables all the Groups
Information Systems teams, and by extension all the
employees, to share clear objectives, good practices and levels
of control adapted to the risks incurred. This policy is
accompanied by an information systems security audit
programme conducted by an outside firm. It is also
supplemented by an Information and Communication
Technologies code of conduct, and a code of conduct for the
correct use of social media.
In LOral, the risk management system applies to the

Company and its consolidated subsidiaries (the Group).
In order to ensure the sustainability of its development and the
achievement of its objectives, the Group strives to anticipate
and manage the risks to which it is exposed in its different
areas of activity.These risks have been identified in section
1.8. on pages 20 to 27 and the systems put in place to better
anticipate and handle risks are mentioned. In addition, the
Internal Rules of the Board of Directors specify the role played
by the Audit Committee which must make sure that the
General Management has at its disposal the means to enable
it to identify and manage the economic, financial and legal
risks facing the Group inside and outside France in carrying
out its routine and exceptional operations.
On the basis of the work by the Internal Audit Department, the
analysis of major accounting and financial risks, in conjunction
with the processes used by subsidiaries, makes it possible to
identify Internal Control improvements and update the Groups
standards (see Management standards in paragraph 2.5.4.2.
on page 71).
Risk mapping
A risk mapping project concerning all LOrals activities was
finalised in 2011.This process of identification and analysis of
the significant risks and processes enhances the knowledge of
the Groups risks by formalising and consolidating the work
already achieved to date. The results of this work were
presented to the Audit Committee. It is the responsibility of the
Risk Management & Compliance Department, created in 2012,
to lead this process.
The measures recommended by the Group
In each area of activity, the recommended measures with

regard to the key control points are determined by the
Functional Divisions.
Meetings are regularly organised aimed at passing on

information about orientations of the General Management to
managers of the subsidiaries.The Functional Divisions also
coordinate their networks of experts through seminars and
training sessions. A newsletter gives managers regular news
and passes on strong messages with regard to Internal
Control. Finally, through the Internal Control Awards, which
were organised for the first time in 2012, good practices are
identified and shared between the Groups subsidiaries.
2.5.2.3. Risk management
2.5.2.4. Control activities
68
prepared and organised, is applicable
to all employees.
In the legal area, the Legal

Charter
reaffirms
the
obligation to comply with
local legislation and notably
sets
out
the
internal
principles for signature on
behalf of the Company, the
general and specific rules
relating
to
contracts,
trademark law, intellectual
property law, company law
and competition law. A
training tool and practical
guides
concerning
the
issues
related
to
competition
law
and
participation in professional
associations define the
principles to be complied
with and provide answers to
any
questions
which
employees may have in this
area.
In the Insurance field, the
Groups choice is to only
have recourse to first-rate
insurers. The Insurance
Charter issues a reminder
that the Group mainly uses
integrated
worldwide
programmes to cover all its
entities notably against third
party liability, damage to
property and operating
losses resulting from an
insured event. With regard
to insurance of its customer
risk, coverage is put in
place inasmuch as this is
permitted
by
local
conditions.The results of
audits
performed
by
insurance companies in
factories and distribution
centres are used to improve
the Internal Control of these
entities.
In the area of finance and
treasury,
the
Financial
Charter and the exchange
risk management standard
specify, in particular, the
principles to be applied by
Group entities to ensure
that
management
of
exchange risk is both
prudent and centralised.
The standard with regard to
bank powers defines the
process for designating the
persons empowered to sign
to make payments and the
rules for implementation of
those powers. In addition,
the Stock Market Code of
Ethics referred to on page
58
in
the
section
concerning the way in
which the Boards work is
In the area of consolidation and

financial control, the control activities
are described in paragraph 2.5.4.2.
Monitoring
process
for
the
organisation of the accounting and
finance functions on page 71.
2.5.2.5. Ongoing
supervision of
the
Internal
Control
system
The supervision carried out
by the Functional Divisions
Through their network of specialists or via
regular audits, the Functional Divisions
review the functioning of their respective
areas of responsibility: in this way, the
Purchasing Department is responsible for
the oversight with regard to suppliers and
their
working
conditions,
the
Environment,
Health
&
Safety
Department is responsible for checks
related to site safety and environmental
compliance while the Quality Department
measures performance and the progress
made by industrial entities with regard to
the quality of production and finally the
Information
Systems
Department
assesses compliance with the Security
Policy.
Indicators
and
reporting
procedures enable the regular monitoring
of the local activities of most of these
Functional Divisions.
The role of the Internal Audit

Department
Internal Audit is carried out by a central
team that reports directly to the VicePresident of the Administration and
Finance Division. This department carries
out regular assignments to audit major
processes and check on the application
of Group principles and standards.
regard to specific topics. Internal Audit assignments systematicall

lead to the preparation of a report comprising a presentation
of the findings and related risks and making recommendations
regarding the action plan to be put in place by the audited entity.
Internal
Audit
assignmen
ts
are
submitted
to
the
General
Managem
ent
and
the Audit
Committee
for
their
approval
and, with
their
agreement
,
are
included in
an annual
audit plan.
The choice
of
assignmen
ts notably
takes into
account
the
assessme
nt of the
risks
identified.
The size,
the
contributio
n to key
economic
indicators,
the history
of
the
entities
together
with
the
pattern of
their
developm
ent,
are
factors
that
are
also taken
into
considerati
on for the
preparatio
n of the
annual
audit plan.
The Internal Audit Department relies on the support of the Group

integrated ERP software package for the performance of its work
and has developed a certain number of specific transactions
that contribute to increasing the efficiency of its work. Since 2007
complementary assignments aimed at verifying certain key
Internal Control points in the configuration of the ERP software
have been performed with the participation of a systems expert.
The Internal Audit Department carried out 7 such assignments
in 2012.
The action plans decided on further to the audits are followed
up regularly by the Internal Audit Department, which measures
the rate of progress made in the implementation of the
recommendations, weighted by the risk levels applied. The
summary of performance and results of the assignments and
the progress of the action plans are presented to the Audit
Committee every year.
The Internal Audit Department shares the results of its audits with
the Groups Statutory Auditors.The remarks made by the externa
auditors within the scope of their annual audit, are also taken into
consideration by the Internal Audit Department when it carries
out its assignments.
2.5.3.
THE PLAYERS
The main players

involved
in
monitoring Internal
Control and risk
management are:
the General Management and its

Management Committee;
the Audit Committee;
the
Functional
Divisions,
including the Risk
Management and
Compliance
Department, the
Internal Control
Department and
the Internal Audit
Department.
General Management and the

Management
Committee
The role of the

General
Management is to
define the general
The Internal Audit Department carried principles
out 41 assignments
regardingin 2012.
These audits concerned 28 commercial
entities
representing
Internal Control and
approximately 31% of the Groups sales and 5 factories; the
to ensure that they
audited factories represent around 13% of worldwide production
are correctly put in
in units. Furthermore, 8 other assignments were carried out with
place.
69
CORPORATE
GOVERNANCE
Internal Control
Within the scope of their worldwide Internal

Control responsibilities, the members of
the Management Committee rely on
operational and functional managers,
according to their respective areas of
expertise. These managers must ensure
implementation of these general principles
and ensure the correct functioning of
procedures enabling the level of Internal
Control required by General Management
to be attained.
The Audit Committee

The Board of Directors has always
asserted the importance that it attributes,
together with General Management, to
Internal Control and to its main areas of
application. Since its creation, the Audit
Committee has been responsible for
monitoring actions undertaken in the area
of Internal Control and it reports thereon to
the Board of Directors. Its remits are
defined in the Internal Rules of the Board
of Directors in paragraph 2.2.2.3. on pages
53 et seq. of this document.
Each year, the committee performs a
review of the Internal Audit plan, its
objectives and the general conclusions of
Internal Audit assignments. Major Internal
Control projects and initiatives are also
presented to it. The committee then
prepares a report with its own remarks for
The Audit Committees work with regard to
accounting and financial information is
described in paragraph 2.5.4.2 on page
71.
The Functional Divisions

The Functional Divisions each define
guidance and procedures for their own
areas, which they communicate to the
different countries and entities.
The Administration & Finance

Division
This Divisions main role is to assist and
control the operational employees in their
administrative, financial and legal activities.
In order to do so, it sets the operating rules
that apply to all entities in these areas and
is responsible for the definition and
deployment of tools, procedures and best
practices, particularly in the following
areas: financial control, accounting and
consolidation, financing and treasury, tax,
legal affairs, financial communication,
information systems, and insurance. An
Internal Control Committee has the task of
taking all measures to promote the proper
understanding and the proper application
of the Groups Internal Control rules and
also to monitor progress on important
Internal Control projects.
The Risk Management &
Compliance Department
The objective of this Department, which was
created in 2012, is to identify, assess and
prioritise risks with all those concerned, and
keep the risk mapping analysis up-to-date. Its
aim is to promote optimal use of resources to
minimise and control the impact of negative
events and maximise the realisation of
opportunities.
The Operations Division
It ensures continued development of the

network of Internal Control managers in
the Groups entities.
This department, which is separate from
Internal Audit and placed under the
responsibility of the Risk Management and
Compliance Department, ensures the
distribution
and
updating
of
the
Fundamentals of Internal Control guide.
Frequent actions at seminars and during
training cycles and the publication of
newsletters help to increase knowledge of
this tool and to improve its application and
use by operational employees and keep
them informed of the Groups projects and
priorities in the area of Internal Control.
In
addition,
the
Internal
Control
Department also monitors compliance with
regulatory Internal Control obligations on
an ongoing basis.
This Division comprises the Quality, EHS

(Environment,
Health
and
Safety),
Purchasing,
Information
Systems
(production),
Human
Resources
(production), Supply Chain, Production
Organisation, Industrial Management and
Real Estate Departments. It defines
standards and methods applicable in the
areas of production quality, safety and the
environment.
It
assists
operational
employees
in
the
definition
and
implementation of their manufacturing and
logistics policies.
The other Functional Divisions

The following departments are also
involved in Internal Control:
the Human Resources Department;
the
Research
and
Innovation
Department which is responsible in
particular for cosmetovigilance and the
quality of the formulae used in product
composition;
the
Communications,
Sustainable
Development
and
Public Affairs
Department
which
co-ordinates
communications initiatives, prepares
crisis management principles and
ensures that they are applied.
The Internal Audit Department

In addition to its role of supervision of
application of the Internal Control system
(see paragraph 2.5.2.5 on page 69), the
Internal Audit Department carries out
cross-functional analyses with regard to
possible Internal Control weaknesses
based on findings noted during their
assignments. These analyses make it
possible to orient the work of the Internal
Control Committee and to identify the
priority areas for improvement and
strengthening of procedures.
The Internal Control Department

The purpose of this department is to
coordinate implementation of the projects
and work decided by the Internal Control
Committee with the experts in each area of
expertise.The update of the standards
mentioned in paragraph 2.5.2.3. on page
68 and paragraph 2.5.4.2. on page 71 is
an example of its work.
2.5.4.
INTERNAL
CONTROL SYSTEM
RELATING TO THE
PREPARATION
AND PROCESSING
OF FINANCIAL AND
ACCOUNTING
INFORMATION
For the preparation of this report, LOral
based itself on the Application Guide for
Internal Control of accounting and financial
information published by issuers, which is
part of the Reference Framework
published by the AMF on July 22nd, 2010.
70
organisation
of
accounting
This approach is part of an
overall process aimed at
making continual progress and
improving the Internal Control
system that has already been
set up.
2.5.4.1. Definition,
scope and objectives
Internal Control of accounting
and financial fields covers the
processes that contribute to
accounting data: i.e. the
process of production of
financial
information,
the
process of accounts closings
and
actions
of
financial
communication.
The Internal Control system
with regard to accounting and
financial aspects aims to
ensure:
compliance with accounting

regulations and the correct
application of the principles
on which the financial
statements are based;
application of the guidelines

set
by
the
General
Management with regard to
financial information;
protection of assets;
quality of the reporting that

contributes
to
the
preparation of the published
financial statements and
the reliability of their
centralised treatment for
the Group with a view to
their distribution and their
use
for
monitoring
purposes;
control of the production of

financial,
general
and
management
accounting
information including fraud
prevention.
The scope of application of

Internal Control procedures
relating to the preparation and
processing of financial and
accounting
information
encompasses
the
parent
company and all subsidiaries
included in the consolidated
financial statements.
2.5.4.2.
Monitor
ing
process
for
the
the
and
finance functions
Organisation of the Finance
Divisions
Dedicated teams of specialists ensure the
implementation of accounting and
financial
monitoring,
under
the
supervision of the General Management,
in the following areas: accounting,
consolidation, financial control, financial
services and treasury.
In the Administration and Finance
Division, the preparation of the Groups
consolidated results is the responsibility
of the Economic Affairs Department. The
presence of a financial controller at each
level of the organisation contributes to the
strengthening of the Internal Control
system.This network of subsidiary
financial controllers is co-ordinated by the
Economic Affairs Department.
Processing and pooling of cash flows and
hedging of exchange and interest rate
risks are carried out by the Financial
Services Department, which is in charge
of identifying commitments and enabling
their proper booking.
General accounting standards

The Group has put in place a set of
accounting policies and standards, which
all consolidated subsidiaries are required
to apply and which enable uniform,
reliable financial information to be
provided.
These
accounting
policies
are
regularly
updated,
taking into
account
the
changes in
regulations
and
accounting
principles:
accounts
in
the
balance sheet and
the
income
statement but also
the controls and
validations
applicable to the key
processes.
Since
the
major
initiative undertaken
between 2008 and
2010 involving a
review
and
improvement of the
management
standards and the
related
Internal
Control procedures,
these
are regularly
accounting standards set out
the principles
required for
supplemented
and They
harmonised accounting treatment
of transactions.
thus partbalance
of the sheet
specify in particular the methodsare
of recording
continuous
items and of identification and valuation
of off-balance sheet
improvement
commitments. They are in accordance
with IFRS standards,
The
the accounting standards used process.
to prepare the consolidated
purpose
of this Department
work
financial statements. The Groups
Accounting
bothaccounting
to take action
monitors, on an ongoing basis,isnew
standards
in with
response
toalerting
the the
currently under preparation,
a view to
findings
of
the
General Management and anticipating their effects on the
Internal
Audit
Groups financial
Department and to
statements;
cover
the
areas
the
corresponding to the
chart of
accounting
and
account
financial risks of
s, which
subsidiaries.This
is
work has made it
commo
possible to bring our
n to all
approach
more
subsidi
closely into line with
aries,
the
provide
recommendations
s
the
set
out
in
the
definitio
Application
Guide
ns and
relating to Internal
the
Control of accounting
method
and
financial
ology
information of the
for the
AMF
Reference
prepara
Framework.
tion of
the
Organisation and security of
reportin
information systems
g
Decisions
with
require
regard to the choices
d
for
of software that is
the
adapted
to
the
prepara
Groups financial and
tion of
accounting
the
requirements
are
financia
made jointly by the
l
Economic
Affairs
stateme
Department and the
nts.
Information Systems
Department.
Management standards
Managem
ent
standards
not
only
specify the
rules
applicable
to
the
valuation
of certain
significant
At
the
level
of
information systems,
the teams work on
strengthening
the
procedures for the
separation of tasks
and improved control
of access rights.Tools
have
been
made
available to enable
them to ensure that
access
rights
comply
with
the
Groups
rules.
Management tools
The
system for
monthly
reporting
of various
economic
indicators
enables
the
monitoring
of
the
evolution
of
the
performan
ce of each
subsidiary
in
a
continuous
and
harmonise
d manner.
It
also
enables
assurance to be
obtained that such
performance is in
line
with
the
objectives set.
The reporting and
consolidation system,
used by all entities,
ensures
the
consistency
and
reliability of figures at
the level of each
subsidiary
through
blocking controls that
operate before the
financial
data
is
uploaded to Group
level. In this regard,
the operating profit
and loss account by
destination, which is
common
to
both
management
and
general
accounting,
contributes
to
strengthening
the
control of accounts in
the
financial
statements
through
the use of a single
reference framework.
71
CORPORATE
GOVERNANCE
Internal Control
In addition, the Groups organisation,

which is based on reporting from each
subsidiary that is provided directly by the
countries to the parent company, without
any intermediate aggregates for the vast
majority of the subsidiaries, enables
optimisation of the data transfer and the
completeness of the information, and in
particular enables the checking of the
accuracy of the exchange conversion
rates.
The Managing Director and the Finance
Director of each subsidiary make a joint
commitment with regard to the quality,
reliability and completeness of the
accounting and financial information they
have prepared and sent to the Groups
Economic Affairs Department, through a
representation letter that they jointly sign.
The Audit Committee

The role and tasks of the Audit Committee
are described above in paragraph
2.2.2.1.2. on pages 49 et seq.. These
tasks are in compliance with the French
ordinance of December 2008 on the
conditions of application of the 8 th
European Directive on statutory audits of
accounts and are based on the report by
the working group on the Audit Committee
published by the AMF on July 22nd, 2010.
accounting
applied;
the consolidated published accounting

and financial data is harmonised and
properly determined and general
accounting data and Management
Reporting figures used
in the
preparation of the financial information
are consistent.
standards
are
correctly
Financial communication
Managers
in
charge
of
financial
communication prepare a precise timetable
for publication of up-to-date information on
the Group to the financial markets. This
timetable complies with the requirements of
market authorities.These managers ensure,
with the assistance of the Legal Department,
that communications are made within the
required deadlines and in accordance with
laws and regulations, which they constantly
monitor.
Their role is also to publish, precisely and

accurately, the information provided by the
Economic Affairs Department and the
Legal Department. All material information
provided to the financial community
reflects with truth and transparency the
situation and activity of the Group and is
carried out in accordance with the principle
of equal provision of information to all
shareholders.
The Statutory Auditors
2.5.4.3. Processes
used to prepare
accounting
and
financial
information
Operational
processes
contributing to
accounting figures
All of the processes that contribute to
accounting figures, particularly sales and
purchases, and inventory, fixed asset,
payroll and treasury management are
covered by specific procedures, follow-up
checks
and
rules
for
validation,
authorisation and booking operations.
Closing of the accounts,

consolidation and
Management Reporting
information
The accounts closing process is governed by
precise instructions and is based on a
detailed time schedule circulated to all the
subsidiaries to make sure that deadlines are
met and the financial statements are prepared
in a consistent manner. For the preparation of
the
consolidated
financial
statements,
validation procedures apply to each stage of
the process of reporting and processing
information.Their purpose is to verify in

particular that:
inter-company
transactions
are
correctly adjusted and eliminated
(these are reported on a monthly
basis);
consolidation operations are checked;
All accounting and financial information

prepared by consolidated subsidiaries is,
at a minimum, subjected to a limited
review at the time of the half-year closing
process and to a full audit at year-end, by
the external auditors. Twice a year, the
Managing Director and the Finance
Director of each consolidated subsidiary
make a joint commitment as to the true
and fair view, reliability and completeness
of the financial information by jointly
signing a representation letter.
Audit assignments in the countries in which
the Group operates are almost all
entrusted to members of the networks of
72
the two Statutory Auditors who, after

having jointly performed the review of all
the Groups accounts and the manner in
which they were prepared, are responsible
for issuing an opinion on the Groups
consolidated financial statements. The
Statutory Auditors issue an opinion as to
whether
the
consolidated
financial
statements and parent company financial
statements give a true and fair view.They
are kept informed from the early stages of
preparation of the financial statements and
present an overview of their work to the
Groups accounting and finance managers
and to the Audit Committee at the time of
the half-year and annual closing.
Statutory Auditors report, prepared in accordance with article L. 225-235 of the French Commercial Code on the
report prepared by the Chairman of the Board of Directors
2.6. Statutory Auditors report, prepared in

accordance with article L. 225-235 of the French
Commercial Code on the report prepared by the
Chairman
of the Board of Directors
(Year ended December 31st, 2012)

To the Shareholders,
In our capacity as Statutory Auditors of LOral and in accordance with article L. 225-235 of the French Commercial Code ( Code de
commerce), we hereby report to you on the report prepared by the Chairman of your Company in accordance with article L.225-37 of
the French Commercial Code for the year ended December 31st, 2012.
It is the Chairmans responsibility to prepare and submit to the Board of Directors for approval, a report describing the internal control
and risk management procedures implemented by the Company and providing the other information required by article L. 225-37 of the
French Commercial Code in particular relating to corporate governance.
It is our responsibility:
to report to you our observations on the information set out in the Chairmans report on internal control and risk management
procedures relating to the preparation and processing of financial and accounting information, and
to attest that the report sets out the other information required by article L. 225-37 of the French Commercial Code, it being specified
that it is not our responsibility to assess the fairness of this information.
We conducted our work in accordance with professional standards applicable in France.
INFORMATION CONCERNING THE INTERNAL CONTROL AND RISK

MANAGEMENT PROCEDURES RELATING TO THE PREPARATION AND
PROCESSING OF FINANCIAL AND ACCOUNTING INFORMATION
The professional standards require that we perform procedures to assess the fairness of the information on internal control and risk
management procedures relating to the preparation and processing of financial and accounting information set out in the Chairmans
report. These procedures mainly consisted of:
obtaining an understanding of the internal control and risk management procedures relating to the preparation and processing of
financial and accounting information on which the information presented in the Chairmans report is based and of the existing
documentation;
obtaining an understanding of the work performed to support the information given in the report and of the existing documentation;
determining if any material weaknesses in the internal control procedures relating to the preparation and processing of the financial
and accounting information that we may have identified in the course of our work are properly described in the Chairmans report.
On the basis of our work, we have no matters to report on the information given on internal control and risk management procedures
relating to the preparation and processing of financial and accounting information, set out in the Chairman of the Boards report,
prepared in accordance with article L. 225-37 of the French Commercial Code.
OTHER INFORMATION
We attest that the Chairmans report sets out the other information required by article L. 225-37 of the French Commercial Code.
Neuilly-sur-Seine, February 15th, 2013
PricewaterhouseCoopers Audit
Deloitte & Associs
Grard Morin
David Dupont-Noel
This is a free translation into English of the Statutory Auditors report issued in French and is provided solely for the convenience of English speaking readers. This
report should be read in conjunction with, and construed in accordance with, French law and professional auditing standards applicable in France.
73
CORPORATE
GOVERNANCE
Statutory Auditors
Special Report on regulated agreements and commitments with third parties
2.7. Statutory Auditors Special Report on

regulated agreements and commitments with
third parties
(Annual General Meeting held to approve the financial statements for the year ended December 31st, 2012)
In our capacity as Statutory Auditors of your Company, we hereby present our report on regulated agreements and commitments with
third parties.
It is our responsibility to communicate to you, based on information provided to us, the principal terms and conditions of these
agreements and commitments brought to our attention or which we may have identified as part of our engagement, without expressing
an opinion on their usefulness or their merit or searching for other agreements or commitments. Under the provisions of article R. 22531 of the French Commercial Code (Code de commerce), it is the responsibility of the shareholders to determine whether the
agreements and commitments are appropriate and should be approved.
Where applicable, it is our responsibility to communicate to you the information pursuant to article L. 225-31 of the French Commercial
Code relating to agreements and commitments previously approved by the Annual General Meeting during the year.
We performed the procedures that we deemed necessary in accordance with professional standards applicable in France. These
procedures consisted in verifying that the information provided to us is consistent with the underlying documents.
AGREEMENTS AND COMMITMENTS TO BE AUTHORIZED BY THE ANNUAL

GENERAL MEETING
Pursuant to article L.225-38 of the French Commercial Code, we hereby advise you that we have not been informed of any agreements
or commitments signed during the year to be approved by the Annual General Meeting.
AGREEMENTS AND COMMITMENTS AUTHORIZED IN PRIOR YEARS BY THE

ANNUAL GENERAL MEETING
Pursuant to article R. 225-30 of the French Commercial Code, we have been advised that the following agreement, previously approved
by the Annual General Meeting of April 27 th, 2010 and mentioned in our Statutory Auditors special report of February 19 th, 2010, has
remained in effect during the year.
Agreement concerning Jean-Paul Agon
Suspension of Mr Jean-Paul Agons employment contract during the period of his corporate office.
Elimination of all rights to indemnification in respect of Mr Jean-Paul Agons corporate office

In the event of departure, and depending on the reasons, Mr Jean-Paul Agon would only be paid the dismissal indemnities, except in
the event of gross misconduct or gross negligence, or retirement indemnities in the event of voluntary retirement or retirement at the
Companys request due pursuant to the employment contract that has been suspended.These indemnities, which are attached
solely to termination of the employment contract and in strict application of the National Collective Bargaining Agreement for the
Chemical Industries and the company-level agreements applicable to all LOral executives, are due in any event pursuant to public
policy rules. They are not subject to any condition other than those provided for by the National Collective Bargaining Agreement for
the Chemical Industries or the above-mentioned company-level agreements. The same applies to the non-competition clause and
the related financial consideration.
Remuneration in respect of the corporate office will in no event be taken into consideration for calculation of the indemnities due
pursuant to the collective bargaining agreement and the company-level agreements applicable to all LOral executives.
Mr Jean-Paul Agon will continue to benefit from the defined benefit pension scheme currently applicable to the Groups senior
managers.
74
Statutory Auditors Special Report on regulated agreements and commitments with third parties
Terms and conditions relating to the suspension of Mr Jean-Paul Agons employment contract:
the reference remuneration to be used to calculate all the rights attached to the employment contract and in particular to
compute the pension under the defined benefit scheme will be based on the amount of remuneration under the employment
contract when it was suspended in 2006, namely fixed remuneration of 1,500,000 and variable remuneration of 1,250,000.
This reference remuneration is reviewed every year by applying the revaluation coefficient in respect of salaries and pension
contributions published by the French State pension fund. As of January 1st, 2013, the fixed remuneration amounts to 1,650,000
and variable remuneration to 1,375,000;
the length of service applied will take into consideration his entire career, including the years during which he was Chairman
and Chief Executive Officer.
Mr Jean-Paul Agon will continue to benefit from the status of senior manager throughout the period of his corporate office, allowing
him to continue to be entitled to benefit from the additional social protection schemes and in particular the employee benefit and
healthcare schemes available to the Companys employees.
Deloitte & Associs
Grard Morin
David Dupont-Noel
This is a free translation into English of the Statutory Auditors special report issued in French and is provided solely for the convenience of English
speaking readers. This report should be read in conjunction with, and construed in accordance with, French law and professional auditing standards
applicable in France. It should be understood that the agreements reported on are only those provided by the French Commercial Code and the report does
not apply to those related party agreements described in IAS 24 or other equivalent accounting standards.
75
76
KEY FIGURES
AND COMMENTS ON THE

2012 FINANCIAL YEAR
3.1. The Groups business
activities in 2012*
3.1.1. Overview of the results for 2012
3.1.2. Consolidated net sales
3.1.3. Results
78
3.3. Recent events and prospects 93
78
3.3.1. Significant events that have occurred

since the beginning of 2013
93
78
3.3.2. Prospects
93
81
84
3.2.1. 2012 strong growth in sales and profit
84
3.2.2. 2012 Results
86
3.2.3. Consolidated sales by geographic

zone and by business segment
88
3.2.4. Simplified consolidated income

statements
91
3.2.5. Sources and applications of funds
91
3.2.6. Financial ratios
91
3.2.7. LOral 2006-2012
92
This information forms an integral part of the Annual Financial Report as provided for in the article L. 451-1-2 of the
French Monetary and Financial Code.
77
KEYThe
FIGURES
AND COMMENTS
Groups business
activities in 2012ON THE 2012 FINANCIAL YEAR
2012 was a good year for LOral on many fronts. The Group achieved strong
sales growth, and once again demonstrated its ability to outperform the
beauty market, and to gain market share, even in the more difficult markets of
Western Europe and the United States. 2012 was also a very good vintage in
terms of innovations amongst the most remarkable in the industry
in each of our Divisions and major business segments.
2012 also marked a milestone in the acceleration of the Groups internationalisation,
as the New Markets became the number one geographic zone.
Lastly, the profits and cash flow have grown very strongly confirming the power
of our business model.
3.1. The Groups business activities in 2012

3.1.1. OVERVIEW OF
RESULTS FOR 2012
THE
2012 sales: 22.46 billion euros (+10.4% based on reported

figures, +5.5% like-for-like)
Operating profit: +12.3%
Net profit after non-controlling interests: +17.6%
3.1.2.
Like-for-like, i.e. based on a comparable structure and identical

exchange rates, the sales trend of the LOral Group was +5.5%.
The net impact of changes in consolidation amounted to +0.7%.
Currency fluctuations had a positive impact of +4.2%. Growth at
constant exchange rates was +6.2%. Based on reported figures,
the Groups sales, at December 31st, 2012, amounted to 22.463
billion euros, an increase of +10.4%.
Net earnings per share (1) : +13.6%

Increase in dividend: +15% at 2.30 per share
(2)
(1)
Diluted net earnings per share based on net profit excluding non-recurring items attributable to the Group.
(2)
Proposed at the Annual General Meeting of April 26 th, 2013.
78
CONSOLIDATED NET SALES
KEY FIGURES AND COMMENTS ON THE 2012 FINANCIAL YEAR

The Groups business activities in 2012
Sales by Operational Division and by geographic zone

millions
By Operational Division
Consumer Products
LOral Luxe
Active Cosmetics
Cosmetics Total
By geographical zone
Western Europe
North America
New Markets, of which:
Asia, Pacific
Eastern Europe
Latin America
Africa, Middle-East
Cosmetics Total
The Body Shop
Dermatology (1)
GROUP TOTAL
2011/2012 progression
Like-for-like Reported figures
2010
2011
2012
2,717.1
9,529.9
4,506.6
1,385.6
2,813.8
9,835.2
4,800.1
1,421.7
3,002.6
10,713.2
5,568.1
1,528.0
+2.1%
+5.0%
+8.3%
+5.8%
+6.7%
+8.9%
+16.0%
+7.5%
18,139.1
18,870.8
20,811.9
+5.5%
+10.3%
7,181.0
4,291.5
6,666.6
3,192.2
1,398.9
1,517.7
557.8
18,139.1
754.9
601.7
19,495.8
7,246.6
4,406.2
7,218.0
3,619.5
1,336.9
1,680.9
580.7
18,870.8
767.6
704.7
20,343.1
7,399.6
5,210.7
8,201.6
4,287.0
1,405.0
1,826.6
683.0
20,811.9
855.3
795.5
22,462.7
+0.6%
+7.2%
+9.2%
+9.6%
+3.9%
+10.4%
+14.7%
+5.5%
+4.9%
+5.9%
+5.5%
+2.1%
+18.3%
+13.6%
+18.4%
+5.1%
+8.7%
+17.6%
+10.3%
+11.4%
+12.9%
+10.4%
(1) Group share, i.e. 50%.
Professional products
In a market affected by the slowdown in southern European countries, and
the low weight of the New Markets, the Professional Products Division
posted +2.1% like-for-like and +6.7% reported growth in 2012.
In hair colourants, the year-end was marked by the launch of Olia by

Garnier, the first home-use hair colourant to feature ODS technology.
This initiative, which marks a breakthrough in the market, is making a
strong start in Western Europe, and will then be rolled out worldwide.
In the technical products category, the new-generation long-lasting hair

colourant ODS2 (Oil Delivery System) was rolled out worldwide under
the brands INOA2 by LOral Professionnel, Chromatics by Redken
and, at the end of the year, ColorInsider by Matrix.
The facial skincare category is growing, thanks to the worldwide

success of Revitalift Laser by LOral Paris, a major anti-ageing
innovation with a high concentration of Proxylane; and BB Cream by
Garnier, whose success has effectively created a completely new
category.
Haircare is growing strongly, boosted by hair oils, and by the rising

momentum of the Divisions luxury brands: Krastase, with Cristalliste
and with the recent launch of Initialiste, the first beauty serum with plant
stem cells, along with PureOlogy and Shu Uemura Art of Hair.
The Division is making progress in Germany, France and the United

Kingdom, but sales have receded in southern Europe because of a decline
in salon visits. In the United States, the year was marked by SalonCentrics
supply chain reorganisation. The Divisions positions are rising strongly in
the New Markets in Eastern Europe, Asia and the Middle East.
Finally, the make-up category was enlivened by the innovative Volume

Express Mega Plush mascara by Maybelline and by the start of the
internationalisation of the Essie brand.
The Division set a new all-time record for market share in Western
Europe notably in France along with North America. In the New
Markets, the Division is improving its positions in Mexico, Chile,
Indonesia, Thailand and Turkey.
LOral Luxe
Consumer Products
The Consumer Products Division achieved sales growth of +5% like-for-like
and +8.9% based on reported figures, driven by strategic advances in
Western Europe and North America, along with major product initiatives.
Haircare is growing strongly, thanks to the good results of the renewal

of Elvive by LOral Paris, its new Arginine Resist for fragile hair, and
hair oils.
79
In 2012, LOral Luxe sales grew by +8.3% like-for-like and +16% based
on reported figures. In each of the four quarters, the Division significantly
outperformed market growth, thanks especially to the dynamism of
Lancme, and the good performances in Asia and North America.
KEYThe
FIGURES
AND COMMENTS
Groups business
The Lancme brand grew strongly, driven by

innovations in facial skincare with Gnifique
Yeux Light Pearl, and in fragrances with the
launch of La Vie est Belle, the top worldwide
launch of the year in its category and
thanks to the brands new premium luxury
positioning, with Absolue LExtrait. The year
2012 also brought a change of status for Yves
Saint Laurent, which received the Prestige
Brand of the Year award from the American
magazine WWD: the brand is strengthening
its multi-business segment dimension with
the launch of Forever Youth Liberator facial
skincare, the success in make-up of Vernis
Lvres, and more recently, the European
launch of the womens perfume, Manifesto.
The strategic facial skincare category is
growing strongly. The successes of Lancme
are backed up by the powerful worldwide
growth of Kiehls and the growth of Clarisonic
in instrumental cosmetics in the United
States.
Womens fragrances are also being
supported by the launch of Ralph Laurens
Big Pony Collection for Women and by the
rising momentum of Flowerbomb by Viktor &
Rolf.
In make-up, the end of the year was notable
for the launch of Maestro foundation by
Giorgio Armani, with a remarkably innovative
formula, and finally for the acquisition in
December of the Californian make-up brand
Urban Decay.
The Division outperformed the market in all

the major zones and in Travel Retail.
Active Cosmetics
2012 was a particularly good year for the
Division, with sales growth of +5.8% like-for-like,
and +7.5% based on reported figures, which is
roughly twice as fast as the trend in the
dermocosmetics market.
2012 brought a new start for Vichy, driven by

its new brand identity, and strong initiatives
such as Idalia, in skincare, and Dercos
Neogenic, the first hair redensifying treatment
with stemoxydine.
The La Roche-Posay brand, strongly
established with 25,000 dermatologists, is
maintaining its strong growth rate, and has in
fact become the top dermocosmetics brand in
Brazil. Its latest innovation, Redermic-R is
extremely promising.
The Divisions relay brands are making a
strong
contribution
to
its
success.
SkinCeuticals, the premium medical and
professional brand, is continuing its
internationalisation.
Lastly, 2012 was the first-ever year in which

the Division made more than 50% of its sales
outside Western Europe. It also made a
breakthrough in North America, and is
maintaining its strong dynamism in Latin

America.
reported figures. The Group is increasing

market share in the region. While the
selective channel context slowed in the
second half, particularly in South Korea and
in Travel Retail, LOral strengthened its
positions thanks to initiatives by Lancme,
Kiehls and Yves Saint Laurent.
Multi-division summary by
geographic zone
In China, the Group grew faster than the

market, especially with LOral Luxe,
Maybelline and LOral Paris Men Expert.
India, Indonesia and Thailand are particularly
dynamic, driven by local initiatives such as
Colossal Kajal by Maybelline, and the Garnier
Men range.
Western Europe
The European context saw the decline of
markets in the southern countries, particularly in
hair salons and the luxury segment, and the
resilience of the rest of Europe. At 12 months,
LOral sales increased by +0.6% like-for-like,
and +2.1% based on reported figures, thus
raising its market share, particularly in the
Consumer Products Division, which consolidated
its number one position. The Group performed
well, particularly in France where the
acquisition of Cadum fully played its part in the
United Kingdom, in Germany and in Northern
Europe.
Eastern Europe: With sales growth of +3.9%

like-for-like and +5.1% based on reported
figures, the Group is continuing its recovery,
and is once again growing faster than the
market. The turnaround is being driven by the
Professional Products Division, with its
conquest of new hair salons, particularly in
Russia and Poland, and by the Consumer
Products Division, thanks to the success of
Elvive Arginine by LOral Paris and Garnier
ColorSensation hair colourants.
Latin America: LOral achieved like-for-like

growth of +10.4% and +8.7% based on
reported figures, with increased growth in the
second half. In 2012, LOral became the
market leader in Mexico, and expanded its
positions in Chile, Argentina and Uruguay.
LOral accelerated its roll-out in the countries
of Central America, and in Colombia, with the
acquisition of the Vogue brand, the massmarket make-up leader in Colombia. In Brazil,
the initiatives of Elvive Arginine Resist, hair
oils and hair colourants led to an improvement
in positions. The dynamism of the Active
Cosmetics Division in this Zone is also worth
noting.
North America
In North America, LOral ended 2012 with
growth of 7.2% like-for-like and 18.3% based on
reported figures. The good results seen in 2011
were surpassed in 2012. The Consumer
Products Division became n1 in its segment,
thanks to strong growth at Garnier, Maybelline
and Essie. The end of the year was marked by
the strategic launch of LOral Paris Advanced
Hair Care. LOral Luxe outperformed its market,
thanks especially to Clarisonic. The Active
Cosmetics Division significantly increased its
presence in drugstores.
New Markets
Asia, Pacific: LOral achieved annual growth

of +9.6% like-for-like and +18.4% based on
80

The Groups business
activities in 2012
Africa, Middle-East: With growth

of +14.7% like-for-like and
+17.6% based on reported
figures, the Africa, Middle East
Zone
recorded
very good
performances in Turkey, the Gulf
States and the Levant. 2012 was
notable for the rising momentum
of new subsidiaries in Egypt and
Kenya, and the opening of a new
subsidiary in Saudi Arabia.
The Body Shop Sales

2012 was a year of acceleration for The
Body Shop, whose sales grew by
+4.9% like-for-like and +11.4% based
on reported figures.
The brand unveiled its new Beauty

with Heart identity in 2012, and
started rolling out the new Pulse
store concept. In addition, The Body
Shop continued its multi-channel
approach with a strong increase in ecommerce.
In 2012, the brand strengthened its
offering in skincare categories, with
the success of the Chocomania
bodycare range, and in facial
skincare, with the innovative Drops
of Youth.
The Body Shop achieved dynamic
sales in the Middle East and in
south-east Asia, while recording
solid scores in Europe.
Galderma sales
Galderma sales increased
by +5.9% like-for-like and
+12.9% based on reported
figures, with a fourth quarter
which,
as
announced,
reflected the impact of
competition from generics in
prescription
products,
especially in the United
States.
Epiduo (acne) and Oracea
(rosacea) are continuing to
grow in the prescription
products category. Epiduo is
the
worlds
leading
prescription product in the
topical
acne
treatment
market.
Sales of over-the-counter
(OTC) products increased
strongly, driven by Cetaphil
(a hydrating and cleansing
skincare range).
The strong growth of the
Restylane range (dermal
filler) and the success of
Azzalure (muscle relaxant)
have this year once again
helped to make Galderma
one of the world leaders in
the aesthetic and corrective
dermatology market.
Asia and Latin America are growing strongly.
2010
Sales
Cost of sales
Gross profit
Research and development expenses
Advertising and promotion expenses
Selling, general and administrative expenses
OPERATING PROFIT
Gross profit increased by 9.5%; it came out at
70.7% of sales, compared with 71.2% in
2011.As in the 1st semester, the gross profit
underwent the combined effects of the
exchange rate effect due to the weakening of
the euro against the main currencies, of the
impact of the consolidation of the American
company Clarisonic, and of a slight increase
in customer allowances, in the context of
arbitrage with advertising and promotion
expenses.
Research expenses increased strongly at

+9.7%, and remained stable as a
percentage of sales at 3.5%.
81
2011
millions
% 2010 sales
millions
% 2011 sales
mil
19,496
-5,697
13,799
-665
-6,029
-4,049
3,057
100%
29.2%
70.8%
3.4%
30.9%
20.8%
15.7%
20,343
-5,851
14,492
-720
-6,292
-4,187
3,293
100%
28.8%
71.2%
3.5%
30.9%
20.6%
16.2%
22
-6
15
Advertising and promotion expenses

increased by 7.7%; they came out at
30.2% of sales, slightly below the figure
for 2011.
Selling,
general
and
administrative
expenses, at 20.5% of sales, once again
declined by 10 basis points compared with
2011.
Overall, operating profit at 3,697 million
euros, has increased by 12.3%, reflecting
a significant improvement in profitability
compared with 2011, at 30 basis points.
-6
-4
3
KEYThe
FIGURES
AND COMMENTS
Groups business
Operating profit by branch and by Division

2010
(2)
2012
% 2010 sales
millions
% 2011 sales
millions
% 2012 sales
552
1,765
791
278
3,385
-513
2,872
65
119
3,057
20.3%
18.5%
17.5%
20.1%
18.7%
-2.8%
15.8%
8.7%
19.8%
15.7%
579
1,859
926
287
3,651
-546
3,105
68
120
3,293
20.6%
18.9%
19.3%
20.2%
19.3%
-2.9%
16.5%
8.9%
17.0%
16.2%
615
2,051
1,077
311
4,054
-577
3,477
77
143
3,697
20.5%
19.1%
19.3%
20.4%
19.5%
-2.8%
16.7%
9.1%
17.9%
16.5%
By Operational Division
Consumer Products
LOral Luxe
Active Cosmetics
Cosmetics Divisions total
Non-allocated (1)
Cosmetics branch total
The Body Shop
Dermatology branch (2)
GROUP
(1)
2011
millions
Non-allocated = Central group expenses, fundamental research expenses, stock options and free grant of shares expenses and
miscellaneous items. As a % of cosmetics sales.
Group share, i.e. 50%.
The Body Shop continued to improve its profitability by 20 basis

points in 2012, at 9.1%.
The profitability of the Professional Products Division at 20.5% is in line

with 2011.The profitability of the Consumer Products Division and the
Active Cosmetics Division once again improved in 2012. The profitability
of LOral Luxe remained stable in 2012, at 19.3%.
Finally, the profitability of Galderma, at 17.9% of sales, grew by 90

basis points in 2012.
Profitability by geographic zone

2010
Operating profit
Western Europe
North America
New Markets
COSMETICS ZONES TOTAL (1)
2011
2012
millions
% 2010 sales
millions
% 2011 sales
millions
% 2012 sales
1,552
709
1,125
3,385
21.6%
16.5%
16.9%
18.7%
1,513
810
1,328
3,651
20.9%
18.4%
18.4%
19.3%
1,576
960
1,518
4,054
21.3%
18.4%
18.5%
19.5%
(1) Before non-allocated.
Profitability in Western Europe improved by 40 basis points at

21.3%. Profitability in North America remained stable and its
operating profit increased by 18.5%.
Net earnings per share
(1)
Profitability in the New Markets increased by 10 basis points at

18.5%, and their operating profit grew by more than 14%.
: 4.91
millions
Operating profit
Finance Costs excluding dividends received
Sanofi dividends
Pre-tax profit excluding non-recurring items
Income tax excluding non-recurring items
Non-controlling interests
Net profit excluding non-recurring items after non-controlling interests
EPS (1) ()
Diluted average number of shares
(1)
(2)
82
(2)
2010
2011
2012
3,057
-36
284
3,305
-932
-2.3
2,371
4.01
591,392,449
3,293
-25
295
3,563
-978
-2.5
2,583
4.32
597,633,103
3,698
-11
313
4,000
-1,025
-2.7
2,972
4.91
605,305,458
Diluted net earnings per share excluding non-recurring items after non-controlling interests.
Non-recurring items include mainly capital gains and losses on long-term asset disposals, impairment of long-term assets, restructuring costs and elements
relating to identified operational incomes and expenses, non-recurring and significant regarding the consolidated performance. See note 10 of the 2012
Consolidated Financial Statement on pages 117 to 118.

The Groups
business activities in
2012
Total finance costs amounted to 11 million

euros.
Dividends from Sanofi amounted to 313
million euros.
Income tax excluding non-recurring items
amounted to 1,025 million euros,
representing a rate of 25.6%, below the
2011 rate of 27.4%, with the benefit of a
non-recurring fiscal change effect in China.
Net profit excluding non-recurring items

after non-controlling interests amounted to
2,972 million euros, up by 15.1%.
Net earnings per share, at 4.91 euros,
increased by +13.6%.
Net profit after non-controlling interests: 2,868 million

millions
2010
2011
2012
Net profit excluding non-recurring items after non-controlling

interests
Non-recurring items not of tax
Net profit after non-controlling interests
Diluted earnings per share ()
2,371
-131
2,240
3.79
2,583
-145
2,438
4.08
2,972
-104
2,868
4.74
After allowing for non-recurring items,

representing in 2012 a charge, net of tax,
of 104 million euros, net profit after noncontrolling interests amounted to 2,868
million euros, an increase of 17.6%.
After dividend payment and acquisitions

(mainly Cadum and Urban Decay), the
Group recorded, at December 31 st, 2012,
a net cash surplus of 1,575 million euros,
compared with 504 million euros at end2011.
Cash flow
Statement,
Balance sheet
and Net Cash
flow
The balance sheet structure is very solid.

The reinforcement of shareholders equity
compared with end-2011 is mainly the
result of profit allocated to reserves and
the net increase in value of the Sanofi
shares, valued at market price.
Gross cash flow amounted to 3,661 million

euros, an increase of +13.5%.
The working capital requirement increased
modestly, in 2012, by 129 million euros.
Proposed dividend at the

Annual General Meeting of
April 26th, 2013
Inventories declined significantly as a

percentage of sales, at 9.1% at end-2012;
trade accounts receivable also declined, at
14.3% of sales; investments, at 955 million
euros, amounted to 4.3% of sales, an
identical level to 2011. As a result,
operating cash flow increased by 26.4%.
The Board of Directors has decided to

propose to the Annual General Meeting of
April 26th, 2013 the payment of a dividend
of 2.30 per share, an increase of +15%
compared with 2012. This dividend will be
paid on May 10th, 2013 (ex-dividend date
May 7th, 2013 at 0:00a.m., Paris time).
83
KEYFinancial
FIGURES
AND COMMENTS ON THE 2012 FINANCIAL YEAR
highlights

3.2.1.
2012:
PROFIT
STRONG
GROWTH
IN
SALES AND
Consolidated sales
2012 consolidated sales by currency
( millions)
(as %)
Chines
e yuan
Russian rouble
3.2%
19,496
20,343
22,463
6.6%
Euro
26.9%
Canadia
n dollar
3.2%
US
dollar
23.7%
Brazilian real
3.7%
Yen
2.5%
2010
2011
Mexica
n peso
Pound sterling
6.3%
2012
1.9%
Consolidated sales by branch (2)

2010
2011
2012
18,139
755
602
18,871
767
705
20,812
855
796
( millions)
Cosmetics
The Body Shop
Dermatology (3)
Operating profit
( millions)
Pre-tax profit excluding

non-recurring items (4)
Net profit excluding non-recurring

items after non-controlling interests (4)
( millions)
( millions)
3,697
4,000
3,293
3,057
2010
2,583
3,305
2011
2010
2,972
3,563
2012
2011
2010
2,371
2011
2012
2012
(1)
Breakdown of consolidated sales in the main currencies in 2012., i.e. 78% of consolidated sales.
(2)
The Groups business is composed of the cosmetics branch, The Body Shop and the dermatology branch.
(3)
(4)
Non-recurring items include mainly capital gains and losses on long-term asset disposals, impairment of longterm assets, restructuring costs and elements relating to identified operational incomes and expenses, nonrecurring and significant regarding the consolidated performance. See note 10 of the 2012 Consolidated
Financial Statement on pages 117 to 118.
84

Financial highlights
2012 consolidated sales of the cosmetics branch

By Division
By business segment
Active
Cosmetics
7.3%
Western Europe
L'Oral
Luxe
26.8%
Consumer
Products
51.5%
By geographic zone
Skincare
29.1%
Make-up
21.5%
Other(1)
4.6%
Haircare
21.0%
Perfumes
Professional
Products
39.4%
Of which:
Asia, Pacific
52.3%
Hair
9.7%
14.4%
35.6%
New Markets
Colourants
14.1%
North America
25.0%
Eastern Europe
17.1%
Latin America
22.3%
Africa,
Middle East
8.3%
3
A solid balance sheet
( millions)
Assets
Liabilities
29,525
24,044
Non-current assets
17,048
26,858
24,044
19,135 21,316
Current assets
5,446
6,071
6,386
Cash and cash equivalents
1,550
1,652
1,823
2010
2011
14,866 17,638 20,936
1,772
1,591
5,815
2012
Net debt
12.31.2010 12.31.2011
Net financial debt/

Equity
2010
2,033
1,148
6,039
2011
2,172
248
6,168
2012
Short-term ratings
Net cash flow (2)

( millions)
29,525
26,858
12.31.2012
-41
504
1,575 (3)
0.3%
-2.9%
-7.5%
Shareholders equity
Non-current liabilities
Debts (current and non-current)
Current liabilities
A-1
Prime 1
F1
(1)
STANDARD & POORS

MOODYS
June 2012
FITCH RATINGS
June 2012
June 2012
Other includes hygiene products, sales made by American distributors with brands outside of the Group.
(2)
Net cash flow = cash and cash equivalents - current and non-current debt.
(3)
Net cash surplus is of 1,575 million euros.
85
KEYFinancial
FIGURES
highlights
3.2.2.
2012 RESULTS
Sales and operating profit by branch
(1)
Consolidated sales
2011/2012 Evolution
Reported
Like-for-like
figures
2010
2011
2012
Cosmetics
The Body Shop
Dermatology (2)
18,139
755
602
18,871
767
705
20,812
855
796
+5.5%
+4.9%
+5.9%
+10.3%
+11.4%
+12.9%
GROUP TOTAL
19,496
20,343
22,463
+5.5%
+10.4%
Evolution
2012
based on
weight Reported sales
% of sales
millions
Operating profit
millions
2010
2011
2012
Cosmetics
The Body Shop
Dermatology (2)
2,872
65
119
3,105
68
120
3,477
77
143
94%
2.1%
3.9%
+12.0%
+13.9%
+18.8%
16.7%
9.1%
17.9%
GROUP TOTAL
3,057
3,293
3,697
100%
+12.3%
16.5%
Sales and operating profit of the cosmetics branch by Division

Consolidated sales
2011/2012 Evolution
Reported
Like-for-like
figures
millions
2010
2011
2012
2012
weight
Consumer Products
LOral Luxe
Active Cosmetics
2,717
9,530
4,506
1,386
2,814
9,835
4,800
1,422
3,003
10,713
5,568
1,528
14.4%
51.5%
26.8%
7.3%
+2.1%
+5.0%
+8.3%
+5.8%
+6.7%
+8.9%
+16.0%
+7.5%
18,139
18,871
20,812
100%
+5.5%
+10.3%
TOTAL COSMETICS SALES
Operating profit
2010
86
2011
millions
% 2010
sales
Consumer Products
LOral Luxe
Consumer Products
552
1,765
791
278
TOTAL COSMETICS DIVISION

Non-allocated (3)
2012
millions
% 2011
sales
millions
% 2012
sales
20.3%
18.5%
17.5%
20.1%
579
1,859
926
287
20.6%
18.9%
19.3%
20.2%
615
2,051
1,077
311
20.5%
19.1%
19.3%
20.4%
3,385
-513
18.7%
-2.8%
3,651
-546
19.3%
-2.9%
4,054
-577
19.5%
-2.8%
2,872
15.8%
3,105
16.5%
3,477
16.7%
(1)
The Groups business is composed of the cosmetics branch, The Body Shop and the dermatology branch.
(2)
(3)
Non-allocated items consist of the expenses of Functional Divisions and fundamental research, stock option and free grant of shares costs, which
are not allocated to the Cosmetics Divisions. This item also includes non-core activities, such as insurance, reinsurance and banking.

Sales and operating profit of the cosmetics branch by geographic zone

Consolidated sales
2011/2012 Evolution
Reported
Like-for-like
figures
millions
2010
2011
2012
Western Europe
North America
New Markets, of which:
Asia, Pacific
Eastern Europe
Latin America
Africa, Middle East
7,181
4,291
6,667
3,192
1,399
1,518
558
7,247
4,406
7,218
3,619
1,337
1,681
581
7,400
5,211
8,202
4,287
1,405
1,827
683
+0.6%
+7.2%
+9.2%
+9.6%
+3.9%
+10.4%
+14.7%
+2.1%
+18.3%
+13.6%
+18.4%
+5.1%
+8.7%
+17.6%
18,139
18,871
20,812
+5.5%
+10.3%
Operating profit
2010
2011
millions
% 2010
sales
Western Europe
North America
New Markets
1,552
708
1,125
TOTAL GEOGRAPHIC ZONES

Non-allocated (1)
2012
millions
% 2011
sales
millions
% 2012
sales
21.6%
16.5%
16.9%
1,513
810
1,328
20.9%
18.4%
18.4%
1,576
960
1,518
21.3%
18.4%
18.5%
3,385
-513
18.7%
-2.8%
3,651
-546
19.3%
-2.9%
4,054
-577
19.5%
-2.8%
2,872
15.8%
3,105
16.5%
3,477
16.7%
Sales of the cosmetics branch by business segment

Consolidated sales
millions
Skincare
Make-up
Haircare
Hair colourants
Perfumes
Other (2)
(1)
(2)
2010
2011
2012
4,936
3,846
4,017
2,716
1,815
809
18,139
5,257
4,029
4,057
2,760
1,840
928
18,871
6,052
4,468
4,371
2,943
2,010
968
20,812
2011/2012 Evoution
Reported
Like-for-like
figures
+8.0%
+5.7%
+5.0%
+3.2%
+5.6%
-1.1%
+5.5%
+15.1%
+10.9%
+7.8%
+6.6%
+9.2%
+4.4%
+10.3%
Non-allocated items consist of the expenses of Functional Divisions and fundamental research, stock option and free grant of shares costs, which
are not allocated to the Cosmetics Divisions. This item also includes non-core activities, such as insurance, reinsurance and banking.
Other includes hygiene products, sales made by American distributors with brands outside of the Group.
87
KEYFinancial
FIGURES
highlights
3.2.3.
CONSOLIDATED SALES BY GEOGRAPHIC ZONE AND BY BUSINESS
SEGMENT
Professional Products Division

Sales by geographic zone
2010
2011
2012
2012 weight
965.1
982.7
769.3
2,717.1
977.6
1,018.6
817.6
2,813.8
981.6
1,101.5
919.5
3,002.6
32.7%
36.7%
30.6%
100%
2010
2011
2012
2012 weight
973.8
340.8
1,402.6
2,717.1
995.8
322.8
1,495.2
2,813.8
1,048.3
317.3
1,637.0
3,002.6
34.9%
10.6%
54.5%
100%
2010
2011
2012
2012 weight
3,664.9
2,167.4
3,697.6
9,529.9
3,686.2
2,191.9
3,957.1
9,835.2
3,783.0
2,555.7
4,374.5
10,713.2
35.3%
23.9%
40.8%
100%
2010
2011
2012
2012 weight
1,742.5
2,428.6
2,712.9
2,212.6
433.2
9,529.9
1,764.1
2,455.4
2,882.3
2,266.7
466.7
9,835.2
1,894.6
2,650.8
3,189.8
2,487.8
490.2
10,713.2
17.7%
24.7%
29.8%
23.2%
4.6%
100%
millions
Western Europe
North America
New Markets
TOTAL
2011/2012 Evolution
Like-for-like
Reported figures
-1.4%
+0.0%
+9.0%
+2.1%
+0.4%
+8.1%
+12.5%
+6.7%
Sales by business segment
millions
Hair colourants
Styling and textures
Shampoos and haircare
TOTAL
2011/2012 Evolution
Like-for-like
Reported figures
+1.2%
-5.6%
+4.4%
+2.1%
+5.3%
-1.7%
+9.5%
+6.7%
Consumer Products Division

millions
Western Europe
North America
New Markets
TOTAL
2011/2012 Evolution
Like-for-like
Reported figures
+0.9%
+7.9%
+7.1%
+5.0%
+2.6%
+16.6%
+10.6%
+8.9%
millions
Hair colourants
Haircare and styling
Make-up
Skincare
Other
TOTAL
88
2011/2012 Evolution
Like-for-like
Reported figures
+4.4%
+5.8%
+5.7%
+5.1%
-1.4%
+5.0%
+7.4%
+8.0%
+10.7%
+9.8%
+5.1%
+8.9%

LOral Luxe
2010
2011
2012
2012 weight
1,798.7
1,016.4
1,691.4
4,506.6
1,836.2
1,064.8
1,899.1
4,800.1
1,872.4
1,393.0
2,302.7
5,568.1
33.6%
25.0%
41.4%
100%
millions
Western Europe
North America
New Markets
TOTAL
2011/2012 Evolution
Like-for-like
Reported figures
+0.7%
+11.5%
+13.3%
+8.3%
+2.0%
+30.8%
+21.3%
+16.0%
2010
2011
2012
2012 weight
1,753.9
1,730.4
1,022.2
4,506.6
1,991.8
1,754.5
1,053.8
4,800.1
2,481.1
1,928.3
1,158.7
5,568.1
44.6%
34.6%
20.8%
100%
2010
2011
2012
2012 weight
752.3
125.0
508.3
1,385.6
746.6
130.9
544.2
1,421.7
762.5
160.6
604.9
1,528.0
49.9%
10.5%
39.6%
100%
millions
2010
2011
2012
2012 weight
Skincare
Haircare
Make-up
Other
TOTAL
1,056.1
103.3
100.6
125.6
1,385.6
1,092.8
102.3
90.8
135.8
1,421.7
1,181.7
108.8
92.7
144.8
1,528.0
77.3%
7.1%
6.1%
9.5%
100%
millions
Skincare
Perfumes
Make-up
TOTAL
2011/2012 Evolution
Like-for-like
Reported figures
+12.0%
+6.2%
+4.4%
+8.3%
+24.6%
+9.9%
+10.0%
+16.0%
Active Cosmetics Division

millions
Western Europe
North America
New Markets
TOTAL
2011/2012 Evolution
Like-for-like
Reported figures
+1.8%
+13.9%
+9.2%
+5.8%
+2.1%
+22.7%
+11.1%
+7.5%
89
2011/2012 Evolution
Like-for-like
Reported figures
+6.0%
+6.8%
+0.7%
+6.8%
+5.8%
+8.1%
+6.4%
+2.1%
+6.6%
+7.5%
KEYFinancial
FIGURES
highlights
The Body Shop

Retail sales (1)
Western Europe
North America
New Markets
TOTAL
2011/2012 Evolution
Like-for-like
Reported figures
2010
2011
2012
2012 weight
508.8
177.8
607.7
1,294.4
518.9
175.5
649.9
1,344.3
548.1
184.8
737.6
1,470.5
37.3%
12.6%
50.1%
100%
2010
2011
2012
2011/2012 Evolution
Like-for-like
1,294.4
1,175.6
754.9
1,344.3
1,207.3
767.6
1,470.5
1,316.2
855.3
+3.7%
+1.3%
+4.9%
millions
+1.9%
-2.3%
+6.7%
+3.7%
+5.6%
+5.3%
+13.5%
+9.4%
Sales
millions
Retail sales (1)

Retail sales with a comparable store base
CONSOLIDATED SALES
(2)
Number of stores
Company owned stores
Franchisees
TOTAL NUMBER OF STORES
12.31.2010
12.31.2011
12.31.2012
Variation in 2012
1,088
1,517
2,605
1,109
1,639
2,748
1,111
1,726
2,837
+2
+87
+89
Galderma (100% of sales)
2010
2011
2012
2012 weight
260.6
700.6
242.2
1,203.4
376.4
698.9
334.2
1,409.5
397.4
740.2
453.4
1,591
25.0%
46.5%
28.5%
100%
millions
Western Europe
North America
New Markets
TOTAL
90
2011/2012 Growth
Like-for-like
Reported figures
-2.5%
-2.1%
+33.7%
+5.9%
+5.6%
+5.9%
+35.7%
+12.9%
(1)
Total sales to consumers through all channels, including franchisees and e-commerce.
(2)
Total consumer sales made by stores and e-commerce websites that were continuously present between January 1 st and December 31st, 2012 and
the same stores and websites present in 2011, and for the same periods for 2011 and 2010, including franchisees.

3.2.4.
SIMPLIFIED CONSOLIDATED INCOME STATEMENTS
millions
Sales
Gross profit
Research and development
Advertising and promotion
Operating profit
Operational profit
Finance costs excluding dividends received
Sanofi dividends
Income tax
Net profit attributable to owners of the Company
Non-recurring items (expense + / income - )
Net profit excluding non-recurring items after non-controlling interests *
Diluted earnings per share attributable to owners of the company (euros)
Diluted earnings per share attributable to owners of the company
excluding non-recurring items (euros)
12.31.2010
12.31.2011
12.31.2012
19,495.8
13,799.3
-664.7
-6,029.1
-4,048.6
3,056.9
2,903.7
-35.6
283.8
-909.9
-2.3
2,239.7
+131.2
2,370.9
3.79
20,343.1
14,491.6
-720.5
-6,291.6
-4,186.9
3,292.6
3,196.3
-25.2
295.6
-1025.8
-2.5
2,438.4
+144.5
2,582.9
4.08
22,462.7
15,875.0
-790.5
-6,776.3
-4,610.9
3,697.3
3,573.5
-11.0
313.4
-1,005.5
-2.7
2,867.7
+104
2,971.7
4.74
4.01
4.32
4.91
% 2012 sales
100.0%
70.7%
16.5%
* Net profit excluding non-recurring items after non-controlling interests does not include impairment of assets, restructuring costs, tax effects or
non-controlling interests.
3.2.5.
SOURCES AND APPLICATIONS OF FUNDS ( millions)
Net profit
Depreciations, amortisations and provisions

Capital gain or losses on disposals
of assets, changes in deferred taxes and other
2,870
692
99
955
Investments in tangible and intangible assets
2,577
129
Operating cash flow

Changes in working capital requirement
Sources
Applications
Gross cash flow: 3,661
3.2.6.
FINANCIAL RATIOS
2010
2011
2012
15.7%
16.2%
16.5%
17.4%
17.4%
16.9%
0.3%
4.7x
-2.9%
3.7x
-7.5%
3.8x
(% of sales)
Operating profit/Sales
(% of shareholders equity)
Net profit excluding non-recurring items after non-controlling interests/Opening shareholders

equity
(% of shareholders equity)
Net gearing (1)

Gross cash flow/Investments
(1) Net gearing = Current and non-current debt Cash and cash equivalents Shareholders equity after noncontrolling interests
91
KEYFinancial
FIGURES
highlights
3.2.7.
LORAL 2006-2012
millions
2006
2007 (1)
2008 (1)
2009
2010
2011
2012
Results
Consolidated sales
15,790
17,063
17,542
17,473
19,496
20,343
22,463
Operating profit
2,541
2,827
2,725
2,578
3,057
3,293
3,697
As a percentage of consolidated sales
16.1%
16.6%
15.5%
14.8%
15.7%
16.2%
16.5%
Profit before tax and non-controlling interests
2,638
2,896
2,788
2,749
3,305
3,563
4,000
Net profit excluding non-recurring items after
non-controlling interests
1,833
2,039
2,064
1,997
2,371
2,583
2,972
Net profit attributable to owners of the
company
2,061
2,656
1,948
1,792
2,240
2,438
2,868
1,397 (2)
Total dividend
739
843
862
899
1,082
1,212
Balance sheet
Non-current assets
19,155
17,030
16,380
17,350
17,048
19,135
21,315
Current assets excl. cash and cash equivalents
4,847
5,015
5,450
4,768
5,446
6,071
6,386
781
1,087
1,077
1,173
1,550
1,652
1,823
Equity (2)
14,624
13,463
11,563
13,598
14,866
17,638
20,936
Net current and non-current debt (3)
3,329
2,373
3,700
1,958
41
-504
-1,575
Gross cash flow
2,410
2,720
2,746
2,758
3,171
3,226
3,661
Per share data ()
Diluted earnings per share attributable
to owners of the company excluding
non-recurring items
2.98
3.36
3.49
3.42
4.01
4.32
4.91
Dividend (5)
2.30 (5)
1.18
1.38
1.44
1.50
1.80
2.00
Share price at December 31st (4)
75.90
97.98
62.30
78.00
83.08
80.70
104.90
Highest share price during the year (4)
84.05
99.97
99.26
79.32
88.00
91.24
106.40
Lowest share price during the year (4)
62.30
74.25
53.32
46.00
70.90
68.83
79.22
Diluted weighted average number of shares
outstanding (4)
615,723,220 606,012,471 590,920,078 583,797,566 591,392,449 597,633,103 605,305,458
(1)
The 2007 and 2008 balance sheets have been restated according to changes in accounting policies relating to advertising and promotion expenses, customer
loyalty programs and the immediate recognition in shareholders equity of actuarial gains and losses linked to employee benefits.
(2) Plus non-controlling interests.

(3) The net cash surplus is 504 million euros in 2011 and 1,575 million euros in 2012.
(4) The LOral share has been listed in euros on the Paris Bourse since January 4 th, 1999, where it was first listed in 1963. The share capital is 121,762,165.40
at December 31st, 2012: the par value of one share is 0.2.
(5) Dividend proposed to the Annual General Meeting of April 26 th, 2013.
92

Recent events and prospects
3.3. Recent events and prospects

3.3.1. SIGNIFICANT
EVENTS THAT HAVE
OCCURRED
SINCE
THE BEGINNING OF
2013
See subsequent events in note 31 of the Consolidated
financial statements page 147.
On January 31st, LOral finalized the acquisition of the
Vogue make-up brand in Colombia.
On February 11th, the Board of Directors has decided
the setting up of a new share buyback plan amounting
to 500 million in the 1st half of 2013.
On February 27th, Galderma finalised the acquisition of
Spirig in Switzerland.
No other significant event has occurred since the
beginning of the 2013 financial year.
3.3.2.
PROSPECTS
In view of these successes and improvements, the Group is

facing the future with optimism and confidence. Confidence in
the positive dynamics of its market. Confidence in the strength
of its Beauty for all mission, in its universalisation strategy, and
in its ambition to conquer one billion new consumers. And finally,
confidence in the fundamentals of LOral: its research, its ability
to innovate and create high quality products, its outstanding
portfolio of brands, its business model, which creates both value
and cash flow, and lastly the unique strength of its teams.
The Group is thus well prepared to outperform the market in 2013,
and to achieve another year of sales and profit growth.
th
To the knowledge of the Company, at February 28 , 2013,

no event has occurred that could have a significant impact
on the financial or commercial situation of the Group since
December 31st, 2012.
93
94
4
2012 CONSOLIDATED
FINANCIAL STATEMENTS
4.1. Compared consolidated
income statements
96
4.2. Consolidated statements of

net profit and gains and losses
recognised directly in equity
97
Note 14

balance sheets
98
4.4. Consolidated statements

of changes in equity
99
125
Note 15 Non-current financial assets

Note 16 Inventories
Note 17 Trade accounts receivable
126
126
127
Note 18 Other current assets
127
Note 19 Cash and cash equivalents
127
Note 20
Equity
128
Note 21
Post-employment benefits, termination

benefits and other long-term employee
benefits
133
Note 22 Provisions for liabilities and charges
137
Note 23 Borrowings and debt
139
Note 24
Derivatives and exposure to market risks 140

statements of cash flows
100
Note 25 Other current liabilities

Note 26 Off-balance sheet commitments
144
145
4.6. Notes to the consolidated

Note 27 Changes in working capital
146
101
Note 28
Note 1
Accounting principles
101
Note 2 Changes in the scope of consolidation

Note 3
Segment information
Note 5
109
110
Note 4 Personnel costs and number

of employees
113
Depreciation and amortisation expense 113
Note 6 Foreign exchange gains and losses

113
Note 7 Other operational income and expenses 114
Property, plant and equipment
Note 8 Other financial income and expenses
115
Note 9
115
Income tax
Note 10 Net profit attributable to owners

of the company excluding non-recurring
items Earnings per share
117
Note 11 Goodwill
119
Note 12 Other intangible assets
122
Note 13 Impairment tests on intangible assets
124
Impact of changes in the scope of

consolidation in the cash flow statement 146
Note 29 Transactions with related parties
146
Note 30 Fees accruing to Auditors and members

of their networks payable by the Group
147
Note 31
147
Subsequent events
4.7. Consolidated companies

148
4.7.1. Fully consolidated companies
148
4.7.2. Proportionally consolidated companies
151
4.8. Statutory Auditors Report

on the consolidated
153
This information forms an integral part of the Annual Financial Report as provided for in the article L. 451-1-2 of the French Monetary
and Financial Code.
95
2012Compared
CONSOLIDATED
FINANCIAL
STATEMENTS
consolidated income
statements
LOral parent company is a French company with its registered office in France,
which performs a sales activity specific to that country. At the same time, LOral
parent company has firstly a role of holding company and strategic coordination
and secondly that of scientific, industrial and marketing coordination of the
LOral Group on a worldwide basis. Most of the subsidiaries have
a role of marketing of the products manufactured by the Groups
factories in the countries or zones in which it is established.
The LOral Group wholly owns the vast majority of its subsidiaries. It also holds 50% of
the share capital of Galderma and Innov developed in a joint venture with Nestl.
The financial statements set out in this chapter present the results of the LOral
Group as a whole, including all subsidiaries. The Statutory Auditors Report on the
consolidated financial statements has been included at the end of this chapter.
4.1. Compared consolidated income statements

millions
Net sales
Cost of sales
Gross profit
Operating profit
Other income and expenses
Operational profit
Finance costs on gross debt
Finance income on cash and cash equivalents
Finance costs, net
Other financial income (expenses)
Sanofi dividends
Income tax
Net profit
attributable to:
owners of the company
Earnings per share attributable to owners of the company (euros)
Diluted earnings per share attributable to owners
of the company (euros)
Earnings per share attributable to owners of the company
excluding non-recurring items (euros)
Diluted earnings per share attributable to owners
of the company excluding non-recurring items (euros)
96
Notes
2012
2011
2010
22,462.7
-6,587.7
15,875.0
-790.5
-6,776.3
-4,610.9
3,697.3
-123.8
3,573.5
-34.5
31.3
-3.2
-7.8
313.4
3,875.9
-1,005.5
2,870.4
20,343.1
-5,851.5
14,491.6
-720.5
-6,291.6
-4,186.9
3,292.6
-96.3
3,196.3
-48.1
28.5
-19.6
-5.6
295.6
3,466.7
-1,025.8
2,440.9
19,495.8
-5,696.5
13,799.3
-664.7
-6,029.1
-4,048.6
3,056.9
-153.2
2,903.7
-43.8
17.2
-26.6
-9.0
283.8
3,151.9
-909.9
2,242.0
10
2,867.7
2.7
4.79
2,438.4
2.5
4.11
2,239.7
2.3
3.82
10
4.74
4.08
3.79
10
4.97
4.36
4.04
10
4.91
4.32
4.01
3
7
2012 CONSOLIDATED FINANCIAL STATEMENTS

Consolidated statements of net profi t and gains and losses recognised directly in equity
4.2. Consolidated statements of net profit and

gains and losses recognised directly in equity
Notes
millions
Consolidated net profit for the period

Financial assets available for sale
Cash flow hedges
Cumulative translation adjustments
Income tax on items that may be reclassified to profit or loss (1)
Items that may be reclassified to profit or loss
Actuarial gains and losses
Income tax on items that may not be reclassified to profit or loss (1)
Items that may not be reclassified to profit or loss
Changes in gains and losses recognised directly in equity
Total net profit and gains and losses recognised
directly in equity
Attributable to:
20.4
2012
2011
2010
2,870.4
1,730.9
103.0
-134.3
-116.9
1,582.7
-271.9
86.7
-185.2
1,397.5
2,440.9
1,051.6
-6.0
114.5
-62.8
1,097.3
-172.4
56.2
-116.2
981.1
2,242.0
-852.3
-8.0
463.3
15.7
-381.3
-213.5
76.3
-137.2
-518.5
4,267.9
3,422.0
1,723.5
4,265.1
2.8
3,419.5
2.5
1,721.2
2.3
2012
2011
2010
-90.0
-26.9
-116.9
86.7
86.7
-30.2
-63.9
1.1
-62.8
56.2
56.2
-6.6
14.6
1.1
15.7
76.3
76.3
92.0
(1) The tax effect is as follows:

millions

Cash flow hedges
Items that may be reclassified to profit or loss
Items that may not be reclassified to profit or loss
TOTAL
97
2012Compared
CONSOLIDATED
FINANCIAL
consolidated balance
sheets STATEMENTS
4.3. Compared consolidated balance sheets

ASSETS
millions
Non-current assets
Goodwill
Other intangible assets
Non-current financial assets
Deferred tax assets
Current assets
Inventories
Trade accounts receivable
Other current assets
Current tax assets
TOTAL
Notes
12.31.2012
12.31.2011
12.31.2010
21,315.5
6,478.2
2,625.4
2,962.8
8,531.3
717.8
8,209.6
2,033.8
3,208.8
1,006.6
137.2
1,823.2
29,525.1
19,135.0
6,204.6
2,477.3
2,880.8
6,900.9
671.4
7,722.6
2,052.1
2,996.2
904.1
118.0
1,652.2
26,857.6
17,048.2
5,729.6
2,177.5
2,677.5
5,837.5
626.1
6,996.3
1,810.1
2,685.3
846.0
104.5
1,550.4
24,044.5
Notes
12.31.2012
12.31.2011
12.31.2010
20
20,936.4
121.8
1,679.0
13,690.6
3,586.4
-109.4
-904.5
2,867.7
20,931.6
4.8
2,219.2
1,226.2
181.7
764.4
46.9
6,369.5
3,318.0
552.3
2,141.1
157.0
201.1
29,525.1
17,637.5
120.6
1,271.4
12,368.8
2,054.7
24.9
-644.4
2,438.4
17,634.4
3.1
2,090.2
1,128.9
226.1
677.7
57.5
7,129.9
3,247.7
500.7
2,066.7
224.0
1,090.8
26,857.6
14,865.8
120.2
1,148.3
11,107.1
1,188.1
-89.6
-850.9
2,239.7
14,862.9
2.9
2,596.6
1,129.0
181.3
462.0
824.3
6,582.1
3,153.5
536.9
1,958.1
166.6
767.0
24,044.5
11
12
14
15
9
16
17
18
19
EQUITY & LIABILITIES

millions
Equity
Share capital
Additional paid-in capital
Other reserves
Items recognised directly in equity
Cumulative translation adjustments
Treasury stock
Net profit attributable to owners of the company
Equity attributable to owners of the company
Non-current liabilities
Provisions for employee retirement obligations and related benefits
Provisions for liabilities and charges
Deferred tax liabilities
Non-current borrowings and debt
Current liabilities
Trade accounts payable
Other current liabilities
Income tax
Current borrowings and debt
TOTAL
98
21
22
9
23
22
25
23

Consolidated statements of changes in equity
4.4. Consolidated statements of changes in equity
millions
Equity
Retained
Items
attributable
NonCommon
Additional earnings recognised
Cumulative to owners controlshares Share
paid-in and net directly in Treasury translation
of the
ling
stock adjustments company interests
outstanding capital
capital
profit
equity
At 12.31.2010
589,655,903 120.2
Cash flow hedges
Cumulative translation
adjustments
Change in gains and losses
and items that may be reclassified
to profit or loss
and items that may not be
reclassified to profit or loss
Total net profit and gains and
losses recognised directly in equity
Capital increase
1,991,497
0.4
Cancellation of Treasury stock
Dividends paid
(not paid on Treasury stock)
Share-based payment
Net changes in Treasury stock
2,739,023
Other movements
At 12.31.2011
594,386,423 120.6
Cash flow hedges
adjustments
and items that may be reclassified
to profit or loss
and items that may not be
reclassified to profit or loss
Total net profit and gains and
losses recognised directly in equity
Capital increase
5,826,745
1.2
Cancellation of Treasury stock
Dividends paid
(not paid on Treasury stock)
Share-based payment
Net changes in Treasury stock
-1,856,506
Other movements
AT 12.31.2012
598,356,662 121.8
99
1,148.3 13,346.8
2,438.4
1,188.1
-850.9
-89.6
14,862.9
2,438.4
987.7
-4.9
2.9 14,865.8
2.5 2,440.9
987.7
-4.9
114.5
114.5
114.5
114.5
1,097.3
-116.2
1,097.3
-116.2
-116.2
-116.2
3,419.5
123.5
-
2.5 3,422.0
123.5
-
-1,065.3
86.8
208.2
-1.2
17,634.4
2,867.7
1,640.9
76.0
-2.2 -1,067.5
86.8
208.2
-0.1
-1.3
3.1 17,637.5
2.7 2,870.4
1,640.9
0.1
76.1
-134.3
-134.3
-134.3
-134.3
1,582.6
-185.2
0.1 1,582.7
-185.2
-185.2
-185.2
4,265.1
408.8
-
2.8 4,267.9
1.4
410.2
-
-1,204.3
86.4
-257.7
-1.1
-2.5 -1,206.8
86.4
-257.7
-1.1
20,931.6
4.8 20,936.4
987.7
-4.9
982.8
-116.2
-116.2
2,438.4
866.6
114.5
123.1
-1,065.3
86.8
1.7
-1.2
1,271.4 14,807.2
2,867.7
206.5
2,054.7
-644.4
24.9
1,640.9
76.0
1,716.9
-185.2
-185.2
2,867.7
1,531.7
-134.3
407.6
-1,204.3
86.4
2.4
-1.1
1,679.0 16,558.3
-260.1
3,586.4
-904.5
Total
equity
-109.4
2012Compared
CONSOLIDATED
FINANCIAL
STATEMENTS
consolidated statements
of cash
fl ows
4.5. Compared consolidated statements of cash flows

millions
Cash flows from operating activities

Elimination of expenses and income with no impact on cash flows:
depreciation, amortisation and provisions
changes in deferred taxes
share-based payment (including free shares)
capital gains and losses on disposals of assets
Gross cash flow
Changes in working capital
Net cash provided by operating activities (A)
Cash flows from investing activities
Purchases of property, plant and equipment and intangible assets
Disposals of property, plant and equipment and intangible assets
Changes in other financial assets
(including investments in non-consolidated companies)
Effect of changes in the scope of consolidation
Net cash (used in) from investing activities (B)
Cash flows from financing activities
Dividends paid
Capital increase of the parent company
Capital increase of subsidiaries
Disposal (acquisition) of Treasury stock
Purchase of non-controlling interests
Issuance (repayment) of short-term loans
Issuance of long-term borrowings
Repayment of long-term borrowings
Net cash (used in) from financing activities (C)
Net effect of changes in exchange rates and fair value (D)
Change in cash and cash equivalents (A+B+C+D)
Cash and cash equivalents at beginning of the year (E)
CASH AND CASH EQUIVALENTS AT END OF THE YEAR
(A+B+C+D+E)
Notes
9.1
20.3
27
28
19
2012
2011
2010
2,867.7
2.7
2,438.4
2.5
2,239.7
2.3
691.6
17.3
86.4
-4.3
3,661.4
-129.1
3,532.3
614.3
85.9
86.8
-1.7
3,226.2
-322.0
2,904.2
734.2
110.0
84.8
0.1
3,171.1
132.5
3,303.6
-955.0
7.3
-865.7
15.2
-677.9
18.3
105.8
-466.2
-1,308.1
-1.2
-717.4
-1,569.1
2.3
-160.7
-818.0
-1,268.2
408.8
1.4
-257.7
-906.7
-13.4
-2,035.8
-17.4
171.0
1,652.2
-1,107.6
123.5
208.2
852.8
-1,333.6
-1,256.7
23.4
101.8
1,550.4
-921.6
152.3
184.0
-8.7
-132.6
4.0
-1,462.5
-2,185.1
76.9
377.4
1,173.1
1,823.2
1,652.2
1,550.4
Income taxes paid amount to 1,114.0 million, 870.5 million and 713.3 million respectively for the years 2012, 2011 and 2010.
Interests paid amount to 34.5 million, 49.9 million and 46.6 million respectively for the years 2012, 2011 and 2010.
Dividends received amount to 313.4 million, 295.6 million and 283.8 million respectively for the years 2012, 2011 and 2010, and are
included within gross cash flow.
100

Notes to the consolidated fi nancial statements
4.6. Notes to the consolidated financial statements

DETAILED LIST OF NOTES
Note 1
101
Note 18 Other current assets
127
Note 2
Changes in the scope of consolidation
109
127
Note 3
Segment information
110
Note 20 Equity
128
Note 4
Personnel costs and number of employees
113
Note 21 Post-employment benefits,
Note 5
Depreciation and amortisation expense
113
Note 6
Foreign exchange gains and losses
113
137
Note 7
Other operational income and expenses
114
139
Note 8
Other financial income and expenses
115
Note 24 Derivatives and exposure to market risks
140
Note 9
Note 10
Income tax
115
Note 25 Other current liabilities

144
146
termination benefits and other long-term

employee benefits
Net profit attributable to owners

of the company excluding non-recurring
items Earnings per share
117
Note 11
Goodwill
119
Note 28 Impact of changes in the scope of
Note 12
122
Note 13
Impairment tests on intangible assets
124
Note 14
125
Note 15
Note 16
126
Inventories
126
Note 17
127
NOTE 1
consolidation in the cash flow statement
Note 29 Transactions with related parties
133
145
146
146
Note 30 Fees accruing to auditors and members

of their networks payable by the Group
Note 31 Subsequent events
147
147
The consolidated financial statements of LOral and its subsidiaries (the

Group) published for 2012 have been prepared in accordance with
International Financial Reporting Standards (IFRS), as adopted in the
European Union as of December 31st, 2012.
On February 11th, 2013, the Board of Directors closed the consolidated
financial statements at December 31 st, 2012. The financial statements will
not become final until they have been approved by the Annual General
Meeting of shareholders to be held on April 26th, 2013.
At the closing date, the Group is not concerned by the standards or
amendments to standards published and applicable as from January 1st,
2012.
101
The Group did not early adopt any standards or interpretations not
mandatorily applicable in 2012.
The Group may be concerned by the following amendments or new
standards, which are applicable as from January 1st, 2013:
Amendments to IAS 19 (revised), Employee benefits. This

amendment requires:
past service cost to be recognised immediately in profit or loss, with

recognition over several periods no longer permitted;
2012Notes
CONSOLIDATED
STATEMENTS
to the consolidatedFINANCIAL
fi nancial statements
information available at the date the
accounts are prepared and described
in detail in each specific associated
note.
the return on plan assets to be

calculated based on the discount
rate for the obligation.
The pro forma impact of these
amendments on net profit for 2012
is not material, representing a
negative 17 million before tax
and a negative 11 million after
tax.
The impact on equity is minimal.
IFRS 10 Consolidated Financial

Statements, IFRS 11 Joint
Arrangements, and IFRS 12
Disclosures of Interests in Other
Entities.
These standards redefine the
notion of control over another
entity, and abolish proportionate
consolidation for jointly controlled
entities.
Only the equity method may now
be used for such entities.
Consequently,
Galderma
and
Innov
which
are
currently
proportionately consolidated will
henceforth be accounted for using
the equity method. At December
31st, 2012, the entities concerned
contributed 824.3 million to net
sales and 138.9 million to
operating profit, based on a 50%
interest. LOral will adopt these
three standards as from January
1st, 2014, as required by the
European Union.
IFRS
13
Measurement.
Fair
Value
LOral is currently analysing the

consequences of IFRS 13 for the
Group. It may be concerned by the
requirement to include credit risk in
the measurement of fair value,
particularly for derivatives. The
Group does not expect IFRS 13 to
have a material impact on its
consolidated financial statements.
1.1.
USE
ESTIMATES
OF
The preparation of the consolidated

financial statements in accordance
with
international
accounting
standards requires that the Group
make a certain number of estimates
and assumptions that may affect the
value of the Groups assets, liabilities,
equity and net profit (loss).
These estimates and assumptions
mainly concern the measurement of
goodwill and other intangible assets,
provisions,
pension
obligations,
deferred taxes and share-based
payment. Estimates used by the
Group in relation to these different
areas are made on the basis of
1.2.SCO
PE
AND
MET
HOD
S
OF
CON
SOL
IDAT
ION
All companies included in the scope
of consolidation have a fiscal year
ending December 31st or close their
accounts on that date.
and options are put in place in order

to hedge items recorded in the
balance sheet (fair value hedges) and
cash flows on highly probable future
commercial transactions (cash flow
hedges).
All companies directly or indirectly

controlled by the parent company
LOral have been fully consolidated.
All
foreign
exchange
hedging
instruments are recorded on the
balance sheet at their market value,
including those which relate to
purchases and sales in the next
accounting period. If the future cash
flow hedging relationship is duly
documented and the effectiveness of
the hedges demonstrated, changes in
the fair value of these hedging
instruments is recorded as follows:
Group companies that are jointly

controlled by the parent company and
a
limited
number
of
other
shareholders under a contractual
agreement have been proportionally
consolidated.
Associates over which the Group has
a significant influence have been
accounted for by the equity method.
changes in the market value linked

to variations in the time value
(forward points and premiums paid
for options) are recorded in the
income statement;
changes in the market value linked to

variations in the spot rate between
the inception of the hedge and the
closing date are charged to equity,
and the amount accumulated in
equity impacts income statements at
the date on which the transactions
hedged
are
completed.
Any
remaining hedge ineffectiveness is
recognised directly in the income
statement.
1.3.FOREIGN
CURRENCY
TRANSLATION
1.3.1.
Accountin
g for foreign
currency
transactions in
consolidated
companies
Foreign currency transactions are
translated at the exchange rate
effective at the transaction date.
Assets and liabilities denominated in
foreign
currencies
have
been
translated using exchange rates
effective at the closing date.
Unrealised exchange gains and
losses impact the income statement.
Forward foreign exchange contracts
102
In application of hedge accounting,

unrealised exchange gains and
losses relating to unsold inventories
are deferred in the inventories item in
the balance sheet. Similarly, if a
currency hedge has been taken out in
respect of fixed assets purchased
with foreign currency, these assets
are valued in the balance sheet on
the basis of the hedging rate.

euros.
The Group may decide to

hedge certain investments
in
foreign
companies.
Exchange gains or losses
relating to these hedges
are directly charged to
consolidated equity, under
the item
adjustments.
1.3.2.
Translatio
n of
the
accou
nts of
foreig
n
subsi
diarie
s
The assets and liabilities of
foreign subsidiaries are
translated
at
closing
exchange rates. Income
statement
items
are
translated
at
average
exchange rates for the
year.
The resulting translation
difference attributable to
the Group is entered
directly under equity under
the
item
Cumulative
translation
adjustments,
while
the
translation
difference attributable to
non-controlling interests is
recognised under the Noncontrolling interests item.
The translation difference
does not impact the
income statement other
than at the time the
Company is sold.
1.3.3. Valuation of
goodwill in foreign
currencies
Goodwill generated on
foreign
companies
is
considered to form part of
the assets and liabilities of
the foreign company, and
is therefore expressed in
the
entitys
functional
currency and translated
using
exchange
rates
effective at the closing
date. Goodwill recorded
before January 1st, 2004
continues to be recorded in
Notes to the
consolidated fi
nancial
statements
1.6.
or sell the products resulting from the project have been

demonstrated;
the resources necessary to complete the project and to u

or sell it are available;
the Group can demonstrate that the project will generate

probable future economic benefits, as the existence of a
potential market for the production resulting from the pro
or its internal usefulness has been demonstrated.
RESEARCH AND DEVELOPMENT

EXPENDITURE In view of the very large number of development projects an
uncertainties
Expenditure during the research phase
is charged
concerning
the to the income
decision
statement for the financial year during
which it istoincurred.
launch
Expenses incurred during the development
products phase are recognised
as Intangible assets only if they meet
all the following
criteria set
relating
to
out in IAS 38:
these projects,
LOral
the project is clearly defined and
the relatedthat
costs are
considers
separately identified and reliably
measured;
some
of these
capitalisation
the technical feasibility of the project has been demonstrated;
criteria are not
met.
the intention and ability to complete the project and to use
1.4.
NET
SALES
Net sales are recognised when
the risks and rewards inherent
to ownership of the goods have
been
transferred
to
the
customer.
Sales
incentives,
cash
discounts and product returns
are deducted from sales, as are
incentives
granted
to
distributors
or
consumers
resulting in a cash outflow, such
as commercial cooperation,
coupons, discounts and loyalty
programmes.
Sales
incentives,
cash
discounts, provisions for returns
and incentives granted to
customers
are
recorded
simultaneously
to
the
recognition of the sales if they
can be estimated in a
reasonably reliable manner,
based mainly on statistics
compiled from past experience
and contractual conditions.
1.7.
AD
VERTISI
NG AND
PROMOT
ION
EXPENS
ES
These expenses consist mainly
of expenses relating to the
advertisement and promotion
of products to customers and
consumers. They are charged
to the income statement for the
financial year in which they are
incurred.
1.8.SELLI
NG,
GENE
RAL
AND
ADMIN
1.5.
COST
OF SALES
The cost of goods sold consists
mainly
of
the
industrial
production cost of products
sold, the cost of distributing
products to customers including
freight and delivery costs, either
directly or indirectly through
depots, inventory impairment
costs, and royalties paid to third
parties.
ISTRA
TIVE
EXPEN
SES
These expenses relate mainly
to sales teams and sales team
management, marketing teams
and administrative services, as
well as general expenses and
the costs of share-based
payment (stock options and
free shares).
1.9.
FOREIG
N
EXC
HAN
GE
GAIN
S
AND
LOS
SES
Foreign exchange gains and
losses resulting from the
difference between the value of

foreign
currency operating
income
and
expenses
translated at the spot rate
effective on the transaction
date and at the exchange rate
effective on the settlement date
are recognised directly on the
appropriate
income
and
expense lines, after allowing for
hedging derivatives. Changes
in the time value of hedging
derivatives (including option
premiums) are systematically
charged
to
the
income
statement (note 1.3).
103
2012Notes
CONSOLIDATED
STATEMENTS
1.10.
OPERATIN
G PROFIT
Operating profit consists of gross
profit less research and development
expenses, advertising and promotion
expenses, and selling, general and
administrative expenses. Operating
profit corresponds to the definition of
current operating profit provided by
Conseil National de la Comptabilit
(CNC) recommendation No. 2009-R03 of July 2nd, 2009 regarding the
presentation of financial statements
for companies applying international
accounting standards. It notably
includes the entire charge relating to
the
Contribution
Economique
Territoriale (CET) tax collected in
France, including its value-added
based component. The classification
of the CET tax in operating expenses
is therefore consistent with the
classification of the former business
tax (taxe professionelle) it replaces.
1.11.
OTHER
INCOME
AND
EXPENSES
The Other income and expenses item
includes capital gains and losses on
disposals of property, plant and
equipment and intangible assets,
impairment of assets, restructuring
costs, and clearly identified, nonrecurring income and expense items
that are material to the consolidated
The cost of restructuring operations is
fully provisioned if it results from a
Group obligation towards a third party
originating from a decision taken by a
competent body which is announced
to the third parties concerned before
the end of the reporting period. This
cost consists mainly of severance
payments, early retirement payments,
the cost of unworked notice periods,
the costs of training for employees
affected
by
the
restructuring
measures, and other costs relating to
site closures. Any write-offs of fixed
assets or impairment charged against
inventories and other assets related
directly
to
these
restructuring
measures are also recorded as
restructuring costs.
1.12.
OPERATIO
NAL PROFIT
Operational profit is calculated based
on operating profit and includes other
income and expenses such as capital
gains and losses on disposals of
1.14.
TAX
INCOME
The income tax charge includes the

current tax expense payable by each
consolidated tax entity and the
deferred tax expense. Deferred tax is
calculated whenever there are
temporary differences between the
tax basis of assets and liabilities and
their
basis
for
consolidated
accounting purposes, using the
balance sheet liability method.
The restatement of assets and
liabilities linked to capital lease
contracts results in the booking of
deferred tax.
Deferred tax includes irrecoverable
taxation on estimated or confirmed
dividends.
Deferred tax is measured using the
tax rate enacted at the closing date
and which will also apply when the
temporary differences reverse.
property, plant, and equipment and
intangible assets, impairment of
assets, and restructuring costs.
1.13.
FINANCE
COSTS, NET
Net financial debt consists of all
current and non-current financial
borrowings and debt, less cash and
cash equivalents.
Net finance costs consist of income
and expenses arising on the items
making up net financial debt during
the accounting period, including gains
and losses on the corresponding
interest rate and foreign exchange
rate hedges. As interest rate
derivatives are fully effective, no
ineffectiveness impacts finance costs.
Deferred tax assets generated by tax

loss
carryforwards
are
only
recognised to the extent it is probable
that the entities will be able to
generate taxable profit against which
they can be utilized.
Under the French system of tax
consolidation, the taxable profits of
some French companies are offset
when determining the overall tax
charge, which is payable only by
LOral, the parent company of the
tax group. Tax consolidation systems
also exist outside France.
1.15.
INTANGIBL
E ASSETS
1.15.1. Goodwill
Business combinations are accounted
for by the purchase method. The
assets, liabilities and contingent
liabilities of the Company acquired
104
are measured at fair value at the

acquisition date. Any valuation
differences identified when the
acquisition is carried out are recorded
under the corresponding asset and
liability items.
Any residual difference between the
cost of an acquisition and the Groups
interest in the fair value of the
identified assets and liabilities is
recorded as Goodwill and allocated to
the Cash-Generating Units expected
to benefit from the acquisition or the
related synergies.
Goodwill generated on the acquisition
of an associate is presented in the
Investments in associates line.
Goodwill is not amortised. It is tested
for impairment at least once a year
during the fourth quarter or whenever
an adverse event occurs. Adverse
events may result among other things
from an increase in market interest
rates or from a decrease in actual
sales or operational profit compared
to forecasts.

Impairment charged against
goodwill cannot be reversed.
Impairment tests consist of

comparing the carrying
amount of assets including
goodwill
with
the
recoverable amount of
each
Cash-Generating
Unit. A Cash-Generating
Unit corresponds to one or
more worldwide brands. A
Cash-Generating Unit can
contain several brands
depending
on
organisational criteria and
particularly
when
distribution circuits and
commercial/ management
structures
are
pooled.
Recoverable values are
determined on the basis of
discounted operating cash
flow forecasts covering a
period of 10 years (the
period
considered
necessary for the strategic
positioning
of
an
acquisition) and a terminal
value. The cash flows are
determined
in
the
currencies of the countries
in
question
and are
translated, in the same way
as
the
net
carrying
amounts to which they are
compared, at the estimated
exchange rate for the
following year.The discount
rate
used
for
these
calculations is based on
the weighted average cost
of capital (WACC), which
amounts to 7.9% in 2012,
2011 and 2010 for amounts
in euro, adjusted where
appropriate by a country
risk premium according to
the
geographic
zones
concerned.The
discount
rates are post-tax rates
applied to post-tax cash
flows,
and
result
in
recoverable
amounts
identical to those obtained
by applying pre-tax rates to
pre-tax cash flows. The
assumptions adopted in
terms of sales growth and
terminal
values
are
reasonable and consistent
with the available market
data (generally around 3%
for terminal values except
in specific cases).
The use of discounted
cash flow forecasts is
preferred in order to
determine
recoverable
amounts, unless details of
similar recent transactions
are readily available.
For business combinations carried

out after January 1st, 2010, the main
changes with regard to previously
applicable accounting principles are
set out below:
for each acquisition, the Group

chooses whether to recognise
the full amount of goodwill
regardless of the ownership
interest acquired, or an amount
of goodwill corresponding to its
interest in the acquired company
(previously the only method
allowed);
deferred tax assets recognised

after the initial accounting is
complete are included in profit or
loss, and in contrast to previous
practices, the amount of goodwill
that would have been recorded
had the deferred tax asset been
recognised as an identifiable
asset at the acquisition date is
not deducted;
costs incurred in respect of a

business combination are now
expensed
and
no
longer
included in the cost of the
acquisition;
the cost of the acquisition, which

includes
contingent
consideration, is recognised and
measured at its acquisition-date
fair value. Subsequent changes
in fair value, affecting in
particular
the
contingent
consideration
recorded
in
liabilities, are taken to Other
income and expenses in the
income statement and no longer
treated as an adjustment to
goodwill;
Notes to the
consolidated fi
nancial
statements
any
pre
vio
us
inte
res
t
hel
d in
the
acq
uir
ee
pri
or
to
the
dat
e
con
trol
wa
s
obt
ain
ed
is
no
w
re
me
asu
red
at
its
acq
uisi
tion
dat
e
fair
val
ue,
wit
h
the
cor
res
po
ndi
ng
gai
n
or
los
s
on
re
me
asu
re
me
nt
tak
en
to
the
income.
1.15.2. Other intangible

assets
Intangible
assets
are
recorded on the
balance sheet
at
cost.
Intangible
assets
identified
following
an
acquisition as
well
as
internally
generated
intangible
assets are also
included in this
item.
A)
IN
T
A
N
G
IB
L
E
A
S
S
E
T
S
A
C
Q
UI
R
E
D
T
H
R
O
U
G
H
B
U
SI
N
E
S
S
C
O
M
BI
N
A
TI
O
N
S
They
mainly
consist
of
trademarks,
customer
relationships
and
formulas
and patents.
With regard to
trademarks, the
use of
the
discou
nted
cash
flow
metho
d
is
preferr
ed to
enable
the
value
in use
to be
monito
red
more
easily
followi
ng the
acquis
ition.
for the use

of
similar
trademarks,
based
on
sales
forecasts
drawn up by
the Group.
Two approaches have

been adopted to date:
premium-based
approach: this method
involves estimating
the portion of future cash
flows that could be
generated
the with
trademark,by
compared
the future cash flows that
the
activity could generate

without the trademark;
roy
alty
bas
ed
ap
pro
ach
:
this
inv
olv
es
esti
ma
ting
the
val
ue
of
the
tra
de
ma
rk
by
ref
ere
nce
to
the
lev
els
of
roy
alti
es
de
ma
nd
ed
These
approaches are
based on a
qualitative
analysis of the
trademark
in
order to ensure
that
the
assumptions
selected
are
relevant. The
discount
rate
used is based
on
the
weighted
average cost of
capital (WACC)
for the target
acquired.Termi
nal
growth
rates
are
consistent with
available
market
data
(generally
around
3%,
except
in
specific cases).
A trademark may have a finite or an
indefinite life span.
Local
trademarks
which are to be
gradually
replaced by an
international
trademark
already existing
within
the
Group have a
finite life span.
They
are
amortised over
their
useful
lives
as
estimated
at
the date of
acquisition.
International
trademarks are
trademarks
which have an
indefinite
life
span. They are
tested
for
impairment at
least once a
year during the
fourth quarter,
and whenever
an
adverse
event occurs.
Adverse events
may
result
among
other
things
from
an
increa
se in
market
interes
t rates
or
from a
decrea
se in
actual
sales
or
operati
onal
profit
compa
red to
foreca
sts.
The
impair
ment
test
consis
ts of
calcul
ating
the recoverable
amount of the
trademark
based on the
model adopted
when
the
acquisition took
place.
Customer
relationships
refer
to
relations
developed with
customers
either through
contractual
arrangements
or
by
noncontractual
means through
constant
revenue
streams
resulting from
the
targets
competitive
position
or
reputation in its
market.
105
2012Notes
CONSOLIDATED
STATEMENTS
The useful life of a customer

relationship is limited and varies
depending on the estimated attrition
rate of existing customers at the time
of the acquisition.
The Group may decide to identify and
value patents and formulas that it
intends to develop.
The value of a patent or a formula is
assessed on the basis of the future
profits expected from its ownership in
the future, in accordance with the
royalty-based approach.
The amortisation period applicable to
patents corresponds to the period
during which they enjoy legal
protection. Formulas, which are not
protected by legal means, are
amortised over a maximum period of
5 years.
B)
INTERNALLY
GENERATED
INTANGIBLE ASSETS
These mainly consist of software.

The development costs of software
for internal use are capitalised for the
programming, coding and testing
phases. The costs of substantial
updates and upgrades resulting in
additional
functions
are
also
capitalised.
Capitalised development costs are
amortised from the date on which the
software is made available in the
entity concerned over its probable
useful life, which in most cases is
between 5 and 8 years.
1.17.
NONCURRENT
FINANCIAL
ASSETS
Non-current financial assets include
investments
in
non-consolidated
companies and long-term loans and
receivables maturing after more than
12 months.
Investments
in
non-consolidated
companies are considered to be
financial assets available for sale. As
such, they are valued on the basis of
their fair value, and unrealised losses
and gains are accounted for through
equity on the line Items directly
recognised in equity.
The fair value of listed securities is
determined on the basis of the share
price at the closing date. If the fair
value of unlisted securities cannot be
reliably determined, these securities
are valued at cost.
If the unrealised loss accounted for
through equity is representative of
significant or prolonged impairment,
this loss is recorded in the income
statement.
Long-term loans and receivables are
considered to be assets generated by
the business. As such, they are
valued at amortised cost. If there is
an indication of a loss in value, a
provision for impairment is recorded.
1.18.
ES
INVENTORI
Inventories are valued at the lower of

cost or net realisable value.
1.16.
PROPERTY, PLANT AND EQUIPMENT
Cost is calculated using the weighted average cost method.

Property, plant and equipment are
recorded on the balance sheet at cost
and are not revalued.
Significant capital assets financed
through capital leases, which transfer
to the Group substantially all of the
risks and rewards inherent to their
ownership, are recorded as assets on
the balance sheet. The corresponding
debt is recorded within borrowings
and debt on the balance sheet.
Investment subsidies are recorded as
liabilities
under
Other
current
liabilities.
The components of property, plant
and
equipment
are
recorded
separately if their estimated useful
lives, and therefore their depreciation
periods, are materially different.
Property, plant and equipment are

depreciated using the straight-line
method, over the following useful
lives:
A provision is made for obsolete and

slow-moving inventories on the basis
of their probable net realisable value,
estimated on the basis of historic and
projected data.
1.19.
TRADE
ACCOUNTS
RECEIVABLE
Accounts receivable from customers

are recorded at their nominal value,
which corresponds to their fair value.
A provision is made for any doubtful
receivables based on an assessment
of the risk of non-recovery.
The Groups policy is to recommend
credit insurance coverage when this
is allowed by local regulations.
1.20.
CASH AND
Buildings
CASH
Industrial machinery and equipment
EQUIVALENTS
Point-of-sales advertising: stands and displays
Other
Cash and cash equivalents consist of
cash in bank accounts, units of cash
Depreciation and impairment losses
unit trusts and liquid short-term
are recorded in the income statement
investments with a negligible risk of
according to the use of the asset.
changes in value and a maturity date
of less than three months at the date
In view of their nature, property, plant
of acquisition.
and equipment are considered to
have a value of zero at the end of the
useful lives indicated above.
106

S
Investments in shares and

cash, which are held in an
account blocked for more
than three months, cannot
be recorded under cash
and are presented under
Other current assets.
Bank overdrafts considered
to be financing are
presented in
Current borrowings and
debt.
Units of cash unit trusts are
considered to be assets
available for sale. As such,
they are valued in the
balance sheet at their
market value at the closing
date.
Any
related
unrealised
gains
are
accounted for in Finance
costs, net in the income
statement.
The carrying amount of
bank
deposits
is
a
reasonable approximation
of their fair value.
1.21.
TRE
ASURY
STOCK
Treasury stock is recorded
at acquisition cost and
deducted
from
equity.
Capital gains/losses on
disposal of Treasury stock
net of tax are charged
directly to equity and do
not contribute to profit for
the financial year.
1.22.
S
HAREBASED
PAYME
NT:
SHARE
SUBSC
RIPTIO
N OR
PURCH
ASE
OPTION
S
FREE
SHARE
In
accordance
with
the
requirements of IFRS 2 Sharebased payment, the value of
options or free shares granted as
calculated at the grant date is
expensed in the income statement
over the vesting period, which is
generally 5 years for purchase
options and 4 years for free shares.
The fair value of stock options is
determined using the Black &
Scholes model. This model takes
into account the characteristics of
the plan such as the exercise price
and exercise period, and market
data at the grant date such as the
risk-free rate, share price, volatility,
expected dividends and behavioural
assumptions
regarding
beneficiaries.
The fair value of free shares
corresponds to the value of the
share at the grant date, less
dividends expected to be paid
during the vesting period. The cost
of the additional 2-year holding
period
applicable
to
French
residents is determined based on
the interest rate granted to the
employee, considered equivalent to
the rate which would be granted by
a bank to a private individual
customer with an average financial
profile.
Only plans issued after November 7th,
2002 and not fully vested at January
1st,
2005
are
accounted
for
in
accordance with IFRS 2.
The impact of IFRS 2 on profit for

the period is booked on the
Selling, general and administrative
expenses line of the income
statement at Group level, and is not
allocated to the Divisions or
geographic zones.
Notes to the
consolidated fi
nancial
statements
of
the
actuarial
value
of
employees
vested
rights.
As
from
January
1st,
2009,
the
1.23. PROVISIONS FOR
EMPLOYEE
Group
decided
to
adopt the
RETIREMENT OBLIGATIONS
IAS 19 option
AND RELATED allowing
BENEFITS
the
direct
The Group operates pension, early retirement and other benefit
recognition in
schemes depending on local legislation and regulations.
equity
of
gains
For obligatory state schemes and actuarial
other defined-contribution
losses
schemes, the Group recognises inand
the income
statement
instead of the
contributions payable when they are due. No provision has
corridor
been set aside in this respect as the Groups obligation does
method.
not exceed the amount of contributions paid.The characteristics
of the defined benefit schemes in The
force within
the Group are as
charges
follows:
recorded in the
income
French regulations provide for specific length-of-service
statement
awards payable to employees on retirement. An early
during plan
the year
retirement plan and a defined benefit
have also been
include:
set up. In some Group companies there are also measures
providing for the payment of certain healthcare costs for
service cost,
retired employees.
i.e.
additional
These obligations are partially funded
by an external fund,
except those relating to healthcarerights
costs for retired employees;
vested
by
for foreign subsidiaries with employee
pension schemes or
employees
during
other specific obligations relating to
definedthe
benefit plans, the
exc
accounting
ess
period;
of
interest
the
pro
cost,
i.e.
ject
change
in
ed
the value of
be
the
nefi
discounted
t
rights over
obli
the
past
gati
year;
on
ove
expected
r
return
on
the
plan assets,
sch
i.e. income
em
from
es
external
ass
funds
ets
calculated
is
on the basis
rec
of
a
og
standard
nis
return
on
ed
long-term
by
investments;
sett
ing
the impact
up
of
any
a
change
to
pro
existing
visi
schemes on
on
for
previous
cha
years or of
rge
any
new
s
schemes.
on
the
To
determine
bas
the discounted
is
value of the
obligat
ion for
each
schem
e, the
Group
applie
s
an
actuari
al
valuati
on
metho
d
based
on the
final
salary
(projec
ted unit credit

method).The
obligations and
the fair value of
plan assets are
assessed each
year
using
length-ofservice,
life
expectancy,
staff
turnover
by category and
economic
assumptions
(such
as
inflation
rate
and
discount
rate).
107
2012Notes
CONSOLIDATED
STATEMENTS
Actuarial gains and losses in relation

to other benefits such as jubilee
awards and long-serve bonuses are
immediately charged to the income
statement.
The liability corresponding to the
Companys net defined benefit
obligation regarding its employees is
recorded in the balance sheet on the
Provisions for employee retirement
obligation and related benefits line.
1.24.
PRO
VISIONS
FOR
LIABILITIE
S
AND
CHARGES
Provisions for liabilities and charges are
set up to cover probable outflows for the
benefit of third parties without any
equivalent consideration being received
by the Group in return. They relate
mainly to restructuring costs and tax
risks
and
litigation,
industrial,
environmental and commercial risks
relating to operations (breach of
contract, product returns) and employeerelated risks.
These provisions are estimated on the

basis of the assumptions deemed
most probable or by using statistical
methods, depending on the type of
provisions.
are recorded either as Non-current
liabilities or as Current liabilities,
depending on their nature. Provisions
for liabilities or litigation which must
be settled within 12 months of the
closing date, and those linked to the
normal operating cycle (such as
product returns), are recorded as
Current liabilities. Other provisions for
liabilities and charges are recorded as
Non-current liabilities.
The carrying amount of floating-rate

debt is a reasonable approximation of
its fair value.
Medium- and long-term borrowings
and debt are recorded under Noncurrent
liabilities.
Short-term
borrowings and debt and the current
portion of medium- and long-term
borrowings and debt are presented
under Current liabilities.
1.26.
FINANCIAL
DERIVATIVES
Derivative instruments entered into to
hedge identifiable foreign exchange
and interest rate risks are accounted
for in accordance with hedge
accounting principles.
The accounting principles applicable
to foreign exchange risk are set out in
detail in note 1.3.
With regard to interest rate risk, fixedrate debt and financial loans hedged
by interest rate swaps are valued in
the balance sheet at their market
value. Changes in the fair value of
these items are recorded as finance
costs and offset by adjustments to the
fair value of the related hedging
derivatives. Floating-rate debt and
financial loans are valued at cost,
which corresponds to their market
value. The swaps or caps which
hedge these items are valued in the
balance sheet at their market value,
with changes in value recorded
directly through equity on the Items
directly recognised in equity line.
The fair value of interest rate
derivative instruments is their market
value. Market value is calculated by
the discounted cash flow method at
the interest rate effective at the
closing date.
interest rate swaps.
1.25.
BORROWI
NGS AND DEBT
Borrowings and debt are valued at
amortised cost based on an effective
interest rate.
In accordance with the principle of fair
value hedge accounting, fixed-rate
borrowings and debt swapped at a
floating rate are valued on the balance
sheet at market value. The resulting
changes in value are recorded as
finance costs and are offset by
changes in the value of the related
The fair value of fixed-rate debt is

determined by the discounted cash
flow method using bond yield curves
at the closing date, allowing for the
spread corresponding to the Groups
risk class to be taken into account.
1.27.
EARNINGS
PER SHARE
Earnings per share are calculated in
accordance with the rules set out in
IAS 33.
Basic earnings per share are obtained
on the basis of the weighted average
number of shares outstanding during
108
the year, less the average number of

treasury shares held deducted from
equity.
Where applicable, diluted earnings
per share take into account dilutive
stock options and free shares in
accordance with the Treasury stock
method, under which sums collected
on exercise or purchase are assumed
to be allocated firstly to share
buybacks at market price.

NOTE 2
2.1.
Changes in the scope of consolidation

2012
On April 26th, 2012, LOral announced that it had

acquired 100% of Cadum, previously majority-owned by
the investment fund Milestone.
In 2011, Cadum had consolidated net sales of 58
million, of which 49 million were made in France,
mainly under the Cadum brand. The acquisition was
fully consolidated as from May 1st, 2012.
On July 13th, 2012, LOral announced that it had
completed the sale of the home care business from the
Cadum Group to Eau Ecarlate SAS.
This business had net sales of 17 million in 2011, two
thirds of which were made in France.
The sale of the home care business resulted in the
derecognition of IBAs entire assets and liabilities, with
no impact on the Groups consolidated net profit.
On October 21st, 2012, LOral USA announced that it had
signed a contract to acquire the professional distribution
business of the New Jersey-based company Emiliani
Enterprises.
Well-established in the New York area, New Jersey and

Connecticut, Emiliani Enterprises supplies hair salons
through a network of representatives and sales outlets
open only to professionals, and in 2011 had net sales of
approximately $73 million.This acquisition was finalised
on December 18th, 2012 and was fully consolidated as
from that date.
On November 26th, 2012, LOral signed an agreement
to acquire Urban Decay, Americas expert make-up
brand. This brand fully complements LOral Luxes
portfolio of brands and strengthens the Groups position
in two very dynamic distribution channels in the USA:
assisted self-service and e-commerce.
Urban Decay had net sales of $130 million in the last
fiscal year ended June 30th, 2012.
This acquisition was finalised on December 17 th, 2012
and was fully consolidated from that date.
The cost of these new acquisitions amounts to 483.0
million.The total amount of goodwill and other intangible
assets resulting from the acquisitions was provisionally
estimated at 306.4 million and 135.6 million,
respectively.
These acquisitions represent around 200 million in fullyear net sales and 10.4 million in full-year operating
profit in 2012. Their impact on 2012 net sales is
approximately 35 million.
2.2.
2011
On January 1st, 2011, Matrix Distribution GmbH, a wholly

owned subsidiary of LOral Deutschland GmbH, took over
the cosmetic and scissors businesses of Germany-based
company Arex GmbH.
Arex GmbH sells exclusive hairdressing brands and

high quality scissors exclusively to hairdressers.
Arex GmbH had sales of 7 million in 2010 and has
been fully consolidated since January 1st, 2011.
On December 13th, 2010, Galderma Holding AB, a wholly owned
subsidiary of Galderma Pharma S.A., announced that it had
launched a cash offer for Q-Med, a company listed on Nasdaq
OMX Nordic in Stockholm.
Created in 1987, Q-Med is a medical device company which
develops, markets and sells high quality medical implants for
aesthetic and medical use. The majority of its products are
based on the companys patented NASHA technology for
the production of stabilized non-animal hyaluronic acid.
Among other products, its current product portfolio includes
Restylane for smoothing out lines and improving facial contours,
and the Macrolane injection for shaping the body.
Sales are made through the companys own subsidiaries and
distributors in over 70 countries. Q-Med has approximately
636 employees in 20 countries, including around 364 based at
the companys head office, R&D laboratories and production
facility in Uppsala, Sweden.
In 2010, the company had total revenues of SEK1.5 billion and
an operating profit of SEK287 million.
The acceptance period for the offer started on
January 4th and ended on March 11th, 2011.
A price of SEK79.00 in cash was offered for each
share, with the exception of shares owned by Q-Med
founder Bengt Agerup, who sold his 47.5% stake at a
price of SEK58.94 per share. An earn-out clause
stipulates that the total price can under no
circumstances exceed SEK74.96 per share.
On March 15th, 2011, Galderma declared the offer
wholly unconditional and acquired 95,361,096
shares, representing 95.95% of the existing issued
share capital of Q-Med. Galderma decided to request
compulsory acquisition of the remaining shares in QMed shares, which was obtained on November 15th,
2011.
Q-Med is proportionally consolidated as from March 1st, 2011.
On December 15th, 2011, LOral announced the
completed acquisition of Pacific Bioscience
Laboratories Inc., the market leader in the rapidly
growing area of sonic skin care devices. The move
gives LOral access to patented sonic skin care
technology enabling the Company to acquire
strategic positions in the booming skin care devices
category.
Clarisonic is sold mainly throughout the US and is
also present in the UK, Australia, Mexico, Canada
and the Far East. It is sold through a distribution
network which includes dermatologists and cosmetic
surgeons, spas, prestige retail, e-tail, television
shopping and clarisonic.com. In full-year 2010,
Clarisonic delivered net sales of $105 million. It has
been fully consolidated since December 15th, 2011.
109
2012Notes
CONSOLIDATED
STATEMENTS
The cost of these new acquisitions

was 815.2 million. The total amount
of goodwill and other intangible assets
resulting from the acquisitions was
estimated at 426.3 million and
320.8 million, respectively.
These acquisitions represent around
193 million in sales and 33 million
in operating profit in 2011.
2.3.
2010
On April 21st, 2010, LOral USA

signed an agreement to acquire the
assets of Essie Cosmetics, the
ultimate nail colour authority in the
US, sold mainly in American salons
and
spas.The
acquisition
was
completed on June 25th, 2010 and the
company has been fully consolidated
since June 30th, 2010. Essies net
sales were $25 million in 2009.
On June 1st, 2010, LOral USA
acquired 100% of the capital of C.B.
Sullivan, a New Hampshire-based
company. C.B. Sullivan supplies hair
salons in six states across the northeastern United States (Vermont, New
Hampshire,
Maine,
Connecticut,
Rhode
Segment
information
NOTE 3
3.1.
SEGMENT
INFORMATION
The Cosmetics branch is organised
into four sectors, each operating with
specific distribution channels:
Professional Products Division:

products used and sold in hair
salons;
Consumer
Products
Division:
products sold in mass-market retail
channels;
LOral Luxury Division: products

sold in selective retail outlets, i.e.
department stores, perfumeries,
travel retail, the Groups own
boutiques and certain online sites;
Active
products
Cosmetics
Division:
for
borderline
Island and Massachusetts), with a

network of representatives and
professional-only
outlets.
The
companys net sales in fiscal year
2009 were approximately $50 million.
The acquisition was fully consolidated
as of June 1st, 2010.
On December 10th, 2010, LOral
USA acquired the professional
distribution business of Peels Salon
Services,
a
Nebraska-based
company. Peels Salon Services
supplies hair salons in 12 states
across the mid-US, with a network of
representatives and professional-only
outlets. The companys net sales are
approximately
$100
million.This
acquisition was fully consolidated as
of December 11th, 2010.
The cost of these new acquisitions
amounts to approximately 204.1
million.The total amount of goodwill
and other intangible assets resulting
from the acquisitions was estimated
after the final purchase price
allocation at 119.9 million and 68.6
million, respectively.
These acquisitions represent around
$170 million in full-year sales and
$7.2 million in full-year operating
profit for 2010. They would have
contributed $130 million in additional
net sales for the Group over the 12
months of 2010.
complexions (i.e. neither healthy
nor problematic), sold through all
health
channels
such
as
pharmacies,
parapharmacies,
drugstores and medispas.
The non-allocated item includes
expenses incurred by the Functional
Divisions, fundamental research and
the costs of stock options not
allocated to the Cosmetics Divisions.
It also
shops (in more than 60 countries), as

well as through home and online
sales. The Body Shop net sales and
operating profit are characterised by
strong seasonal fluctuations due to a
high level of activity during the last
few months of the year.
includes activities that are auxiliary to
the Groups core businesses, such as
insurance, reinsurance and banking.
TheThe Body Shop branch: The
Body Shop offers a wide range of
naturally inspired cosmetics and
toiletry products. The brand, originally
created in the United Kingdom,
distributes its products and expresses
its values through a large multichannel network of exclusive retail
110
The Dermatology branch, consisting

of Galderma, a joint venture between
LOral and Nestl, meets the needs
of dermatologists and their patients.
Data by branch and by Division are
prepared using the same accounting
principles as those used for the
preparation of the consolidated
The performance of each branch and
Division is measured on the basis of
operating profit.

millions
2012
Consumer Products
LOral Luxury
Active Cosmetics
COSMETICS DIVISIONS TOTAL
Non-allocated
Cosmetics branch
The Body Shop branch
Dermatology branch
GROUP
Sales
3,002.6
10,713.2
5,568.1
1,528.0
20,811.9
20,811.9
855.3
795.5
22,462.7
Operating
profit
Operational
assets (1)
Investments in
property, plant and
equipment and
intangible assets
615.2
2,050.8
1,077.0
311.2
4,054.3
-577.2
3,477.1
77.5
142.6
3,697.3
2,707.4
6,563.2
4,592.1
851.9
14,714.6
556.1
15,270.7
1,169.8
1,017.4
17,457.9
67.2
483.1
199.9
30.0
780.2
122.4
902.6
34.8
32.6
970.0
Depreciation,
amortisation
and provisions
103.9
402.0
197.2
41.7
744.8
117.6
862.4
40.2
71.8
974.4
(1) Operational assets mainly include goodwill, intangible assets and property, plant and equipment, trade accounts receivable and inventories.
millions
2011
Consumer Products
LOral Luxury
Active Cosmetics
Non-allocated
Cosmetics branch
Dermatology branch
GROUP
Sales
2,813.8
9,835.2
4,800.1
1,421.7
18,870.8
18,870.8
767.6
704.7
20,343.1
Operating
Profit
Operational
assets (1)
Investments in
property, plant and
equipment and
intangible assets
578.6
1,859.0
926.3
286.7
3,650.6
-546.2
3,104.4
68.1
120.1
3,292.6
2,728.7
6,167.0
4,304.5
857.3
14,057.5
511.7
14,569.2
1,163.6
1,017.2
16,750.0
83.0
427.6
160.7
28.0
699.3
107.6
806.9
24.0
32.8
863.7
Depreciation,
amortisation
and provisions
97.8
344.8
184.9
43.3
670.8
121.2
792.0
30.9
66.7
889.6
millions
2010
Consumer Products
LOral Luxury
Active Cosmetics
Non-allocated
Cosmetics branch
Dermatology branch
GROUP
Sales
2,717.1
9,529.9
4,506.6
1,385.6
18,139.1
18,139.1
754.9
601.7
19,495.8
Operating
Profit
Operational
assets (1)
Investments in
property, plant and
equipment and
intangible assets
551.9
1,764.6
790.5
278.2
3,385.3
-512.9
2,872.4
65.3
119.2
3,056.9
2,624.0
5,994.0
3,651.2
829.6
13,098.8
396.1
13,494.9
1,104.7
612.4
15,212.0
53.4
359.3
113.3
23.2
549.1
106.1
655.2
11.9
24.0
691.1
Depreciation,
amortisation
and provisions
101.4
409.0
172.2
40.2
722.8
82.7
805.4
34.9
47.5
887.8
Operational assets can be reconciled to the 2012, 2011 and 2010 balance sheets as follows:
millions
Operational assets
Deferred tax assets
Cash and cash equivalent
Non-allocated assets
TOTAL ASSETS
111
2012
2011
2010
17,457.9
8,531.3
717.8
994.9
1,823.2
12,067.2
29,525.1
16,750.0
6,900.9
671.4
883.0
1,652.2
10,107.6
26,857.6
15,212.0
5,837.5
626.1
818.5
1,550.4
8,832.5
24,044.5
2012Notes
CONSOLIDATED
STATEMENTS
3.2.
INFORMATION BY GEOGRAPHIC ZONE
All information is presented on the basis of geographic location of the subsidiaries.
3.2.1. Consolidated net sales by geographic zone

2012
Western Europe
of which France
North America
New Markets
GROUP
Growth (%)
2011
millions
% of total
Published
data
Excluding
exchange
effect
8,156.2
2,528.6
5,773.0
8,533.4
22,462.7
36.3%
11.3%
25.7%
38.0%
100.0%
2.8%
5.0%
17.0%
14.1%
10.4%
1.5%
5.0%
8.3%
9.6%
6.2%
2010
millions
% of total
millions
% of total
7,931.1
2,408.6
4,932.1
7,479.9
20,343.1
39.0%
11.8%
24.2%
36.8%
100.0%
7,801.7
2,323.9
4,818.7
6,875.4
19,495.8
40.0%
11.9%
24.7%
35.3%
100.0%
3.2.2. Cosmetics net sales by geographic zone

2012
Western Europe
of which France
North America
New Markets
Asia, Pacific
Eastern Europe
Latin America
Africa, Middle East
COSMETICS
BRANCH
Growth (%)
2011
2010
millions
% of total
Published
data
Excluding
exchange
effect
7,399.6
2,469.7
5,210.7
8,201.6
4,287.0
1,405.0
1,826.6
683.0
35.6%
11.9%
25.0%
39.4%
20.6%
6.8%
8.8%
3.3%
2.1%
4.8%
18.3%
13.6%
18.4%
5.1%
8.7%
17.6%
1.0%
4.8%
9.4%
9.2%
9.6%
3.9%
10.4%
14.7%
7,246.6
2,355.7
4,406.2
7,218.0
3,619.5
1,336.9
1,680.9
580.7
38.4%
12.5%
23.3%
38.2%
19.2%
7.1%
8.9%
3.1%
7,181.0
2,264.9
4,291.5
6,666.6
3,192.2
1,398.9
1,517.7
557.8
39.6%
12.5%
23.7%
36.8%
17.6%
7.7%
8.4%
3.1%
20,811.9
100.0%
10.3%
6.2%
18,870.8
100.0%
18,139.1
100.0%
millions
% of total
millions
% of total
3.2.3. Breakdown of operating profit of Cosmetics branch by geographic zone

millions
Western Europe
North America
New Markets
Non-allocated
COSMETICS BRANCH
2012
2011
2010
1,576.2
959.7
1,518.4
4,054.3
-577.2
3,477.1
1,512.3
810.1
1,328.1
3,650.6
-546.2
3,104.4
1,552.0
708.5
1,124.8
3,385.3
-512.9
2,872.4
3.2.4. Breakdown of operational assets and consolidated investments by geographic zone

2012
millions
Western Europe
North America
New Markets
Non-allocated
GROUP
112
2011
Operational
assets
Investments in
property, plant
and equipment
and intangible
assets
8,462.0
4,699.6
3,740.2
556.1
17,457.9
2010
Operational
assets
Investments in
property, plant
and equipment
and intangible
assets
Operational
assets
Investments in
property, plant
and equipment
and intangible
assets
299.0
8,213.4
271.5
7,743.9
215.2
212.5
336.1
122.4
970.0
4,486.9
3,538.0
511.7
16,750.0
190.4
294.3
107.6
863.7
3,981.2
3,090.8
396.1
15,212.0
167.8
202.0
106.1
691.1

NOTE 4
Personnel costs and number of employees

NUMBER OF EMPLOYEES (1)
4.1.
12.31.2012
12.31.2011
12.31.2010
30,798
16,180
25,659
72,637
30,155
15,195
23,536
68,886
29,542
14,811
22,266
66,619
2012
2011
2010
4,414.4
3,976.8
3,764.9
Western Europe
North America
New Markets
TOTAL
(1) Including proportionally consolidated companies.
4.2.
PERSONNEL COSTS
millions
Personnel costs (including welfare contributions)
Personnel costs include pension costs, share-based payment and taxes on wages and salaries.
4.3.
EXECUTIVE COMPENSATION
Costs recorded in respect of compensation and similar benefits granted to the Management Committee and the Board of Directors can
be analysed as follows:
millions
Directors fees
Salaries and benefits including employer welfare contributions
Employee retirement obligation charges
Share-based payment (Stock option and free shares)
2012
2011
2010
1.1
26.5
11.5
21.2
1.1
25.9
10.8
21.0
1.0
24.3
9.2
28.4
The number of executives who were members of the Management Committee was 15 at December 31 st, 2012 as at December 31st,
2011 and was 13 at December 31st, 2010.
NOTE 5
Depreciation and amortisation expense
Depreciation and amortisation of property, plant and equipment and intangible assets included in operating expenses amount to 830.9
million, 742.2 million and 767.7 million, respectively, for 2012, 2011 and 2010.
NOTE 6
Foreign exchange gains and losses
Foreign exchange gains and losses break down as follows:

millions
Change in time value

Other foreign exchange gains and losses
TOTAL
113
2012
2011
2010
-73.7
-66.1
-139.8
-39.6
13.2
-26.4
-17.0
-115.0
-132.0
2012Notes
CONSOLIDATED
STATEMENTS
Foreign currency transactions are

translated at the spot rate at the
transaction date.
Assets and liabilities denominated in
foreign
currencies
have
been
translated using the exchange rates
effective at the closing date. Foreign
exchange gains and losses also
include the following items relating to
derivative instruments:
changes in market value linked to

variations in the spot rate between
the inception of the hedge and the
date on which the hedged
transactions are completed;
residual ineffectiveness linked to

excess hedges and recognised
directly in the income statement
under other foreign exchange
gains and losses for a negative
0.9 million in 2012, for a negative
0.2 million in 2011 and a negative
0.4 million in 2010.
changes in market value linked to

variations in the time value
(forward points and premiums paid
for options);
These amounts are allocated to the appropriate operating expense items as

follows:
millions
Cost of sales
FOREIGN EXCHANGE GAINS AND LOSSES
2012
2011
2010
-121.2
10.0
-17.8
-10.8
-139.8
-15.2
-8.0
-2.1
-1.1
-26.4
-118.1
11.1
-15.9
-9.1
-132.0
2012
2011
2010
4.3
-98.0
-30.1
-123.8
1.7
-69.9
-39.9
11.8
-96.3
0.3
-56.4
-17.9
-79.2
-153.2
Other operational income and

expenses
NOTE 7
This item breaks down as follows:

millions
Capital gains and losses on disposals of property,

plant and equipment and intangible assets
Impairment of property, plant and equipment and intangible assets
Restructuring costs (2)
Other (3)
TOTAL
(1)
(1) These impairment charges mainly relate to:

in 2011, the Softsheen Carson brand and goodwill for 32.8 million and 31.8 million
respectively as well as Sanoflore goodwill for 5.3 million;
in 2010, the Softsheen Carson brand for 14.5 million, the Yue Sai brand for 11.5
million, as well as Sanoflore goodwill for 20.4 million and Softsheen Carson goodwill
for 10.0 million.
(2) Including:
in 2012, the cost of specialising operations in European factories for 16.6 million, of
sales force adjustments in Germany for 5.1 million, of reorganising industrial operations
within the Professional Products Division in the US for 35.1 million, and of streamlining
logistics activities in the Salon Centric Division which supplies American hair salons for
27.0 million;
in 2011, the reorganisation of industrial operations in the United States for 34.6 million;
in 2010, 4.7 million relating to the discontinuation of Shu Uemura in the United States, 5.5 million relating to the discontinuation of Helena Rubinstein in France,
5.0 million relating to the reorganisation of YSL Beaut, and 3.2 million relating to the reorganisation of industrial and logistics operations in France.
(3)
In 2012, the revision of risks relating to investigations carried out by competition

authorities for 3.1 million (see note 22.1) as well as costs relating to acquisitions for
12.9 million and revision of the earn out clause regarding Essie Cosmetics for 10.4
million;
in 2011, the positive revision of risks relating to investigations carried out by competition
authorities for 23 million (see note 22.1) as well as costs relating

to the acquisition of Q-Med and Pacific Bioscience Laboratories Inc. for 9.6 million and revision
of the earn out clause regarding Essie Cosmetics for 3.0 million;
in 2010, risks relating to investigations carried out by competition authorities (see note
22.1.).
114

NOTE 8
Other financial income and expenses
This item breaks down as follows:

millions
Other financial income

Other financial expenses
TOTAL
NOTE 9
2011
2010
-7.8
-7.8
0.9
-6.5
-5.6
7.5
-16.5
-9.0
2012
2011
2010
988.2
17.3
1,005.5
939.9
85.9
1,025.8
799.9
110.0
909.9
2012
2011
2010
3,875.9
29.83%
1,156.1
8.7
-103.2
2.6
-58.7
1,005.5
3,466.7
29.91%
1,036.7
54.9
-50.4
-8.4
-7.0
1,025.8
3,151.9
30.13%
949.7
93.1
-107.7
-18.5
-6.7
909.9
Income tax
9.1.
DETAILED BREAKDOWN OF INCOME TAX
millions
Current tax
Deferred tax
INCOME TAX
9.2.
2012
ANALYSIS OF TAX CHARGE
The income tax charge may be analysed as follows:

millions

Theoretical tax rate
Expected tax charge
Impact of permanent differences
Impact of tax rate differences
Change in unrecognised deferred taxes
Other (1)
GROUP TAX CHARGE
(1)
Including tax credits, withholding taxes on distributions, tax reassessments and provisions for tax liabilities. In 2012, this amount includes a
35 million tax reimbursement in China relating to fiscal years 2008 to 2011 following a change in tax legislation.
The expected tax charge reflects, for each country, the sum of pre-tax profit multiplied by the normal taxation rate. The theoretical tax
rate reflects the total expected tax charge as a percentage of profit before tax and non-controlling interests.
115
2012Notes
CONSOLIDATED
STATEMENTS
9.3.
DEFERRED TAXES IN THE BALANCE SHEET
The net change in deferred taxes (assets and liabilities) can be analysed as follows:
millions
Balance of deferred tax assets at December 31st, 2009

Balance of deferred tax liabilities at December 31st, 2009
Income statement impact
Translation differences
Other effects (1)
Other effects (1)
Other effects (1)
570.8
-418.0
-110.0
6.7
114.6
626.1
-462.0
-85.9
-5.6
-78.9
671.4
-677.7
-17.3
-7.6
-15.4
717.8
-764.4
(1) Including mainly the tax effect on actuarial gains and losses recognised in equity and in 2011 on newly consolidated companies for 100 million.
Deferred tax assets and liabilities recorded in the balance sheet may be broken as follows:
millions
Temporary differences
Deferred tax liabilities on remeasurement of Sanofi (1)
Tax credits and tax loss carry-forwards
DEFERRED TAX TOTAL
12.31.2012
12.31.2011
Deferred
Deferred
Deferred
tax
Deferred
tax
tax assets
liabilities tax assets
liabilities
703.7
14.1
717.8
433.2
331.2
764.4
645.5
25.9
671.4
461.5
216.2
677.7
12.31.2010
Deferred
Deferred
tax
tax assets
liabilities
599.0
27.1
626.1
371.9
90.1
462.0
(1) In 2012, the deferred tax rate increased to 4.13% (3.44% in 2011 and 1.72% in 2010).
Deferred tax assets on temporary differences mainly relate to

provisions for pensions and early retirement (359.0 million, 321.6
million and 313.2 million, respectively, at the end of 2012, 2011
and 2010) and provisions for liabilities and charges (191.6 million,
164.1 million and 197.9 million, respectively, at the end of 2012,
2011 and 2010).
116
Deferred tax liabilities on temporary differences mainly relate to

intangible assets acquired in the context of business combinations
other than non tax-deductible goodwill.
Deferred tax assets whose recovery is not considered probable are
not recorded in the financial statements; such assets amount to
66.0 millions at December 31 st, 2012 compared with 67.5 million
at December 31st, 2011 and 80.9 million at December 31st, 2010.

NOTE 10 Net
profit attributable to owners of the company

excluding non-recurring items Earnings per share
10.1.
RECONCILIATION WITH NET PROFIT
Net profit attributable to owners of the company excluding non-recurring items reconciles as follows with net profit attributable to owners
of the company:
millions

Capital gains and losses on property, plant and equipment and intangible assets
Impairment of property, plant and equipment and intangible assets
Restructuring costs
Other
Tax effect on non-recurring items
Effect of changes in tax rates on the deferred tax liability arising
on the remeasurement of Sanofi
Tax effect on the acquisition of Pacific Bioscience Laboratories Inc.
NET PROFIT ATTRIBUTABLE TO OWNERS OF THE COMPANY
EXCLUDING NON-RECURRING ITEMS
2012
2011
2010
2,867.7
-4.3
98.0
30.1
-44.8
2,438.4
-1.7
69.9
39.9
-11.8
-33.0
2,239.7
-0.3
56.4
17.9
79.2
-22.0
25.0
-
62.0
19.2
2,971.7
2,582.9
2,370.9
10.2. EARNINGS PER SHARE

The tables below set out earnings per share attributable to owners of the company:
Net profit attributable to

2012
Earnings per share
Stock options
Free shares
DILUTED EARNINGS PER SHARE
Number of shares
2,867.7
2,867.7
598,482,929
5,491,789
1,330,740
605,305,458

2011
( millions)
Earnings per share

Stock options
Free shares
2,438.4
2,438.4

2010
( millions)
Earnings per share

Stock options
Free shares
( millions)
2,239.7
2,239.7
117
Number of shares
592,763,295
4,247,654
622,154
597,633,103
Number of shares
586,582,918
4,538,021
271,510
591,392,449
Earnings per share

attributable to owners
of the company
()
4.79
4.74
Earnings per share

of the company
()
4.11
4.08
Earnings per share

of the company
()
3.82
3.79
2012Notes
CONSOLIDATED
STATEMENTS
1.6.
EARNINGS PER SHARE EXCLUDING NON-RECURRING ITEMS
The tables below set out in detail earnings per share attributable to owners of the company excluding non-recurring items:
2012
Earnings per share excluding non-recurring items
Stock options
Free shares
DILUTED EARNINGS PER SHARE EXCLUDING
NON-RECURRING ITEMS
2011
Stock options
Free shares
NON-RECURRING ITEMS
2010
Stock options
Free shares
NON-RECURRING ITEMS
Net profit
attributable to
owners of the
company excluding
non-recurring items
Earnings per
share attributable
to owners of the
company excluding
non-recurring items
( millions)
Number of shares
2,971.7
-
598,482,929
5,491,789
1,330,740
4.97
-
2,971.7
605,305,458
4.91
Net profit attributable

to owners of the
company excluding
non-recurring items
()
Earnings per
share attributable
to owners of the
company excluding
non-recurring items
( millions)
Number of shares
2,582.9
-
592,763,295
4,247,654
622,154
4.36
-
2,582.9
597,633,103
4.32
Net profit
attributable
to owners of the
company excluding
non-recurring items
()
Earnings per share

attributable to
owners of the
company excluding
non-recurring items
( millions)
Number of shares
2,370.9
-
586,582,918
4,538,021
271,510
4.04
-
2,370.9
591,392,449
4.01
()
10.4. CALCULATION OF THE NUMBER OF SHARES

The table below sets out the number of potential ordinary shares excluded from the calculation of earnings per share as they
correspond to stock option plans with no dilutive effect on the periods presented:
Stock option plans
118
2012
2011
2010
1,445,000
10,676,150
14,858,900

NOTE 11
Goodwill
Goodwill is allocated by Cash-Generating Unit or by groups of Cash-Generating Units. A Cash-Generating Unit consists of one or more
worldwide trademarks. The methodology used to carry out impairment tests is described in note 1.
millions
2012
12.31.2011
LOral Professionnel/Krastase
Matrix
Redken/PureOlogy
Professional Products Total
LOral Paris
Maybelline/Garnier
Cadum
Other
Consumer Products Total
Lancme
Shu Uemura
YSL Beaut
Perfumes
Clarisonic
Urban Decay
Other
LOral Luxury Total
Vichy/Dermablend
Other
Active Cosmetics Total
Other
The Body Shop
Dermatology
GROUP TOTAL
348.1
343.0
492.6
1,183.7
773.8
1,102.7
98.2
1,974.7
780.8
163.9
519.8
334.0
260.0
63.6
2,122.1
269.4
110.8
380.2
9.2
330.8
203.9
6,204.6
2012 acquisitions mainly relate to Cadum, Urban Decay and Emiliani

Enterprises for 306.4 million. No significant disposals took place during
2012. Other movements mainly reflect the negative impact of changes in
exchange rates for 48.4 million, partly offset by the allocation of the
purchase price of Clarisonic for 10.6.million.
119
Acquisitions/
Disposals
Other
movements
5.5
18.1
-2.0
-4.8
-7.4
-14.2
1.7
-14.8
23.6
156.4
3.3
159.7
-1.5
-14.6
-17.4
126.4
126.4
1.6
311.3
0.7
6.3
-0.3
0.2
-10.5
-0.5
-0.6
-1.1
-9.2
7.7
4.2
-37.7
12.31.2012
351.6
356.3
485.2
1,193.1
775.5
1,087.9
156.4
100.0
2,119.8
780.8
146.5
519.8
334.7
266.3
126.1
63.8
2,238.0
268.9
110.2
379.1
340.1
208.1
6,478.2
No impairment loss has been recorded on 2012.

The accumulated impairment losses relating to SoftSheen Carson, Yue Sai
and Sanoflore amount to 133.4 million, 29.5 million and 35.7 million
respectively, at December 31st, 2012.
2012Notes
CONSOLIDATED
STATEMENTS
millions
2011
Matrix
Redken/PureOlogy
Other
LOral Paris
Maybelline/Garnier
SoftSheen Carson
Other
Lancme
Shu Uemura
YSL Beaut
Perfumes
Clarisonic
Other
LOral Luxury Total
Vichy/Dermablend
Other
Other
The Body Shop
Dermatology
GROUP TOTAL
2011 acquisitions mainly relate to Arex GmbH, Q-Med and Pacific
Bioscience Laboratories Inc. (Clarisonic) for 415.6 million. No
significant disposals took place during 2011. Other movements mainly
reflect the positive impact of changes in exchange rates for 82.7
million, partly offset by the allocation of the purchase price of the Peels
Salon Services for 6.1 million and by impairment losses on Softsheen
Carson for 31.8 million and on Sanoflore for 5.3 million (included in
the Other line of Active Cosmetics).
120
12.31.2010
343.1
296.3
467.7
31.9
1,139.0
768.1
1,079.0
45.0
84.9
1,977.0
775.2
152.5
519.8
334.0
63.4
1,844.9
268.0
114.4
382.4
9.2
321.8
55.3
5,729.6
Acquisitions/
Disposals
6.5
0.9
7.4
260.8
260.8
1.1
149.5
418.8
Other
movements
5.0
40.2
24.0
-31.9
37.3
5.7
23.7
-32.7
1.0
-2.3
5.6
11.4
-0.8
0.2
16.4
1.4
-3.6
-2.2
7.9
-0.9
56.2
12.31.2011
348.1
343.0
492.6
1,183.7
773.8
1,102.7
12.3
85.9
1,974.7
780.8
163.9
519.8
334.0
260.0
63.6
2,122.1
269.4
110.8
380.2
9.2
330.8
203.9
6,204.6
Impairment losses have been recorded against these CashGenerating Units as their performance did not meet forecasts.
The accumulated impairment losses relating to Softsheen Carson,
Yue Sai and Sanoflore amount to 136.8 million, 29.8 million and
35.7 million, respectively, at December 31st, 2011.

millions
2010
12.31.2009
Matrix
Redken/PureOlogy
Other
LOral Paris
Maybelline/Garnier
SoftSheen Carson
Other
Lancme
Shu Uemura
YSL Beaut (1)
Perfumes
Other
LOral Luxury Total
Vichy/Dermablend (1)
Other
Other
The Body Shop
Dermatology
GROUP TOTAL
328.6
266.3
419.4
40.0
1,054.3
756.6
992.8
50.9
35.2
1,835.5
767.6
123.7
528.4
334.0
62.9
1,816.6
264.8
131.0
395.8
9.2
312.5
42.2
5,466.0
Acquisitions/
Disposals
Other
movements
2.5
9.3
2.1
34.8
48.7
12.0
20.7
46.2
-42.9
36.0
11.5
61.7
-5.9
-0.1
67.2
7.6
28.8
-8.6
24.5
49.8
74.3
0.5
28.3
3.2
-16.6
-13.4
1.9
124.9
7.4
13.1
138.7
12.31.2010
343.1
296.3
467.7
31.9
1,139.0
768.1
1,079.0
45.0
84.9
1,977.0
775.2
152.5
519.8
334.0
63.4
1,844.9
268.0
114.4
382.4
9.2
321.8
55.3
5,729.6
(1) After reclassification of the Roger & Gallet business from the LOral Luxury Division to the Active Cosmetics Division.
2010 acquisitions mainly relate to Essie Cosmetics, C.B. Sullivan and Peels
Salon Services for 123.0 million. The provisional goodwill totalling 74.3 million
resulting from the acquisition of Essie Cosmetics has been allocated to the
Essie Cosmetics Cash-Generating Unit (included on the Other line of
Consumer Products) for 49.8 million, with the remainder allocated to the
Maybelline/Garnier Cash-Generating Unit based on expected synergies for
24.5 million. The goodwill representing the difference between the acquisition
cost and Peels Salon Services identifiable assets and liabilities is shown in full
for 34.8 million on the Other line of the Professional Products Division,
pending the final purchase price allocation. No significant disposals took
place during 2010. Other movements consist mainly of a positive impact of

changes in exchange rates for 187.4 million, partly offset by the allocation of
the purchase price of the American distributors acquired in 2009 for 16.3
million, and by impairment losses on Softsheen Carson for 10.0 million and on
Sanoflore for 20.4 million (included in the Other line of Active Cosmetics).
Impairment losses have been recorded against these Cash-Generating Units as
their performance did not meet forecasts.
The accumulated impairment losses relating to Softsheen Carson, Yue Sai

and Sanoflore amount to 103.2 million, 27.6 million and 30.4 million,
respectively, at December 31st, 2010.
121
2012Notes
CONSOLIDATED
STATEMENTS
NOTE 12
millions
2012
12.31.2011
Brands with an indefinite life span (2)

Amortisable brands and product ranges
Licences and patents
Software
Other
Gross value
Brands with an indefinite life span
Software
Other
Amortisation and provisions
Other intangible assets net
(1)
(2)
Acquisitions/
Amortisation
1,454.3
74.4
930.4
538.6
459.8
3,457.5
104.3
54.8
319.1
350.2
151.9
980.2
2,477.3
Other
movements 12.31.2012
-10.2
-10.5
-0.9
-21.6
3.5
52.4
93.6
29.8
179.3
-59.8
-10.4
-11.0
-0.4
-21.8
0.2
-10.5
3.2
198.3
-32.1
158.9
-1.1
-0.3
-0.5
91.7
-0.8
89.0
69.9
0.3
40.1
137.9
0.1
0.1
137.8
1,539.1
79.4
943.0
791.9
498.8
3,852.2
103.2
58.0
360.6
524.6
180.5
1,226.8
2,625.4
This item consists mainly of changes in the scope of consolidation resulting from Cadum, Urban Decay and Emiliani Enterprises.
At December 31st, 2012, brands with an indefinite life span consist mainly of The Body Shop (507.8 million), Matrix (276.8 million), Kiehls
(123.8 million), Shu Uemura (117.2 million) and Clarisonic (85.1 million).
12.31.2010
Acquisitions/
Amortisation
1,295.5
66.8
725.6
906.5
2,994.3
66.3
48.6
270.9
431.2
816.9
2,177.5
0.7
9.0
98.6
108.3
32.8
3.7
42.4
88.3
167.2
-58.9
millions
2011
(2)
Brands with an indefinite life span

Other
Gross value
Other
(3)
Change in
the scope of
consolidation (1)
95.3
2.2
2.8
19.6
65.2
31.9
119.5
Other movements mainly consisted of the reclassification of

software from property, plant and equipment to intangible assets for
79.3 million, offset by changes in exchange rates with a negative
12.7 million impact over the period.
(1)
(2)
Disposals/
Reversals
Accumulated impairment losses amount to 14.0 million on

Biomedic, 40.4 million on Yue Sai and 48.9 million on Softsheen
Carson at December 31st, 2012.
Disposals/
Reversals
Change in
the scope of
consolidation (1)
-0.1
-23.2
-23.3
119.9
5.0
185.5
9.7
320.1
-0.1
-23.2
-23.3
0.0
-0.7
-0.7
320.8
Other
movements
12.31.2011
38.9
2.0
10.4
6.9
58.2
5.3
2.5
6.6
5.8
20.1
38.0
1,454.3
74.4
930.4
998.4
3,457.5
104.3
54.8
319.1
502.1
980.2
2,477.3
This item consists mainly of changes in the scope of consolidation resulting from Arex GmbH, Q-Med and Pacific Bioscience Laboratories Inc.
At December 31st, 2011, brands with an indefinite life span consist mainly of The Body Shop (495.8 million), Matrix (281.1 million), Kiehls (125.6
million), Shu Uemura (129.3 million) and Clarisonic (86.5 million).
Impairment losses were recognised during the period against the Softsheen Carson brand, for 32.8 million.
Other movements mainly consisted of changes in exchange rates with

a positive 44.1 million impact over the period, as well as the allocation
of the purchase price of the American distributors acquired in 2010
(shown on the Other line for 9.8 million).
122
Accumulated impairment losses amount to 14.0 million on

Biomedic, 40.8 million on Yue Sai and 49.5 million on Softsheen

2010
Other
Gross value
Other
(1)
(2)
(3)
Change in
the scope of
consolidation (1)
12,31.2009
Acquisitions/
Amortisation
Disposals/
Reversals
1,183.1
62.6
662.9
776.2
2,684.8
37.3
32.4
217.8
354.9
642.4
2,042.4
0.6
7.6
84.8
93.0
26.0
13.8
32.5
83.9
156.2
-63.2
-0.4
-1.6
-19.0
-21.0
11.9
57.9
-0.4
-1.6
-18.8
-20.8
-0.2
57.9
millions
46.0
Other
movements 12.31.2010
66.4
4.0
56.7
52.6
179.7
2.9
2.8
22.2
11.2
39.1
140.6
1,295.5
66.8
725.6
906.5
2,994.3
66.3
48.6
270.9
431.2
816.9
2,177.5
This item consists mainly of changes in the scope of consolidation resulting from Essie Cosmetics and C.B. Sullivan.
At December 31st, 2010, brands with an indefinite life span consist mainly of The Body Shop (481.1 million), Matrix (274.5 million), Kiehls
(122.9 million) and Shu Uemura (121.5 million).
Impairment losses were recognised during the period against the Yue Sai and Softsheen Carson brands, for 11.5 million and 14.5 million, respectively.
Other movements mainly consisted of changes in

exchange rates with a positive 128.1 million impact
over the period, as well as the allocation of the
purchase price of the American distributors acquired in
2009 (shown on the Other line for 16.3 million).
123
Accumulated impairment losses amount to 14.0 million

on Biomedic, 37.8 million on Yue Sai and 14.5 million
on Softsheen
2012Notes
CONSOLIDATED
STATEMENTS
NOTE 13
Impairment tests on intangible assets
Impairment tests of Cash-Generating Units for which the carrying amount of goodwill and intangible assets with indefinite useful lives is
significant, are carried out based on the following data and assumptions:
Discount rate (%)

millions
Net carrying amount of goodwill

and brands with indefinite useful lives
International
excluding USA
1,087.9
847.9
780.8
775.5
633.1
546.9
519.8
351.6
351.4
304.7
7.9
7.9
7.9
7.9
7.9
7.9
7.9
7.9
7.9
7.9
8.9
1,102.7
826.6
780.8
773.8
624.1
555.6
519.8
348.1
346.5
305.4
7.9
7.9
7.9
7.9
7.9
7.9
7.9
7.9
7.9
7.9
8.9
1,079.0
802.9
775.2
768.1
570.8
528.8
519.8
343.1
303.6
7.9
7.9
7.9
7.9
7.9
7.9
7.9
7.9
7.9
8.9
USA
2012 test
Maybelline/Garnier
The Body Shop
Lancme
LOral Paris
Matrix
Redken/PureOlogy
YSL Beaut
Clarisonic
Vichy/Dermablend
(1)
8.9
8.9
8.9
8.9
(1)
8.9
8.9
(1)
2011 test
Maybelline/Garnier
The Body Shop
Lancme
LOral Paris
Matrix
Redken/PureOlogy
YSL Beaut
Clarisonic
Vichy/Dermablend
(1)
8.9
8.9
8.9
8.9
(1)
8.9
8.9
(1)
2010 test
Maybelline/Garnier
The Body Shop
Lancme
LOral Paris
Matrix
Redken/PureOlogy
YSL Beaut
Vichy/Dermablend
(1)
8.9
8.9
8.9
8.9
(1)
8.9
(1)
(1) Since the USD amounts for the YSL Beaut, The Body Shop and Vichy/Dermablend CGUs are not material, no specific discount rate has been used in this
respect.
At December 31st, 2012, a 1-point increase in the discount rate on all

Cash-Generating Units would not lead to an impairment loss.
1-point decrease in the terminal growth rate on all CashGenerating Units would not lead to an impairment loss.
The terminal growth rate is consistent in accordance with market

data, i.e. 3%.
1-point decrease in the margin rate over the business plan period
on all Cash-Generating Units would not lead to an impairment loss.
124

NOTE 14
millions
2012
12.31.2011
Land and buildings

Machinery and equipment
Other property, plant and equipment and fixed
assets in progress
Gross value
Land and buildings
Other property, plant and equipment
Depreciation and provisions
Property, plant and equipment - net
(1)
Acquisitions/ Disposals/ Translation

Depreciation Reversals difference
Other
movements (1) 12.31.2012
1,888.8
2,747.1
1,245.4
98.0
185.6
281.6
-14.1
-79.7
-185.8
-12.2
-25.4
-5.4
32.6
48.4
20.1
1,993.1
2,876.0
1,356.0
1,425.7
7,307.0
979.1
1,864.0
842.6
740.5
4,426.2
2,880.8
285.4
850.6
72.1
231.1
258.8
99.4
661.4
189.1
-46.4
-326.0
-12.1
-76.2
-184.9
-46.1
-319.4
-6.6
-17.1
-60.1
-5.5
-15.0
-2.0
-8.0
-30.5
-29.6
-301.5
-200.4
-0.3
-33.4
0.0
-95.9
-129.5
-70.9
1,346.1
7,571.1
1,033.4
1,970.5
914.6
689.9
4,608.4
2,962.8
These mainly include the impact of changes in the scope of consolidation and fixed assets in progress allocated to other fixed asset items as well
as the reclassification of software within intangible assets for a gross value of 176.8 million and a net amount of 79.3 million.
millions
2011
12.31.2010

Other
movements (1) 12.31.2011
Land and buildings
1,729.4
65.2
-35.2
2.3
127.1
1,888.8

assets in progress
Gross value
Land and buildings
2,585.3
1,161.0
156.9
245.7
-78.7
-191.5
-1.6
18.5
85.2
11.7
2,747.1
1,245.4
1,337.5
6,813.2
924.8
1,725.2
797.9
687.8
4,135.7
2,677.5
287.7
755.5
68.2
209.3
223.1
107.1
607.7
147.7
-64.4
-369.8
-28.3
-75.8
-190.5
-63.4
-358.0
-11.8
19.2
38.4
2.8
2.6
10.8
12.6
28.8
9.6
-154.3
69.7
11.6
2.7
1.3
-3.5
12.1
57.7
1,425.7
7,307.0
979.1
1,864.0
842.6
740.5
4,426.2
2,880.8
(1) These mainly include the impact of changes in the scope of consolidation and fixed assets in progress allocated to other fixed asset items.
millions
2010
12.31.2009
Land and buildings

assets in progress
Gross value
Land and buildings

Other
movements (1) 12.31.2010
1,663.7
2,495.1
1,080.7
43.3
100.7
197.0
-38.5
-139.3
-207.9
54.2
91.5
75.5
6.7
37.3
15.7
1,729.4
2,585.3
1,161.0
1,164.1
6,403.6
871.6
1,617.6
718.6
596.8
3,804.6
2,599.0
257.0
598.0
68.0
223.1
236.9
109.4
637.4
-39.4
-44.9
-430.6
-29.6
-132.9
-207.6
-42.6
-412.7
-17.8
71.6
292.8
21.7
50.8
51.0
33.7
157.2
135.6
-110.3
-50.6
-6.9
-33.4
-1.0
-9.5
-50.8
0.2
1,337.5
6,813.2
924.8
1,725.2
797.9
687.8
4,135.7
2,677.5
(1) These mainly include the impact of changes in the scope of consolidation and fixed assets in progress allocated to other fixed asset items.
125
2012Notes
CONSOLIDATED
STATEMENTS
Property, plant and equipment include capital lease contracts for the following amounts:
millions
12.31.2012
12.31.2011
12.31.2010
114.4
2.3
20.5
137.2
70.4
66.8
113.4
2.4
18.8
134.6
63.1
71.5
112.8
3.0
16.7
132.5
58.1
74.4
Land and buildings

Other property, plant and equipment and fixed assets in progress
Gross value
Depreciation
Net value
NOTE 15

12.31.2012
Carrying
Acquisition
amount
cost
millions

(1)
Sanofi
(2)
Unlisted securities
Financial assets at amortised cost
Non-current loans and receivables
TOTAL
12.31.2010
Carrying
Acquisition
amount
cost
8,440.2
5.1
4,033.5
7.3
6,709.4
6.0
4,033.5
7.1
5,657.2
3.5
4,033.5
4.3
86.0
8,531.3
90.8
4,131.6
185.6
6,900.9
190.6
4,231.2
176.8
5,837.5
182.8
4,220.6
(1)
LOrals stake in Sanofi was 8.91% at December 31st,, 2012. The carrying amount at December 31st, 2010, December 31st, 2011 and December 31st,
2012 (5,657.2 million, 6,709.4 million and 8,440.2 million respectively) corresponds to the market value of the shares based on the closing price at
each of these dates ( 47.85, 56.75 and 71.39, respectively). The acquisition cost of 4,033.5 million corresponds to an entry cost of 34.12.
(2)
As the fair value of unlisted securities cannot be reliably determined, they are stated at cost less any impairment losses.
NOTE 16
Inventories
millions
Finished products and consumables

Raw materials, packaging and semi-finished products
Gross value
Valuation allowance
Inventories net
126
12.31.2011
Carrying
Acquisition
amount
cost
12.31.2012
12.31.2011
12.31.2010
1,792.4
472.7
2,265.1
231.3
2,033.8
1,839.8
438.9
2,278.7
226.7
2,052.1
1,606.0
416.3
2,022.3
212.2
1,810.1

NOTE 17
millions
12.31.2012
12.31.2011
12.31.2010
3,253.1
44.3
3,208.8
3,042.3
46.2
2,996.2
2,733.4
48.1
2,685.3
Gross value
Valuation allowance
Net value
Trade accounts receivable are due within one year. Group policy
is to recommend credit insurance coverage as far as local
conditions allow. The non-collection risk on trade receivables
NOTE 18
is therefore minimised, and this is reflected in the level of the

allowance, which is less than 2% of gross receivables at the end
of 2012.
millions
12.31.2012
12.31.2011
12.31.2010
336.8
234.3
162.5
273.0
1,006.6
309.2
231.3
114.0
249.6
904.1
310.9
208.9
83.2
243.0
846.0
Tax and employee-related receivables (excluding income tax)

Prepaid expenses
Derivatives
TOTAL
NOTE 19
millions
Marketable securities
Bank accounts and other cash
and cash equivalents
TOTAL
12.31.2012
Carrying
Acquisition
amount
cost
12.31.2010
Carrying
Acquisition
amount
cost
150.0
150.1
598.2
597.0
523.6
522.9
1,673.2
1,823.2
1,673.2
1,823.3
1,054.0
1,652.2
1,054.0
1,651.0
1,026.8
1,550.4
1,026.8
1,549.7
Marketable securities consist mainly of SICAV money-market

funds and unit trusts (on which the return is based on EONIA).
Marketable securities are considered as Financial assets
available for sale.
At December 31st, 2012, they consisted solely of investments in
euro zone government bonds through mutual funds.
12.31.2011
Carrying
Acquisition
amount
cost
127
Unrealised gains amount to -0.1 million compared with 1.2

million and 0.7 million, respectively, in 2011 and in 2010.
Term accounts with a maturity of less than 3 months at inception
are shown on the Bank accounts and other cash and cash
equivalents line.
2012Notes
CONSOLIDATED
STATEMENTS
NOTE 20
Equity
20.1.
SHARE
CAPITAL AND
ADDITIONAL
PAID
IN
CAPITAL
decision on April 27th, 2010 to cancel

500,000 shares and the exercise of
subscription options for 2,520,175
shares.
Share capital consists of 608,810,827

shares with a par value of 0.20 at
December 31st, 2012, following the
exercise of subscription options for
5,826,745 shares.
Share
capital
consisted
of
602,984,082 shares with a par value
of 0.20 at December 31st, 2011,
following the exercise of subscription
options for 1,991,097 shares and 400
free shares.
20.2.
TREASUR
Y STOCK
Shares
acquired
under
the
shareholder-approved LOral share
buyback programme are deducted
from consolidated equity. Capital
gains or losses relating to these
shares are also recorded in equity net
of tax.
Share capital consisted of 600,992,585

shares with a par value of 0.20 at
December 31st, 2010, following the
Board of Directors
a) 2012
The change in the number of shares in 2012 was as follows:
In shares
Share capital
Treasury stock
Common shares outstanding
602,984,082
-8,597,659
5,826,745
608,810,827
3,220,744
-5,077,250
-10,454,165
594,386,423
9,047,489
-5,077,250
598,356,662
At 01.01.2012
Shares cancelled
Options and free shares exercised
Treasury stock purchased
At 12.31.2012
The change in Treasury stock in 2012 is as follows:
In shares
At 01.01.2012
Shares cancelled
At 12.31.2012
millions
Buyback programme
Allocated to stock options/

free shares plans
Total
millions
8,597,659
8,597,659
644.4
5,077,250
5,077,250
499.2
-3,220,744
5,376,915
405.3
-3,220,744
5,077,250
10,454,165
904.5
-239.1
499.2
904.5
-
b) 2011
The change in the number of shares in 2011 was as follows:
In shares
At 01.01.2011
Shares cancelled
At 12.31.2011
Share capital
Treasury stock
600,992,585
-11,336,682
1,991,497
602,984,082
2,739,023
589,655,903
4,730,520
-8,597,659
594,386,423
128

In shares
Buyback programme

free shares plans
Total
millions
11,336,682
11,336,682
850.9
-2,739,023
8,597,659
644.4
-2,739,023
8,597,659
644.4
-206.5
644.4
At 01.01.2011
Shares cancelled
At 12.31.2011
millions
c) 2010
The change in the number of shares in 2010 is as follows:
In shares
At 01.01.2010
Shares cancelled
At 12.31.2010
Share capital
Treasury stock
598,972,410
-500,000
2,520,175
600,992,585
-14,236,750
500,000
2,400,068
584,735,660
4,920,243
-11,336,682
589,655,903
Buyback programme
In shares
At 01.01.2010
Shares cancelled
Options and free shares
exercised
At 12.31.2010
Total
14,236,750
-500,000
14,236,750
-500,000
1,071.6
-37.9
-2,400,068
11,336,682
850.9
-2,400,068
11,336,682
850.9
-182.8
850.9
millions
20.3.

free shares plans
millions
SHARE SUBSCRIPTION OR PURCHASE OPTIONS FREE SHARES
1) Share subscription or purchase options

The table below sets out data concerning option plans issued after November 7th, 2002 and in force at December 31st, 2012.
Grant date
Number of options
Number of options
not yet exercised
2,500,000
2,500,000
2,000,000
4,000,000
400,000
4,200,000
1,800,000
2,000,000
5,500,000
4,000,000
3,650,000
4,200,000
1,470,000
756,300
852,375
145,893
1,335,250
200,000
1,572,640
658,785
2,000,000
2,456,500
3,258,200
3,475,500
4,054,000
1,445,000
12.03.2003
12.03.2003
03.24.2004
12.01.2004
06.29.2005
11.30.2005
11.30.2005
04.25.2006
12.01.2006
11.30.2007
03.25.2009
04.27.2010
04.22.2011
129
Exercise period
from
to
12.04.2008
12.04.2008
03.25.2009
12.02.2009
06.30.2010
12.01.2010
12.01.2010
04.26.2011
12.02.2011
12.01.2012
03.26.2014
04.28.2015
04.23.2016
12.03.2013
12.03.2013
03.24.2014
12.01.2014
06.29.2015
11.30.2015
11.30.2015
04.25.2016
12.01.2016
11.30.2017
03.25.2019
04.27.2020
04.22.2021
Exercise price
63.02
71.90
64.69
55.54
60.17
61.37
62.94
72.60
78.06
91.66
50.11
80.03
83.19
2012Notes
CONSOLIDATED
STATEMENTS
All plans have a 5-year exercise

period and no performance-related
conditions, except the April 22nd, 2011
plan (for all participants) and the April
27th, 2010 and March 25th, 2009 plans
(for members of the Management
Committee).The
performance
conditions associated with these
plans concern:
April 27th, 2010 and March 25th,

2009 plans:
for 50% of options granted, the

increase
in
comparable
Cosmetic revenues for the
2011, 2012, 2013 and 2014
fiscal years for the 2010 plan
and for the 2010, 2011, 2012
and 2013 fiscal years for the
2009 plan compared to the
growth of the cosmetics
market;
for 50% of shares granted, the

percentage, over the same
period, resulting from the ratio
between the contribution before
advertising
and
promotion
expenses, i.e. the sum of
operating profit and advertising
and promotion expenses, and
published Cosmetic revenues.
April 22nd, 2011 plan:

increase
in
comparable
Cosmetic revenues for the
2012, 2013, 2014 and 2015
fiscal years in relation to the
growth in revenues for a panel
of competitors;
increase over the same period
in
Group
consolidated
operating profit.
The calculation will be based on the

arithmetic average of the performance
in 2012, 2013, 2014 and 2015 fiscal
years and will use a predefined
allocation scale based on the
performance percentage reached.
The calculation will be based on the

arithmetic average of performance in
the 2011, 2012, 2013 and 2014 fiscal
years for the 2010 plan and in the
2010, 2011, 2012 and 2013 fiscal
years for the 2009 plan, and will use
a predefined allocation scale based
on the performance percentage
achieved.
At December 31st, 2012, the
performance conditions were deemed
to have been met.
The fair value of options is determined using the Black & Scholes method based
on the following assumptions:
Purchase options
Subscription options
December November December March December

2003
2005
2003 2004
2004
Risk-free rate
of return
Expected life
span
Expected
volatility
Expected
dividends
Share price
Exercise
price
Fair value
4.22%
3.16%
8 years
3.39%
3.17% 2.63%
6 years
6 years 7 years
21.50%
21.00%
1.00%
63.45
71.90
15.24
3.16%
April December November March

2006
2006
2007 2009
April
2010
April
2011
3.80%
3.62%
4.01% 3.15% 2.83% 3.42%
6 years 6 years
6 years 6 years
7 years
7 years 7 years 7 years 8 years
21.50% 23.67%
18.70% 17.00%
21.00% 20.50%
22.52%
23.00% 31.95% 23.53% 22.60%
1.35%
61.30
1.00% 1.20%
63.45 60.60
1.34% 1.38%
54.60 59.40
1.35% 1.35%
61.30 74.10
1.35%
74.60
1.24% 2,83% 1.86% 2.10%

94.93 50.94 80.50 85.68
62.94
12.30
63.02 64.69
15.66 14.67
55.54 60.17
10.15 9.45
61.37 72.60
12.88 17.48
78.06
17.19
91.66 50.11 80.03 83.19

25.88 12.16 17.17 18.58
Expected volatility is equal to the

implied volatility of the options listed
on MONEP at the grant dates. As
from 2007, in order to mitigate the
effects of atypical phenomena, the
volatility used corresponds to the
average between implied volatility at
the
3.92%
June November
2005
2005
grant date and historic volatility over

the expected life span of the option.
The expected life span has been
adjusted
to
take
account
of
behavioural assumptions relating to
the beneficiaries.
130

Data concerning all share option plans during fiscal years 2010, 2011 and 2012 are set out below:
12.31.2012
12.31.2011
12.31.2010
Weighted
Weighted
Weighted
Number
average
Number
average
Number
average
of options exercise price of options exercise price of options exercise price
Number of options not exercised at beginning
of period
Options granted
Options exercised
Options expired
Number of options not exercised at end of period
Of which:
number of exercisable options at end of period
expired options at end of period
32,524,432
-9,047,489
-1,266,500
22,210,443
72.02 37,296,504
1,470,000
71.96 -4,730,120
-1,511,952
71.90 32,524,432
71.55 40,051,000
83.19
4,200,000
70.24 -4,920,243
-2,034,253
72.02 37,296,504
70.86
80.03
68.40
13,235,943
45,000
73.90 19,450,832
214,750
69.63 18,299,654
326,750
67.61
71.55
The weighted average share price was 93.60, 81.60 and 80.47, respectively, for 2012, 2011 and 2010.
The total charge recorded in 2012, 2011 and 2010 amounted to 41.2 million, 62.8 million and 76.5 million, respectively.
2) Free shares
On April 17th, 2012, April 22nd, 2011, April 27th, 2010 and
March 25th, 2009, the Board of Directors decided to
grant respectively 1,325,050, 1,038,000, 450,000 and
270,000 free shares.
VESTING CONDITIONS
For the conditional grant of shares, the plan provides for
a 4-year vesting period after which vesting is effective
and final, subject to meeting the conditions of the plan.
After this vesting period, a 2-year mandatory holding
period applies for French residents, during which the
shares cannot be sold.
The performance conditions concern:
April 17th, 2012 and April 22nd, 2011 plans:
for 50% of shares granted, the increase in

comparable Cosmetic revenues for the 2013,
2014 and 2015 fiscal years under the 2012 plan
and for the 2012, 2013 and 2014 fiscal years
under the 2011 plan in relation to the growth in
revenues for a panel of competitors;
for 50% of shares granted, the increase over the
same period in Group consolidated operating
profit.
The calculation will be based on the arithmetic average

of the performance in the 2013, 2014 and 2015 fiscal
years under the 2012 plan and in the 2012, 2013 and
2014 fiscal years under the 2011 plan and will use a
predefined allocation scale based on the performance
percentage achieved. No performance condition applies
below a block of 200 shares.
April 27th, 2010 and March 25th, 2009 plans:
for 25% of shares granted under the 2010 plan

and 50% of shares granted under the 2009 plan,
the increase in comparable Cosmetic revenues
for the 2011, 2012 and
2013 fiscal years for the 2010 plan and for the
2010, 2011 and 2012 fiscal years for the 2009
plan compared with the growth of the
cosmetics market;
for 75% of shares granted under the 2010 plan and 50%
of shares granted under the 2009 plan, the percentage,
over the same period, resulting from the ratio
between operating profit and published
Cosmetic revenues.
The calculation will be based on the arithmetic
average of performance in the 2011, 2012 and 2013
fiscal years for the 2010 plan and 2010, 2011 and
2012 fiscal years for the 2009 plan, and will use a
predefined allocation scale based on the
performance percentage achieved.
At December 31st, 2012, the performance conditions
were deemed to have been met.
FAIR VALUE OF FREE SHARES GRANTED
The fair value corresponds to the value of the share at
the grant date, less dividends expected to be paid during
the vesting period. The cost of the additional 2-year
holding period applicable to French residents is
determined based on the interest rate granted to the
employee, considered equivalent to the rate which would
be granted by a bank to a private individual customer
with an average financial profile.The cost of the holding
period amounts respectively to 8.06%, 8.54%, 8.64%
and 8.47% of the share value at the grant date for the
2012, 2011, 2010 and 2009 plans.
On the basis of these assumptions, the fair values for
the 2012, 2011, 2010 and 2009 plans amount to 77.07,
70.36, 66.78 and 40.23 respectively for French
residents, and to 84.62, 77.67, 73.73 and 44.55
respectively, for non-residents, compared to a share
price of 93.68, 85.68, 80.50 and 50.94,
respectively.
The expense recorded in 2012, 2011and 2010

amounted to 45.2 million, 24.0 million and 8.4
million, respectively.
131
2012Notes
CONSOLIDATED
STATEMENTS
20.4. ITEMS DIRECTLY RECOGNISED IN EQUITY

The following tables indicate movements in these items:
millions

Reserve at beginning of period
Changes in fair value over period
Impairment loss recorded in profit and loss
Changes in fair value recorded in profit and loss
Reserve at end of period
millions
12.31.2012
12.31.2011
12.31.2010
2,675.8
1,730.9
4,406.7
1,624.1
1,052.2
-0.5
2,675.8
2,476.4
-852.3
1,624.1
12.31.2012
12.31.2011
12.31.2010
-7.4
20.1
82.7
95.4
0.2
-16.9
9.3
-7.4
8.1
-151.5
143.6
0.2
Cash flow hedges - foreign exchange

Changes in fair value over period
A 10% increase (decrease) in the euro against all Group currencies
would have had an impact of +209.7 million (-195.1 million) on
the foreign exchange cash flow hedge reserve and the market
value of hedging instruments at December 31st, 2012.
A 10% increase (decrease) in the USD against the main Group

currencies would have had an impact of -55.1 million (+68.3
million) on the foreign exchange cash flow hedge reserve and the
market value of hedging instruments at December 31st, 2012.


currencies would have had an impact of -12.8 million (+25.8


currencies would have had an impact of +3.3 million (+8.2
millions
Cash flow hedges - interest rates

Changes in fair value over the period
millions
Actuarial gains/(losses) and impact of asset ceiling

Actuarial gains/(losses) over the period
Impact of asset ceiling
millions
Total items recognised directly in equity

Gross reserve
Associated tax effect
Reserve net of tax
132
12.31.2012
12.31.2011
12.31.2010
-1.7
-0.3
2.0
-
-1.6
-0.7
0.6
-1.7
12.31.2012
12.31.2011
12.31.2010
-796.4
-272.0
0.1
-1,068.4
-624.0
-172.5
0.1
-796.4
-410.5
-215.7
2.2
-624.0
12.31.2012
12.31.2011
12.31.2010
3,433.7
152.7
3,586.4
1,872.0
182.7
2,054.7
998.6
189.5
1,188.1

NOTE 21 Post-employment
benefits, termination benefits

and other long-term employee benefits
The Group operates pension, early retirement and other benefit

schemes depending on local legislation and regulations.
For obligatory state schemes and other defined-contribution
schemes, the Group recognises in the income statement
contributions payable when they are due. No provision has been
set aside in this respect as the Groups obligation does not
exceed the amount of contributions paid.
The characteristics of the defined benefit schemes in force
within the Group are as follows:
French regulations provide for specific length-of-service

awards payable to employees on retirement. An early
retirement plan and a defined benefit plan have also been set
up. In some Group companies there are also measures
providing for the payment of certain healthcare costs for
retired employees.
These obligations are partially funded by an external fund, except

those relating to healthcare costs for retired employees;
for foreign subsidiaries with employee pension schemes or

other specific obligations relating to defined benefit plans, the
excess of the projected benefit obligation over the schemes
assets is recognised by setting up a provision for charges on
the basis of the actuarial value of employees vested rights.
Pension obligations are determined and recognised in

accordance with the accounting principles presented in note
1.23. As from January 1st, 2009, the Group decided to adopt the
IAS 19 option allowing the direct recognition in equity of
actuarial gains and losses instead of the corridor method.
The actuarial assumptions used to calculate these obligations take into account the economic conditions specific to each country
or Group company. The weighted average assumptions for the Group are as follows:
Discount rate
Salary increase
Expected long-term return on plan assets
Initial
rate
Expected rate of
health care inflation
5.7%
12.31.2012
Final
Application
rate
of final rate
3.8%
Initial
rate
2019
The discount rates are obtained by reference to market yields on

high quality corporate bonds having maturity dates equivalent to
those of the obligations. Bond quality is assessed by reference to
133
5.4%
12.31.2012
12.31.2011
12.31.2010
3.6%
4.9%
3.6%
4.5%
4.7%
5.5%
4.6%
4.7%
5.7%
12.31.2011
Final
Application
rate
of final rate
3.7%
2016
Initial
rate
5.5%
12.31.2010
Final
Application
rate
of final rate
3.6%
2016
the AA-/Aa3 minimum rating provided by one of the three main

credit-rating agencies.
2012Notes
CONSOLIDATED
STATEMENTS
They can be broken down by geographic zone as follows:

In %
2012
2011
2010
Weighted average (all countries)

of which:
euro zone (1)
United States
United Kingdom
3.6%
4.5%
4.6%
3.4%
3.5%
4.5%
4.7%
4.3%
5.0%
4.4%
5.0%
5.5%
(1)
The weighted average for 2012 consists of a 3.5% discount rate on annuity plans with an average term of 22.1 years and a 3% discount rate on
capital plans with an average term of 12.7 years.
A 50 basis point decrease in the discount rates would increase the projected defined benefit obligation by 206.1 million for the euro
zone, 56.9 million for the United States and 52.5 million for the United Kingdom.
The expected return on plan assets is determined on the basis of the asset allocation of the investment portfolio, taking into account the
associated risks and past performance for each asset category.
It can be broken down by geographic zone as follows:
In %
2012
2011
2010
Weighted average (all countries)

of which:
euro zone
United States
United Kingdom
3.6%
5.5%
5.7%
3.4%
3.5%
4.5%
5.5%
6.0%
5.8%
5.6%
6.8%
6.0%
A 50 basis point decrease in the expected return would decrease the assets as well as the expected return on plan assets by -6.6
million for the euro zone, -2.8 million for the United States and -2.1 million for the United Kingdom.
The breakdown of plan assets is as follows:
In %
Equity securities (1)

Bonds
Property assets (2)
Monetary instruments
Other
TOTAL
(1)
(2)
12.31.2012
12.31.2011
12.31.2010
35.1%
55.6%
3.5%
1.1%
4.7%
100%
34.3%
53.1%
4.2%
3.9%
4.5%
100%
38.2%
50.0%
4.4%
2.1%
5.3%
100%
Of which LOral shares: nil.

Of which property assets occupied by Group entities: nil.
The allocation of plan assets has to comply with specific investment limits for the different classes of assets and meet minimum rating
criteria for monetary instruments and bonds.
134

The variations during 2012, 2011 and 2010 are set out below:
millions
Present value of
defined benefit
obligations
2,600.5
Balance at December 31st, 2009

Service cost
Interest cost
Expected return on assets
Past service cost: new plans/plan amendments
Curtailments
Settlements
Benefits paid
Contributions paid
Other movements
Service cost
Interest cost
Curtailments
Settlements
Benefits paid
Contributions paid
Other movements
Service cost
Interest cost
Curtailments
Settlements
Benefits paid
Contributions paid
Other movements
BALANCE AT DECEMBER 31st, 2012
Plan assets
Unrecognised
plan
amendments
Net
provisions
-1,585.0
5.9
1,021.4
99.0
135.2
99.0
135.2
-102.9
-3.1
-1.0
-34.6
-225.2
213.5
29.0
-2.3
1,129.0
111.7
131.4
-114.5
-0.3
-2.1
-
-102.9
14.3
-0.2
-0.3
-139.8
7.2
245.9
87.5
-0.5
3,048.8
111.7
131.4
-17.4
-0.8
0.3
105.2
-232.4
-32.4
-58.6
-1.8
-1,907.6
0.1
-12.2
-114.5
2.8
-1.3
-0.1
-139.2
6.6
45.5
45.4
1.1
3,252.7
121.7
142.8
-3.1
-0.8
0.1
102.8
-280.0
126.9
-35.1
-0.3
-2,107.7
-36.4
-273.4
172.4
10.3
0.8
1,128.9
121.7
142.8
-121.5
1.3
-0.9
0.1
-45.1
-267.6
271.9
-6.9
1.6
1,226.2
-16.1
-121.5
1.2
-0.1
0.1
-162.5
5.6
416.7
-17.5
-0.2
3,760.5
0.1
-0.8
117.3
-273.2
-144.8
10.6
1.8
-2,517.4
-16.8
The total present value of defined benefit obligations breaks down as follows between wholly or partly funded plans and wholly
unfunded plans:
millions
Present value of defined benefit obligations wholly or partly funded

Fair value of plan assets
Net position of defined benefit obligations wholly or partly funded
Present value of defined benefit obligations wholly unfunded
135
12.31.2012
12.31.2011
12.31.2010
3,293.9
2,517.4
776.5
466.5
2,860.7
2,107.7
753.0
392.0
2,625.4
1,907.6
717.8
423.4
2012Notes
CONSOLIDATED
STATEMENTS
The retirement expense charged to the income statement is recorded within personnel expenses under operational profit and can be
analysed as follows:
millions
Service cost
Interest cost
Expected return on plan assets
Amortisation of actuarial gains and losses
New plans/plan amendments
Curtailments
Settlements
TOTAL
2012
2011
2010
121.7
142.8
-121.5
1.3
-0.9
0.1
143.5
111.7
131.4
-114.5
-0.3
-2.1
126.2
99.0
135.2
-102.9
-3.1
-1.0
127.2
Contributions to defined contribution plans recognised as an expense in 2012, 2011 and 2010 amounted to 388.6 million, 344.8
million and 310.6 million, respectively.
A change of one percentage point in medical cost inflation would have the following impact:
Increase of 1%
Decrease of 1%
19.0
2.0
-15.2
-1.5
Impact on projected benefit obligation

Impact on current service cost and interest costs
The benefit obligation, fair value of plan assets and actuarial gains and losses for the periods presented are as follows:
millions
Benefit obligation
Plan assets
(Surplus)/Deficit
Experience adjustments arising
on the benefit obligation
Experience adjustments arising on plan assets
136
12.31.2012
12.31.2011
12.31.2010
12.31.2009
12.31.2008
3,760.5
-2,517.4
1,243.1
3,252.7
-2,107.7
1,145.0
3,048.8
-1,907.6
1,141.2
2,600.5
-1,585.0
1,015.5
2,288.4
-1,321.7
966.7
6.9
144.8
15.1
-127.0
-5.6
30.2
-33.0
81.0
12.1
-373.3

NOTE 22
22.1. CLOSING BALANCES

millions
12.31.2012
12.31.2011
12.31.2010
181.7
181.7
552.3
129.4
226.3
196.6
734.0
226.1
226.1
500.7
93.6
219.2
187.9
726.8
181.3
181.3
536.9
90.6
209.4
236.9
718.2
Non-current provisions for liabilities and charges

Other non-current provisions (1)
Current provisions for liabilities and charges
Provisions for restructuring
Provisions for product returns
Other current provisions (1) (2)
TOTAL
(1)
(2)
This item includes provisions for tax risks and litigation, industrial, environmental and commercial risks relating to operations (breach of contract),
personnel-related costs and risks relating to investigations carried out by competition authorities.
National competition authorities from several European countries have launched investigations focusing on the cosmetics industry. Statements
of objections were sent to the Groups subsidiaries in Belgium, Germany, Italy, the Netherlands, Spain and Switzerland.
In 2011, the investigations initiated and/or financial penalties levied on our subsidiaries in the Netherlands and Switzerland were withdrawn. Spain still has
a provision it set aside following notification of a fine which it is challenging on appeal.
In Italy, the fine was paid to avoid any late-payment interest. The decision handed down on appeal in March 2012 reduced the fine by 25%. However, the proceedings
are still in progress before Italys highest Administrative Court.
Proceedings initiated in Germany in 2007 and 2008, respectively, are still in progress.
On January 26th, 2012 in France, the Paris Court of Appeal, to which the case had been referred following a decision by the Court of Cassation (Frances highest civil
court), upheld the decision handed down by the French Competition Council on March 13 th, 2006 following its investigation of 13 suppliers and 3 distributors
in the luxury perfumes and cosmetics industries between 1997 and 1999. The Appeal Courts decision has been appealed before the Court of Cassation.
The financial penalties handed down against LOral have already been provisioned and paid.
Other requests for information have also been sent and investigations launched in Europe, although no statement of objections had been received at December 31 st,
2012.
st
st
The provision was increased accordingly, and represented 45.0 million at December 31 , 2012 compared with 35.1 million at December 31 , 2011.
22.2.
CHANGES IN PROVISIONS FOR LIABILITIES AND CHARGES DURING THE PERIOD
millions
12.31.2010 12.31.2011 Charges (2)

Other provisions for liabilities
and charges
TOTAL
(1)
(2)
Impact of
change
in scope/
Reversals
Reversals
Exchange
(used) (2) (not used) (2) rate/Other (1) 12.31.2012
90.6
209.4
93.6
219.2
71.3
165.1
-32.1
-137.3
-1.2
-23.0
-2.2
2.3
129.4
226.3
418.2
718.2
414.0
726.8
157.5
393.9
-170.2
-339.6
-22.8
-47.0
-0.2
-0.1
378.3
734.0
Mainly resulting from translation differences.

These figures can be analysed as follows:
millions

Operating profit
Financial (income)/expense
Income tax
137
Charges
Reversals (used)
Reversals (not used)
84.7
268.6
0.2
40.4
-32.1
-216.6
-0.1
-90.8
-1.2
-39.2
-6.6
2012Notes
CONSOLIDATED
STATEMENTS
The change in this caption in 2011 can be analysed as follows:
millions
12.31.2009 12.31.2010 Charges (2)

and charges
TOTAL
(1)
(2)
Impact of
change
in scope/
Reversals
Reversals
Exchange
180.2
174.6
90.6
209.4
44.2
138.2
-38.0
-100.7
-6.7
-36.1
3.4
8.4
93.6
219.2
280.8
635.6
418.2
718.2
140.2
322.6
-100.6
-239.3
-54.9
-97.7
11.2
23.0
414.0
726.8

millions

Operating profit
Income tax
Charges
Reversals (used)
47.4
299.3
0.4
45.6
-71.1
-164.4
-0.3
-3.5
-33.2
-56.9
-0.1
-7.6
The change in this caption in 2010 can be analysed as follows:
millions
12.31.2008 12.31.2009 Charges (2)

and charges
TOTAL
(1)
(2)
125.1
162.9
180.2
174.6
20.4
184.6
-106.4
-161.3
-6.1
-21.4
2.5
32.9
90.6
209.4
254.5
542.5
280.8
635.6
216.6
421.6
-62.6
-330.3
-21.6
-49.1
5.0
40.4
418.2
718.2

millions
138
Impact of
change
in scope/
Reversals
Reversals
Exchange

Operating profit
Income tax
Charges
Reversals (used)
95.2
263.9
0.6
61.9
-106.7
-217.3
-0.1
-6.2
-6.1
-35.1
-7.9

NOTE 23
Borrowings and debt
The Group uses bank loans for its medium-term financing needs and commercial paper issues in France and in the US for its short-term
financing needs. None of these loans contain an early repayment clause linked to financial ratios (covenants).
23.1.
DEBT BY TYPE
12.31.2012
Non-current
Current
millions
Short-term paper
MLT bank loans
Debt on capital lease contracts
Overdrafts
Other borrowings and debt
TOTAL
39.1
7.8
46.9
12.31.2011
Non-current
Current
12.5
20.8
167.8
201.1
47.5
10.0
57.5
12.31.2010
Non-current
Current
795.7
11.6
10.3
273.2
1,090.8
751.2
53.2
19.9
824.3
71.1
563.0
10.9
47.9
74.1
767.0
23.2. DEBT BY MATURITY DATE

millions
Under 1 year
1 to 5 years
Over 5 years
TOTAL
(1)
(1)
12.31.2012
12.31.2011
12.31.2010
201.1
27.7
19.2
248.0
1,090.8
36.1
21.4
1,148.3
767.0
796.1
28.2
1,591.3
At December 31st, 2012, the Group had confirmed undrawn credit lines for 2,550.0 million compared with 2,438.6 million at December
31st, 2011. These lines were not subject to any covenants.
At the end of 2012, estimated interest payments were not material due to
the debt outstanding at December 31 st, 2012, which consisted of very
short-term loans contracted locally by subsidiaries, and payments
outstanding under finance leases.
At the end of 2011, estimated interest payments totalled around 2.6
million for 2012, 0 million for the period 2013-2016 and 0 million after
2016.
At the end of 2010, estimated interest payments totalled around 12.6

million for 2011, 5.0 million for the period 2012-2015 and 1.0 million after
2015.
These estimates are computed on the basis of the effective interest rate at
the end of the financial year, after allowing for hedging instruments and
assuming that no debt is rolled over at maturity. Amounts payable under
capital leases are not taken into account as they are not material.
23.3.
DEBT BY CURRENCY
(AFTER ALLOWING FOR CURRENCY HEDGING INSTRUMENTS)
millions
Brazilian Real (BRL)

Yen (JPY)
Canadian dollar (CAD)
Yuan (CNY)
Rupiah (IDR)
US dollar (USD)
Swedish Krona (SEK)
Euro (EUR)
Other
TOTAL
139
12.31.2012
12.31.2011
12.31.2010
43.7
39.4
30.5
28.9
20.8
14.7
4.4
65.6
248.0
55.6
45.0
37.9
32.0
29.8
480.1
344.4
123.5
1,148.3
4.6
64.4
25.5
29.7
22.2
127.2
6.7
1,122.8
188.2
1,591.3
2012Notes
CONSOLIDATED
STATEMENTS
23.4. BREAKDOWN OF FIXED RATE AND FLOATING RATE DEBT

(AFTER ALLOWING FOR INTEREST RATE HEDGING INSTRUMENTS)
millions
12.31.2012
12.31.2011
12.31.2010
204.0
44.0
248.0
1,094.0
54.3
1,148.3
1,517.3
74.0
1,591.3
Floating rate
Fixed rate
TOTAL
23.5.
EFFECTIVE INTEREST RATES
Effective interest rates on Group debt after allowing for hedging

instruments were 0.21% in 2010 and 1.47% in 2011 for short-term
paper, and 1.15% in 2010 for bank loans. The Group no longer had
any short-term paper at December 31st, 2012 and no longer held
any bank loans at either December 31 st, 2012 or December 31 st,
2011.
23.6.
AVERAGE
RATES
DEBT
The net carrying amount of outstanding bank loans and other

floating-rate loans is a reasonable approximation of their fair value.
The fair value of borrowings and debt amounted to 248.5 million at
December 31st, 2012.The fair value of borrowings and debt
amounted to 1,148.4 million at December 31st, 2011. The fair
value of borrowings and debt amounted to 1,591.8 million at
December 31st, 2010.
INTEREST
Average interest rates after allowing for hedging instruments were

0.99% in 2010, 1.39% in 2011 and 0.35% in 2012 on eurodenominated debt, 0.36% in 2010, 0.19% in 2011 and 0.14% in
2012 on USD-denominated debt and 2.50% in 2011 and 3.22% in
2012 on the Swedish krona-denominated debt.
23.8.
DEBT
COLLATERAL
OF
The fair value of fixed-rate debt is determined for each loan by

discounting future cash flows, based on bond yield curves at the
balance sheet date, after allowing for the spread corresponding to
the Groups risk rating.
NOTE 24
December 31st, 2012, 2011 or 2010.
CONFIRMED CREDIT LINES
At December 31st, 2012, LOral and its subsidiaries had 2,550.0

million of confirmed undrawn credit lines, compared with 2,438.6
million at December 31st, 2011 and 2,387 million at December
31st, 2010.
Credit lines fall due as follows:
250.0 million in less than 1 year;
2,300.0 million between 1 year and 4 years.
Derivatives and exposure to market risks
To manage its exposure to currency and interest rate risks arising in the
course of its normal operations, the Group uses derivatives negotiated
with counterparties rated investment grade.
In accordance with Group rules, currency and interest rate

derivatives are set up exclusively for hedging purposes.
24.1.
HEDGING
RISK
OF
CURRENCY
The Group is exposed to currency risk on commercial transactions

recorded on the balance sheet and on highly probable future
transactions.
140
BY
No debt was covered by material amounts of collateral at
23.9.
23.7.
FAIR
VALUE
BORROWINGS AND DEBT
COVERED
The Groups policy regarding its exposure to currency risk on future

commercial transactions is to hedge at the end of the year a large
part of the currency risk for the following year, using derivatives
based on operating budgets in each subsidiary.
All the Groups future foreign currency flows are analysed in
detailed forecasts for the coming budgetary year. Any currency
risks identified are hedged by forward contracts or by options in
order to reduce as far as possible the currency exposure of each
subsidiary. The term of the derivatives is aligned with the Groups
settlements. Exchange rate derivatives are negotiated by REGEFI
(the Groups bank) or, in exceptional cases, directly by the Groups
subsidiaries when required by local regulations. Such operations
are supervised by REGEFI.

Notes to the
consolidated fi
nancial statements
As the Groups bank, REGEFI

is subject to the European
Market
Infrastructure
Regulation (EMIR). Published
by the European Commission
in September 2012, EMIR is
aimed at moving OTC markets
towards a centralized model,
thereby
enhancing
market
transparency and regulatory
oversight
and
decreasing
systemic risk using a guarantee
mechanism. EMIR will be
gradually applicable as from
the first quarter of 2013 and the
application period will span until
2014.
As the Groups companies

must borrow and invest their
cash in their own currency, the
exchange rate risks generated
by managing their own cash
and debt are almost nonexistent.
Owing to the Groups policy of
hedging a large part of annual
requirements for the following
year at the end of the current
year, the sensitivity of profit or
loss to changes in foreign
exchange rates at December
31st is marginal. The impact of
changes in foreign exchange
rates on the foreign exchange
cash flow hedges reserve is
described in note 20.4.
The following derivatives, all of which have a maturity of less than 18

months at inception, are held for currency risk hedging purposes:
millions
12.31.2012
Nominal
12.31.2011
12.31.2010
2,499.8
806.5
425.6
198.6
176.6
126.2
118.3
89.2
88.8
80.3
80.0
140.4
96.0
73.3
1,662.1
265.3
161.6
300.7
87.1
165.3
85.0
64.9
69.8
4.0
81.0
162.9
85.9
128.6
1,595.9
170.2
255.8
301.8
78.3
85.4
-0.7
60.8
79.3
64.1
84.0
188.8
100.6
127.5
159.4
77.0
27.9
54.5
344.4
169.4
175.0
296.4
3,300.0
305.3
133.0
45.2
112.6
14.5
192.1
192.1
245.2
2,404.7
247.4
119.5
39.2
72.3
16.4
232.9
2,076.2
117.9
73.7
246.6
64.4
21.1
523.7
523.7
3,823.7
121.0
73.5
231.3
96.3
14.8
536.8
536.8
2,941.5
122.8
82.3
222.7
30.3
458.1
458.2
-0.1
2,534.3
Currency futures
Purchase of EUR against foreign currencies
EUR/USD
EUR/CHF
EUR/RUB
EUR/MXN
EUR/CNY
EUR/GBP
EUR/AUD
EUR/CAD
EUR/JPY
EUR/BRL
EUR/Asia, Pacific currencies
EUR/Eastern European currencies
EUR/Other currencies
Purchase of USD against foreign
currencies
USD/Latin American currencies
USD/CAD
USD/Asia, Pacific currencies
USD/Other currencies
Sale of USD against foreign currencies
USD/CHF
USD/Asia, Pacific currencies
Other currency pairs
Currency futures total
Currency options
EUR/USD
EUR/GBP
CHF/USD
Currency options total
of which total options purchased
of which total options sold
TOTAL
The total amount of options sold corresponds
exclusively to the sale of previously purchased
12
options when it was considered appropriate to

replace them with other hedging instruments.
141
2012Notes
CONSOLIDATED
STATEMENTS
The market values by type of hedging are as follows:

millions
(1)
Fair value hedges

Cash flow hedges
Net foreign investment hedges
TOTAL
2012
2011
2010
5.8
56.5
62.3
-5.4
-31.8
-37.2
-18.7
-20.1
-38.8
(1) Fair value hedges relate to currency risks on operating receivables and payables as well as on foreign currency investments and financing.
The fair value of the derivatives is their market value.

The Group has no significant foreign currency exposures that are not hedged in the balance sheet.
24.2. HEDGING OF INTEREST RATE RISK
The derivatives are mainly swaps and interest rate options

(purchase of caps) which are traded with specific counterparties.
The Group mainly refinances at floating rates and uses interest

rate derivatives to reduce net exposure to interest rate risk. Interest
rate derivatives are never held for speculative purposes.
The market values of the derivatives set out below should be

compared with the market values of the debt that they hedge.
Interest rate derivatives are as follows:
12.31.2012
Notional
12.31.2011
12.31.2010
12.31.2012
Market value
12.31.2011
12.31.2010
14.3
-
-1.7
-
14.3
-1.7
millions
Interest rate derivatives

Cash flow hedges
Fixed-rate borrower interest rate swaps
EUR Euribor/fixed rate
USD Libor/fixed rate
Purchase of caps
USD Libor
Fair value hedges
Floating-rate borrower interest rate swaps
EUR Euribor/fixed rate
TOTAL
The fair value of interest rate derivatives is their market value. The market value of interest rate derivatives is calculated by discounting
future flows at the interest rate prevailing at the balance sheet date.
Maturities of interest rate derivatives broken down by type of hedge are as follows:
millions
Cash flow hedges

Fixed-rate borrower interest
rate swaps
Purchase of caps
Fair value hedges
Floating-rate borrower interest
rate swaps
TOTAL
142
12.31.2012
< 1 1 to 5
>5
year years
years Total
Nominal by maturity
12.31.2011
< 1 1 to 5
>5
year years
years Total
12.31.2010
< 1 1 to 5
>5
year years
years Total
1.0
-
4.6
-
8.7
-
14.3
-
1.0
4.6
8.7
14.3

derivatives, and assumes that total
net debt/net cash remains stable
and that fixed-rate debt at maturity
is replaced by floating-rate debt.
24.3.
SEN
S
I
T
The impact of a 100 basis point rise

in interest rates on the fair value of
the Groups fixed-rate financial
assets and liabilities, after allowing
for derivatives, can be estimated at
0.3 million at December 31st, 2012
compared with 0.2 million at
December 31st, 2011 and 1.3
million at December 31st, 2010.
I
V
I
T
Y
T
O
C
H
A
N
G
E
S
I
N
I
N
T
E
R
E
S
T
R
A
T
E
S
An increase of 100 basis
points in interest rates
would have a direct
positive impact of 16.3
million on the Groups net
finance costs at December
31st, 2012, compared with
a positive impact of 5.6
million at December 31st,
2011 and a positive impact
of
0.5
million
at
December 31st, 2010. This
calculation allows for cash,
cash
equivalents
and
24.4.
COUNTE
RPARTY RISK
The Group has financial relations
with international banks rated
investment grade. The Group thus
considers that its exposure to
counterparty risk is low.
Furthermore,
the
financial
instruments used to manage
exchange rate and interest rate risk
are issued by leading international
banking counterparties.
24.5.
LIQUIDIT
Y RISK
The Groups liquidity risk can be
assessed on the basis of its
outstanding short-term debt under
its paper programme. If these bank
facilities were not renewed, the
Group had confirmed undrawn
credit lines of 2,550.0 million at
December
31st,
2012.
The
availability of these credit lines is
not
dependent
on
financial
covenants.The Group no longer had
any short-term paper at the end of
December 2012.
Notes to the
consolidated fi
nancial
statements
market price of 56.75 on December 31st, 2011 would have

impact of plus or minus 670.9 million before tax on Group e
At December 31st, 2010, the Group held 118,227,307 Sanof

for an amount of 5,657.2 million (note 15). A change of plu
or minus 10% in the market price of these shares relative to
market price of 47.85 on December 31st, 2010 would have
impact of plus or minus 565.7 million before tax on Group e
24.6. SHAREHOLDING RISK

No cash has been invested in shares.
24.7.
FAIR VALUE HIERARCHY
Available cash is invested with top-ranking

IFRS
7financial
as institutions
in the form of non-speculative instruments
amendedwhichincan be drawn
in very short periods. At December2009
31
requires
exclusively in Euro-zone government
bondsassets
through mutual funds
financial
(note 19).
and
liabilities
recognised at
At December 31st, 2012, the Group
holds
118,227,307
Sanofi
fair
value
in the
shares for an amount of 8,440.2 million (note 15). A change of
balance sheet
plus or minus 10% in the market price of these shares relative to
to be classified
the market price of 71.39 on December 31
according
to
impact of plus or minus 844.0 million before tax on Group equity.
three levels:
If the share price were to fall significantly below 34.12 (the initial
level 1: quoted prices on an
cost of the Sanofi shares), or fall below
price for a prolonged
activethat
market;
length of time, LOral may have to recognise an impairment loss
on its asset through profit or loss. level 2: valuation techniques
using observable inputs;
At December 31st, 2011, the Group held 118,227,307 Sanofi shares
for an amount of 6,709.4 million (note
level
15).
3:Avaluation
change of
techniques
plus
using
unobservable
inputs.
or minus 10% in the market price of
these
shares relative
to the
143
2012Notes
CONSOLIDATED
STATEMENTS
The following table provides an analysis of financial instruments recorded at fair value by level of the fair value hierarchy.
millions
December 31st, 2012
Level 1
Level 2
Level 3
Total fair value
Assets at fair value

Foreign exchange derivatives
Sanofi shares
TOTAL ASSETS AT FAIR VALUE
162.6
8,440.2
150.0
8,590.2
162.6
162.6
8,440.2
150.0
8,752.8
104.7
104.7
104.7
104.7
Liabilities at fair value

TOTAL LIABILITIES AT FAIR VALUE
millions
December 31st, 2011
Level 1
Level 2
Level 3
Total fair value

Sanofi shares
114.0
6,709.4
598.2
7,307.6
114.0
114.0
6,709.4
598.2
7,421.6
147.2
147.2
147.2
147.2

millions
December 31st, 2010
Level 1
Level 2
Level 3
Total fair value

Sanofi shares
83.2
5,657.2
523.6
6,180.8
83.2
83.2
5,657.2
523.6
6,264.0
115.3
1.8
117.1
115.3
1.8
117.1

NOTE 25
millions
Tax and employee-related payables (excluding income tax)

Credit balances on trade receivables
Fixed asset payables
Derivatives
TOTAL
144
12.31.2012
12.31.2011
12.31.2010
1,115.7
608.2
150.1
104.7
162.4
2,141.1
1,039.0
598.4
124.0
147.2
158.0
2,066.7
986.8
582.2
121.2
117.1
150.8
1,958.1

NOTE 26
Off-balance sheet commitments
26.1.
OPERATING
COMMITMENTS
LEASE
These amount to 1,789.6 million at December 31st, 2012

compared with 1,784.2 million at December 31 st, 2011 and
1,764.3 million at December 31st, 2010, of which:
1,082.0 million was due in 1 to 5 years at December 31st,

2012 compared with 1,070.5 million at December 31 st, 2011
and 975.9 million at December 31st, 2010;
255.0 million was due in over 5 years at December 31 st,

2012 compared with 296.9 million at December 31 st, 2011
and 411.8 million at December 31st, 2010.
452.6 million was due in within 1 year at December 31 st,

2012 compared with 416.8 million at December 31st, 2011
and 376.6 million at December 31st, 2010;
26.2.
OTHER OFF-BALANCE SHEET COMMITMENTS
Confirmed credit lines are discussed in note 23.

Other significant off-balance sheet commitments have been identified and measured.They chiefly fall due within 1 year and are as
follows:
millions
12.31.2012
12.31.2011
12.31.2010
134.2
59.9
75.1
40.9
249.5
487.2
121.5
54.8
60.2
33.5
229.8
448.9
109.5
45.8
48.5
220.8
461.8
(1)
Guarantees given
Guarantees received
Commitments given under Dermatology contracts
Commitments received under Dermatology contracts
Capital expenditure orders
Firm purchase commitments under logistics supply contracts
(1)
These consist mainly of guarantees given to governmental bodies or concerning loans granted to third parties who
are partners of the Group, and the net commitment toward the LOral Foundation for its long-term action program.
26.3.
CONTINGENT LIABILITIES
In the course of its normal operations, the Group is involved in

legal actions and is subject to tax assessments, customs
controls and administrative audits. The Group sets aside a
provision wherever a risk is found to exist, and the related cost
can be reliably estimated.
On this basis, a provision has been set aside for risks relating to
investigations carried out by competition authorities described in
note 22.1.
In terms of taxation, in early January 2013, LOral Brasil
received a tax reassessment notice regarding the indirect IPI tax
for fiscal year 2008. The reassessment concerned an amount of
BRL 333 million including BRL 180 million (129 million) in
interest and penalties. The Brazilian tax authorities questioned
the price used to calculate the IPI tax base. After consulting its
tax advisors, LOral Brasil considers that the Brazilian tax
authorities position is unfounded and plans to challenge this
notice. Consequently, no provision has been recorded.
145
At the present time, no exceptional event or dispute is highly

likely to have a material impact on the earnings, financial
position, assets or operations of the LOral Company or Group.
26.4.
ENVIRONMENTAL RISKS
The Group strictly complies with regulations and laws relating to

environmental protection, and does not expect that they will
have any significant impact on the future operations, financial
position, earnings or assets.
The risks identified at December 31st, 2012 are not material.
2012Notes
CONSOLIDATED
STATEMENTS
NOTE 27
This caption amounts to a negative 129.1 million in 2012, a negative 322.0 million in 2011 and a positive 132.5 million in 2010, and
can be analysed as follows:
millions
Inventories
Other receivables and payables
TOTAL
2012
2011
2010
14.6
-214.8
83.2
-12.1
-129.1
-200.9
-275.2
60.9
93.2
-322.0
-217.0
-90.6
415.8
24.3
132.5
NOTE 28 Impact
of changes in the scope of consolidation in the

cash flow statement
In 2012, this item mainly related to the acquisition of Cadum, Urban Decay and Emiliani Enterprises.
In 2011, this item mainly related to the acquisitions of Q-Med and Pacific Bioscience Laboratories Inc.
In 2010, this item mainly related to the acquisitions of Essie Cosmetics and US distributors.
NOTE 29
Transactions with related parties
29.1. JOINT VENTURES

Transactions with proportionally consolidated companies were as follows:
millions
Sales of goods and services

Financial expenses and income
2012
2011
2010
1.0
4.0
0.9
6.4
0.9
0.8
12.31.2012
12.31.2011
12.31.2010
2.4
0.2
194.1
2.8
0.1
211.9
2.7
0.2
80.6
The following receivables and payables were recorded on the balance sheet for the related parties:
millions
Operating receivables
Operating payables
Financial receivables
29.2. RELATED PARTIES WITH A SIGNIFICANT INFLUENCE ON THE GROUP

No significant transactions have been carried out with a member of senior management or a shareholder with a significant influence on
the Group.
29.3. ASSOCIATES
The Group had no equity-accounted companies in 2012, 2011 or 2010.
146

29.4.
ADDITIONAL INFORMATION ON JOINTLY CONTROLLED ENTITIES
The information presented below corresponds to amounts attributable to the Group based on its ownership interest.
millions
2012
Galderma
Innov
millions
2011
Galderma
Innov
millions
2010
Galderma
Innov
NOTE 30
Current
assets
Non-current
assets
Current
liabilities
Non-current
liabilities
Revenue for
the Group
Expenses for
the Group
Operating
profit (loss)
333.6
13.2
832.4
1.1
617.2
20.9
134.3
0.1
795.5
28.8
-652.9
-32.6
142.6
-3.8
Current
assets
Non-current
assets
Current
liabilities
Non-current
liabilities
Revenue for
the Group
Expenses for
the Group
Operating
profit (loss)
320.2
11.5
852.0
1.3
690.8
21.5
138.0
0.1
704.7
31.5
-584.6
-32.9
120.1
-1.4
Current
assets
Non-current
assets
Current
liabilities
Non-current
liabilities
Revenue for
the Group
Expenses for
the Group
Operating
profit (loss)
228.3
9.7
481.0
1.6
326.9
17.9
75.3
0.1
601.7
31.1
-482.5
-30.7
119.2
0.4
Fees accruing to Auditors and members of their networks

payable by the Group
millions excl. VAT
Audit
Statutory audit
LOral
Fully consolidated subsidiaries
Other directly related audit
assignments (1)
LOral
Fully consolidated subsidiaries
Audit sub-total
Other services
Other services
(legal, tax, employee-related, other)
TOTAL
Amount
%
2012
2011
2012
2011
Deloitte & Associs

Amount
%
2012
2011
2012
2011
6.0
1.0
5.0
5.5
1.0
4.5
67%
12%
55%
73%
13%
60%
6.2
1.0
5.2
5.8
1.0
4.8
76%
12%
64%
76%
12%
64%
2.5
0.6
1.9
8.5
1.6
0.2
1.4
7.1
28%
6%
22%
95%
21%
3%
18%
93%
1.5
1.0
0.5
7.7
1.2
1.0
0.2
7.0
18%
13%
5%
94%
16%
14%
2%
92%
0.5
9.0
0.5
7.6
5%
100%
7%
100%
0.4
8.1
0.6
7.6
6%
100%
8%
100%
(1) Mainly concerning acquisition audits.
NOTE 31
Subsequent events
On October 11th, 2012, LOral announced it had signed a contract to

acquire the Colombia-based Vogue group, the countrys leader in massmarket make-up.
147
In 2011, the Vogue group reported consolidated net sales of approximately

30 million.
The acquisition was finalised on January 31st, 2013.
st
2012Consolidated
CONSOLIDATED
companiesFINANCIAL
at December 31STATEMENTS
, 2012
On December 12th, 2012, Galderma

Pharma S.A. announced that it had
signed an agreement to acquire
Spirig Pharma A.G.
Daylong and Daylong Actinica.

Based in Egerkingen in
Switzerland.
Spirigs products treat conditions such

as sun-provoked skin diseases and
skin barrier function impairment. The c
ompany also has a range of
medically-proven
products
that
prevent pre-cancerous conditions
such as actinic keratosis, a type of
non-melanoma skin cancer. Leading
brands include Excipial,
Switzerland. Spirig generated sales of
Spirig is the leader in dermatology in

CHF 98.4 million in 2011, and had 390
employees.
The transaction is expected to be

carried out in early 2013, subject to
fulfilment of customary closing
conditions
4.7. Consolidated companies at

December 31st, 2012
4.7.1.
FULLY CONSOLIDATED COMPANIES (1)
Company
Areca & Cie

Avenamite S.A.
Banque de Ralisations de Gestion et de Financement (Regefi)
Beaut Crateurs
Beaut, Recherche & Industries
Beautycos International Co. Limited
Beautylux International Cosmetics (Shanghai) Co. Ltd
Belcos Ltd
Biotherm
Cadum
Cadum International SA
Canan Kozmetik Sanayi Ve Ticaret A.S.
Canan Tuketim Urunleri Pazarlama A.S.
Centre Logistique dEssigny
Centrex
Chimex
Cobelsa Cosmeticos, S.A.
Colainaf
Compagnie Thermale Htelire et Financire
Consortium Gnral de Publicit
Cosbel S.A. de C.V.
Cosmelor KK
Cosmelor Ltd
Cosmephil Holdings Corporation Philippines
Cosmetil
Cosmtique Active France
Cosmtique Active International
Cosmtique Active Ireland Ltd
Cosmtique Active Production
Egyptelor LLC
Elebelle (Pty) Ltd
EpiSkin
EpiSkin Biomatriaux
(1)
(2)
Pursuant to the provisions of Article R 233-14 of the French Commercial Code, some of
the information provided above is incomplete.
Equivalent to the percentage interest unless otherwise indicated.
Head office
% interest
France
Spain
France
France
France
China
China
Japan
Monaco
France
Luxemburg
Turkey
Turkey
France
France
France
Spain
Morocco
France
France
Mexico
Japan
Japan
Philippines
Morocco
France
France
Ireland
France
Egypt
South Africa
France
France
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
99.80
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
99.98
100.00
100.00
100.00
100.00
100.00
49.80
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
% control (2)
100.00
148

Consolidated companies at December 31st, 2012
Company
Erwiton S.A.
Exclusive Signatures International
Fapagau & Cie
Faprogi
Finval
Frabel S.A. de C.V.
Gemey Maybelline Garnier
Gemey Paris Maybelline New York
Goldys International
Groupe Cadum SAS
Helena Rubinstein
Helena Rubinstein Italia S.p.A
Holdial
Hygine Beaut Distribution France
Kosmepol Sp z.o.o
L & J R
LOA3
La Roche-Posay Laboratoire Pharmaceutique
Laboratoire Sanoflore
Lai Mei Cosmetics International Trading (Shanghai) Co. Ltd
Lancme Parfums & Beaut & Cie
Lancos Ltd
LaScad
Le Club des Crateurs de Beaut
Lehoux et Jacque
LOral Adria d.o.o.
LOral Argentina S.A.
LOral Australia Pty Ltd
LOral Balkan d.o.o.
LOral Baltic SIA
LOral Belgilux S.A.
LOral Brasil Comercial de Cosmticos Ltda
LOral Brasil Licenciamentos Empresariais, Cosmeticos e Perfumes Ltda
LOral Bulgaria EOOD
LOral Canada, Inc.
LOral Central America
LOral Central West Africa
LOral Ceska Republika s.r.o
LOral Chile S.A.
LOral (China) Co. Ltd
LOral Colombia S.A.
LOral Cosmetics Industry SAE
LOral Danmark A/S
LOral Deutschland GmbH
LOral East Africa Ltd
LOral Egypt LLC
LOral Espaa S.A.
LOral Finland Oy
LOral Guatemala S.A.
LOral Hellas S.A.
LOral Hong Kong Ltd
LOral India Pvt Ltd
LOral Investments B.V.
LOral Israel Ltd
LOral Italia S.p.A
(1)
(2)
Head office
% interest
Uruguay
France
France
France
France
Mexico
France
France
France
France
France
Italy
France
France
Poland
France
France
France
France
China
France
Japan
France
Belgium
France
Croatia
Argentina
Australia
Serbia
Latvia
Belgium
Brazil
Brazil
Bulgaria
Canada
Panama
Nigeria
Czech Republic
Chile
China
Colombia
Egypt
Denmark
Germany
Kenya
Egypt
Spain
Finland
Guatemala
Greece
Hong-Kong
India
The Netherlands
Israel
Italy
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
99.98
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
92.97
100.00
Pursuant to the provisions of Article R 233-14 of the French Commercial Code, some of the information provided above is incomplete.
149
% control (2)
st
2012Consolidated
CONSOLIDATED
companiesFINANCIAL
, 2012
Company
LOral Japan Ltd

LOral Kazakhstan LLP
LOral Korea Ltd
LOral Liban SAL
LOral Libramont
LOral Magyarorszag Kozmetikai Kft
LOral Malaysia SDN BHD
LOral Manufacturing Midrand Pty Ltd
LOral Maroc
LOral Mexico S.A. de C.V.
LOral Mexico Servicios S.A. de C.V.
LOral Middle East
LOral Nederland B.V.
LOral New Zealand Ltd
LOral Norge A/S
LOral sterreich GmbH
LOral Pakistan Private Limited
LOral Panama S.A.
LOral Peru S.A.
LOral Philippines, Inc.
LOral Polska Sp z.o.o
LOral Portugal, Lda
LOral Produits de Luxe France
LOral Produits de Luxe International
LOral Produktion Deutschland Beteiligung GmbH
LOral Produktion Deutschland GmbH & Co. Kg
LOral Romania SRL
LOral Saipo Industriale S.p.A
LOral Saudi Arabia
LOral Singapore Pte Ltd
LOral Slovenija Kozmetika d.o.o
LOral Slovensko s.r.o
LOral SLP S.A. de C.V.
LOral South Africa Holdings Pty Ltd
LOral Suisse S.A.
LOral Sverige AB
LOral Taiwan Co. Ltd
LOral Thailand Ltd
LOral Turkiye Kozmetik Sanayi Ve Ticaret Anonim Sirketi
LOral UK Ltd
LOral Ukraine
LOral Uruguay S.A.
LOral USA, Inc. (as a group)
LOral Venezuela, C.A.
LOral Verwaltungs GmbH
LOral Vietnam Co. Ltd
LOral West Africa Ltd
Marigny Manufacturing Australia Pty Ltd
Masrelor LLC
Matrix Distribution GmbH
Nihon LOral K.K.
NLO K.K.
P.T. LOral Indonesia
P.T. Yasulor Indonesia
Parbel of Florida, Inc.
(1)
(2)
150
Head office
% interest
Japan
Kazakhstan
Korea
Lebanon
Belgium
Hungary
Malaysia
South Africa
Morocco
Mexico
Mexico
United Arab Emirates
The Netherlands
New Zealand
Norway
Austria
Pakistan
Panama
Peru
Philippines
Poland
Portugal
France
France
Germany
Germany
Rumania
Italy
Saudi Arabia
Singapore
Slovenia
Slovakia
Mexico
South Africa
Switzerland
Sweden
Taiwan
Thailand
Turkey
United Kingdom
Ukraine
Uruguay
United States
Venezuela
Germany
Vietnam
Ghana
Australia
Egypt
Germany
Japan
Japan
Indonesia
Indonesia
United States
100.00
100.00
100.00
99.88
100.00
100.00
100.00
100.00
50.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
75.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
% control (2)
100.00
100.00

Consolidated companies at December 31st, 2012
Company
Parfums Cacharel & Cie

Parfums Guy Laroche
Parfums Paloma Picasso & Cie
Parfums Ralph Lauren
Prestige et Collections International
Procosa Productos de Beleza Ltda
Productos Capilares LOral S.A.
Redken France
Roger & Gallet
SLP Asistencia S.A. de C.V.
Scental Ltd
Seda Plastik Ve Boya Sanayi Ithalat ve Ihracat Ticaret Anonim Sirketi
Shu Uemura Cosmetics Inc.
Sics & Cie
SkinEthic
Socit de Dveloppement Artistique
Socit Hydrominrale de La Roche-Posay
Sofamo
Soprocos
Soproral
Sparlys
The Body Shop (as a group)
Venprobel
Viktor & Rolf Parfums
Yichang Tianmei International Cosmetics Co. Ltd
YSL Beaut
YSL Beaut Hong Kong Ltd
YSL Beaut Middle East Fze
YSL Beaut Singapore Pte Ltd
YSL Beaut Vostok o.o.o.
Zao LOral
(1)
(2)
% interest
France
France
France
France
France
Brazil
Spain
France
France
Mexico
Hong-Kong
Turkey
Japan
France
France
France
France
Monaco
France
France
France
United Kingdom
Venezuela
France
China
France
Hong-Kong
United Arab Emirates
Singapore
Russia
Russia
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
99.09
100.00
99.98
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
% control (2)
4.7.2.
PROPORTIONALLY CONSOLIDATED COMPANIES
Company
Galderma Argentina S.A.

Galderma Australia Pty Ltd
Galderma Benelux BV
Galderma Brasil Limitada
Galderma Canada Inc.
Galderma Colombia S.A.
Galderma Hellas Trade of Pharmaceuticals Products S.A.
Galderma Holding AB
Galderma Hong Kong
Galderma India Private Ltd
Galderma International
Galderma Italia S.p.A
Galderma K.K.
Galderma Korea Ltd
Galderma Laboratories Inc.
Galderma Laboratories South Africa Pty Ltd
(1)
(2)
Head office
Companies jointly owned with Nestl.

151
Head office
% interest
Argentina
Australia
The Netherlands
Brazil
Canada
Colombia
Greece
Sweden
Hong-Kong
India
France
Italy
Japan
Korea
United States
South Africa
(1)
50.00
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
% control (2)
st
2012Consolidated
CONSOLIDATED
companiesFINANCIAL
, 2012
Company
Galderma Laboratorium GmbH

Galderma Mexico S.A. de C.V.
Galderma Nordic AB
Galderma o.o.o.
Galderma Peru Laboratorios S.A.
Galderma Pharma S.A.
Galderma Philippines Inc.
Galderma Polska Sp. z.o.o.
G. Production Inc.
Galderma Research & Development
Galderma Research and Development Inc.
Galderma S.A.
Galderma Singapore Pvt Ltd
Galderma (UK) Ltd
Galderma Uruguay
Galderma-Q-Med
Innov Adria d.o.o. for trade and services
Innov Argentina S.A.
Innov Belgique
Innov Brasil Nutricosmeticos Ltda
Innov Canada, Inc.
Innov Chile S.A.
Innov CZ s.r.o.
Innov d.o.o.
Innov Deutschland GmbH
Innov Espaa S.A.
Innov France
Innov Hellas A.E.
Innov Italia S.p.A.
Innov Mexico S.A. de C.V.
Innov Nederland B.V.
Innov Nutrikozmetik Ticaret Ve Sanayi Ltd Sirketi
Innov sterreich Handelsgesellschaft mbH
Innov Polska Sp. z.o.o.
Innov (Shanghai) Trading Co., Ltd
Innov SK s.r.o.
Innov Suisse
Innov Taiwan Co. Ltd
Laboratoires Galderma
Laboratoires Innov
Laboratoires Innov Portugal Unipessoal Lda
Laboratorios Galderma Chile Limitada
Laboratorios Galderma S.A.
Laboratorios Galderma Venezuela S.A.
O.O.O Innov
Q-Med (as a group)
(1)
(2)
152
Companies jointly owned with Nestl.

Head office
% interest
Germany
Mexico
Sweden
Russia
Peru
Switzerland
Philippines
Poland
Canada
France
United States
Switzerland
Singapore
United Kingdom
Uruguay
France
Croatia
Argentina
Belgium
Brazil
Canada
Chile
Czech Republic
Slovenia
Germany
Spain
France
Greece
Italy
Mexico
The Netherlands
Turkey
Austria
Poland
China
Slovakia
Switzerland
Taiwan
France
France
Portugal
Chile
Spain
Venezuela
Russia
Sweden
(1)
50.00
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50,00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
50.00 (1)
% control (2)

Statutory Auditors Report on the consolidated fi nancial statements
4.8. Statutory Auditors Report on the

consolidated financial statements
(Year ended December 31th, 2012)
In compliance with the assignment entrusted to us by your Annual General Meeting, we hereby report to you, for the year ended
December 31th, 2012, on:
the audit of the accompanying consolidated financial statements of LOral;
the justification of our assessments;
the specific verification required by law.
These consolidated financial statements have been approved by the Board of Directors. Our role is to express an opinion on these
consolidated financial statements, based on our audit.
I. OPINION ON THE CONSOLIDATED FINANCIAL STATEMENTS

We conducted our audit in accordance with professional standards applicable in France. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material
misstatement. An audit involves performing procedures, using sampling techniques or other methods of selection, to obtain audit
the consolidated financial statements. An audit also includes evaluating the
4 evidence about the amounts and disclosures in
appropriateness of accounting policies used and the reasonableness of accounting estimates made, as well as the overall presentation
of the consolidated financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a
basis for our audit opinion.
In our opinion, the consolidated financial statements give a true and fair view of the assets and liabilities and of the financial position of
the Group at December 31st, 2012 and of the results of its operations for the year then ended in accordance with International Financial
Reporting Standards as adopted by the European Union.
II. JUSTIFICATION OF OUR ASSESSMENTS

In accordance with the requirements of article L. 823-9 of French Commercial Code (Code de commerce) relating to the justification of
our assessments, we bring to your attention the following matters:
LOral performs impairment tests on goodwill and intangible assets with indefinite useful lives at least once a year and whenever
there is an indication that an asset may be impaired, in accordance with the methods set out in Notes 1.15 and 13 to the
consolidated financial statements. We have reviewed the terms and conditions for implementing these impairment tests as well as
the assumptions applied;
obligations relating to pensions, early retirement benefits and other related benefits granted to employees have been valued and
recorded in accordance with the accounting policies described in Notes 1.23 and 21 to the consolidated financial statements. We
have reviewed and analyzed the valuation methods of these obligations and the data used and the assumptions applied.
These assessments were made as part of our audit of the consolidated financial statements taken as a whole, and therefore contributed
to the opinion we formed which is expressed in the first part of this report.
153
III. SPECIFIC VERIFICATION

As required by law and in accordance with professional standards applicable in France, we have also verified the information presented
in the Groups Management Report. We have no matters to report as to its fair presentation and its consistency with the consolidated
Deloitte & Associs
Grard Morin
David Dupont-Noel
This is a free translation into English of the Statutory Auditors Report issued in French and is provided solely for the convenience of English speaking
readers. The Statutory Auditors Report includes information specifically required by French law in such reports, whether modified or not. This information is
presented below the opinion on the consolidated financial statements and includes explanatory paragraphs discussing the Auditors assessments of certain
significant accounting and auditing matters.These assessments were considered for the purpose of issuing an audit opinion on the consolidated financial
statements taken as a whole and not to provide separate assurance on individual account captions or on information taken outside of the consolidated
financial statements. This report also includes information relating to the specific verification of information given in the Groups Management Report.
This report should be read in conjunction with, and construed in accordance with, French law and professional auditing standards applicable in France.
154
5
2012 PARENT COMPANY
5.1. Compared income statements 156
Note 21 Unrealised exchange gains and losses

Note 22 Derivative financial instruments
171
172
5.2. Compared balance sheets
Note 23 Transactions and balances

with related entities and parties
173
173
174
Note 26 Changes in other financial assets
174

at the end of the year
Note 28 Other disclosures
174
174
174
5.3. Changes in shareholders

equity
5.4. Statements of cash flows
157
158
159
5.5. Notes to the parent company

160
Note 1
Note 2
Sales
160
163
Note 3
Other revenue
163
Note 4
Average headcount
163
Note 5
Depreciation, amortisation
and charges to provisions
163
Note 6
Net financial income
164
Note 7
Exceptional items
164
Note 8
Income tax
164
Note 9
Increases or reductions in future tax liabilities

165
Note 10
Research costs
165
Note 11
Intangible assets
165
Note 12
Note 13
166
5.8. Five-year financial summary 180
Note 14
Tangible assets
Non-current assets held under finance
leases
Financial assets
166
167
Note 15
167
5.9. Investments (main changes

including shareholding
threshold changes)
181
Note 16
Maturity of receivables
168
Note 17
Stock purchase and subscription
Note 18
options Free shares

168
169
Note 19
Borrowings and debt
170
Note 20
Maturity of payables
171
5.6. Table of subsidiaries

and holdings
175
5.7. Other information relating

to the financial statements
of LOral parent company 179
5.7.1. Expenses and charges falling
under Article 223 quater
of the French Tax Code
179
5.7.2 Trade accounts payable
179
5.7.3 Net sales (excluding taxes)
179
5.10. Statutory Auditors Report 182

on the financial statements
and Financial Code.
155
2012Compared
PARENT
COMPANY
income
statements
The individual financial statements set out in this chapter

are those of LOral parent company. They show the financial position
of the parent company stricto sensu. Unlike the consolidated financial statements,
they do not include the results of the Groups subsidiaries.
The information with regard to the parent company financial statements that
was previously included in the Management Report of the Board of Directors
is now included in this chapter. The pages concerned are the table showing the main
changes and thresholds crossed regarding investments in subsidiaries and holdings,
the table of subsidiaries and holdings and the five-year financial summary as well as
the amount of expenses and charges provided for in Article 223 quater of the French
Tax Code and the table showing trade accounts payable provided
for by Articles L. 441-6-1 and D. 441-4 of the French Commercial Code. The Statutory
Auditors Report on the parent company financial statements completes this information
5.1. Compared income statements

millions
Operating revenue
Sales
Reversals of provisions and transfers of charges
Other revenue
Operating expenses
Purchases and change in inventories
Other purchases and external charges
Taxes and similar payments
Personnel costs
Depreciation, amortisation and charges to provisions
Other charges
Operating profit
Net financial revenue
Net charges to (-)/reversals of (+) provisions and transfers
of charges
Exchange gains and losses
Profit before tax and exceptional items
Exceptional items
Employee Profit Sharing
Income tax
NET PROFIT
156
Notes
2
3
6
6
7
8
12.31.2012
12.31.2011
12.31.2010
2,865.5
2,606.8
38.3
220.4
-2,619.6
-209.2
-1,380.0
-113.2
-698.1
-134.0
-85.1
245.9
2,234.0
2,597.7
2,421.1
28.6
148.0
-2,409.0
-196.0
-1,275.6
-95.3
-659.4
-102.6
-80.1
188.7
2,033.0
2,400.8
2,231.0
35.4
134.4
-2,293.8
-185.6
-1,191.3
-96.3
-609.1
-134.4
-77.1
107.0
1,913.9
-25.7
-62.4
2,145.9
2,391.8
43.1
-15.5
-11.4
2,408.0
-74.4
-21.8
1,936.8
2,125.5
14.4
-21.4
51.3
2,169.8
28.7
-58.7
1,883.9
1,990.9
-79.0
-21.2
104.6
1,995.3
2012 PARENT COMPANY FINANCIAL STATEMENTS

Compared balance sheets
5.2. Compared balance sheets

ASSETS
millions
(net amounts)
Intangible assets
Tangible assets
Financial assets
Non-current assets
Inventories
Prepayments to suppliers
Current assets
Prepaid expenses
Unrealised exchange losses
TOTAL ASSETS
Notes
12.31.2012
12.31.2011
12.31.2010
11
12
14
707.3
345.6
9,846.9
10,899.8
34.0
23.3
548.4
171.8
309.4
1,093.1
2,180.0
27.0
10.4
13,117.2
669.4
299.4
9,200.5
10,169.3
34.6
25.1
423.5
149.6
596.5
238.4
1,467.7
26.8
18.0
11,681.8
545.4
278.8
8,814.9
9,639.1
34.7
26.2
323.9
167.9
861.0
157.9
1,571.6
25.9
9.8
11,246.3
12.31.2012
12.31.2011
12.31.2010
121.8
1,679.0
7,527.8
2,408.0
88.6
11,825.2
238.2
330.4
414.0
304.7
1,049.1
4.7
13,117.2
120.6
1,271.4
6,562.4
2,169.8
82.5
10,206.7
268.8
506.8
382.3
305.9
1,195.0
11.3
11,681.8
120.2
1,148.3
5,632.3
1,995.3
66.5
8,962.6
221.1
1,384.5
379.6
292.5
2,056.6
6.0
11,246.3
16
16
15
27
21
SHAREHOLDERS EQUITY AND LIABILITIES

Notes
millions
Share capital
Additional paid-in capital
Reserves and retained earnings
Net profit
Regulated provisions
Shareholders equity
Borrowings and debts
Other liabilities
Unrealised exchange gains
TOTAL SHAREHOLDERS EQUITY AND LIABILITIES
157
18
19
20
20
21
2012Changes
PARENT
COMPANY
in shareholders
equity
5.3. Changes in shareholders equity

The share capital of 121,762,165.40 comprises 608,810,827 shares with a par value of 0.2 each following transactions carried out in 2012:
subscription to 5,826,745 shares following the exercise of options.

Changes in shareholders equity are as follows:
millions

before appropriation of net profit
Changes in share capital
Appropriation of 2009 net profit
Dividends paid for 2009
2010 net profit
Other movements during the period
2011 net profit
2012 net profit
BALANCE AT DECEMBER 31ST, 2012
BEFORE APPROPRIATION OF NET
PROFIT
Share
capital
Additional
paid-in
capital
1976
revaluation
reserve
119.8
996.5
45.4
0.4
151.8
120.2
0.4
1,148.3
123.1
120.6
1.2
121.8
1,271.4
407.6
1,679.0
Regulated provisions consist partially of the provision for investments

which amounted to 21 million at December 31 st, 2012, compared with
23.7 million at December 31 st, 2011 and 18.4 million at December
31st, 2010. In 2012, no charge was done to the provision for investments
consequently to the changes of law (6.1 million in 2011 and 5.7 million
in 2010). This provision includes the transfer to the Company of some of
the provisions
4,661.0
-37.1
963.0
45.4
1,841.8
Regulated
provisions
Total
60.2
7,724.7
6.3
115.1
0.0
-878.8
1,995.3
6.3
-963.0
-878.8
1,995.3
5,586.9
1,995.3
930.1
-930.1
-1,065.2
2,169.8
66.5
16,0
Reserves include an amount of 12.3 million in 2012 corresponding

to unpaid dividends on treasury shares, compared with 18.2
million in 2011 and 20.1 million in 2010.
158
Reserves
and retained
earnings Net profit
45.4
45.4
6,517.0
2,169.8
965.5
-965.5
-1,204.3
2,408.0
7,482.5
2,408.0
82.5
8,962.6
123.5
0.0
-1,065.2
2,169.8
16,0
6.0
10,206.7
408.8
0.0
-1,204.3
2,408.0
6.0
88.5
11,825.2
set aside by our subsidiaries under a Group agreement. In 2012, an

amount of 2.7million set aside to the provision in 2007 was
reversed (compared with 0.8 million in 2011 and 3.5 million in
2010).
Accelerated tax-driven depreciation at December 31st, 2012 amount
to 67.3 million compared with 58.4 million at December 31 st,
2011 and 47.6 million at December 31st, 2010.
Details of share subscription option and free share plans are
provided in note 17.

Statements of cash fl ows
5.4. Statements of cash flows

Notes
millions
12.31.2012
12.31.2011
12.31.2010
Operating activities
Net profit
Depreciation and amortisation
Charges to provisions (net of reversals)
Gains and losses on disposals of non-current assets
Other non-cash transactions (complete transfer of assets and liabilities)
Gross cash flow
Net cash provided by operating activities
2,408.0
81.2
1.4
20.1
25
2,510.7
-129.1
2,381.6
2,169.8
71.1
133.8
1.3
-45.4
2,330.6
-60.7
2,269.9
1,995.3
93.4
43.0
13.6
2,145.3
41.5
2,186.8
-1,069.4
474.5
33.6
-561.3
-220.8
-185.7
0.4
-406.1
-211.3
194.7
51.6
35.0
408.8
-1,204.3
-342.0
-1,137.5
123.5
-1,065.2
-965.3
-1,907.0
40.3
-2.9
149.8
146.9
152.2
-878.8
-1,452.0
-2,178.6
1.9
45.1
104.7
149.8
Investing activities
Investments in non-current assets
Disposals of non-current assets
Net cash from (used in) investing activities
26
Financing activities
Capital increase
Dividends paid
Changes in financial debt
Net cash from (used in) financing activities
Cash acquired or sold in the period (complete transfer of assets and liabilities)
Change in cash and cash equivalents
Cash and cash equivalents at beginning of year
CASH AND CASH EQUIVALENTS AT END OF YEAR
159
27
682.8
146.9
829.7
2012Notes
PARENT
COMPANY
STATEMENTS
to the parent
companyFINANCIAL
5.5. Notes to the parent company financial statements

DETAILED LIST OF NOTES
Note 1
160
Note 16 Maturity of receivables
Note 2
Sales
163
Note 17 Stock purchase and subscription
Note 3
Other revenue
163
Note 4
Average headcount
163
Note 5
Depreciation, amortisation
and charges to provisions
Note 6
options Free shares
168
168
169
170
163
Note 20 Maturity of payables
171
164
Note 21 Unrealised exchange gains and losses
171
Note 7
Exceptional items
164
Note 22 Derivative financial instruments
172
Note 8
Income tax
164
Note 23 Transactions and balances
Note 9
Increases or reductions
in future tax liabilities
165
173
Note 10
Research costs
165
174
Note 11
Intangible assets
165
Note 26 Changes in other financial assets
174
Note 12
Tangible assets
166
Note 13
Non-current assets held under finance leases
with related entities and parties
at the end of the year
173
174
166
Note 28 Other disclosures
174
174
Note 14
Financial assets
167
Note 15
167
The following notes form an integral part of the parent company financial statements.
The financial statements are presented in millions of euros, while the figures in the table detailing subsidiaries and affiliates are
expressed in thousands of euros.
NOTE 1
The Companys annual financial statements are prepared in

accordance with French law and regulations (1999 French Chart of
Accounts) and with French generally accepted accounting
principles.
The items recorded in the financial statements are valued at
historical cost, except for non-current assets revalued in
accordance with legal requirements.
160
1.1.
SALES
These are comprised of sales of goods (net of rebates and

discounts) and services (including technological assistance fees).

Notes to the parent company fi nancial statements
ASSETS
Intangible assets are recorded in the
balance sheet at purchase cost.
1.2.
A
DVERT
ISING
AND
PROM
OTION
EXPEN
SES
The value of newly acquired

trademarks is calculated based on a
multi-criteria approach taking into
consideration their reputation and
their future contribution to profits.
Expenses relating to the

advertisement
and
promotion of products to
customers and consumers
are recognised as expenses
for the year in which the
advertisement
or
promotional initiative takes
place.
Non-amortisable
trademarks
are
tested for impairment at least once a
year on the basis of the valuation
model used at the time of their
acquisition. A provision for impairment
is recorded where appropriate.
1.3.
R
ESEAR
CH
AND
DEVEL
OPMEN
T
COSTS
costs are recognised in
expenses in the period in
which they are incurred.
1.4.
INCO
ME TAX
The Company has opted for
the French tax group
regime. French companies
included in the scope of tax
consolidation recognise an
income tax charge in their
own accounts on the basis
of their own taxable profits
and losses.
LOral, as the parent
company of the tax group,
recognises as tax income
the difference between the
aggregate
tax
charges
recognised
by
the
subsidiaries and the tax due
on the basis of consolidated
taxable profit or loss of the
tax group.
1.5.
INTA
NGIBLE
In accordance with regulation no.

2004-06
on
assets,
certain
trademarks have been identified as
amortisable in accordance with their
estimated useful life.
Initial trademark registration costs

have been recorded as expenses
since 2005.
Patents are amortised over a period
ranging from two to ten years.
Business goodwill is not amortised. It is
written down whenever the present value
of future cash flows is less than the book
value.
Software of material value is

amortised using the straight-line
method over its probable useful life,
generally between five and seven
years. It is also subject to accelerated
tax-driven amortisation, which is
recognised over a 12-month period.
Other intangible assets are usually
amortised over periods not exceeding
20 years.
accelerated taxdriven
depreciation.
1.6.
TAN
GIBLE
ASSETS
Tangible
assets
are
recogni
sed at
purchas
e cost,
includin
g
acquisiti
on
expens
es.
The useful lives of tangible
assets are as follows:
1.7.
FINANCIAL
ASSETS
1.7.1. Investments and
advances
These items are
recognised in the
balance sheet at
purchase
cost
excluding
incidental
expenses.
Their
value
is
assessed annually
by reference to
their value in use,
which is mainly
based
on
the
current
and
forecast profitability
of the subsidiary concerned and the share

Buildings
Fixtures and fittings
of
equity
If 5cost,
the value
in usefor
falls
below
theowned.
purchase
a provision
Industrial machinery and equipmentimpairment is recognised.
Other tangible assets
Both
straightline and
declinin
gbalance
deprecia
tion
is
calculat
ed over
the
actual
useful
lives of
the
assets
concern
ed.
Exceptio
nally,
industria
l
machine
ry and
equipme
nt
is
deprecia
ted
using
the
straightline
method
over a
period of
ten
years,
with all
addition
al
deprecia
tion
classifie
d
as
1.7.2. Other financial

assets
Loans and other
receivables
are
valued at their
nominal amount.
Loans and other
receivables
denominated
in
foreign currencies
are translated at
the exchange rate
prevailing at the
end
of
the
financial year. If
necessary,
provisions
are
recognised
against
these
items to reflect
their value in use
at the end of the
financial year.
Treasury
stock
acquired
in
connection with
buyback
programmes
is
recognised
in
other long-term
investments.
At the end of the
financial
year,
other long-term
investments are
compared
with
their
probable
sale price and a
provision
for
impairment
recognised where
appropriate.
1.8.
INVE
NTORIES
Inventories are valued using
the weighted average cost
method.
A
provisio
n
for
impairment
of
obsolete
and
slow-moving
inventories
is
recognised
by
reference to their
probable
net
realisable value,
which
is
measured on the
basis of historical
and
forecast
data.
161
2012Notes
PARENT
COMPANY
STATEMENTS
to the parent
companyFINANCIAL
actions, product returns, etc.) and to tax
and employee-related contingencies.
1.9.TRADE
ACCOUNTS
RECEIVABLE
AND
OTHER
RECEIVABLES
Trade accounts receivable and other
receivables are recorded at their
nominal value. Where appropriate, a
provision is recognised based on an
assessment of the risk of non-recovery.
1.10.
MARKETAB
LE SECURITIES
Marketable securities are recognised at
purchase cost and are valued at the
end of the financial year at their
probable sale price.
Treasury stock held that is specifically
allocated to employee stock option
plans is recognised in marketable
securities.
Since January 1st, 2000, no discount
has been granted on the exercise price
of the options. Provided that the shares
are purchased at a lower price than the
exercise price, no provision for
impairment is required. However, a
provision for impairment is recognised
in the event of a decline in the market
price, representing the difference
between the book value of the Treasury
stock and the average share price in
the month preceding the reporting date.
A provision for liabilities and charges in
respect of shares of Treasury stock
allocated to free share plans for LOral
parent company employees is recognised
over the period during which the rights to
the free shares vest. Shares of Treasury
stock allocated to free share plans for
employees of other Group subsidiaries are
written down in full. However, the
subsidiaries concerned will bear most of
the cost of granting these free shares.
1.11.
PROVI
SIONS FOR
LIABILITIES
AND
CHARGES
Provisions for liabilities and charges are
recognised to cover probable outflows
of resources to third parties, without
receipt of equivalent consideration by
the Company.They relate mainly to
industrial
and
commercial
contingencies and litigation (legal
These provisions are estimated on the

basis of the most likely assumptions or
by using statistical methods, depending
on their type.
liabilities exposed to interest rate risk

are recorded on a time-proportion basis
symmetrically with the gains and losses
on the items hedged.
Exchange rate hedging instruments are
contracted to hedge commercial
transactions recognised in the balance
sheet or future transactions that are
considered to be highly probable. Gains
and losses generated by these
instruments
are
recognised
symmetrically with the gains and losses
arising on the hedged items.
Translation differences on operating
assets and liabilities and related
hedging instruments are recognised in
the balance sheet as Unrealised
exchange
losses
or
Unrealised
exchange gains. A provision is
recognised if the sum of these
unrealised exchange gains and losses
shows a potential exchange loss based
on the overall exchange position of all
currencies taken together.
Hedges have already been taken out in
respect
of
forecast
operating
transactions for the next financial year.
The impact of such hedges on profit or
loss will be recorded during the same
accounting period as the transactions
hedged.
1.13.
ACCOUNTI
NG
FOR
INTEREST RATE
INSTRUMENTS
Gains and losses arising on interest
rate swaps and caps hedging financial
1.12.
ACCOU
NTING FOR
FOREIGN
CURRENCY
TRANSACTION
S AND
EXCHANGE
RATE HEDGES
All
receivables
and
payables
denominated in foreign currencies are
translated at the exchange rates
prevailing at the end of the financial
year.
162
1.14.
EMP
LOYEE
RETIREME
NT
OBLIGATIO
NS AND
RELATED
BENEFITS
LOral S.A. operates pension, early
retirement and other benefit schemes
for employees and retired employees in
accordance with local legislation and
regulations. Corporate officers are
regarded as employees for all
additional benefits relating to their
remuneration, and are therefore
covered by the same employee benefit
schemes.
These obligations are partially funded
by an external scheme where the funds
are gradually built up through
contributions paid.The contributions are
expensed as incurred under the Other
purchases and external charges
caption.
The related obligations are measured
using an actuarial valuation method
based on final salaries. The method
takes account of length of service, life
expectancy, turnover by category of
personnel and economic assumptions
such as inflation and discount rates.
No provision is recognised in the
balance sheet for net unfunded
obligations, which are shown in offbalance sheet commitments.
Since 2004, the obligation in respect of
long-service awards is no longer
recognised as an off-balance sheet
commitment; instead, a provision is
recognised in the balance sheet based
on an actuarial valuation of the
obligation.

NOTE 2
Sales
millions
12.31.2012
12.31.2011
12.31.2010
896.6
1,309.2
40.0
361.0
2,606.8
887.1
1,238.9
46.4
248.7
2,421.1
834.2
1,185.1
41.6
170.1
2,231.0
Goods
Services (1)
Rentals
Other revenues from ancillary activities
TOTAL
(1) Mainly invoicing of technological assistance.
The Company generated 1,289.2 million of its sales in France in 2012, compared with 1,362.1 million in 2011 and 1,272.0 million in 2010.
NOTE 3
Other revenue
This account mainly includes trademark royalties.
NOTE 4
Average headcount
Average headcount can be broken down as follows:
Executives
Supervisors
Administrative staff
Manual workers
Sales representatives
TOTAL
of which apprentices
External temporary staff
NOTE 5
2012
2011
2010
3,299
2,001
270
239
288
6,097
166
158
3,146
2,028
307
250
285
6,016
171
166
3,046
2,031
323
272
285
5,957
170
184
Depreciation, amortisation and charges to provisions
Depreciation, amortisation and charges to provisions can be broken down as follows:

millions
Depreciation and amortisation

Impairment of non-current assets
Impairment of current assets
TOTAL
163
12.31.2012
12.31.2011
12.31.2010
-79.7
-4.7
-49.6
-134.0
-63.5
-7.1
-2.6
-29.4
-102.6
-59.3
-48.5
-1.9
-24.7
-134.4
2012Notes
PARENT
COMPANY
STATEMENTS
to the parent
companyFINANCIAL
NOTE 6
Net financial income amounts to 2,234.0 million in 2012 (2,033.0 million in 2011 and 1,913.9 million in 2010), and mainly includes
the following items:
millions
Dividends received
Revenues on other receivables and marketable securities
Interest expense on borrowings and financial debt
Losses settled at the level of partnership entities (SNCs)
Other items not broken down (1)
TOTAL
12.31.2012
12.31.2011
12.31.2010
2,187.1
1.6
-3.3
-0.8
49.4
2,234.0
1,957.6
5.0
-23.4
-0.1
93.9
2,033.0
1,951.3
1.1
-23.8
-9.8
-4.9
1,913.9
(1) Including recharges to subsidiaries of the cost of free share grants for 51.3 million in 2012 and 48.2 million in 2011, and a merger
surplus relating to the complete transfer of assets and liabilities of Laboratoire Garnier et Cie for 45.4 million ind 2011.
The Net (charges to)/reversals of provisions and transfers of charges) caption represents net charges of -25.7 million in 2012
compared with net reversals of -74.4 million in 2011 and net reversals of 28.7 million in 2010. The caption mainly includes:
millions
Net charges to (-)/reversals of (+) provisions for impairment of financial assets

(excluding Treasury stock)
Net charges to (-)/reversals of (+) provisions for impairment of Treasury stock (1)
Net charges to (-)/reversals of (+) provisions for liabilities and charges relating
to financial items
Net charges to (-)/reversals of (+) provisions for impairment of other financial assets
Other movements not broken down
TOTAL
12.31.2012
12.31.2011
12.31.2010
29.5
- 54.5
-16.4
-54.8
4.6
22.1
- 0.6
ns
-0.1
-25.7
-5.3
1.1
1.0
-74.4
10.6
-8.5
-0.1
28.7
(1) Charges offset by accrued revenue relating to recharge to subsidiaries of the cost of free share grants in 2012 and 2011.
NOTE 7
Exceptional items
In 2010, 2011 and 2012, this caption notably includes charges to provisions or reversals of provisions for liabilities and charges.
NOTE 8
Income tax
The income tax for the year breaks down as follows:

millions
Tax on profit before tax and exceptional items

Tax on exceptional items and employee Profit Sharing
INCOME TAX
The income tax booked by LOral S.A. in 2012 takes into account
the effect of tax audits, as well as savings of 77.9 million resulting
from tax consolidation (72.8 million in 2011 and 117.9 million in
2010). These savings mainly result from the utilisation of tax losses
from group companies.
The application of tax legislation led to an increase of 47.3 million
in net profit for 2012, mainly reflecting the net
164
12.31.2012
12.31.2011
12.31.2010
-21.8
10.4
-11.4
37.6
13.7
51.3
90.0
14.6
104.6
charge to regulated provisions along with tax credits on research,

corporate sponsorship activities and employee Profit Sharing.
Income tax has been calculated taking account of the additional
temporary 5% contribution for 2012 and 2011.

NOTE 9
Increases or reductions in future tax liabilities

12.31.2010
Asset Liability
millions
Temporary differences
Regulated provisions
Temporarily non-deductible charges
Charges deducted (or revenue taxed)
for tax purposes but not yet recognised
Temporarily non-taxable revenue
Deductible items
Tax losses, deferred items
Potentially taxable items
Special reserve for long-term capital gains
12.31.2011
Asset Liability
Changes
Asset Liability
12.31.2012
Asset Liability
44.4
18.4
-
51.3
22.2
-
9.3
45.3
10.2
26.3
70.3
23.1
-
1.3
188.6
2.3
188.6
7.8
-
7.4
-
1.9
188.6
The figures have been calculated taking account of 3.3% social contribution which increases income tax at both statutory and reduced
tax rates.
NOTE 10
Research costs
Amounts invested in Research activities in 2012 totalled 695.4 million compared with 619.4 million in 2011 and 596.0 million
in 2010.
NOTE 11
Intangible assets
millions
12.31.2010
12.31.2011
379.4
113.3
175.4
128.3
26.7
823.1
40.2
0.3
112.8
35.0
188.3
34.6
54.8
89.4
545.4
452.6
113.3
204.4
181.9
30.1
982.3
44.2
0.3
134.5
37.4
216.4
34.6
61.9
96.5
669.4
Patents and trademarks

Business goodwill
Software
Intangible assets in progress
Gross value
Business goodwill
Software
Amortisation
Provisions
NET BOOK VALUE
Acquisitions/
Charges
Disposals/
Reversals
Other
movements
2.5
19.9
5.2
55.6
83.2
11.0
27.7
2.4
41.1
42.1
-6.3
-0.6
-6.9
24.4
-25.2
-0.8
-3.5
-3.5
-3.4
-0.8
12.31.2012
455.1
113.3
242.4
187.1
59.9
1,057.8
55.2
0.3
158.7
39.8
254.0
34.6
61.9
96.5
707.3
In 2012, changes in assets in progress mainly come from the acquisition of

Urban Decay trademark.
of the increase results from the complete transfer of assets and liabilities
involving Laboratoire Garnier & Cie.
In 2011, the increase in the Patents and trademarks and Other intangible
assets captions mainly results from the acquisition of Pacific Bioscience
Laboratories (Clarisonic) for 124.7 million, of which 71.1 million relates
to patents and trademarks. The rest
In 2010, the increase in the Patents and trademarks and Other intangible
assets captions mainly resulted from the acquisition of Essie.
165
2012Notes
PARENT
COMPANY
STATEMENTS
to the parent
companyFINANCIAL
NOTE 12
Tangible assets
millions
12.31.2010
12.31.2011
Acquisitions/
Charges
Disposals/
Reversals
Other
movements
12.31.2012
60.5
393.0
182.0
89.3
79.2
1.9
805.9
305.1
152.9
69.1
527.1
278.8
63.5
464.8
190.9
110.1
20.5
2.8
852.6
319.2
161.8
72.2
553.2
299.4
14.3
20.8
12.0
14.5
25.8
87.4
19.6
9.5
10.9
40.0
47.4
-7.5
-5.3
-12.8
-7.5
-4.9
-12.4
-0.4
1.6
7.9
0.3
2.8
-11.9
-1.5
-0.8
-0.8
79.4
493.5
195.7
122.1
34.4
1.3
926.4
338.8
163.8
78.2
580.8
345.6
Land
Buildings
Tangible assets in progress
Advances and prepayments
Gross value
Buildings
Depreciation
Land
Provisions
NET BOOK VALUE
Depreciation and amortisation recognised in 2012 against tangible and intangible assets included:
a charge of 68.8 million on a straight-line basis;
a charge of 10.8 million on a declining-balance basis;
a charge of 1.5 million relating to exceptional depreciation and amortisation.
NOTE 13
millions
Balance sheet captions

at 12.31.2012
Depreciation (2)
Cost on initial
Net book
(1)
recognition
Period Accumulated
value
Land and buildings

TOTAL AT 12.31.2012
Total at 12.31.2011
Total at 12.31.2010
(1)
(2)
43.5
43.5
43.5
43.5
-1.7
-1.7
-1.7
-1.7
20.8
20.8
22.5
24.2
616.4
616.4
762.7
679.0
-361.5
-361.5
-501.9
-477.3
254.9
254.9
260.8
201.7
Value of the assets on the date the leases were signed.

Depreciation charge for the year and accumulated depreciation that would have been recognised for these assets had they been purchased
outright Depreciation method used: straight-line 2% to 5%.
millions
Lease payments made

Balance sheet captions
Period
Accumulated
5.3
5.3
4.9
4.8
67.3
67.3
62.0
57.1
Land and buildings

TOTAL AT 12.31.2012
Total at 12.31.2011
Total at 12.31.2010
166
-22.7
-22.7
-21.0
-19.3
Balance sheet total including

non-current assets held under
finance leases
Gross
Net book
value Depreciation
value
Finance lease commitments

Lease payments outstanding at year-end
Less
More
than
1 to
than
1 year
5 years 5 years Total payable
4.9
4.9
5.4
5.3
15.8
15.8
19.6
19.7
1.6
1.6
2.7
8.0
22.3
22.3
27.7
33.0
Residual
purchase price
under
the lease
1.4
1.4
1.4
90.1

NOTE 14
Financial assets
millions
12.31.2010
12.31.2011
Acquisitions/
Subscriptions
Disposals/
Reductions
Other
movements
12.31.2012
9,027.0
125.3
3.8
9,156.1
298.2
42.9
0.1
341.2
8,814.9
9,047.5
504.8
3.8
9,556.1
314.6
40.9
0.1
355.6
9,200.5
402.7
137.6
503.7
1,044.0
36.3
1.1
37.4
1,006.6
-49.6
-377.1
-0.4
-427.1
-65.9
-1.0
-66.9
-360.2
87.5
-87.5
-
9,488.1
177.8
507.1
10,173.0
285.0
41.0
0.1
326.1
9,846.9
Investments
Loans and other receivables
Other (1)
Gross value
Investments
Other
Provision for impairment
NET BOOK VALUE
(1) Purchase of LOral shares to be cancelled for 498.3 million.
The table detailing subsidiaries and affiliates is presented at the end of the present notes.
NOTE 15
This account can be broken down as follows:
12.31.2012
12.31.2011
12.31.2010
LOral shares
Financial instruments/Premiums paid on options
405.3
13.4
644.5
6.8
850.9
10.1
Gross value
LOral shares
Financial instruments/Premiums paid on options
Provision for impairment
NET BOOK VALUE
418.7
-109.3
-109.3
309.4
651.3
-54.8
-54.8
596.5
861.0
n/s
n/s
861.0
millions
The 5,376,915 LOral shares of Treasury stock held in connection with

employee stock purchase option plans had a net value of 296.0 million at
In 2012, the total market value of Treasury stock amounted to 563.8

million based on the average share price in December and to 564.0
December 31st, 2012 against 589.7 million at December 31 st, 2011 and 850.9
million based on the closing share price on December 31st.
st
million at December 31 , 2010.

In 2012, stock options were exercised in respect of 3,220,744 shares.
Stock purchase options expiring in 2012 represented a total of 1,570,105

shares or 119.4 million (gross and net basis).

167
2012Notes
PARENT
COMPANY
STATEMENTS
to the parent
companyFINANCIAL
NOTE 16
Maturity of receivables
millions
Less than 1 year
More than 1 year
Gross
Provision for
impairment
Net
104.9
8.6
451.8
172.3
113.5
20.5
38.3
27.0
72.9
99.5
-
177.8
8.6
551.3
172.3
113.5
20.5
38.3
27.0
41.1
2.9
0.5
0.5
-
136.7
8.6
548.4
171.8
113.5
20.5
37.8
27.0

Other financial assets
Other current assets, of which
Tax and employee-related receivables
Receivable from Group and shareholders
Other receivables
Prepaid expenses
Accrual accounts included in receivables amounted to 113.8 million at December 31 st, 2012 compared with 58.9 million at December
31st, 2011 and 15.9 million at December 31st, 2010.
NOTE 17
Stock purchase and subscription options Free shares
17.1. STOCK PURCHASE AND SUBSCRIPTION OPTIONS

The table below sets out data concerning the option plans in force at December 31 st, 2012.
Grant date
12.03.2003
12.03.2003
03.24.2004
12.01.2004
06.29.2005
11.30.2005
11.30.2005
04.25.2006
12.01.2006
11.30.2007
03.25.2009
04.27.2010
04.22.2011
Number
of options
Number of options
not yet exercised
2,500,000
2,500,000
2,000,000
4,000,000
400,000
4,200,000
1,800,000
2,000,000
5,500,000
4,000,000
3,650,000
4,200,000
1,470,000
756,300
852,375
145,893
1,335,250
200,000
1,572,640
658,785
2,000,000
2,456,500
3,258,200
3,475,500
4,054,000
1,445,000
All plans have a 5-year exercise period and no performance-related

conditions, except the April 22 nd, 2011 plan (for all participants) and
the April 27th, 2010 and March 25th, 2009 plans (for members of the
Management Committee).The performance conditions associated
with these plans concern:
April 22nd, 2011 plan:
168
for 50% of options granted, the increase in comparable

Cosmetics revenues for the 2012, 2013, 2014 and 2015
fiscal years in relation to the growth in revenues for a panel
of competitors;
Exercise period
From
12.04.2008
12.04.2008
03.25.2009
12.02.2009
06.30.2010
12.01.2010
12.01.2010
04.26.2011
12.02.2011
12.01.2012
03.26.2014
04.28.2015
04.23.2016
To
Exercise
price
12.03.2013
12.03.2013
03.24.2014
12.01.2014
06.29.2015
11.30.2015
11.30.2015
04.25.2016
12.01.2016
11.30.2017
03.25.2019
04.27.2020
04.22.2021
63.02
71.90
64.69
55.54
60.17
61.37
62.94
72.60
78.06
91.66
50.11
80.03
83.19
for 50% of options granted, the increase over the same

period in the Groups consolidated operating profit.
The calculation will be based on the arithmetic average of the

performance in 2012, 2013, 2014 and 2015 fiscal years and will
use a predefined allocation scale based on the performance
percentage reached.
April 27th, 2010 and March 25th, 2009 plans:
for 50% of options granted, the increase in comparable

Cosmetics revenues for the 2011, 2012, 2013 and 2014 fiscal
years for the 2010 plan and for the 2010, 2011, 2012 and

April 17th, 2012 and April 22nd, 2011
plans:
2013 fiscal years for

the 2009 plan
compared to the
growth of the
cosmetics market;
for 50% of shares

granted,
the
percentage, over the
same period, resulting
from the ratio between
the contribution before
advertising
and
promotion expenses,
i.e.
the
sum
of
operating profit and
advertising
and
promotion expenses,
and
published
Cosmetics revenues.
The calculation will be based

on the arithmetic average of
performance in the 2011,
2012, 2013 and 2014 fiscal
years for the 2010 plan and
in the 2010, 2011, 2012 and
2013 fiscal years for the
2009 plan, and will use a
predefined allocation scale
based on the performance
percentage achieved.
At December 31st, 2012, the
performance
conditions
were deemed to have been
met.
The share price used as the
basis for calculating the 10%
social contribution for the
April 22nd, 2011 plan was
18.58.
17.2.
FRE
E SHARES
On April 17th, 2012, April
22nd, 2011, April 27th, 2010
and March 25th, 2009, the
Board of Directors decided
to
grant
respectively
1,325,050,
1,038,000,
450,000 and 270,000 free
shares.
For the conditional grant of
shares, the plan provides for
a 4-year vesting period after
which vesting is effective and
final, subject to meeting the
conditions of the plan. After
this vesting period, a 2-year
mandatory holding period
applies for French residents,
during which the shares
cannot be sold.
The performance conditions
concern:
for 50% of shares granted, the

increase
in
comparable
Cosmetics revenues for the 2013,
2014 and 2015 for 2012 plan and
2012, 2013 et 2014 for 2011 plan
fiscal years in relation to the
growth in revenues for a panel of
competitors;
Notes to the parent

company fi nancial
statements
fo
r
5
0
%
of
s
h
ar
e
s
gr
a
nt
e
d,
th
e
in
cr
e
a
s
e
o
v
er
th
e
s
a
m
e
p
er
io
d
in
th
e
G
ro
u
p
s
c
o
n
s
oli
d
at
e
d
o
p
er
at
in
g
pr
of
it.
The
calculati
on will
be
based
on the
arithmeti
c
average
of
the
perform
ance in
the
2013,
2014
and 2015 for 2012

plan and 2012,
2013 et 2014 for
2011 plan fiscal
years and will use
a
predefined
allocation
scale
based on the
performance
percentage
achieved.
No
performance
condition applies
below a block of
200 shares.
April 27th, 2010 and March 25th,
2009 plans:
for 25% of
shares
granted
under the
2010 plan
and 50% of
shares
granted
under the
2009 plan,
the
increase in
comparable
Cosmetics
revenues
for
the
2011, 2012
and 2013
fiscal years
for
the
2010 plan
and for the
2010, 2011
and 2012
fiscal years
for
the
2009 plan
compared
with
the
growth of
the
cosmetics
market;
for 75% of
shares
granted
under the
2010 plan
and 50% of
shares
granted
under the
2009 plan,
the
percentage,
over
the
same
period,
resulting
from
the
ratio
between
operating
profit and
published
Cosmetics
revenues.
The
calculation
will be based on
the
arithmetic
average
of
perform
ance in
the
2011,
2012
and
2013
fiscal
years
for the
2010
plan
and
2010,
2011
and
2012
fiscal
years
for the
2009
plan,
and will
use
a
predefin
ed
allocation
scale based on
the performance
percentage
achieved.
At
December
31st, 2012, the
performance
conditions were
deemed to have
been met.
A rebilling agreement concerning the cost of free shares has

been set up since 2011 between LOral parent company and
the subsidiaries concerned.
The share price
used as the basis
for calculating the
10%
social
contribution was
77.07 for free
shares for the
April 17th, 2012
plan and 70.36
for the April 22nd,
2011 plan.
Provisions for liabilities and

charges
NOTE 18
millions
Provisions for litigation

Provisions for exchange losses
Provisions for charges
Other provisions for liabilities (1)
TOTAL
(1)
12.31.2010
12.31.2011
Charges
Revers
(provisio
us
6.8
3.7
38.6
172.0
221.1
7.4
6.6
55.8
199.0
268.8
1.5
5.7
70.6
43.3
121.1
3
10
14
This caption notably includes provisions for tax contingencies and

for industrial and commercial risks relating to operations
(contracts, product returns) and employee-related liabilities.
169
2012Notes
PARENT
COMPANY
STATEMENTS
to the parent
companyFINANCIAL
The impacts of changes in provisions for liabilities and charges at different levels of the income statement are shown below:
millions
Charges
Reversals
(provisions used)
Reversals
(provisions not used)
49.6
48.1
23.4
121.1
26.7
32.0
89.3
148.0
2.9
0.8
3.7
Operating profit
Exceptional items
Income tax
TOTAL
NOTE 19
Borrowings and debt
LOral obtains financing through medium-term bank loans and

from short-term commercial paper issued in France. The amount of
the programme is 2,600 million. None of the Groups borrowings
or debt contains an early repayment clause linked to financial ratios
(covenants).
Liquidity on the commercial paper issues is provided by confirmed

short-term credit facilities with banks, which amounted to 2,550.0
million at December 31st, 2012 (2,400.0 million at December 31 st, 2011
and 2,350.0 million at December 31st, 2010).
All borrowings and debt are denominated in euros and can be broken down as follows:
BREAKDOWN BY TYPE OF DEBT

millions
12.31.2012
12.31.2011
12.31.2010
n/s
66.9
263.5
330.4
n/s
0.1
344.3
71.1
91.3
506.8
n/s
1,314.8
61.7
8.0
1,384.5
12.31.2012
12.31.2011
12.31.2010
300.1
29.0
1.3
330.4
468.9
36.7
1.2
506.8
591.8
791.4
1.3
1,384.5
Bonds
Borrowings and debt due to financial institutions
Commercial paper
Other borrowings and debt
Overdrafts
TOTAL
BREAKDOWN BY MATURITY
millions
Less than 1 year

1 to 5 years
More than 5 years
TOTAL
During 2012, no change has been recorded on borrowings with financial institutions.
EFFECTIVE INTEREST RATE AND AVERAGE INTEREST RATE ON BORROWINGS AND DEBT
The effective interest rate on borrowings and debt after taking into
account hedging instruments was 3.25% in 2011 and 1.15% in
2010. At the end of 2012, there are no commercial papers and
borrowings with financial institutions left.
170
The average interest rate on borrowings and debt after taking into
account hedging instruments was 0.97% in 2012, 1.59% in 2011
and 0.97% in 2010.

NOTE 20
Maturity of payables
millions
Less than 1 year
More than 1 year
Total
414.0
292.9
227.5
36.0
0.4
29.0
11.8
11.8
414.0
304.7
227.5
36.0
0.4
40.8

Other current liabilities, of which
Tax and employee-related payables
Payables related to non-current assets
Payable to Group and shareholders
Other payables
Accrual accounts included in trade accounts payable and other current liabilities are as follows:
millions
12.31.2012
12.31.2011
12.31.2010
218.0
26.3
145.2
18.8
62.0
29.3
418.8
205.4
24.6
144.6
23.0
61.1
29.1
403.7
202.3
25.9
138.3
21.7
62.3
29.1
395.6

Payables related to non-current assets (1)
Tax and employee-related payables, of which
Provision for employee Profit Sharing
Provision for incentives
Other payables
TOTAL
(1) Mainly concerning Essie in 2010 et 2011 and 2012.
NOTE 21
Unrealised exchange gains and losses
The revaluation of foreign currency receivables and payables at the exchange rates prevailing at December 31 st, taking account of
the related hedging instruments, led to the recognition of the following unrealised exchange gains and losses:
millions
Unrealised exchange losses

12.31.2012 12.31.2011 12.31.2010
Financial receivables
Borrowings and debt
Other payables
Derivative financial instruments
TOTAL
6.2
2.8
0.1
1.3
10.4
6.1
0.1
6.2
3.5
2.1
18.0
In accordance with the accounting principles described above, the overall

foreign exchange position at December 31st, 2012 is an unrealised loss of
5.7 million arising mainly on the Venezuelan bolivar. This loss was
recognised through profit
171
5.9
0.6
0.4
2.9
9.8
Unrealised exchange gains

12.31.2012 12.31.2011 12.31.2010
0.8
0.1
1.5
2.3
4.7
2.9
6.1
0.1
2.2
11.3
0.8
0.2
1.0
1.1
2.9
6.0
and loss. At December 31st, 2011, the overall foreign exchange position
was an unrealised loss of 6.7 million compared with an unrealised loss of
3.8 million recognised through profit and loss at December 31st, 2010.
2012Notes
PARENT
COMPANY
STATEMENTS
to the parent
companyFINANCIAL
NOTE 22
Derivative financial instruments
Derivative financial instruments mainly consist of future transactions and can be broken down as follows:
millions
Currency futures
Purchase of EUR against foreign currencies
EUR/RUB
EUR/CNY
EUR/USD
EUR/BRL
EUR/GBP
EUR/AUD
EUR/CAD
EUR/IDR
EUR/KZT
EUR/MXN
EUR/PLN
EUR/INR
EUR/CHF
EUR/THB
EUR/CLP
EUR/ZAR
EUR/UAH
EUR/ARS
Sale of EUR against foreign currencies
EUR/JPY
EUR/SGD
EUR/USD
Purchase of USD against foreign currencies
USD/BRL
USD/ARS
USD/RUB
USD/PHP
USD/Other currencies
Sale of USD against foreign currencies
USD/CNY
USD/IDR
JPY/CNY
ARS/BRL
Other currencies
Currency futures total
Currency options
USD/EUR
GBP/EUR
CAD/EUR
EUR/CNY
EUR/BRL
USD/BRL
Other currencies/EUR
Currency options total
Of which total options purchased
Of which total options sold
TOTAL INSTRUMENTS
12.31.2012
Notional
12.31.2011
12.31.2010
12.31.2012
Market value
12.31.2011
12.31.2010
176.2
126.3
74.0
73.1
29.3
17.4
17.4
14.9
13.9
13.6
10.2
8.3
7.5
7.0
6.6
4.4
1.7
0.0
51.5
264.6
165.4
77.2
73.4
29.8
16.7
15.2
23.8
11.1
11.0
8.5
6.8
7.9
4.9
6.3
3.4
0.7
0.6
39.2
288.6
85.7
0.0
77.3
16.6
13.2
12.4
25.0
11.8
5.8
4.7
0.6
5.8
3.5
5.7
9.3
18.0
5.4
28.0
-3.5
-0.3
3.1
3.0
0.3
0.1
0.4
0.4
0.6
0.0
-0.4
0.3
0.0
0.2
0.0
0.0
-0.1
0.0
-0.3
0.3
-9.1
-6.1
0.2
-1.0
-1.2
-0.6
-1.4
-0.7
0.5
0.1
0.2
-0.1
-0.1
-0.1
-0.2
-0.1
-0.1
-0.3
-6.2
-2.9
0.0
-5.5
0.3
-1.1
-0.4
-0.9
-0.1
-0.1
-0.1
0.0
-0.5
-0.1
-0.4
-1.7
0.1
-0.1
-0.9
15.6
5.0
0.0
1.3
17.5
0.0
1.6
18.4
11.8
2.0
-3.9
-0.1
0.0
-0.1
0.7
0.0
0.1
0.1
-1.0
0.0
73.2
9.8
8.7
7.1
0.4
64.7
39.0
9.6
0.4
55.6
30.9
11.3
4.4
-0.3
-0.9
-0.7
-0.2
0.0
3.2
-0.3
0.1
0.0
-3.1
0.1
-0.3
-0.1
28.4
1.4
32.3
8.3
32.6
18.5
0.6
-0.1
0.0
0.0
0.0
0.1
11.0
4.1
5.1
824.4
12.7
24.4
5.5
982.5
8.7
35.6
4.8
852.0
-1.3
-0.4
-0.1
-3.7
-0.1
-2.0
-0.2
-18.3
0.3
0.9
0.0
-23.6
43.4
8.9
6.0
33.1
27.6
17.7
18.4
155.1
155.1
979.5
48.5
9.0
4.9
33.4
22.3
14.7
132.8
132.8
1,115.3
45.3
5.5
3.8
36.0
26.4
8.0
125.0
125.0
977.0
3.2
0.3
0.4
2.0
2.7
1.1
1.5
11.2
11.2
7.5
1.1
0.2
0.1
0.8
1.6
0.7
4.5
4.5
-13.8
3.0
0.3
0.2
1.6
1.8
0.2
7.1
7.1
-16.5
Total options sold correspond exclusively to the resale of previously purchased options when it appeared appropriate to replace them
with other hedging instruments.
172

NOTE 23
Transactions and balances with related entities and parties
Related-party data is as follows:

millions
Financial assets
Trade accounts receivable/
Other accounts receivable
Borrowings
Other payables
Financial expenses
Financial revenues
12.31.2012
12.31.2011
12.31.2010
9,296.9
438.3
21.2
1,080.4
287.2
96.4
n/s
1.4
2,242.1
9,185.2
331.0
2.4
193.5
114.3
87.6
n/s
0.6
2,059.8
8,799.3
233.0
6.0
152.4
17.1
78.5
0.3
10.2
1,951.9
All material related-party transactions were entered into on an arms length basis.
NOTE 24
Off-balance sheet commitments
24.1. LEASE COMMITMENTS

Operating lease commitments amount to 81.8 million due in less than one year, 227.6 million due between 1 and 5 years and 18.2
million due after 5 years.
The breakdown of finance lease commitments is provided in note 13.
24.2.
OTHER OFF-BALANCE SHEET COMMITMENTS
Confirmed credit facilities are set out in note 19.

Other off-balance sheet commitments can be broken down as follows:
millions
Commitments granted in connection with employee retirement obligations

and related benefits (1)
Commitments to buy out non-controlling interests
Guarantees given (2)
Guarantees received
Capital expenditure orders
Documentary credits
12.31.2012
12.31.2011
12.31.2010
565.2
6.7
679.5
10.1
72.2
4.4
508.5
6.8
662.1
10.1
64.0
4.8
536.6
6.4
657.5
10.1
44.8
3.9
(1)
The discount rate used to measure these commitments at December 31 st, 2012 was 3% for plans providing for payment of capital and 3.50% for
annuity plans, compared with respectively, 4.50% and 4.75% at end-2011, and 4.25% and 4.50% at end-2010.
An agreement for the pooling of employee-related liabilities was set up in 2004. Pursuant to this agreement, commitments are allocated among the
French companies in the Group and their financing is organised in proportion to their respective payroll costs (customised for each plan) so that the
companies are joint and severally liable for meeting the aforementioned commitments within the limit of the collective funds built up.
(2)
This caption includes miscellaneous guarantees and warranties, including 642.3 million at December 31 st, 2012 on behalf of direct and indirect subsidiaries (659.4
million at December 31st, 2011 and 641.5 million at December 31st, 2010). Sellers warranties are also included in this amount as appropriate.
24.3.
CONTINGENT LIABILITIES
In the ordinary course of its operations, LOral is involved in legal actions

and is subject to tax assessments, customs controls and administrative
audits. The Company sets aside a provision wherever a risk is found to
exist and the related cost can be reliably estimated.
173
At the present time, no exceptional event or dispute is highly likely to have

a material impact on the earnings, financial position, assets or operations
of the Company.
2012Notes
PARENT
COMPANY
STATEMENTS
to the parent
companyFINANCIAL
NOTE 25
Changes in working capital represented a negative 129.1 million at December 31 st, 2012, compared to a negative 60.7 million at
December 31st, 2011 and a positive 41.5 million at December 31st, 2010, and can be broken down as follows:
millions
Inventories
Receivables
Payables
TOTAL
NOTE 26
12.31.2012
12.31.2011
12.31.2010
0.7
-173.6
43.8
-129.1
0.2
-93.0
32.1
-60.7
-7.9
-49.5
98.9
41.5
This caption includes flows related to Treasury stock in the year, classified within marketable securities.
NOTE 27
Cash and cash equivalents at the end of the year
Cash and cash equivalents amount to 829.7 million at December 31 st, 2012 compared with 146.9 million at December 31 st, 2011 and
149.8 million at December 31st, 2010, and can be broken down as follows:
millions
Cash
Accrued interest receivable
Bank overdrafts (note 19)
Accrued interest payable
TOTAL
NOTE 28
12.31.2012
12.31.2011
12.31.2010
1,093.1
-263.5
0.1
829.7
238.4
-0.2
-91.3
146.9
157.9
-0.1
-8.0
149.8
Other disclosures
Statutory audit fees for 2012 are not presented in the notes to the parent company financial statements but in note 30 to the
Consolidated financial statements of the LOral Group.
NOTE 29
Subsequent events
No events occurred between the end of the financial year and the date the Board of Directors authorised the consolidated financial
statements for issue.
174

Table of subsidiaries and holdings at December 31st, 2012
5.6. Table of subsidiaries and

holdings at December 31st, 2012
Table of subsidiaries and holdings at December 31st, 2012 ( thousands)
Detailed information
CAPITAL
Reserves
and retained
earnings
before
appropriation
of profits % holding
A. MAIN FRENCH SUBSIDIARIES (Holding of over 50%)

Areca & Cie
35
8
Banque de Ralisations de Gestion
et de Financement (Regefi)
19,250
88,968
Beaut Crateurs
612
344
Beaut, Recherche & Industries
10,690
3,194
Centrex
1,800
29
Chimex
1,958
31,924
Cosmtique Active France
24
19,305
Cosmtique Active International
19
19,014
Cosmtique Active Production
186
19,198
EpiSkin
9,402
0
Exclusive Signatures International
10
0
Fapagau & Cie
15
5,438
Faprogi
15
4,313
Finval
2
0
Gemey Maybelline Garnier
50
705
Gemey Paris - Maybelline New York
35
5,104
Goldys International
15
0
Helena Rubinstein
30
1
Holdial
1
0
L & J R
1,500
8,206
La Roche-Posay Laboratoire
Pharmaceutique
380
4,437
Laboratoires Innov
400
-4,680
Laboratoire Sanoflore
10
-291
Lancme Parfums & Beaut & Cie
1,192
0
LaScad
18
0
Lehoux et Jacque
39
56
L'Oral Produits de Luxe France
84
56,209
L'Oral Produits de Luxe International
98
75,253
Parfums Cacharel & Cie
1
1
Parfums Guy Laroche
332
54
Parfums Paloma Picasso & Cie
2
0
Parfums Ralph Lauren
2
-491
Prestige & Collections International
32
3,952
Roger & Gallet
3,034
10,390
Sics & Cie
375
7,175
Socit de Dveloppement Artistique
2
0
Soprocos
8,250
9,550
Soproral
15
4,171
Sparlys
750
90
Viktor & Rolf Parfums
2
0
YSL Beaut
130,786
-5,940
BOOK VALUE
of shares held
Gross
PROFIT or DIVIDENDS (1)

LOSS in last booked during
financial
the financial
Net
year
year
99.78
35
35
63
99.99
100.00
100.00
99.99
100.00
61.97
80.43
80.14
99.99
99.00
79.00
59.90
99.00
66.61
99.96
99.90
99.95
98.00
99.99
75,670
31,599
20,311
3,532
21,501
130
15
5,081
9,402
10
12
9
2
34
46
15
46,661
1
1,500
75,670
31,599
12,150
3,532
21,501
130
15
5,081
9,402
10
12
9
2
34
46
15
46,661
1
1,500
20,173
52
-5,882
671
2,649
20,635
11,396
4,564
108
3,145
4,690
2,103
6,955
39,603
15,668
-5
4,491
600
530
99.98
50.00
100.00
99.99
99.17
100.00
68.55
77.36
99.00
100.00
99.00
99.00
81.67
100.00
80.00
99.00
100.00
99.90
100.00
99.00
89.80
27,579
25,750
5,197
3,235
18
263
1,457
76
2
1,656
2
2
3,823
109,693
999
2
11,904
15
3,826
1
299,622
27,579
0
0
3,235
18
263
1,457
76
2
1,656
2
0
3,823
109,693
999
2
11,904
15
3,826
1
299,622
15,364
-7,563
563
61,312
54,605
258
15,721
40,810
408
145
32
28
17,845
665
4,604
-2
-2,930
-277
1,876
299
17,217
(1) The SNCs (general partnership), and Socits Civiles (non trading companies), that are not tax consolidated, distribute all their profit
175
44
1,632
386
2,998
10,635
12,180
4,292
3,642
6,517
1,284
7,651
26,114
15,120
3,503
473
11,952
64,917
50,143
321
10,583
31,675
425
5,594
34
14,985
543
8,812
2,341
3,413
2,529
368
0
2012Table
PARENT
COMPANY
FINANCIAL
STATEMENTS
of subsidiaries
and holdings
at December
31st, 2012
CAPITAL
Reserves
and retained
earnings
before
appropriation
B. MAIN FRENCH INVESTMENTS (Holdings of less than 50%)

Galderma International
466
44,050
Innov France
105
-2,086
La Roche -Posay Dermato-Cosmtique
2
n/s
(2)
Sanofi
(1)
(2)
26.44
0.00
1.00
8.91
BOOK VALUE
of shares held
Gross
2
n/s
n/s
423,887
PROFIT or DIVIDENDS (1)

LOSS in last booked during
financial
the financial
Net
year
year
2
n/s
n/s
423,887
20,112
-935
n/s
7,467
(2)
313,302
The SNCs (general partnership), and Socits Civiles (non trading companies), that are not tax consolidated, distribute all their profit
Sanofi : this information is not available
At the balance sheet date, LOral owns 118,227,307 shares. Their total stock market value at the price prevailing at 12.31.2012 is 8,440,247 thousand euros
CAPITAL
Reserves
and retained
earnings
before
appropriation
A. MAIN FOREIGN SUBSIDIARIES (Holdings of over 50%)

Avenamite S.A. (Spain)
242
48
Beautycos International Co. Ltd (China)
52,482
52,043
Beautylux International Cosmetics
(Shanghai) Co.Ltd (China)
5,629
-2,036
Biotherm (Monaco)
152
16
Cadum Internationnal S.A. (Luxembourg)
7,550
-2,034
Canan Kozmetik Sanayi Ve Ticaret A.S.
(Turkey)
5,245
12,994
Canan Tuketim Urunleri Pazarlama A.S.
(Turkey)
1,149
-3,060
Club des Crateurs de Beaut (Belgium)
81
-59
Cosmelor Ltd (Japan)
3,554
27,964
Cosmephil Holdings Corporation
(Philippines)
171
-137
Cosmtique Active Ireland Ltd (Ireland)
82
1,662
Egyptelor LLC (Egypt)
6
70
Elebelle (Proprietary) Ltd (South Africa)
806
35,912
Erwiton S.A. (Uruguay)
739
3,115
Galderma Pharma S.A.(Switzerland)
15,694
106,975
Kosmepol Sp. z.o.o. (Poland)
38,844
33,906
Lai Mei Cosmetics Int. Trading (Shanghai)
Co Ltd (China)
9,500
7,559
L'Oral Adria d.o.o. (Croatia)
131
1,315
L'Oral Argentina S.A. (Argentina)
13,081
15,505
L'Oral Australia Pty Ltd
2,711
28,584
L'Oral Balkan d.o.o. (Serbia)
1,283
-372
L'Oral Baltic SIA (Latvia)
387
3,818
L'Oral Belgilux S.A. (Belgium)
16,124
18,209
L'Oral Bulgaria EOOD
102
708
L'Oral Canada Inc.
3,979
16,532
L'Oral Ceska Republika s.r.o
(Czech Republic)
5,939
2,971
L'Oral Central West Africa (Nigeria)
1,176
-287
L'Oral Chile S.A. (Chile)
20,888
12,580
L'Oral China Co Ltd (China)
43,498
21,201
L'Oral Colombia S.A. (Colombia)
1,931
4,242
BOOK VALUE
of shares held
Gross
PROFIT or
LOSS in last
financial
Net
year
100.00
73.46
6,216
46,195
6,216
46,195
51
3,556
100.00
99.80
100.00
16,871
3,545
170,520
3,822
3,545
170,520
48
5,760
-663
100.00
28,439
28,439
5,656
100.00
100.00
100.00
11,128
3,821
35,810
5,140
36
35,810
10
0
2,012
100.00
99.99
99.80
100.00
100.00
50.00
99.73
400
732
7
61,123
17
10,124
48,965
14
732
7
46,783
17
10,124
48,965
0
0
47
4,953
9,674
95,501
6,533
100.00
100.00
99.99
100.00
100.00
100.00
98.93
100.00
100.00
11,197
1,503
81,068
33,867
1,285
529
77,150
102
146,517
11,197
1,503
35,154
33,867
1,285
529
77,150
102
146,517
-2,195
4,066
29,530
35,379
709
1,970
19,645
2,336
82,197
100.00
99.91
99.99
100.00
94.00
8,678
1,176
43,784
345,733
6,395
8,678
1,176
43,784
345,733
6,395
7,577
-2,101
28,899
259,395
1,946
DIVIDENDS
booked during
the financial
year
For foreign subsidiaries and investments, the capital reserves and retained earnings have been translated into thousands of euros on the basis of
year-end exchange rates, while profits and losses have been translated at average rate.
It is specified that the list above is not exhaustive.
176
74
5,509
1,369
4,660
9,186
40,580
298
3,327
38,925
952
28,244
1,914
74,981
7,273
20,504
165,389
2,322

Table of subsidiaries and holdings at December 31st, 2012
CAPITAL
L'Oral Cosmetics Industry S.A.E (Egypt)
L'Oral Danmark A/S (Danmark)
L'Oral Deutschland GmbH (Germany)
L'Oral East Africa Ltd (Kenya)
L'Oral Espana S.A. (Spain)
L'Oral Finland Oy (Finland)
L'Oral Guatemala S.A.
L'Oral Hellas S.A. (Greece)
L'Oral Hong-Kong Ltd
L'Oral India Private Ltd (India)
L'Oral Investments B.V. (Netherlands)
L'Oral Israel Ltd
L'Oral Italia Spa
L'Oral Japan Ltd (Japan)
L'Oral Kazakhstan Llp (Kazakhstan)
L'Oral Korea Ltd (Korea)
L'Oral Liban SAL (Lebanon)
L'Oral Magyarorszag Kosmetikai Kft
(Hungary)
L'Oral Malaysia SDN BHD (Malaysia)
L'Oral Mexico S.A de C.V (Mexico)
L'Oral Middle East
(United Arab Emirates)
L'Oral Nederland B.V. (Netherlands)
L'Oral New Zealand Ltd (New Zealand)
L'Oral Norge A/S (Norway)
L'Oral Osterreich GmbH (Austria)
L'Oral Pakistan Private Ltd
L'Oral Panama S.A.
L'Oral Peru S.A.(Peru)
L'Oral Philippines Inc.
L'Oral Polska Sp. Z.O.O. (Poland)
L'Oral Portugal Lda
L'Oral Romania SRL (Romania)
L'Oral Saudi Arabia (Saudi Arabia)
L'Oral Singapore Pte Ltd (Singapore)
L'Oral Slovenija kosmetika
d.o.o.(Slovenia)
L'Oral Slovensko s.r.o. (Slovaquia)
L'Oral Suisse S.A.
L'Oral Sverige AB (Sweden)
L'Oral Taiwan Co Ltd (Taiwan)
L'Oral Thailand Ltd
L'Oral Turkiye Kozmetik Sanayi Ve Ticaret
Anonim Sirketi
L'Oral UK Ltd (Great Britain)
L'Oral Ukraine
L'Oral Uruguay S.A.
L'Oral USA Inc. (3)
L'Oral Venezuela C.A.
L'Oral Vietnam Co Ltd
Masrelor LLC (Egypt)
Reserves
and retained
earnings
before
appropriation
BOOK VALUE
of shares held
Gross
PROFIT or
LOSS in last
financial
Net
year
DIVIDENDS
booked during
the financial
year
26,623
270
12,647
191
59,911
673
1,044
9,736
3
49,919
18
4,137
1,680
370
422
1,991
3,139
-2,465
5,550
275,912
-306
19,456
17
399
1,886
-1,314
-10,452
0
10,311
56,001
-921
817
-1,664
1,333
99.99
100.00
100.00
99.90
63.86
100.00
99.99
99.99
99.97
100.00
100.00
92.97
100.00
100.00
100.00
99.99
99.88
26,603
8,336
76,855
191
299,154
1,280
2,162
35,307
604
68,467
18
38,497
226,469
275
422
20,794
7,694
22,938
8,336
76,855
191
299,154
1,280
2,162
35,307
604
47,285
18
33,597
226,469
0
422
20,794
7,694
-3,132
10,624
159,661
-791
51,276
11,850
1,410
5,525
60,150
5,633
0
5,393
72,970
-619
9,235
17,832
9,519
428
3,268
2,349
-2
1,783
81,930
100.00
100.00
99.99
787
6,762
8,443
787
6,762
8,443
2,958
12,049
61,615
1,066
10,052
36,588
2,752
1,178
44
1,384
2,915
11,025
159
2,096
9,005
405
495
2,187
5,682
1,165
2,081
-37
2,708
5,101
1,070
-7,702
1,598
765
-4,037
1,000
186
526
-238
-616
100.00
100.00
100.00
100.00
100.00
99.99
100.00
99.99
99.27
100.00
100.00
100.00
74.63
100.00
37,284
22,014
6,110
4,050
3,818
11,043
168
3,739
19,421
707
6,459
5,883
4,260
18,991
37,284
22,014
6,110
4,050
3,818
2,320
168
3,739
0
707
6,459
5,883
4,260
18,991
30,005
26,679
6,189
17,886
12,858
-2,968
10,852
1,961
-10,566
20,309
9,699
2,669
58
9,124
22,955
42,739
5,728
17,197
12,021
465
1,598
346
2,038
187
3,992
384
798
2,062
6,655
3,611
966
100.00
100.00
100.00
100.00
100.00
99.99
856
1,673
160,311
2,247
17,881
5,238
856
1,673
160,311
2,247
17,881
5,238
1,023
4,973
36,025
12,050
21,792
19,646
2,702
4,984
47,232
15,417
19,799
9,047
37,993
121,150
3,033
485
4,402
6,201
7,239
12,585
-25,505
-32,515
-754
1,043
2,589,668
5,778
-5,349
-778
100.00
99.99
100.00
100.00
100.00
100.00
100.00
99.99
43,965
13,837
145,573
145,573
2,990
2,990
5,435
3,281
3,797,447 3,797,447
16,970
7,079
7,348
3,002
12,472
12,472
444
104,736
18,740
1,951
346,248
6,715
-3,844
43
(3) Figures from the sub-consolidation of LOral USA Inc.
177
8,771
179,294
30,962
11,667
883
9,349
104,407
5,349
88,397
6,736
26,243
8,727
9,708
1,862
22,959
10,795
1,741
6,666
64,535
19,393
154,250
2012Table
PARENT
COMPANY
FINANCIAL
STATEMENTS
of subsidiaries
and holdings
at December
31st,2012
CAPITAL
Nihon L'Oral KK (Japan)
Parbel of Florida Inc. (USA)
Procosa Productos de Beleza Ltda (Brazil)
P.T. L'Oral Indonesia
P.T. Yasulor Indonesia
Scental Limited (Hong-Kong)
Seda Plastik Ve Boya Sanayi Ith. Tic. Ldt.
Sti (Turkey)
Sofamo (Monaco)
The Body Shop International PLC
(Great Britain) (4)
Venprobel (Venezuela)
YSL Beaut Hong Kong Ltd
YSL Beaut Middle East fzco (United
Arabes Emirates)
YSL Beaut Singapore Pte ltd
YSL Beaut Vostok o.o.o. (Russia)
B. MAIN FOREIGN INVESTMENTS
(Holdings of less than 50%)
Reserves
and retained
earnings
before
appropriation
BOOK VALUE
of shares held
Gross
PROFIT or
LOSS in last
financial
Net
year
DIVIDENDS
booked during
the financial
year
138,845
40
100,647
1,510
62,363
5
97,938
-2,601
111,398
3,803
6,097
167
100.00
100.00
99.99
99.00
99.99
99.99
415,182
100,317
170,243
2,305
98,453
8
396,441
100,317
170,243
2,305
72,279
8
30,983
28,098
42,532
2,334
1,336
0
1,206
160
914
-41,071
100.00
100.00
1,851
1,852
1,851
0
-46
-47
13,885
20
0
892,632
-65
1,396
100.00
100.00
100.00
992,445
2,722
6,405
992,445
0
1,373
73,358
0
0
57,171
5,698
280
2,707
913
1,570
-4,682
100.00
100.00
99.48
17,096
336
2,802
17,096
336
0
7,376
-19
-236
12,314
n/s
n/s
n/s
n/s
n/s
n/s
n/s
24,620
23,874
(4) The Body Shop : Consolidated figures for the sub-group
Information relating to all subsidiaries and investments

SUBSIDIARIES
French
Book value of shares held
gross restated
net
Amount of loans and advances granted
Amount of guarantees and security granted
Amount of dividends booked
178
711,561
672,025
48,485
16,841
305,159
Foreign
8,352,699
8,107,229
67,790
625,429
1,561,208
INVESTMENTS
French
Foreign
423,888
423,888
17,434
1
1
320,769

Other information relating to the fi nancial statements of LOral parent company
5.7. Other information relating to the

financial statements of LOral parent
company
5.7.1. EXPENSES AND CHARGES FALLING UNDER ARTICLE
223 QUATER OF THE FRENCH TAX CODE
It is stipulated that the total amount of expenses and charges falling under Article 223 quater of the French Tax Code and the amount of
tax applicable to such expenses and charges are as follows:
Expenses and charges
Corresponding tax amount
5.7.2
1.2 million
0.4 million
TRADE ACCOUNTS PAYABLE
In accordance with the French Law on the Modernisation of the Economy of August 4 th, 2008 and the resulting Articles L. 441-6-1 and
D. 441-4 of the French Commercial Code, the breakdown of the balance of trade accounts payable by LOral parent company at yearend is as follows:
millions
2012
2011
2010
Trade accounts payable not yet due

including:
at 30 days
between 30 days and 45 days
more than 45 days
Trade accounts payable due
191.6
171.8
170.7
122.1
69.5
10.5
97.8
74.0
6.3
95.6
75.1
4.6
2012
2011
Variation in %
701.6
635.2
622.8
647.2
2,606.8
635.9
623.7
576.5
585.0
2,421.1
10.33%
1.83%
8.03%
10.63%
7.67%
5.7.3
Net sales
millions
1st quarter
2nd quarter
3rd quarter
4th quarter
TOTAL
NET SALES (EXCLUDING TAXES)
N.B: These net sales figures include sales of goods and finished products, accessories, waste and services, less reductions in respect
of sales. These sales include, in particular, supplies of goods to various subsidiaries which are recorded as intercompany sales from a
consolidated accounts standpoint.
179
2012Five-year
PARENT
COMPANY
fi nancial
summaryFINANCIAL STATEMENTS
5.8. Five-year financial summary

LOral parent company (excluding subsidiaries)
millions (except for earnings per share, shown in euros)
2008
2009
2010
2011
2012
120.5
602,415,810
0
119.8
598,972,410
0
120.2
600,992,585
0
120.6
602,984,082
0
121.8
608,810,827(1)
0
2,115.2
2,051.1
2,231.0
2,421.1
2,606.8
1,713.4
-143.4
1,552.1
861.8
1,766.3
-114.9
1,841.8
898.9
2,048.4
-104.6
1,995.3
1,082.5
2,344.8
-51.3
2,169.8
1,212.4
2,517.5
11.4
2,408.0
1,397.4 (2)
3.05
2.58
3.11
3.07
3.55
3.32
3.94
3.60
4.09
3.96
1.44
1.50
1.80
2.00
2.30(2)
5,848
381.1
5,855
403.8
5,957
426.7
6,016
459.0
6,097
489.5
159.3
172.8
182.5
200.4
208.6
I. Financial position at financial year-end
a) Share capital
b) Number of shares
c) Number of convertible bonds
II. Overall results of operations
a) Net pre-tax sales

b) Pre-tax profit before depreciation, amortisation, provisions and
reversals of provisions (including provision for investment
and Profit Sharing reserve)

c) ncome tax
d) Net profit
e) Amount of distributed profits
III. Results of operations per share
a) Profit after tax and Profit Sharing, but before depreciation,

amortisation and provisions
b) Net profit
c) Dividend paid on each share
(not including tax credit)
IV. Personnel
a) Number of employees
b) Total salaries
c) Amount paid for welfare benefits
(social security, provident schemes, etc)
(1) The share capital comprises 608 810 827 shares with a par value of 0.2, following the subscription of 5 826 745 shares of Treasury stock by means of exercise
of stock options and free shares.
(2) The dividend will be proposed to the Annual General Meeting of April 26 th, 2013
180

Investments (main changes including shareholding threshold changes)
5.9. Investments
(main
including shareholding
changes)
changes
threshold
Investments
(main changes including shareholding threshold changes > 5%)
Situation at
12.31.2011
( thousands)
Including revaluation
Amount
Groupement du Plessis
Mornay
L'Oral Cosmetics
Industry (Egypt)
L'Oral Pakistan Private
LTD (Pakistan)
Masrelor LLC (Egypt)
PT Yasulor (Indonesia)
L'Oral Hellas (Greece)
L'Oral Philippines
Cadum International S.A.
Maybelline Suzhou
(China)
L'Oral Saudi Arabia
L'Oral East Africa LTD
(Kenya)
Laboratoire Inneov
L'Oral Magyarorszag
Kosmetikai (Hungary)
L'Oral Vietnam
L'Oral USA Inc.
Acquisitions
Amount
%
Subscriptions
Amount
%
0.6
Amount
Sales
%
0.6
2,352.1
99.99
24,251.0
99.99
6,160.9
5,949.1
67,692.1
24,880.9
12,477.7
0.0
99.99
99.99
99.98
91.82
95.38
0.00
4,882.6
6,523.1
30,761.3
4,000.0
6,943.2
99.99
99.99
0.01
3.13
3.89
6,425.7
5.04
Situation at
12.31.2012
Amount
%
0.0
0.00
26,603.1
99.99
11,043.5 99.99
12,472.2 99.99
98,453.4 99.99
35,306.6 99.99
19,420.9 99.27
170,520.2 100.00
170,520.2 100.00
49,600.8 100.00,(1)
49,600.8 100.00
0.0
0.00
4,260.0
74.63
0.0
4,260.0
0.00
74.63
0.0
18,800.0
190.6
6,950.0
99.90
50.00
190.6
25,750.0
99.90
50.00
0.00
50.00
7,814.8 100.00
4,345.8 100.00
3,569,656.7 100.00
3,769,731.5
(1) Transfer of all the assets and liabilities
176,945.9
-7,027.7 100.00
3,002.1 100.00
227,790.4 100.00
312,526.6
49,601.4
787.1 100.00
7,347.9 100.00
3,797,447.1 100.00
4,209,602.6
181
2012Statutory
PARENT
COMPANY
STATEMENTS
Auditors
Report onFINANCIAL
the fi nancial statements
5.10. Statutory Auditors Report on

the financial statements
In compliance with the assignment entrusted to us by your Annual General Meeting, we hereby report to you, for the year ended
December 31st, 2012, on:
the audit of the accompanying financial statements of LOral;
the justification of our assessments;
the specific verifications and information required by law.
These financial statements have been approved by the Board of Directors. Our role is to express an opinion on these financial
statements based on our audit.
I - OPINION ON THE FINANCIAL STATEMENTS

We conducted our audit in accordance with professional standards applicable in France. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit
involves performing procedures, using sampling techniques or other methods of selection, to obtain audit evidence about the amounts
and disclosures in the financial statements. An audit also includes evaluating the appropriateness of accounting policies used and the
reasonableness of accounting estimates made, as well as the overall presentation of the financial statements. We believe that the audit
evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
In our opinion, the financial statements give a true and fair view of the assets and liabilities and of the financial position of the Company
at December 31st, 2012, and of the results of its operations for the year then ended in accordance with French accounting principles.
II - JUSTIFICATION OF OUR ASSESSMENTS

In accordance with the requirements of Article L. 823-9 of the French Commercial Code (Code de commerce) relating to the justification
of our assessments, we bring to your attention the following matter:
Investments have been valued in accordance with the accounting methods described in note 1.7.1 Accounting policies Financial
Assets Investments and advances to the Companys financial statements. As part of our audit, we reviewed whether these accounting
methods were appropriate and evaluated the assumptions used.
These assessments were made as part of our audit of the financial statements taken as a whole, and therefore contributed to the
opinion we formed which is expressed in the first part of this report.
III - SPECIFIC VERIFICATIONS AND INFORMATION

In accordance with professional standards applicable in France, we have also performed the specific verifications required by law.
We have no matters to report as to the fair presentation and the consistency with the financial statements of the information given in the
Management Report of the Board of Directors and in the documents addressed to the shareholders with respect to the financial position
and the financial statements.
182

Statutory Auditors Report on the fi nancial statements
Concerning the information given in accordance with the requirements of Article L. 225-102-1 of the French Commercial Code relating
to remuneration and benefits received by corporate officers and any other commitments made in their favour, we have verified its
consistency with the financial statements, or with the underlying information used to prepare these financial statements and, where
applicable, with the information obtained by your Company from companies controlling it or controlled by it. Based on this work, we
attest to the accuracy and fair presentation of this information.
In accordance with French law, we have verified that the required information concerning the identity of shareholders and holders of the
voting rights has been properly disclosed in the Management Report.
Deloitte & Associs
Grard Morin
David Dupont-Noel
This is a free translation into English of the Statutory Auditors Report issued in French and is provided solely for the convenience of English speaking
readers. The Statutory Auditors Report includes information specifically required by French law in such reports, whether modified or not. This information is
presented below the opinion on the financial statements and includes an explanatory paragraph discussing the Auditors assessments of certain significant
accounting and auditing matters. These assessments were considered for the purpose of issuing an audit opinion on the financial statements taken as a
whole and not to provide separate assurance on individual account captions or on information taken outside of the financial statements.
This report also includes information relating to the specific verification of information given in the Management Report.
This report should be read in conjunction with, and construed in accordance with, French law and professional auditing standards applicable in France.
183
184
CORPORATE SOCIAL,
ENVIRONMENTAL AND SOCIETAL
RESPONSIBILITY
6.1. Social information
187
6.1.1. The LOral Groups Human Resources

policy
6.1.2. Social information
consolidated scope
of the LOral Group
with
regard
to
the
187
187
199
Methodological note
6.2. Environmental information
200
201
6.2.1. General environmental policy
201
6.2.2. Pollution and waste management
203
6.2.3. Sustainable use of resources

6.2.4. Contribution to adapting to and combating global
warming
6.2.5.
Protection of biodiversity Methodological
note
205
6.3. Societal information
207
6.3.1. Territorial, economic

and social impact of activities
207
6.3.2. Relations with stakeholders

6.3.3. Subcontracting with suppliers
208
6.3.4. Fair Business practices
211
6.3.5. Other actions taken in favour of

Human Rights
212
Methodological note
213
6.4. Table of concordance

in respect of social,
environnemental and
societal matters
210
214
205
206 6.5. Attestation of completeness and
limited assurance report of the Statutory

Auditors on selected social, environmental
and other sustainable development
information
216
This information forms an integral part of the Annual Financial Report as provided for in the article L. 451-1-2 of the French Monetary and Financial Code.
185
CORPORATE SOCIAL, ENVIRONMENTAL AND SOCIETAL RESPONSIBILITY
Signatory of the United Nations Global Compact since 2003,

the Group is committed to supporting and implementing the ten
fundamental principles of the Compact within its sphere
of influence.
The Group describes each year the progress made in the
various areas concerned (Human Rights, labour standards,
environmental standards
and anti-corruption measures), namely in its Sustainable Development
Report. The Global Reporting Initiative (GRI) indicators and those of
the United Nations Global Compact are used by the Group to measure
the progress made
and communicate on actions taken.

In 2012, Vigeo, the European ratings agency, published a range
of ESG (Environmental, Social and Governance) indexes and
designated LOral
as the leading company in social responsibility in France. In this same
ranking, LOral is in 4th place in Europe and ranks 5th in the World (out of
120 companies).
Furthermore, LOral was recognised for the third year running as one of the
Worlds Most Ethical Companies by the Ethisphere Institute, a leading
international
think tank with regard to ethical business practices.

Keen to constantly improve the Groups transparency in this
area, LOral has brought together in this chapter the information
provided for by the French Decree of April 24th, 2012, as well as
examples of the Groups
achievements in the social, environmental and societal fields and a table of

concordance putting the GRI indicators into perspective with the
information under Grenelle II reporting and the principles of the Global
Compact. This table of concordance is set out on pages 214 and 215.
The reporting scope and the methodology are detailed in the
methodological note placed at the end of each section of
this chapter.
LOrals Statutory Auditors set out on page 216, their attestation with
regard
to the presence of the consolidated social, environmental and societal
information in this chapter pursuant to the provisions of Article L. 225102-1 of the French Commercial Code as well as their moderate
assurance report on a selection
of such information, identified by the sign ( ).
186

Social information
6.1. Social information

6.1.1. THE
LORAL
GROUPS
HUMAN
RESOURCES POLICY
LOral, the world leader in beauty, a greatly expanding
market, has built a human and social project in which
individual and collective performances are closely
linked: LOral ramps up its work force and actively
makes sure that the Companys men and women thrive
in a dynamic of permanent progress, a key component
of the Groups social and economic performance.
Thus, LOrals Human Resources policy is founded on:
Particular attention to the Groups social performance.

LOral has set itself the target of promoting is
values and creating a pleasant working
environment marked by solidarity, respect and
attention to everyone:
The desire to recognise the effective

contribution made by everyone through a
dynamic remuneration policy and short-,
medium- and long-term global incentive
systems.
A regular evaluation of the expectations of

employees throughout the world through
large-scale opinion polls leading to the
implementation of action plans.
The search for a work environment and

working conditions that will help to make it
possible for everyone to achieve personal
satisfaction.
An active dialogue between management and

employees and their representatives at
worldwide level.
An active policy with regard to diversity as a

factor of progress, innovation and creation of
labour relations with global priorities of gender,
social origin and disabilities.
A vision focusing on the individual talent of men and

women:
LOral has always put the human dimension and
individual performance at the centre of the Company
as part of a long-term vision. The responsibility of
the human resources staff is to increase the number
of best talents, particularly in the New Markets, in
order to durably boost the Groups growth.
Recognised as one of the most attractive

companies in the world for young graduates and
one of the companies that provide the most
training for development of the leadership of its
senior managers, LOral always tries to achieve
the right balance between constant improvement
of the efficiency of its organisation and the
enhancement of its pool of talents, at all levels
and in all countries.
An active recruitment policy which is based on
partnerships with the best educational institutions
in the world and the use of novel corporate
gaming and methods that make it possible to
identify and attract the best talents and select
them effectively from among the million
spontaneous applications received every year.
The ambition to enable each employee to evolve
thanks to individual performance monitoring and
a large number of career development
opportunities supported by comprehensive
training programmes that are accessible to
everyone. The international locations of training
structures make it possible to roll out our training
programmes throughout the world.The largescale mobility between jobs and between
countries and the many individual promotions
each year attest to the vitality of career
management at LOral.This momentum is
ensured by a Human Resources network which
is both in tune with employee expectations and
aware of the requirements of our business.
6.1.2.
SOCIAL INFORMATION
WITH REGARD TO THE
CONSOLIDATED SCOPE
OF THE LORAL GROUP
The workforce indicated in the Total workforce and

Geographic distribution of workforce charts is the
total workforce present in the Group at December
31st, 2012(1).
For Galderma and Innov that are proportionally consolidated,
the workforce at December 31st, 2012 is recorded on a prorated
basis according to the stake held by LOral, i.e. 50%.
All the other social indicators set out in this chapter
relate to the Cosmetics and The Body Shop
branches(2).
If an indicator relates to a scope different from that of
the Cosmetics and The Body Shop branches, the
scope of consolidation is indicated in a note.
(1)
Including employees with a permanent or fixed-term contract of employment.
(2)
Innov is included, Galderma (dermatology) is excluded.
187
CORPORATE
SOCIAL, ENVIRONMENTAL AND SOCIETAL RESPONSIBILITY
Social information
6.1.2.1. Employment
Average age by geographic zone
Total workforce and distribution of

employees by geographic zone, by gender
and by age
Western
Europe
In 2012, LOral had 72,637 employees ( ).
North
America
Distribution of
workforce by
geographic zone
30,798
N
e
w
16,180
25,659
2012
72,637
a
r
k
30,155
15,195
23,536
2011
68,886
30 years
29,542
14,811
22,266
34 years
2011
66,619
2010
32 years
36 years
38 years
40 years
2012
Recruitments and departures (1)

Western Europe
North America
New markets
The number of employees hired on permanent

contracts in 2012 is 9,053 ( ).
LOral does not have any problems in recruiting either

executives or other categories of staff.
LOral is pursuing its active recruitment policy for all its
businesses and all categories of staff in the C ompany.
Distribution by gender at 12.31.2012 (

)
33%
67%
29%
71%
35%
65%
Western
Europe
North
America
67%
Total
Men
Women
Breakdown by age at 12.31.2012 ( )

25.25%
30.58%
The number of departures (on the Companys

initiative) in 2012 is 1,913 ( ).
To achieve the objective of durable growth which is the

best guarantee it can offer its employees, LOral has to
continually adapt to its environment.
New
markets
33%
LOrals aim is to create a durable relationship with its

employees in order to enable each and every one of
them to develop their potential and to build long-term
growth together, become more competitive, and continue
geographic expansion and the promotion of innovation.
26.52%
17.65%
This may lead to restructuring, particularly in light of the

current difficult economic climate. Nevertheless, any
decision that may affect the working life and jobs of
employees is made after in-depth consideration and is the
subject of clear, regular communication with regard to
employees and an ongoing dialogue with the employees
themselves and their representatives, in accordance with
LOrals values of integrity and transparency.
Western
Europe
32.62%
23.83%
21.67%
21.88%
North
America
New
markets
33.85%
< 30 years
44.67%
30 - 40 years
40 - 50 years
16.36% 5.12%
> 50 years
Remuneration and trends

LOrals remuneration policy is inseparable from the
general objectives of Human Res ources policy and
accompanies the Groups development strategy defined
by the General Management.
The principle of this policy is to reward all its employees
everywhere in the world fairly by recognising the individual
contribution made by each of them and by proposing
diversified remuneration intended to fulfil the different
expectations of its employees.
(1) Cosmetics scope excluding The Body Shop.
188

Social
inform
ation
Its purpose is to reward the commitment made by

each of them and encourage individual and
collective performances. For this purpose, it is
based on an annual performance assessment
system (MAP) for employees applied in all the
Groups
subsidiaries.
This
performance
assessment system makes it possible to revise the
various fixed and variable components of
remuneration regularly depending on the position
held, the skills used, the performances and the
potential of each and every employee. It also
makes it possible to communicate clearly and
transparently on the rules for determining
remuneration, the process and the decisions
made.
As LOral wants to be one of the most attractive

companies wherever it has subsidiaries, surveys
aimed at positioning remuneration as compared to
the market are conducted by specialist firms every
year. Furthermore, internal opinion polls, that are
carried out periodically, make it possible in
particular to evaluate the perceptions and
expectations of employees with regard to
remuneration and adapt the Groups action plans
accordingly.
Finally, LOral wishes to associate its employees
collectively with the Groups results through global
incentive profit sharing systems and thus strike a
balance between social performance and
economic performance.
In most countries, the minimum salaries ( ) paid

are much higher than the statutory minimum wage
(at a national or regional level or according to the
collective bargaining agreement).
Personnel costs (including payroll costs)

( million)
2010
2011
20
TOTAL
3,624
3,832.1
4,227.9
The comparison between the three years takes into account the foreign exchange impacts and is not representative of the
real evolution in personnel costs.
Worldwide Profit Sharing,

Incentive and Mandatory
Profit Sharing schemes
a Worldwide Profit Sharing Program WPS since

2001 in all the Groups subsidiaries in which the
employees do not benefit from profit sharing
arrangements provided for by law.
For many years, LOrals policy has been to associate

employees with the results of the C ompany aimed at
making employees feel that they are part of the
Company and enhancing their motivation.This led to a
redistribution of 210 million in 2012 at the scale of the
Group, on the basis of the income for 2011.
The amounts paid are calculated locally on the

basis of sales and profits generated by each
subsidiary as compared to budgeted targets.
Implementation of the programme takes place
locally and compliance with the principles and
rules of the programme is coordinated, at
Corporate level, by the International Labour
Relations Department.
Above and beyond the legal systems applicable in

certain countries, and particularly in France,
LOral has implemented
Worldwide Profit Sharing

( million)
TOTAL
2010
2011
20
187
204
210
The comparison between the three years takes into account foreign exchange impacts and structural changes.
EXAMPLE OF FRANCE
A mandatory employee profit scheme was set up in
1968 and an incentive profit sharing scheme has
been in force since 1988.
Incentive profit sharing is a system provided for by
law but is of a non-mandatory nature. Renegotiated
every 3 years, it was the subject of a new Group
agreement in 2012.
The incentive amount is proportional to the pre-tax
profit on ordinary operations after exceptional items
and weighted on the basis of the salary/value
added ratio.
The incentive amount is available immediately, but
may also be frozen in the Company savings plan for
5 years and benefit from a corresponding tax
exemption.
On a full-time basis, for 12 months presence in 2011.
Within the framework of the regulations on sharing

profits (Article 1 of French Law No. 2011-894 of July
28th, 2011), LOral proposed the payment in 2012
of a gross additional incentive amount of 600 per
employee in respect of the non-mandatory
monetary benefits provided for by the legislation,
linked with the increase in the dividend per share
paid in 2012 in respect of the results for 2011.
LOral chose to propose the payment of an
additional incentive amount as it corresponds to the
189
system which is the closest to the notion of value

sharing.
Company-level agreements providing for the payment
of an additional incentive amount of 600 gross* were
thus entered into with the Works Councils of LOral
and its subsidiaries in France. It was paid on
September 30th, 2012. The total net amount of
incentives allocated in 2012 and the additional
incentive payment to share in profits for 2012 is
110,054,461.
CORPORATE
Social information
Changes in gross incentive amount

( million)
2008 (1)
2009(1)(2)
2010(1)(2)
2011(1)(2)
99.8
103.2
106.9
112.6
(1) Paid the following year.

(2) Amounts after the forfait social levy.
For an annual gross salary of
The gross Incentive amount

for 2011paid in 2012 represented
Additional Incentive payment

to share in profits for 2012
Total
6,767 i.e. 3.3 months

7,934 i.e. 2.7 months
9,102 i.e. 2.4 months
11,437 i.e. 2.1 months
600
600
600
600
7,367
8,534
9,702
12,037
25,000
35,000
45,000
65,000
Mandatory employee profit sharing is a mandatory system in France,

introduced in 1968, for all profit-making companies with over 50
employees. Signed for a term of 3 years, the mandatory profit sharing
agreement was renewed in May 2012.
Within the framework of this Group agreement, which pools the

results of all the companies that are signatories, LOral has made
favourable adjustments to the legal formula to take account of the
Groups international development.
Mandatory profit sharing is available immediately but may be

frozen for 5 years in the Company savings plan or the frozen
current account, or invested until retirement in the collective
retirement savings plan (PERCO) on which an additional employer
contribution is paid equal to +50%, which allows employees to
benefit from a tax exemption.
Changes in gross mandatory employee profit sharing

( million)
(1)
(2)
2008(1)
2009(1)(2)
2010(1)(2)
2011(1)(2)
38.1
34.4
34.3
32.8
Paid the following year.

Amounts after the forfait social levy.
Mandatory profit sharing for 2011 paid in 2012 represented the

equivalent of 0.7 months salary.
For employees who so wish, the amounts paid in respect of
incentive and mandatory profit sharing may be invested for a
minimum period of 5 years in the Company savings plan which
proposes, in particular, an employee investment fund invested in
LOral Shares, on which an additional employer contribution of
25% is paid for incentive profit sharing payments.
In 2012, the following amount net of CSG, CRDS and the forfait social
levy was invested by the employees of LOral and its
subsidiaries in France in the fund which is 100% composed of

LOral shares, LOral Intressement: 47,909,419, plus the net
additional incentive amount to share in profits for 2012 of
2,329,277.
The employer contributions added to these payments were
respectively 10,266,484 and 470,237, which, at the opening
trading price for the LOral share on the date of each of these
additional employer contributions, namely 92.00 on April 30 th,
2012 for LOral Intressement and 98.76 for the Supplment
dIntressement on September 28th, 2012, represented the
equivalent of 116,353 LOral shares.
Company savings plan and frozen current account

Outstanding balances for all the companies concerned in France:
( million)
Company savings plan + frozen current account + PERCO
2010
2011
2012
716
720
863
At December 31st, 2012, 51% of the savings of LOral employees were invested in LOral shares, and 9,741 Group employees in France
were shareholders of LOral through the savings plan.
190

retirement plan by creating on January 1 st, 2001 a
defined benefit scheme with conditional entitlements
based on the employees presence in the Company at
the end of his/her career. Then, on September 1 st,
2003, a defined contribution scheme with accrued
entitlements was introduced.
Long-term Incentive Plans

At worldwide level, in addition to the
mandatory profit sharing, incentive profit
sharing or Worldwide Profit Sharing
programmes for its employees, the Group
has for several years granted stock option
plans and made conditional grants of shares
(ACAs) in an international context, in order
to associate those who have made big
contributions with the future evolution of the
Groups results and help to instil a Group
spirit.
In 2009, LOral enlarged its policy by
introducing a mechanism for the conditional
grant of shares (ACAs), in order to reach out to
a broader population of potential beneficiaries
thanks to a long-term incentive tool offering
greater motivation than stock-options.
In 2012, the Group developed its policy for

conditional grants of shares:
by enlarging the number of beneficiaries

further.
Thus,
the
number
of
beneficiaries of conditional grants of
shares according to the April 17 th, 2012
Plan was increased to 2,177 (1,991 in
2011);
by internationalising conditional grants of

shares.
Thus,
the
number
of
beneficiaries outside France is 62% of
the total number of beneficiaries (59.5%
in 2011);
by making conditional grants of shares

to replace stock options to all
beneficiaries.
In total, more than 3,000 employees, i.e.

13% of the managers worldwide, benefit
from at least one stock option plan or plan
for the conditional grant of shares,
according to the terms and conditions set
out in chapter 7.4. Information concerning
the share capital on page 228.
Employee Benefit and

pension schemes and
other benefits
Depending on the legislation and practices
in each country, LOral adheres to pension
schemes, pre-retirement arrangements and
Employee Benefit schemes offering a
variety of additional coverage for its
employees.
In 2002, LOral set up a Supervisory
Committee for pension and Employee
Benefit schemes offered by its subsidiaries.
This committee ensures the implementation
and the monitoring of
EXAMPLE OF FRANCE
Pension schemes in France
In France, LOral has supplemented its
Defined benefit scheme

In order to provide additional cover, if applicable, to
compulsory pensions provided by the French Social
Security compulsory pension scheme, the ARRCO or
AGIRC (mandatory French supplementary pension
schemes), LOral introduced on January 1st, 2001, a
defined benefit scheme with conditional
SocialPensions
information
exceeding the legal minima required by national social
security systems are now paid in 80% ( ) of LOrals subsidiaries
throughout the world. In countries which already offer sufficient
social coverage, LOral does not propose company pension
schemes. This is also the case in countries which do not have
appropriate
LOrals pension and Employee Benefits policy asan
defined
by thelegal framework or a long-term investment
instrument.The
Supervisory
LOral Executive Committee.
Committee continues to be attentive
to changes in local situations and,
This policy provides for general principles in the following
when required, additional employee
areas: definition and implementation of schemes, relations
benefit
with employees, financing and cost of the schemes,
and schemes are put in place.
management of the schemes. Approval must first be obtained
from the Supervisory Committee prior to the introduction of
any new scheme or the modification of any existing scheme.
entitlements,
the
Retirement
The Supervisory Committee works together closely
with the
Income Guarantee for former
operational management of the Divisions and Zones.
Senior Managers (Garantie de
Ressources
des Retraits Anciens
The characteristics of the pension schemes and other
preCadres
Dirigeants). Prior to this,
retirement benefits offered by the subsidiaries outside
France
vary depending on the applicable laws and regulations
as well 31st, 2000, LOral
on December
as the practices of the companies in each country.closed another defined benefit
scheme, also with conditional
In many countries, LOral participates in establishing
additionalthe Pension Cover of
entitlements,
retirement benefits for its employees through a whole
of of the Comit de
the series
Members
defined benefit schemes and/or defined contribution
schemes
Conjoncture
(Garantie
de
(e.g. United States, the Netherlands, Belgium, Canada,
and
Retraite
des Membres du Comit
South American countries). In some cases, the defined
benefit
de Conjoncture).
schemes have been closed to new recruits who are offered
the Retirement Income
defined contribution schemes (Germany, BelgiumAccess
and theto
United
Guarantee
Kingdom).This series of defined benefit and defined
contributionfor former Senior
created on January 1 st,
schemes makes it possible to share the financial Managers,
risks and ensure
2001, is
improved cost stability. In defined contribution schemes,
theopen to former LOral
Managers who fulfil, in
Companys commitment mainly consists in payingSenior
a percentage
addition
to the requirement of
of the employees annual salary into a pension plan
each year.
having ended their career with the
The defined benefit schemes are financed by payments
into the condition of having
Company,
specialist funds or by setting up provisions, in accordance
with of Senior Manager
had the status
the accounting standards adopted by LOral.Thewithin
performance
the meaning of Article L.
the French Labour Code
of the managers of the main funds established, as3111-2
well asofthe
for at reviewed
least ten years at the end of
financial stability rating of the custodians, are regularly
their career.
by the Supervisory Committee.
191
CORPORATE
Social information
This scheme provides entitlement to payment to the

beneficiary retiree of a Life Annuity, as well as, after his/her
death, the payment to the beneficiarys spouse and/or exspouse(s) of a surviving Spouse Pension and, to the children,
of an Orphan Pension, subject to the children fulfilling certain
conditions.The calculation basis for the Guaranteed Income is
the average of the salaries for the best three years out of the
seven calendar years prior to the end of the Senior Managers
career at LOral. The Guaranteed Income is calculated based
on the beneficiarys number of years of professional activity in
the Company at the date of the end of his/her career at
LOral, and limited to a maximum of 25 years, each year
leading to a steady, gradual increase of 1.8% in the level of
the Guarantee. At this date, the gross Guaranteed Income
may not exceed 50% of the calculation basis for the
Guaranteed Income, nor exceed the average of the fixed part
of the salaries for the three years used for the calculation
basis. A gross annuity and gross Lump Sum Equivalent are
then calculated taking into account the sum of the annual
pensions accrued on the date when the retiree applies for
his/her pension as a result of his/her professional activity and
on the basis of a beneficiary who is 65 years of age. The Life
Annuity is the result of the conversion into an annuity at the
beneficiarys age on the date he/she applies for his/her
pension of the gross Lump Sum Equivalent, less the amount
of all payments due as a result of termination of the
employment contract, excluding any paid notice period and
paid holiday and less all salaries paid under an early
retirement leave plan, if such lump sum equivalent is the
result of these operations. Around 450 Senior Managers are
eligible for this scheme, subject to their fulfilling all the
conditions after having ended their career with the Company.
Access to the Pension Cover for Members of the Comit

de Conjoncture has been closed since December 31 st,
2000.
This former scheme granted entitlement to payment to the
beneficiary retiree, after having ended his/her career with
the Company, of a Life Annuity as well as, after his/her
death, the payment to the spouse and/or ex-spouse(s) of
a surviving Spouse Pension and, to the children, of an
Orphan Pension, subject to the children fulfilling certain
conditions. The calculation basis for the Pension Cover is
the average of
the salaries for the best three years out of the seven
calendar years prior to the end of the beneficiarys career
at LOral. The Pension Cover is calculated on the basis
of the beneficiarys number of years service and limited to
a maximum of 40 years, it being specified that at the date
of closure of the scheme, on December 31 st, 2000, the
minimum length of service required was 10 years. The
Pension Cover may not exceed 40% of the calculation
basis for the Pension Cover, plus 0,5% per year for the
first twenty years, then 1% per year for the following
twenty years, nor exceed the average of the fixed part of
the salaries for the three years used for the calculation
basis. Around 120 Senior Managers (active or retired) are
eligible for this scheme subject to the proviso, for those in
active employment, that they fulfil all the conditions after
having ended their career with the Company.
Defined contribution scheme
In September 2003, LOral set up a defined contribution
pension scheme.
A new agreement was signed in December 2007, with
effect from January 1st, 2008, as well as a supplemental
agreement applicable as from January 1st, 2009.
All executives and sales representatives affiliated with the
CIPC-R are beneficiaries of this scheme.
The basis for contributions, which remains unchanged,
amounts to between once and 6 times the French social
security ceiling, with a contribution of 4% since January
1st, 2008, shared by the Company and the employees.
This scheme grants entitlement to the payment to the
beneficiary retiree, after he/she has applied for his/her
pension entitlement from the French Social Security
compulsory pension scheme, of a Life Annuity as well as,
after his/her death, the payment to the spouse and/or exspouse(s) of a surviving Spouse Pension. The Life Annuity
is calculated on the basis of the capital formed by the
contributions made and the financial income on such
contributions at the end of the employees career. The
employers commitment is limited to the payment of the
contributions stipulated.
Number of members
TOTAL NET CONTRIBUTIONS (in million)
Pre-retirement arrangements
the early retirement leave (CFC): this pre-retirement

arrangement consists of exempting employees from
the requirement to perform their activities; but during
this period, they remain employees of LOral and
continue to receive their remuneration (within the limit
of 9,280 gross/month) as well as mandatory profit
sharing, incentive payments and paid leave;
12.31.2011
12.31.2012
11,967
8.02
12,594
8.74
13,549
9.20
early retirement leave under the time savings account:

this arrangement, linked to the 35-hour working week
agreement and the Time Savings Account (Compte
Epargne Temps CET), enables an employee who
has saved 3 days leave per year under the CET since
2001, to benefit from the possibility to terminate his/her
activities at least 3 months earlier than scheduled (6
months for sales representatives), and this possibility
can be combined with the early retirement leave;
retirement indemnities: a new scale of indemnities at

LOral was implemented by a collective agreement as
from 2011, which is more favourable than the French
National Collective Bargaining Agreement for the
Chemical Industries.
LOral pays close attention to the retirement conditions of

its employees and pre-retirement arrangements that have
been in force for a number of years, which have been
confirmed and improved within the scope of the
agreement on the employment of older workers, signed on
December 3rd, 2009, which provides in particular for the
introduction of a time savings account for older
employees:
12.31.2010
192

Social information
Thus, when he/she retires, an employee may

benefit from retirement indemnities ranging from two
months salary for five years service, to eight
months salary for 40 years service.
Men
Early retirement leave
Compulsory retirement on the
Companys initiative
Voluntary retirement
12.31.2010
Women
49
102
In order to increase the special leave prior to

retirement, the employee may opt to convert his/her
retirement indemnities into time, or he/she may
choose to receive payment of the retirement
indemnities which will be made at the time when
he/she leaves the Company.
Total
Men
151
51
25
234
12.31.2011
Women
127
12.31.2012
Women
Total
Men
178
65
128
193
5
162
3
66
0
135
3
201
(Source: HR France statistics- 2010, 2011 and 2012).
These commitments are guaranteed partly by

external financial cover aimed at gradually building
up funds resulting from premiums paid to external
organisations.
The evaluation method adopted to calculate the

retirement and pre-retirement benefit commitments
is the retrospective method based on estimated
calculations of the final salary.
The commitments net of funds invested and the

actuarial differences are booked as a provision in
consolidated balance sheet liabilities.
These commitments take into account the

employers contribution to the healthcare schemes
for retirees.
Total
million
Provision for pension commitments in consolidated balance sheet liabilities
12.31.2010
12.31.2011
12.31.2012
687.8
662.6
706.7
(Source: Administration and Finance Department)
Employees Benefit schemes in France

In addition to the compulsory Lump Sum
Death Benefit for executives under Articles
4 and 4 bis of the French National
Collective Bargaining Agreement of 1947
(1.5% of Bracket A of income as defined by
the French Social Security) and the
guarantees accorded under the French
National Collective Bargaining Agreement
for the Chemical Industries, LOral has set
up, in France, under an agreement, an
Employee Benefit scheme providing
additional collective guarantees to its
employees.
All these guarantees are based on the gross
income up to eight times the Social Security
ceiling, except for the education annuity which
is limited to up to four times the ceiling. They
are generally financed on Brackets A, B and C
of income as defined by the French Social
Security, except for the Education Annuity
which is based on Brackets A and B, and the
surviving Spouse Pension which is based on
Brackets B and C.
This Employee Benefit scheme provides

guarantees in the event of:
temporary disability: for all employees,

90% of their gross income limited to
eight times the French Social Security
ceiling, net of all deductions, after the
first 90 days off work;
permanent disability: for all employees,

a fraction, depending on the extent of
the disability, ranging up to 90% of their
gross income, limited to eight times the
French Social Security ceiling, net of all
deductions;
Death:
a)
for all employees, the payment

of a Lump Sum Death Benefit,
increased depending on the
employees family status. The
amount of this Benefit is
doubled in the event of
accidental death,
b) for executives and comparable categories of employees,

the payment of a Spouse Pension to the surviving spouse.
This ensures the spouse has an income similar to the
Spouse Pension that would have been paid by AGIRC if
death had occurred at the age of 65,
c) for all employees, the payment of an Education Annuity
to each dependent child, according to an age-based
schedule.
The total amount of the Lump Sum Equivalent for these

guarantees may not exceed 2.3 million per event.
The capital for the Spouse Pension is the first to be applied,
followed by the Education Annuity; the balance of the basic
scheme is then used to calculate the Lump Sum Death Benefit,
possibly increased by the minimum guaranteed Lump Sum
Death Benefit.
thousand
Net Employee Benefit Contributions for the financial year

(1) Estimated
193
12.31.2010
12.31.2011
12.31.2012
9,877
10,688
10,950(1)
CORPORATE
Social information
Minimum guaranteed Lump Sum Death Benefits

Since December 1st, 2004, and January 1st, 2005 for
sales representatives, LOral has put in place an
additional guaranteed Lump Sum Death Benefit that
supplements, where applicable, for all employees, the
Lump Sum Death Benefits to the extent of three years
average income. A maximum limit is set for this
guarantee.
The total amount of the capital needed to fund the
surviving Spouse Pension and Education Annuity, the
Lump Sum Death Benefits and the minimum
guaranteed Lump Sum Death Benefit is also subject to
a ceiling.
Healthcare expenses
The employees of LOral parent company and its
French subsidiaries benefit from additional schemes
covering healthcare costs.
The healthcare scheme is compulsory for all the

employees of LOral and its French subsidiaries.
Employees have the option of including their family
members in these schemes.
Contributions are generally individual.The contribution
by the employee is partly financed by the Company.
Retirees can generally continue to benefit from the
healthcare scheme, with a contribution by LOral,
subject to a membership duration clause.
The scheme for LOral parent company retirees has
been specified in the regulations for the additional
defined benefit pension scheme applicable as from
January 1st, 2008. The financial management of this
scheme was outsourced to insurance companies in
July 2011.
Employees who have chosen to work part-time come

from all categories.The number of part-time employees is
9,688 ( ) on a worldwide basis, 9,065 ( ) of whom are
women and 623 ( ) men.
6.1.2.2. Work organisation

Organisation of working time
LOral complies with the statutory and contractual
obligations with regard to working time in each of its
subsidiaries. Working time depends on the local
environment and the business activities carried out.
EXAMPLE OF ITALY
In case of use of the optional parental leave for 6

months following maternity leave, LOral Italy
supplements the portion of the salary paid by the
social security system, 30% of the salary, to bring it
up to 45% in total;
2 half days of paid leave are allowed in order to

enable the mother to make arrangements if the
child is sick;
The annual leave amounting to 40 hours to which

employees are entitled for doctors appointments
may be used by mothers for examinations
concerning their child until the child reaches 3 years
of age;
In addition to these measures, if the child goes to a

day nursery, a contribution of 130/month is paid
until the child reaches 3 years of age.
LOral Italy made a commitment in 2011 in favour of

mums at work, following a project conducted with
employees and their representatives, involving
mothers of young children.
The signed agreement defines the provisions which go
beyond the legal obligations and which are aimed at
improving the private life-professional life balance for
mothers of young children; several of them concern
flexible management of working hours.
In particular:
The variable working hours already in force for all

employees are enlarged (possibility of starting work
between 08.30 a.m. and 10.30 a.m.) for mothers
until their children reach 3 years of age;
The possibility of working part-time 6 hours a day is
granted, at the mothers request, until the child reaches
2 years of age;
Absenteeism ( )
The overall rate of absenteeism is 4.04%, 2.67%(1) of
which is due to sickness, calculated using the following
method:
Method of calculation:
Total absenteeism:B/(A+B)
Sickness absenteeism:C/(A+B)
(A) Number of days effectively worked by all employees

with contracts, including training days.
(B) Number of days of absence (sick leave, occupational

diseases, maternity leave, accidents in the workplace
and/ or travel-to-work accidents or any other absence
not provided for by contract).
(C) Number of days of sick leave (excluding occupational
diseases, maternity leave, accidents in the workplace
and/ or travel to work accidents...).
(1)
The scope with regard to this information covers the United States and France (excluding The Body Shop), i.e. 36.9% of the Groups
workforce. The definition of this indicator is currently being made uniform in all Group companies.
194

employees, customers and the communities in which
LOral performs its activities. This approach is part of an
overall environmental, health and safety policy described
in the section on Environmental information on pages 200
et seq.
6.1.2.3. Labour relations

Organisation of the dialogue
between employees and
management and in particular the
procedures for information and
consultation of the employees and
negotiations with them.
The quality of the social climate at LOral is
the fruit of an ongoing dialogue between
Management,
employees
and
their
representatives, in accordance with trade
union rights in each country and with a
neutral attitude with regard to the various
trade union organisations.
Employee representative institutions have
been set up in most of the European
subsidiaries, the Asian subsidiaries (China,
Indonesia, South Korea), Africa (Morocco,
South Africa), and
The Instance Europenne de dialogue

social / European Works Council
An agreement signed in 1996 between
LOral and French and European trade
unions (FECCIA and EMCEF) led to the
establishment of the Companys Instance
Europenne de Dialogue Social/European
Works Council (IEDS/EWC). The initial
agreement has been regularly updated, in
particular in 2009 to introduce a new
information and consultation procedure
which applies to transnational projects
involving local consultation procedures. This
procedure allows for the possibility of an
opinion from the IEDS/EWC. It is then
implemented with the Liaison Secretariat
extended to include members from the
countries concerned or with the entire IEDS/
EWC, depending on the geographic and
strategic dimensions
Situation with regard to collective

agreements ( )
The social policy at LOral permits the
signature of a certain number of collective
agreements in the subsidiaries every year.
In 2012, 33 agreements were signed in
France and 69 agreements were signed in
the rest of the world. In total, the number of
agreements in force at December 31st, 2012
was 298.
6.1.2.4. Health and Safety

For several years, LOral has applied a
well-established policy in the field of health
and safety (EHS policy). This defines the
Companys commitment to developing,
producing,
distributing
and
selling
innovative products of the highest quality,
while having an ethical conduct and
guaranteeing the health and safety of
LOral is eager to provide a safe and healthy work

environment for its employees. Health and safety are of
paramount importance and LOrals ultimate goal is a
zero accident rate.
26 countries which are part of the European Economic Area;
Social
information
among
these 26 countries, the 16 countries with more than
145 employees are represented.
Comprehensive measures have been taken focused on risk

in North and South America (the United States, Canada, Mexico,
reduction and continuous improvement. A safety culture has
Brazil and Argentina), and also in Australia and New Zealand.
been instilled, setting high standards and involving employees
at all levels of the Company.
In the few cases where there is no employee representative
institution (essentially in subsidiaries with a small workforce), the
Keen to increase safety in the workplace, the General
dialogue is conducted directly with the employees, in complete
Management has set an ambitious objective to improve the
compliance with the principles of transparency and trust that
results obtained.
are applied uniformly throughout the Group.
Performance
summary
Since 2003, LOral has carried out a global employee
opinion
poll with the assistance of the international firm of Towers
Watson,
Overall, 2012 was a good year in
a survey that was repeated in 2011-2012. The results
areof
shared
terms
performance. The Groups
with the employees and employee representatives.performance
They are theimproved by 14.42% as
subject of actions plans implemented in a decentralised
manner,
compared
to 2011 despite the
as closely as possible to the expectations expressed.
deterioration of the performance of
the factories. Out of the 193 lost-time
accidents registered in the Group in
2012, 72% occurred at administrative
sites,
including 5% in Research &
of the project.This revision represented an important
advance
Innovation laboratories or sites, and
which aims to reinforce social dialogue at LOral while
remaining a step ahead of changes in legislation. 28% in the factories and distribution
centres.
The IEDS/EWC contributes to discussions and formal meetings
situation
Sites of factories and distribution
with IEDS/EWC members about the Groups current
centres: TFc* = 1.49 vs. 1.36 in
and future prospects.
2011 (+9.7 %);
It has 30 members, who receive regular training on economic
Administrative sites (including
and social issues.
R&I): TFc* = 1.80 vs. 2.30 in 2011
(-21.6%);
Today, the IEDS/EWC covers more than 30,000 employees
in
Group: all sites: TFc *= 1.72 ( ) vs.

2.01 in 2011 (-14.42%).
* TFc (Conventional Frequency Rate) = number of lost-time accidents per million hours worked by LOral staff.
195
CORPORATE
Social information
Performance summary for factories and

distribution centres since 2005
Management is the guiding force behind this change in

safety culture, supported and assisted by the EHS
network. LOral has set up the necessary tools and
programmes to achieve excellence in this area.
TFc* (conventional frequency rate) - Factories and distribution

centres
The basic safety improvement programmes rest on the

following elements:
EHS steering committees;
Mesur;
SIO (Safety Improvement Opportunities);
Safety Training for management:
2012
2011
2010
2009
2008
2007
2006
In 2012, 60 participants from LOral attended

seminars open to site managers on the theme of
Safety & leadership, held at the CEDEP, the
European Centre for Continuing Education (Centre
Europen dEducation Permanente) on the campus of
INSEAD in France. The main objectives of these
seminars are to change the attitudes of managers
with regard to safety, raise their awareness to the
crucial problem posed by safety for companies and
their management executives, and to increase their
ability to have safer behaviour adopted and
maintained over the long term.
2005
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
Target: Zero accident in 2012(1)

Out of 104 factories and distribution centres, 69 recorded
zero lost-time accident.
An accident severity rate that has fallen

As well as a reduction in the number of accidents, it is
also important to note that the accident severity rate has
fallen by 40% since 2005. It is 0.09 ( ) in 2012.
Ergonomic Attitude;
Millions of hours LOral staff - without

a lost-time accident since 2005
Operational and administrative sites
EHS Culture Audits.
Safety Target for Factories and

distribution centres
8 factories, 4 distribution centres and 17

administrative sites reached or passed the threshold
of one million hours worked without a lost-time
accident;
3 factories and 7 administrative sites have now

reached
3 million hours.
The initial target is an 81% improvement in our safety record

by 2015 (base year 2005: TFc* = 3.09), representing a TFc*
of < 0.60.
HEALTH AND SAFETY CONDITIONS AT LORAL FRANCE :
For many years, LOral has been committed to a

proactive policy for continuous improvement in the
working conditions of its employees, thereby
contributing to the development of an environment
favouring the quality of life at work.
Within this framework, and beyond the systems that
already exist, LOral wished to go one step further firstly
by implementing a stress prevention and management
programme and secondly by introducing a reflection on the
prevention of arduous working conditions pursuant to the
provisions of French Law No. 2010-1330 of November 9 th,
2010.
Attentive to the stress which could be experienced

by employees whatever the circumstances, at the
start of 2009 LOral undertook a stress prevention
and management programme with the support of a
network of occupational doctors (7 exclusively
dedicated to LOral) and a duly empowered body,
the Intervenant en Prvention des Risques
Professionnels (IPRP).
This programme is based on 3 main measures:
a prevention plan including in particular two training

modules enabling both employees (1 day) and
managers (2 days) to understand stress
mechanisms better and give them operational
solutions to regulate their impact.
an individual assessment of the employees level of

stress, anxiety and depression via a questionnaire
proposed at the time of the annual employee
medical
check-up,
based
on
scientifically
recognised scales; at the end of the process, results
are shared with the occupational doctor.
an annual analysis of the Companys collective

results by the Health, Safety and Working
Conditions Committees.
This action plan, which was favourably received by
employees, the Health, Safety and Working
Conditions Committees and the Works Councils, is
effective in all LOral entities in France.
(1) LOral permanent staff.

*
TFc (Conventional Frequency Rate) = number of lost-time accidents per million hours worked by LOral staff.
196

Social information
Within the scope of the provisions of

French Law No. 2010-1330 of
November 9th, 2010 and French
decrees No. 2011-354 of March 30 th,
2011 and No. 2011-824 of July 7 th,
2011, LOral continued its reflections
on the way to improve working
conditions and the prevention of
arduous working conditions with the
aim of enabling employees to remain
in active employment longer and
under better conditions.
In 2012, there were 37 Health, Safety and Working

Conditions
Committees (CHSCT) and 1 Health , Hygiene and Safety
and
Working Conditions (SHSCT) at LOral.
Although not obligatory, discussions

have begun in certain of LOrals
business sectors or entities, in
conjunction with the Health, Safety
and Working Conditions Committees
and the EHS teams, in order to
prepare
action
plans for the
prevention
of
arduous
working
conditions.
MEASURES TAKEN TO IMPROVE SAFETY:
In application of the French decree of

November
5th,
2011
relating
to
occupational risks, LOral has updated
the single document for the evaluation of
occupational risks in the Company by
including these two points in particular.
Status report on collective agreements with

regard to health and safety: number of
agreements in force with regard to health
and safety: 18
6.1.2.5. Training
Training is an integral part of employee
development policy at LOral. In a continual
search for excellence and creativity and the
desire to be one step ahead to deal with the
growing complexity of the challenges of our
business, the Learning for Development
teams provide employees and managers
with ongoing support to help them not only
to be high-performing, but also to achieve
fulfilment.
Training has always been at the heart of the
Human Resources strategy: this enables
LOral to attract the best talents, prepare
Number of hours of training
An occupational doctor is available

for each LOral site and 7 of these
occupational
doctors
work
exclusively for LOral. They are
assisted by 5 dedicated social
workers.
Preservation of the health and

safety
of
employees
is
a
fundamental objective which forms
an integral part of the human and
social policy. It rests on risk
prevention both at an individual
level, through screening tests
making it possible to provide
employees with thorough, adapted
individual medical attention, and at
collective
level
through
the
evaluation and management of
occupational risks.
The health and safety policy is part
of
an
overall
programme,
conducted in close cooperation with
the occupational doctors, safety
officers and the Health, Safety and
Working Conditions Committees.
the leaders of the future, but also

provide all the employees throughout
the world with the best possible
response in terms of training.
Personal training paths are built from
the needs identified with the manager at
a specific individual interview held each
year. The employee then has access to
a whole set of personal development
resources with a mix of in-room training,
training videos, digital and social
experiences and coaching in the work
situation. Employees can thus build their
own training experience, while sharing
their practices with colleagues all over
the world.
In a highly competitive, multicultural environment, LOrals

ambition is to enable all of its employees to receive training at
each stage of their career, to develop their potential, but also
to achieve fulfilment with enthusiasm, within the scope of their
duties.
TOTAL
6
2011
20
1,022,772
1,063,172
197
CORPORATE
Social information
actions in favour of the disabled. These awards,

which are presented every two years, make it
possible to showcase and share the best practices of
the various LOral entities both in France and in
Europe. In 2012, this initiative was made international,
which enabled 14 countries from four geographic
zones to participate.
Finally, 46 countries, in which the Group is established,

have implemented actions to diversify the origin of their
recruitments (Brazil, Italy, France, Spain, etc.) with one
objective: enable all talented individuals to assume highlevel responsibilities within the Company, whatever their
differences or their origins.
LOral has moreover developed a diversity assessment
in France with a hundred or so indicators that together
cover the 6 dimensions of Diversity policy. For the same
purpose, all the subsidiaries have access to an online
Diversity Reporting tool.
In order to support these initiatives, LOral has

undertaken to train its employees in diversity by
organising Diversity Workshops. This is a one-day
training session which made it possible to raise
awareness among over 12,000 employees in more
than 20 countries by the end of 2012.
6.1.2.7.
Promotion and compliance
with the provisions of the

fundamental conventions of the
International Labour Organisation
LOral became a signatory of the United Nations Global
Compact in 2003 and undertakes to respect and promote
the Fundamental Conventions of the International Labour
Organisation even though not all these Conventions have
been ratified by all the countries in which LOral is
present.
This means in particular respecting freedom of
association and the recognition of the right to collective
bargaining, contributing to the elimination of all forms of
forced or compulsory labour, contributing to the effective
abolition of child labour and eliminating all forms of
discrimination in respect of employment and occupation.
LOral ensures that these conventions are observed with
regard to its employees thanks to the actions taken by
the Human Resources functions and at its suppliers and
subcontractors premises thanks to the actions taken by
the Purchasing function
(see the section on Societal Information 6.3.3.

Subcontracting with suppliers on page 210 for further
details).
Concerning respect of freedom of association and
recognition of the right to collective bargaining, the
measures taken are described in paragraph 6.1.2.3.
Labour Relations on page 195. In countries where
freedom of association and the right to collective
bargaining are limited or prohibited , LOral ensures that
other modes of dialogue with employees exist enabling
them to report any concerns they may have.
Concerning the elimination of all forms of discrimination
in respect of employment and occupation, the measures
taken are described in the paragraph 6.1.2.6. Diversity
and Equal Opportunities on page 197.
Concerning the elimination of all forms of forced or
compulsory labour, recourse to prison labour is only
possible, either directly or via a supplier/subcontractor,
when it is voluntary within the scope of a professional
reinsertion programme, and paid at market price.
Concerning the abolition of child labour, all LOral
entities are required to verify the age of their new
employees when they are hired.
LOral has chosen to set a compulsory minimum age of
16 for its entire staff, a minimum age which is higher than
that required by the International Labour Organisation.
In light of their young age, employees who are between
16 and 18 years old are subject to specific measures and
in particular: no night work, no overtime, no work
involving the use of hazardous substances or tools, no
carrying of heavy loads, the implementation of a
reinforced training programme, appointment of an
internal tutor and inclusion on a special register. In
2012, 434 employees aged between 16 and18 worked
within the Groups entities.
LOrals Open Talk policy enables employees to raise
any concerns they may have directly with the Groups
Chief Ethics Officer including via a secure website.
LOral follows, inter alia,the Global Reporting Initiative
indicators HR4, HR5, HR6 and HR7 which correspond to
the four fundamental conventions.
198

Social information
METHODOLOGICAL
NOTE
from the available results for the entities

connected to the local Information Systems
(IS), provided that the scope covered by
such entities is representative (3)..
Social, Health and Safety

data scope, indicators,
reporting method and
systems
Social data
SCOPE OF CONSOLIDATION
The
workforce
indicated
in
the
Total
Workforce and Geographic distribution of

workforce charts is the total workforce
present
at
concerned
(1)
December
31st
of
the
year
For proportionally consolidated companies,

the workforce at December 31st is recorded
on a prorata basis according to the stake
held by LOral.
All the other social indicators set out in the
Social information section relate to the
Cosmetics and The Body Shop
branches (2).
If an indicator relates to a scope different
from that of the Cosmetics and The Body
Shop branches, the scope of consolidation
is indicated in a note.
The scope with regard to absenteeism
covers the United States and France
(excluding The Body Shop), i.e. 36.9% of
the Groups workforce.The definition of this
indicator is currently being made uniform in
all Group companies.
INDICATORS
The indicators chosen are those used in
the management of employees and of the
social aspects of the Company. They
reflect the results of the Human Resources
policy.
DATA
Four methods are used to collect data for
the defined scope:
Most of the data are collected using the

dedicated Country Reporting intranet
system, available in all countries in which
there is a LOral subsidiary.The system
covers several topics: workforce, ethics,
Worldwide Profit Sharing, labour relations,
remuneration,
Human
Resources
expenses, recruitment and training, and
absenteeism.
At the beginning of each year, the local

Human Resources Directors provide
the required data for the previous year.
When the data are compiled, each
country must validate a charter
committing to the accuracy of all the
data provided.
Other data are collected by each corporate department

concerned (i.e. Training, Recruitment) using dedicated
systems which follow the same operational and
dissemination approach.
If information is not consolidated for the entire Cosmetics

branch scope, it is recognised that it can be extrapolated
Lastly,
the
specific
data
relating
to
executives are
gathered from
the
CAROL
online
career
monitoring
system,
deployed in all
Cosmetics
subsidiaries.
A
process
of
continuous
improvement
of
these systems is in
place.The systems
are reviewed each
year, taking into
account
the
Statutory Auditors
recommendations
and
monitoring
objectives
for
subsequent years:
updating
the
indicators
to
be
monitored,
improving
their
definitions,
and
improving
the
communication,
monitoring
and
control process.
Health and safety data

SCOPE OF CONSOLIDATION
The safety indicators set out relate to the factories and
distribution centres but also the administrative sites and
research centres of the Cosmetics, Dermatology and The
Body Shop branches.
Safety reporting covers 99% of factories and distribution
centres. In 2012, it covers over 95% of the workforce of the
administrative sites and research centres. Moreover, out of the
61 distribution centres included in the security perimeter, two
reported partial information in 2012.
The safety indicators of the factories and distribution centres
sold or closed during the financial year are reported in full up to
the date of their exit from the scope.The factories or distribution
centres that join the Group have a maximum period of 2 years
to connect to the environmental and safety reporting systems.
INDICATORS
The indicators applied are those used in the management
of the Companys sites. They reflect the results of the Groups
Environmental, Health and Safety (EHS) policy.
DATA
The following method is used to collect data for the defined
scope:
The health and safety data are collected using the dedicated
site reporting QIS intranet system, available in all countries
in which there is a LOral subsidiary. The required data are
reported every month by the local managers.
When the data are compiled, each site must validate the
accuracy of all the data provided.
A process of continuous improvement of these systems is in
place.The systems are reviewed each year, taking into account
the Statutory Auditors recommendations and monitoring
objectives for subsequent years: updating the indicators to
be monitored, improving their definitions, and improving the
communication, monitoring and control process.
(1)
Including employees with a permanent or fixed-term contract of employment.
(2)
Innov is included, Galderma (dermatology) is excluded.
(3)
In France, the gender distribution of the Cosmetics workforce was extrapolated from the gender distribution of the
entities connected to the France HRIS. The extrapolation method concerns 5% of the French workforce, which is not yet
connected to the local HRIS.
199
CORPORATE
SOCIAL,
Environmental
informationENVIRONMENTAL AND SOCIETAL RESPONSIBILITY
6.2. Environmental information

LOrals environmental policy is aimed at minimising
environmental impact while guaranteeing the health and
safety of employees, customers and the communities in
which LOral performs its business activities. The cosmetics
industry has a limited impact on the environment but, as with
any manufacturing activity, risks do exist. Before building or
renovating a factory anywhere in the world, and before
introducing new manufacturing equipment and processes,
LOral assesses all the potential Environment Health and
Safety (EHS) impacts and develops mitigation strategies
where required.
The health and safety measures adopted in favour of

LOrals employees are described in section 6.1.2.4.
Health and Safety on page 195.
THE GROUPS EHS POLICY AND

MANUAL
In 2010, LOral updated and brought together in one
place all the elements that support implementation of its
EHS policy across LOrals worldwide sites.
EHS policy at LOral is organised and managed in
accordance with an EHS manual, which sets out the
measures to be applied by all operational sites under
LOrals control. It covers safety measures and safety
objectives (zero accident), resource efficiency, greenhouse
gas emissions, EHS responsibilities, internal procedures, etc.
For LOral sites, the EHS manual is a key tool to drive
further improvements in their EHS performances. Distributed
to all operational sites in 2011, it will be rolled out to the
Research & Innovation centres and administrative sites in
2013.
ORGANISATION OF EHS
There are clear accountabilities for EHS at every level.
LOrals Executive Vice-President Operations, who
reports to the Groups CEO, is responsible for health,
safety and environmental issues. EHS managers liaise
with the EHS Department for each aspect of operations.
The remuneration of factory managers and distribution
centre managers is partly linked to their performances in
the field of health, safety and the environment.
WORLDWIDE AUDIT PROGRAMME

External experts regularly visit LOrals production and
distribution sites to assess the progress made and the risks
they present.Third-party audits are also carried out at
supplier sites in accordance with the same criteria as those
used for Group entities.
LOral has a comprehensive programme of EHS audits,

which includes in particular risk audits, Culture Audits
and subcontractor audits.
Risk audits are designed to ensure that procedures and
methods used by employees do not carry inherent risks.
They are carried out by independent experts across all
international operations. As a general rule, it takes about
five days for a team of three or four auditors to evaluate a
factory and around three days to evaluate a distribution
centre. In 2012, risk audits were carried out at eleven
factories, fourteen distribution centres, one administrative
site and one research centre.
Initially launched in 2009, the EHS Culture Audits
programme, which aims at enabling employees to grasp
the risks inherent in their work environment, focuses on
leadership, an EHS culture and industrial excellence.
EHS Culture Audits are triggered by a sites
performance and conducted by internal EHS specialists
through group interviews with 20-30% of the sites
employees. In 2012, EHS Culture Audits were carried
out at fourteen factories and thirteen distribution centres.
In addition to these audits, an insurance company
offering environmental harm liability insurance visits
several sites every year in order to improve
environmental risk management. In 2012, eleven visits
were made to sites in Germany, Canada, Korea, Spain,
France, India and Italy.
EHS POLICY TRAINING

A targeted training programme is provided on LOrals
EHS policy for managers and EHS professionals across
the Group. The objectives of this training programme are
as follows:
identify and share EHS vision, challenges and values

across the Group;
identify the risks inherent in a role, task, behaviour or

use of equipment and implement tailored corrective
solutions;
enable managers to implement EHS policy effectively

within their teams.
In 2012, training sessions in EHS policy were provided to

managers and EHS specialists in Europe (109 people),
Latin America (30 people), North America (30 people)
and Asia (16 people), who all have operational functions
in this area.
In addition, within the scope of deployment of the
Ergonomic Attitude programme throughout the Group,
54 people received ErgoAct training. This training will be
developed further in 2013.
200
LOral Groups factories and

distribution centres:
Our global industrial policy demands all sites

to:
ensure compliance with the regulations;
apply best practices in energy efficiency

or efficient consumption of resources;
roll out breakthrough projects in a

permanent search for operational
performance allied with environmental
performance.
LOral has made an important commitment

to reducing its environmental footprint for its
factories and distribution centres between
2005 and 2015: an absolute reduction of
50% (in direct and indirect) CO 2 emissions
and a reduction in water consumption and
waste generated per finished product by
50%. Concrete, measurable actions are
being taken by the LOral teams by
reinforcing the Companys corporate
societal responsibility principles and sharing
them with others.
6.2.1. GENERA
L
ENVIRONME
NTAL
POLICY
LOral has undertaken to reduce its impact
on the environment and its use of natural
resources through absolute reductions.
When this is not possible, LOral strives to
improve its eco-efficiency and to adopt a
more ecological approach.
Furthermore, LOral applies the ISO 14001
environmental management standard. All
the Groups factories are certified except the
BRI Lassigny (France) and Kaluga (Russia)
factories, as well as the new factories in
Jababeka (Indonesia) and San Luis Potosi
(Mexico) opened in 2012.
The factories and distribution centres are
committed to improving their environmental
indicators:
50% absolute reduction in greenhouse

gas emissions (scope I and II);
50% reduction in waste generated per

finished product;
50% reduction in water consumption per

finished product. The reductions are
calculated on a like-for-like basis (20052015).
Summary of the
environmental
performances of the
17.7% increase in manufacturing capacity (2005-2012);
greenhouse gas emissions: absolute reduction of

38.8% (tonnes of CO2, direct and indirect, 2005-2012)
on a like-for-like basis according to the GHG
Protocol(1);
(1) Greenhouse Gas Protocol : international method of carbon

accounting.
Environm
ental
informati
on
22.8% reduction in
water consumption
(litres per finished
product, 2005-2012);
23.9% reduction in
the production of
transportable waste
(grams per finished
product
including
shuttle pallets, at the
factories
and
distribution centres,
2005-2012);
the waste recycling

rate increased from
89.0% in 2005 to
95.0% ( ) in 2012,
with 20 factories at
100% in 2012;
absolute
improvement
of
17.6%
in
the
wastewater quality
index (tonnes of
COD) (2005-2012).
6.2.2. P
OLLU
TION
AND
WAST
E
MANA
GEME
NT
a) Solid waste
For many years, LOral has followed
an ambitious waste management
policy. This policy goes beyond
regulatory compliance and the
prevention of human risks to the
environment and consists of waste
prevention, recycling and reuse and
energy recovery in order to avoid
waste to landfill.
In 2012, in order to continue to be in
line with the targets that LOral set in
2009, namely to reduce the quantity
of waste per finished product by 50%
(2005-2015), new initiatives were
implemented across the Group in
order to go one step further
Provisions for environmental

risks:
in
reducing waste
at source while also reducing the overall
environmental
footprint:
The amount of the

provisions booked for
environmental risks is
not material. Two sites
have set aside a
provision
for
the
treatment of their soil.
Most of this provision
corresponds to land
which does not require any treatment

for the activities which are currently
carried out on the site.
201
95.0% ( ) of waste is reused, recycled or recovered;
55% ( ) of the sites send zero waste to landfill;
waste per finished product,

including the weight of packaging
and shuttle pallets going back and
forth between suppliers and
LOral, was reduced by 1.0% as
compared with 2011.
CORPORATE
SOCIAL,
Environmental
2012
Total
126,871
32,635
14,525
120,530
95.0
Transportable waste with packaging and shuttle pallets (tonnes)

fraction represented by shuttle packaging
of which shuttle pallets
Total recycled waste (tonnes)
Recycling ratio (%)
The transportable waste is directly related to the activities at the
site. For a factory, for example, it consists of raw material
packaging waste or packaging items, waste oil or wastewater
treatment unit sludge. Shuttle packaging on pallets used to protect
goods during transportation between suppliers and LOral sites is
also taken into account.
Transportable waste does not include exceptional waste which is
related to work on an exceptional scale carried out at sites resulting
in tonnage of waste which would completely disrupt the routine
handling of waste on these sites.
(
(
(
(
(
)
)
)
)
)
b) Atmospheric emissions
Atmospheric emissions are essentially CO2 emissions, linked to
fossil energy consumption on the sites.
The low emissions of SO2 come from the fuel oil used (4% of fossil
energy consumed).
The small quantities of VOCs result essentially from the alcohol
used in our production processes.
Please refer to the table below for each of these emissions:
Direct CO2 (t)

Indirect CO2 related to energy used (t)
SO2 (t)
VOCs (t)
Ozone depleting substances
*
2011
2012
71,447
95,272
6.5
121.8
Negligible *
66,920 ( )
78,540 ( )
6.1( )
125.6 ( )
Negligible *
These emissions come from the refrigeration units used in our sites.
c) Water emissions: wastewater

On production sites
In 2012, chemical oxygen demand (COD kg/tonne of bulk
products) of wastewater before treatment rose by 3%. It
corresponds to 19.1 kg ( ) of COD per tonne of bulk products.
Approximately half of LOrals sites have on-site wastewater
treatment plants. These use a range of methods including physical,
chemical and biological processes, or other technologies adapted
to the characteristics of the wastewater and local discharge
conditions.
Total COD for the wastewater after on-site treatment has fallen by
3.6%. It amounts to 1.2g ( ) of COD per finished product.
With the aim of minimising overall energy use and solid waste
production while maximising residual water treatment efficiency,
LOral supports a European research project with the University of
Newcastle in the United Kingdom, which is looking into energy
efficiency in wastewater treatment. In practice, this has led to the
introduction of a new technology making it possible to reduce the
environmental footprint of wastewater treatment, which is currently
in the start-up stage at one of our factories in China.
2012
Total
3
Accidental spills (m )
Wastewater discharge (m3)
On the sites of end customers

Beyond wastewater management on its production sites, LOral pays
close attention to the impact of its products, and in particular rinsed
products (shampoos, conditioners, shower gels, etc.) on aquatic
environments when they are used by consumers.
Since 1995, the date of creation of its ecotoxicology laboratory,

LOral has developed expertise with regard to the potential impacts
of its cosmetics products on aquatic environments. In fact, the
improvement in the biodegradability percentage and/ or the
ecotoxicological profile of a formula is an essential way to reduce
these impacts.To constantly minimise the environmental
202
0
1,756,270
impact of ingredients, Research teams work on improving the
biodegradability of formulas. Shampoos and conditioners with
highly biodegradable formulas have been launched in consumer
brands such as Garnier Fructis and Ultra Doux (94 and 97%) as
well as Dop (94-98%).
d) Noise pollution
LOrals industrial activities are not particularly noisy. The sites comply
with the noise standards to which they are subject. Every month, the
internal environmental reporting system informs

in the industrial sites.
LOral of any instances of non-compliance

on this topic. According to this reporting
system, only one site exceeds the standard,
but does not generate noise pollution as
there are no close neighbours.
6.2.3.
UST
AIN
ABL
E
USE
OF
RES
OUR
CES
LOrals strategy for raw materials is a
fundamental component of Sustainable
Development vision.The impact of the raw
materials used is measured with the help of
the environmental evaluation guide. LOral
encourages the use of raw materials having
a favourable impact, evaluates those raw
materials having an unfavourable profile
and promotes those which are renewable
and of plant origin, with respect for
biodiversity.
Water is first on the list of resources to be
preserved, and LOral endeavours to
control the use made of water throughout
the entire production cycle.
a) Water
LOral has had a global water conservation
programme in place since 2003, which has
made it possible to make significant progress
in reducing total water use and increasing ecoefficiency.
In 2012, water consumption per finished
product was reduced by 0.3% while overall
water consumption in factories and distribution
centres increased by 1.4% as compared to
2011, due to an increase in production
(+1.7%). Total water consumption amounted to
2,925 ( ) thousand cubic metres in 2012.
Over the past 5 years (2008-2012), water

use per finished product has been reduced
by 11.3% and absolute consumption has
increased by 0.3%, while production has
increased by 13%. This good result has
been obtained by re-thinking each use
made of water and optimising the systems.
A lot of the water consumed in LOral
factories is used for cleaning production
equipment and packaging lines to maintain
very
strict
hygiene
standards.This
represents 37% ( ) of all water consumption
To meet the targets set, LOrals teams aim to reduce the

amount of water used for cleaning operations as far as
possible without affecting quality. This is a major
challenge because cleaning is a complex process that
takes place in different ways, depending on the formulas
involved and the equipment used.
A new cleaning method called OptiCIP has been
developed. It makes it possible to take into account site
specifics such as equipment and type of product, then
apply the most effective cleaning processes in the
factories.
To reduce net water consumption for cleaning equipment,
several pilot trials were carried out in 2012, in order to
recycle the waste used after specific treatment.The first
recycling process has been operational in the factory in
Montreal since the end of 2012.This recycling will make it
possible to reduce cleaning water consumption by up to
40%.
Environ
mental
informati
on
Transparency in
water reporting:
water disclosure of
the Carbon
Disclosure Project
Stewardship Council) of which

LOral is a member in France. Over
95% of its cardboard packaging
comes from certified forests. In order
to ensure that the entire control chain
is certified, LOral also encourages
its printers to obtain FSC certification;
over 90% of its printers sites are
FSC-certified.
Reduce: weight and volume reduction
in packaging is an integral part of
design. Every year, actions are taken
to reduce the weight of packaging
and
are
recognized
through
indicators. Between 2008 and the end
of 2012, 2,900 tonnes of packaging
materials did not need to be produced
due to actions reducing them at
source. As concerns the volume of
packaging,
as
there
are
no
international regulations in this area,
LOral has developed a procedure
which defines ratios to be complied
with between the various levels of
packaging.
Since 2010, LOral has

been
a
Founding
Responder
to
the
Carbon
Disclosure
Project (CDP) water
reporting initiative. The
CDP is a leading,
independent,
not-forprofit organisation that
promotes transparency
in
climate
change
reporting. In 2010, the
CDP
expanded
its
scope to include water
reporting.
LOral
reports every year on
its water management
strategies,
water
consumption and water
discharges
and
describes the Groups
initiatives in this area.
Replace: aware that non-renewable resources are not

sustainable, LOral looks for alternatives to the materials
based on these resources. One of the solutions that LOral has
implemented to limit their use is by using recycled materials.
A certain number of our brands include recycled plastic in
their bottles, which may be up to
100% plastic (Kiehls, Garnier, LOral
Professionnel, Matrix), or recycled
glass in their jars (Vichy, Biotherm).
c) Raw Materials
b) Packaging
Renewable raw materials
Since 2007 LOral has

implemented
a
Packaging
and
Environment
policy
based on three pillars:
Respect, Reduce and
Replace.
In 2012, 22% of the Groups new raw

materials are plant-based and 10%
respect green chemistry principles.
Currently, 100% of new renewable
raw materials are assessed for their
potential impact on biodiversity. Thus,
out of the 250 plant species from
which our renewable raw materials
are derived, 80% of those identified
as being sensitive have led to action
plans with suppliers.
Respect:
LOral
imposes
the
requirement that its
paper and cardboard
packaging must come
from
responsibly
managed forests that
are certified, ideally by
the
FSC
(Forest
Particular attention has been paid to

two of these raw materials, which are
known
for
their
impact
on
deforestation.
203
CORPORATE
SOCIAL,
Environmental
Although LOral consumes only 1,000 tonnes of palm oil

a year on a worldwide basis, it has taken an active part in
the Round Table on Sustainable Palm Oil (RSPO) since
2006. Membership of this Round table to promote
responsible sourcing enables LOral to provide its
support for responsible use of palm oil by industry. In
accordance with its resolute commitment made in 2008,
LOral exclusively sources sustainable palm oil, certified
CSPO since 2010. In 2009 then again in 2011, LOral
was furthermore ranked by WWF* among the top 10
most responsible users due to the use of sustainable
palm oil.
Total energy consumption

2012
2011
2010
2009
2008
2007
2006
2005
0
In the same way for soya oil, the exploitation of which is

often associated with deforestation and therefore the
widespread erosion of biodiversity in Latin America, the
LOral Group exclusively sources non-GMO soya oil,
which is organically produced and is fair trade certified
(The Body Shops Community Fair Trade Program).
In 2011 and also in 2012, LOral was named sector
leader for its sustainable sourcing system by the Forest
Footprint Disclosure Project.
Fair Trade
Responsible sourcing of renewable raw materials is also
recognized as a powerful social inclusion factor by the
LOral Group.
Thus, for example, in 2012, 55% of the Groups shea
butter purchases were made through the Solidarity
Sourcing programme which complies with fair trade
principles in Burkina Faso. Today, 13,000 women
grouped together in producer organisations benefit from
LOrals solidarity programme: in April-May, at the end of
the dry season when stocks of food have been almost
used up, they receive pre-financing for their crops in
order to be able to survive through to the next season
and receive a purchase price that is higher than the
market price. In 2013, 100% of supplies will originate
from Solidarity Sourcing.
In the same way, in Morocco since 2011, for purchases of
argan oil, 6 womens cooperatives are supported by the
LOral Group and working conditions, remuneration or
access to healthcare and education have been improved
for nearly 300 women.
400
600
800
1,000
kWh/1,000 PF
1,000 MWh
e) Ground use
LOral has several requirements relating to ground use:
Reducing the impact of construction on the environment,

for example by using a zone which is already industrially
developed, or an existing industrial site or industrial
wasteland;
If possible, the site will have to be on a plot of land

located over 30 m away from any water body (sea, ponds,
lakes, rivers, etc.);
The site will avoid land situated on natural spaces,

public green spaces, land which is the habitat for
endangered or disappearing species or any other
undeveloped zone (for example: farmland, etc.);
Rehabilitating polluted sites (industrial wasteland)

where development is more difficult due to
environmental contamination (real contamination or
contamination perceived as such), thus avoiding
construction on natural or undeveloped land;
Preventing soil erosion which may result from

rainwater runoff or wind erosion during construction,
inter alia by protecting the arable soil layer which is
stored to enable it to be reused;
Maintaining or restoring existing natural habitats and

biodiversity;
Maximising the green space areas on the site (even in

excess of the local regulations) and minimising the
impermeable areas or natural spaces.
d) Energy
LOrals objective is to reduce its greenhouse gas
emissions.The main driver to achieve this consists in
improving energy efficiency across all operations:green
energy purchases are maintained but renewable energy
production projects are developed on-site in order to
achieve the objectives.
200
Furthermore, at the time of a project for a new site,

preparation of an overall environmental impact study is
required immediately during the design phase (with the
objective of minimising the projects negative impact on
the environment and health), and this study must then
evolve to adapt the project to the conditions imposed by
the site and its environment.
At the time of the acquisition of land or buildings, LOral
conducts a due diligence review. During operation of the
site, the Groups policy is to take all the preventive measures
described in internal documents in order to avoid soil or
rainwater pollution. These measures are verified at the time
of audits and site visits made by insurers. Finally, at the time
of the sale of a site, a pollution assessment is conducted
according to an internal procedure.
WWF: World Wildlife Fund.
204

technical recommendations and rolled out throughout the
whole Group.
Methodology for the calculation of

indirect emissions (Scope 2)
6.2.4.
CONTRIBU
TION
TO
ADAPTING
TO
AND
COMBATING
GLOBAL
WARMING
To help address climate change, LOral
made a significant pledge in 2009: to
achieve an absolute reduction of 50% (in its
direct and indirect) carbon emissions
between 2005 and 2015. Good progress
has been made and in 2012, carbon
emissions have been reduced by 38.8% as
compared to 2005.The change in the scope
taken into account satisfies the GHG
Protocol(1) rules.
Energy and greenhouse gases in

manufacturing
The cosmetics industry has a relatively low
energy demand as compared with other
sectors. For example, LOral is exempt
from the European regulations on carbon
emission quotas.
However, the LOral sites are committed to
using energy efficiently and reducing
dependency on fossil fuels.
Wherever possible, natural gas is preferred
to fuel oil (which has a higher sulphur
content) and renewable energies (solar
energy, biomass) are developed on site.
Each initiative taken by every site across the
world is valued in this respect, because
each contribution is important in reducing
the overall carbon footprint.
Data relating to
consumption with an
impact on global
warming:
2012
Electricity (MWh)
Gas (MWh)
Fuel oil (MWh)
Others (MWh)
Energy consumption (MWh)
BUS Project (Better Utilities for

Sustainability)
The BUS project, a Group-wide pilot project
run by operations managers, draws on
expertise from across LOral to identify
methods, technical solutions and good
practices
in
cleaning,
cooling,
air
compression and other factory processes.
To date, 11 good practices have been
identified, notably to improve energy
efficiency; they are accompanied by
The methodology used for calculation of the 2005

reference is based on the 2003 emission factors of local
electricity suppliers
when they are available. When these emission factors
are not available, IEA (International Energy Agency) and
eGrid(2)
(1)
Greenhouse Gas Protocol international carbon accounting

tool.
(2)
The Emissions & Generation Resource Integrated Database.
(3)
Environmental Protection Agency.
promote biodiversity. LOral more

particularly ensures responsible
sourcing for commodities such as
palm oil, soya, paper and
cardboard. LOral was once
again recognised by the Forest
Footprint Disclosure Project as a
leader in its sector in 2012;
Environ
mental
informati
on
emission
factors,
available
in
2006,
corresponding to IEA
factors for 2003 and
EPA(3) (eGRID) factors
for 2000, are used.
Adaptation to climate change

LOral has always
considered
climate
change as one of the
priority challenges.
6.2.5. PROTECTION
BIODIVERSITY
The Group has made a

significant pledge to
this
by
setting
ambitious targets, in
particular an absolute
reduction of 50% in its
CO2
between
2015.
emissions
2005 and
assessing or limiting the impact of raw materials on the

environment;
establishing a responsible supply chain.
Assessment of the
by a whole set of
actions taken to limit
the
atmospheric
emissions of
its
enlarged scope of
activities.
For
example,
since
2003, LOral has
been a member of
the
CDP
(2012
scores: performance
B, transparency 94)
and associated 133
suppliers with this
project in 2012;
by a
actions
series
taken
impact of raw
materials on the
environment and on
ecosystems
LOrals commitment to biodiversity
goes back to 1995 with the creation of
its
first
ecotoxicology
laboratory.
Anticipating and minimising the potential
impact of the ingredients used in its
products on the natural environment
and,
in
particular,
on
aquatic
ecosystems, is of utmost importance to
LOral. From the product-conception
phase onwards, therefore, raw materials
undergo a robust selection process
before entering a formulation.
of
to
OF
For many years, LOral has

implemented a programme for the
protection of biodiversity aimed in
priority at:
In practice, the action

plans are steered on
both a worldwide and
local scale:
When developing its products,

LOral takes care to limit the use
of resources, both for products
and for their packaging. Actions to
achieve reductions at source
undertaken by the teams made it
possible to save nearly 500 tonnes
in packaging materials in 2012.
Finally, LOral does everything it
can to limit the impact of its
products and its activities on
natural environments, like water.
205
CORPORATE
SOCIAL,
Environmental
The Group has developed several tools and procedures

to determine the potential impact on biodiversity of the
ingredients used:
Development in its ecotoxicology laboratory of

innovative methods for early environmental evaluation
of raw materials (e.g. automation of the safety test on
microalgae);
Launch in 2004 of the assessment of its entire raw

materials portfolio for persistence, bioaccumulation
and toxicity criteria.
As of the end of 2008: 99% of raw materials were

assessed in this way. All new raw materials now
systematically have to undergo this assessment before
they can be accepted into the ingredients portfolio.
Establishment of responsible supply

chains
A systematic analysis of the impacts on biodiversity was

implemented and is based on two tools which make it
possible:
To identify upstream the potential stakes linked to the

use of a plant with 3 areas of vigilance (ecology,
equity and social challenges). The information is
consolidated in an internal database. In 2010, the
portfolios of raw materials of natural origin for the
recent acquisitions made by the Group were also
analysed;
To minimise the impacts at the level of the supply

chains concerned, using the RMSA (Raw Material
Sustainability Assessment) Framework for the
evaluation of supplier practices, in particular in the
area of respect for biodiversity. Thus, out of the 250
plant species from which our renewable raw materials
are derived, 80% of those identified as being sensitive
have led to action plans with suppliers.
As from 2005, in a desire to preserve biodiversity, LOral

introduced a process for procurement of plant-based raw
materials showing respect for biodiversity.
METHODOLOGICAL NOTE
Environmental data scope, indicators,
reporting method and systems
Scope of consolidation
The environmental indicators set out relate to the
factories and the distribution centres of the
Cosmetics,Dermatology and The Body Shop
branches.
The Safety reporting scope is defined in the
methodological note at the end of the Human Resources
information.
The environmental indicators of the factories and
distribution centres sold or closed during the financial
year are reported in full up to the date of their exit from
the scope. The factories or distribution centres that join
the Group have a maximum period of 2 years to connect
to the environmental reporting systems. However, for the
2012 financial year, 99% of the factories and distribution
centres participated in the reporting system. Out of the 61
distribution centres, 2 provided partial information.
Indicators
The indicators chosen are those used in the management
of the sites of the Company.They reflect the results of the
Groups Environment, Health and Safety (EHS) policy.
Data
The following method is used to collect data for the
defined scope:
The data are collected using the dedicated site reporting
QIS intranet system, available in all countries in which
there is a LOral subsidiary.The system covers several
topics, including: quality, process performance, EHS data.
The required data are reported every month by the local
managers.
When the data are compiled, each site must validate the
accuracy of all the data provided.
A process of continuous improvement of these systems is in
place.The systems are reviewed each year, taking into
account the Statutory Auditors recommendations and
monitoring objectives for subsequent years: updating the
indicators to be monitored, improving their definitions, and
improving the communication, monitoring and control
process.
206

impact of their activities on the environment and to
provide exemplary working conditions for their employees.
The internal competitions Environment, Health & Safety
Civic Initiative Prizes recognise, by awarding a prize, the
commitment, mobilisation and involvement of a site
(factory, distribution centre or administrative site) with
regard to the community in which it operates. Awards are
presented for the best local initiatives conducted each
year in partnership with local authorities, local residents
and schools in the fields of solidarity, education or the
environment. By these initiatives, LOral is eager to
demonstrate its good citizenship, and to show that it firmly
respects the ethical values of the surrounding community.
6.3. Societal
information
6.3.1.
TERRITORIA
L,
ECONOMIC
AND
SOCIAL
IMPACT
OF
ACTIVITIES
The LOral Group is a leading economic
player in all the geographical zones where it
is established. On this basis, LOral
contributes to local employment and thus
participates in regional development.
Territorial impact of LOral in

France
on employment and regional
development
In France, LOrals establishments are
situated in the Paris region: Paris, Clichy-laGarenne, St Ouen, Asnires, Aulnay-SousBois, Chevilly-Larue, Marly-la-Ville and
Mitry-Mory.
Over the past three years on all these sites
in France, LOral has hired 4,201
employees on permanent and fixed-term
contracts and has thus contributed to the
countrys development.
LOral promotes partnerships with the local
authorities with regard to employment.
Since 2007, the Le Floral site in St-Ouen
in France, in partnership with Un Emploi
dans ma ville, has made it possible to
integrate young people into employment in
LOrals workforce in order to carry out
various tasks.
LOral will have to pay an amount of 24.7
million for the territorial economic contribution
(CET) in respect of the 2012 financial year.
Regional development and

local populations
Due
to
its
many
industrial
and
administrative sites all over the world, the
LOral group is strongly involved, in the
vicinity of its sites, in the life of the
surrounding local communities. A company
committed to demonstrating good corporate
citizenship, LOral makes a contribution to
many useful local projects.
As a general rule, LOrals establishments
and its subsidiaries build good relations with
the communities in the areas in which they
operate, and make every effort to limit the
S
oc
iet
al
inf
or
m
ati
on
Each LOral site has

implemented initiatives
in order to anchor itself
on a lasting basis in its
socio-economic
environment. A few
examples of
these
initiatives are described
below.
The Mourenx site in France plays an

active role in several professional
associations and competitiveness
centres (Lacq Plus, UIC Aquitaine,
Aquitaine Chimie Durable, the
Association Chemstartup, ) and is
a partner of local schools with the
organisation of educational actions
with the Cit Scolaire de Mourenx, of
ESAT (places offering assisted
employment for disabled workers),
and
the
association
Vivre
Ensemble, where employees were
able to take part in the Day for the
Disabled. In partnership with their
pallet suppliers, they also conducted
the Protge ma Fort project in
order to plant new trees in a part of
the Landes forest which was
devastated by a storm.
Outside France, the Group inaugurated
a new factory in Jababeka in Indonesia
on November 7th, 2012. This 66,000m
plant
is
the
Groups
largest
manufacturing facility. It is intended to
take over from a factory opened in 1986 in Ciracas near Jakarta,
the capacity of which was becoming insufficient for this region.
6
The new factory has an installed
For
example,
the
industrial site in Ormes in
France has linked up with
the Ecole de la 2e
Chance which is aimed at
promoting the integration
into
employment
of
young people between
18 and 25 years of age
who
have
left
the
educational
system
without any job or
training. They are offered
a 9- to 12-month training
period during which they
are confronted with the
corporate world. The
factory
received
10
young people for work
placements of from 2 to 8
weeks between 2011 and
2012.
In
September
2012, it started up a
contract
offering
professional experience
with a young woman from
the school which will
enable her to obtain
professional
qualifications.The factory
has
also
asked
a
protected workshop for
disabled
workers,
la
Couronnerie, to edit its
internal newspaper and
has organically-produced
fruit
and
vegetables
delivered to its site every Thursday by

the association Solembio.
capacity of 300 million units, which may

be increased to up to 500 million units
by 2015. The construction of this new
factory, 60km away from the old one,
has meant that the employees of the
Ciracas factory have had to move. 96%
of them followed the move to
Jababeka.This was made possible in
particular
thanks
to
assistance
measures enabling employees to
become first home owners. 75% of the
employees did not own their own homes
and 40% of them were still living with
their parents.Thanks to zero-interest
loans granted by the Group, 262
families were thus able to become home
owners.
Because a companys purchasing

power is an economic development
and societal impact factor, LOral
has decided to make its purchases a
novel way of promoting social
inclusion.The Group thus created a
global
solidarity
purchasing
programme in mid-2010:Solidarity
Sourcing. Its aim is to help to give
people from economically vulnerable
communities durable access to
employment and income.
Several initiatives had already been
developed in the Group and in
particular The Body Shop Community
Trade programme. With Solidarity
Sourcing, the LOral group wants to
spread
207
CORPORATE
this philosophy by opening up its procurement process to

new categories of suppliers who create employment in
fragile communities. The aim is to build sustainable, fair
trade partnerships with these suppliers, creating
economic value and value for society.
Five communities of suppliers are concerned by the
programme: enterprises endeavouring to employ
disabled persons, social insertion companies, very small
companies that find it difficult to forge business
relationships with large companies, companies owned by
minorities and fair trade producers (see the results for
2012 in the Subcontracting section 6.3.3. on pages 210
et seq.).
Through these initiatives LOral wants to demonstrate its
corporate citizenship and its attachment to the territories
in which it is established.
6.3.2. RELATI
ONS WITH
STAKEHOLD
ERS
LOral attaches crucial importance to the dialogue with
its stakeholders. Admittedly, this dialogue provide the
opportunity to present LOrals achievements and its
strategy with regard to corporate social and
environmental responsibility but it is also the occasion to
learn about the expectations of stakeholders in a desire
for constant improvement.
The importance and handling of the challenges related to
corporate social responsibility differ from one country to
the next; this is why LOral has set up stakeholder
forums all over the world in order to promote a dialogue
at a local level with regard to both local and global issues.
Since 2011, forums have been organised in this respect
in Brazil, China, the USA, the United Kingdom, India and
South Africa. Over this period, 527 organisations were
contacted and 163 of them took part in a forum. For
example, the forum organised in Johannesburg in
November 2012 was attended by 29 local and
international organisations, and addressed environmental
issues, access to education for the most underprivileged
communities, social challenges in the broadest sense,
social business and even animal protection.
Following these forums, local actions are encouraged and put
in place, notably by organising working meetings during
which NGOs are invited to participate as experts or advisors
in areas such as responsible raw material sourcing or waste
management.
Each external stakeholder forum is followed by an

internal forum during which global strategy but also local
actions with regard to corporate social responsibility are
presented to employees in order to raise awareness
among them and fuel the debate.
Relations with educational

establishments in France and
associations
Educational establishments
LOral has always built close partnerships with primary
and secondary schools but also with universities,
graduate engineering and business schools and research
establishments.
LOral offers students the possibility of discovering the
Company during their courses by offering them internships
every year and, for over 20 years, through apprenticeship
contracts and contracts offering professional experience
across all its businesses.
In 2012, 1,439 joined the Company under this type of

internship scheme. LOral also offers conferences,
factory visits and case studies.
613 young people on work and training contracts
(315 apprenticeship contracts and 298 contracts offering
professional experience) were present in the Group in
France at December 31st, 2012, 305 of whom worked at
LOral parent company.
Over 87% of the apprentices are preparing for
qualifications at bac+2 level (equivalent to a 2-year
course after A levels) or higher. Their pass rate is
approximately 80%.
A qualitative assessment of the apprentice training
centres is carried out each year.
In 2012, LOral will have to pay an amount of
3,384,282 in apprenticeship tax.
Environmental defence associations

LOral has undertaken to reduce its greenhouse gas
emissions, its water consumption and its waste
generated per unit produced by 50% over the period
2005-2015. LOral actively contributes to environmental
protection through its commitments in associations or
societies at national level (e.g. Eco-Emballages, the
French eco-packaging organisation), European level (e.g.
Forest Footprint Disclosure project in the United
Kingdom) and international level (e.g. the World Business
Council for Sustainable Development).
LOral is also involved in a large number of working groups,
which play a crucial role in the exchange of expertise and
advice.
LOral philanthropy in 2012

LOral has always been committed to worthy causes
and taken an interest in its surrounding communities. In
the 1990s, the Group created with UNESCO the first
programme to support women in their scientific careers
called For Women in Science, an initiative that is now
implemented throughout the world. Since that time,
LOral has never stopped developing philanthropy
projects all over the world, through its subsidiaries, its
brands and its Foundation, the creation of which in 2007
showed the Groups intention to go one step further and
make commitment to good corporate citizenship a real
strategy in the Company.
LOrals commitments are aimed at promoting science
and scientific careers for women, restoring peoples

physical appearance (a major factor in establishing social
relations) or giving everyone a future thanks to beauty, all
208
reflecting one ambition: to give meaning to the beauty

sector.

programme consisting of product donations, socioaesthetic workshops and reconstructive surgery, which
relies on LOrals expertise in the field of beauty to help
vulnerable people whose appearance has suffered to
regain self-confidence and find their way back into society.
The LOral Foundation

Created in 2007, the LOral Foundation
develops the Groups major global
programmes, which are rolled out in all the
countries in which LOral is present.
It develops programmes in two main areas
which reflect the Groups values and its
businesses: science and generous beauty:
In the field of science, LOral promotes

scientific education and the participation
of women in scientific careers, by
recognising the excellence of wellknown
women
researchers
and
encouraging young girls to follow
scientific vocations;
In the field of beauty, LOral supports

programmes
which
care
for
appearances to restore confidence to
vulnerable people and help them to
recover their self-esteem and re-enter a
social life. The Foundation also develops
a
major
professional
insertion
programme aimed at offering training in
beauty professions for underprivileged
people or those cut off from
employment.
Governance
Under the chairmanship of LOrals
Chairman, the LOral Foundations Board
of Directors has 12 members, made up of
seven personalities from LOral and five
from outside the Company, chosen for their
expertise in the Foundations areas of
intervention.
The main programmes supported by

the Foundation
FOR WOMEN IN SCIENCE
To fight against the lack of representation of
women in the scientific world, LOral
created the For Women in Science
programme with UNESCO in 1998. This
programme aims to encourage, recognise
and
accompany
women
scientists
throughout their entire career, through
awards and research fellowships in 198
countries. Some 240 women are thus
rewarded every year, making a total of
nearly 1,500 women to date, including
Elisabeth Blackburn and Ada Yonath, who
have since become Nobel Prize winners in
2009. 46 LOral subsidiaries have now
developed fellowships for promising young
women scientists in their countries.
BEAUTY FROM THE HEART
Illness, unemployment or precarious living
conditions can lead to exclusion and cut
people off from society.
Convinced that an improvement in
appearance is a first step on the road back
to social and professional reinsertion, the
LOral
Foundation
has created
a
The Foundation has chosen to support worthy causes

such as cancer, young people who are suffering or those
living in precarious conditions.
The LOral Foundation and the Groups brands
distributed 835,000 products to beneficiaries from
underprivileged environments, thanks to associations that
take action in the field, such as the Agence du don en
nature (Agency for gifts in kind), the Restaurants du cur
(Restaurants of the Heart) or the Samu-social in Paris.
The socio-aesthetic care it finances helped
S
oc
iet
al
inf
or
m
ati
on
people who are having difficulties in

finding a job, men and women in
precarious
situations.
This
programme relies on LOrals beauty
know-how and offers the possibility to
bounce back thanks to creative
professions, involving others that are
rapidly accessible. The programme
has now been rolled out in 12
countries where LOral is present.
In France, the LOral Foundation has
linked up with the Fondation Apprentis
dAuteuil, a specialist in welcoming,
educating and integrating children and
young people in difficulty, to create a
certificate of professional aptitude
(C.A.P) in hairdressing at the Apprentis
dAuteuil technical college in Thiais,
south of Paris. LOral Vietnam has
helped nearly 300 young women over
the last three years to escape from
deprived conditions by training them in
hairdressing, which has enabled them
all to open their own hair salons or find a
job and to receive an income that is 3 to
8 times higher than before. Another
example can be found at LOral Brazil,
which has trained some 131 young
people from
more
than
2,300
beneficiaries in 2012,
particularly women with
cancer, people in a
precarious situation or
young
people
with
serious psychological
disorders.
Finally, in dramatic
cases where children or
women are outcast
from society due to an
appearance disfigured
by illness, accidents or
honour crimes, the
Foundation
has
considered that it is of
crucial importance to
support reconstructive
surgery in countries
where these operations
are not reimbursed by
the health insurance
schemes in order for
these patients to be
able to lead a normal
life. In 2012, it enabled
nearly 1,000 operations
of this kind to be carried
out in Asia and Africa,
through its support for
the Mdecins du Monde
associations
Opration
Sourire
programme and the
Enfants du NOMA and
Humani
Terra
associations.
deprived
communities
hairdressing
with a ratetrained
of insertion
the job market
of 66%.in
Finally,
in 2012,Thailand
107 on
women
who were victims of the floods at the end of 2011.

HAIRDRESSERS AGAINST AIDS
For eleven years, LOral and UNESCO
have believed that they could contribute
to the prophylaxis of HIV infection by
devising a programme based on the
network of hairdressers.This preventive
and education programme centres
round professional hairdressers, whose
special
relationships
with
their
customers and ability to communicate
make them very effective in passing on
information and raising awareness of
HIV issues. More than 1.5 million
hairdressers have been trained since
the start of the programme and close to
40 countries have now rolled out the
programme, including Norway and
Sweden in 2012.
BEAUTY FOR A BETTER LIFE
Local initiatives on all continents
Because beauty can

really be a springboard
to employment, the
LOral Foundation has
developed Beauty for a
Better life, a training
programme for beauty
professions intended to
offer a professional
future
to
underprivileged
populations:
young
In addition to the major global

programmes
initiated
by
the
Foundation and rolled out across the
world, each and every LOral entity
is encouraged to take local actions in
relation with the situations in their
particular countries. In 2012, LOral
thus supported several hundreds of
projects
throughout
the
world,
involving actions in the fields of
solidarity and education or the
environment.
209
CORPORATE
China thus organises a charity sale every year in the

countrys biggest universities, by making products
available to students, who sell them in favour of the
poorest students. 333 students were helped in this way in
2012 at ten universities. The country is also engaged in a
vast programme to raise public environmental awareness
with its Mother River tree programme, which consists of
rewarding a project in the field of environmental
protection, planting trees by the riverside and training
young people in sustainable development. Another
example is Russia, which has supported an orphanage in
the region of Kaluga for the last three years, by supplying
the necessary equipment for the life of the children, by
equipping speech therapists and psychologists offices,
and by opening hairdressing classes to provide basic
teaching in this profession to the older children.
6.3.3.
SUBCON
TRACTING
WITH
SUPPLIERS
How the Company promotes the provisions
of the Fundamental Conventions of the ILO
to its subcontractors and ensures that its
subsidiaries comply with these Fundamental
Conventions
LOral works with thousands of suppliers throughout the
world to cover its needs in terms of packaging, raw
materials,
subcontractors,
production
equipment,
promotional and advertising items, and non-productionrelated products and services (commonly referred to as
indirect).
The global volume of purchases directly related to
production (packaging, raw materials and subcontracting)
represented 3.24 billion in 2012 (Cosmetics scope,
excluding The Body Shop).
LOral, which has signed the United Nations Global
Compact, makes sure that Human Rights are respected
throughout its logistics chain.
Thus, our Purchasing policy is aimed at building a balanced,
long-lasting relationship with its subcontractors and suppliers
with respect for social and environmental issues. LOrals
Buy & Care programme, adhered to by all the Groups
purchasers, thus contributes to sharing good Responsible
Purchasing practices, and the Companys values and
standards with its suppliers.
Within the framework of this programme, suppliers and

subcontractors are asked to comply with the Groups
general terms of purchase, which require them to comply
with the Fundamental Conventions of the International
Labour Organisation as well as local legislation, in
particular with regard to minimum wages, working time
and health and safety.
LOral actively seeks to work with suppliers who share
its ethical values and commitments and therefore
attaches importance to providing these suppliers with
support during the referencing process. For industrial
purchases, dedicated purchasing teams have the task of
identifying new suppliers and integrating them in light of
the Groups expectations and its strategy via the
welcome on board (WOB) supplier referencing process.
This makes it possible to make sure that the supplier is

of real interest, provide it with all the information,
documents and contacts required for it to understand the
expectations and processes at LOral, and finally to
obtain he suppliers commitment to LOrals values that
are shared in this manner.
Following on from this commitment, LOrals Buy &

Care programme consists, since 2002, of a section
aimed at an audit of this compliance with social
legislation enabling it to ensure that its suppliers comply
with the applicable laws, Human Rights and labour law,
and ensure safety and health for their teams in the
workplace.
Thus, subcontractors, wherever they are based in the world,
and suppliers of raw materials, packaging, production
equipment and POS advertising/Promotional items and
materials located in countries where there is considered to
be a risk are mandatorily subject to a social audit.To prepare
the risk map for the countries presenting risks, LOral uses
the MaplecroftTM indexes.
The social audits are carried out on behalf of LOral by

independent external services providers.
The initial audits are financed by LOral and the followup audits are paid for by the suppliers.
The audits cover the following 10 chapters:
child labour;
forced labour;
health and safety;
compliance with the laws relating to trade unions;
non-discrimination;
210
disciplinary practices;
sexual harassment or a hostile working environment;
due payment of wages/compensation and benefits;
working time;
relations with subcontractors.
Furthermore, questions concerning the environment will

be a mandatory part of all social audits as from January
2013.
LOrals social audit is based to a great extent on the
internationally recognised SA 8000 standard, but does
comprise a few exceptions, particularly with regard to the
minimum age for child labour. In this respect, the Group
has chosen to set the compulsory minimum age at 16 for
all employees working for its suppliers, an age limit which
is higher than that required by the Fundamental
Conventions of the International Labour Organisation
(ILO).
With regard to the employment of young workers,
suppliers and subcontractors may request waivers from
the Group Purchasing Director for the use of employees
under the age of 16 upon presentation of a complete file
(schooling, type of contract, working conditions, type of
work). Pursuant to the Suppliers/ Subcontractors and
Child Labour policy, formally laid down in 2011, waivers
of this kind are only possible for apprenticeship
programmes or for children carrying out light work if this
work does not affect their health and safety or their
regular attendance at school, where the local law allows
it and when the supplier/ subcontractor has appointed an
internal tutor for the children.

to make them accessible for purchasing teams.
In this way, in 2012, 133 suppliers ( ) (out of the 156
suppliers ( ) who were invited) responded positively to
LOrals invitation to also join the CDP.
Since 2006 when LOral set up a reporting
tool, it has conducted social audits at over
3,700 supplier sites.
1,120 audits ( ) were carried out in 2012,
making over 4,400 audits of this kind since
2006.
In 2012, 54% of these audits were carried
out in Asia.
In 2012, there were major instances of noncompliance at 58% of supplier sites that
were audited for the first time (initial audits).
During follow-up audits, there is no longer
any major non-compliance at 62% of the
suppliers who were initially non-compliant.
Added to this are the social audits conducted
by The Body Shop (TBS). Indeed, since its
integration into the LOral Group in 2006, TBS
has pursued its longstanding programme of
social audits.TBS is one of the founding
members of the Ethical Trading Initiative (ETI)
and has adopted their Supplier Code of
Conduct. The Body Shop has developed a
programme enabling them to support their
commitment to responsible sourcing. One of
the activities under this programme is control of
working conditions, defined in the Supplier
Code of Conduct, on the production sites of
their suppliers (62 audits were conducted in
2012).
Suppliers and measures to

combat global warming: working
with the Groups suppliers on
environmental issues
LOral considers that the CO2 emissions of
its suppliers are part of its wider
environmental footprint and that they must
unite their efforts to succeed in reducing
them.
A member of the Carbon Disclosure Project
(CDP) since 2003 and the CDP Supply
Chain since 2007, LOral continues to
encourage its suppliers to measure and
reduce their CO2 emissions.
In 2012, LOral stepped up its strategy with
regard to the CDP: it is no longer only the
environmental experts who discuss these
issues with suppliers, purchasers trained in
the CDP have now become ambassadors of
this approach.
This method of functioning made it possible to
address the CDP Supply Chain with suppliers
at strategic meetings (Business Reviews), to
launch 156 invitations ( ) in 2012 as compared
with 55 in 2011 and mobilise teams to convince
suppliers that measures aimed at reducing
greenhouse gas emissions from now on play
an inevitable part of a companys global
performance.
In order to assess suppliers environmental

performance, a Scorecard has been
developed
jointly
with
the
CDP,
summarising suppliers answers to the CDP
This number is higher than the average (2,415

participants ( ) for more than 6,000 suppliers invited) for
members of the CDP. The high response rate obtained
due to the joint commitment
S
oc
iet
al
inf
or
m
ati
on
large predominance in terms of value

and number of beneficiaries of
strategic fair trade projects is
observed in Africa for natural raw
material sourcing.
6.3.4.
FAIR BUSINESS PRACTICES
Actions taken to prevent all forms of corruption

Commitment
of the purchasing and
environmental
teams
has led to the CDP
recognising LOral as
one of the companies
that
is
the
most
committed to this area.
LOral is a signatory of the United Nations Global Compact,

supports the fight against corruption, abides by the United Nations
Anti-Corruption Convention of October 31st, 2003 and undertakes
to respect all applicable laws, including anti-corruption laws.
This commitment is supported at the highest-level of the
Company by LOrals Chairman and Chief Executive Officer
who renews LOrals commitment to the United Nations Global
Compact every year.
Beyond
promoting
issues with regard to
Responsible
Purchasing, and the
management of the
social risks concerning
working conditions at
our suppliers, the Buy &
Care also aims at
promoting
social
inclusion through work.
LOral is a member of the International Chamber of Commerce

Anti-Corruption Commission.
Policy
LOrals Code of Business Ethics publicly states a zero-tolerance
policy on corruption. It applies to all
employees and covers themes such
as bribery and facilitation payments,
conflicts of interests, gifts and
entertainment.
Thus, in 2012, the

Solidarity
Sourcing
programme (see the
presentation of this
programme in section
6.3.1. Territorial Impact
on pages 207 et seq.),
excluding purchases by
The
Body
Shop,
represented a total
value in terms of
purchases
of
30
million, and access to
employment for 15,000
people.
Solidarity
sourcing partnerships
are set up with all the
five communities of
suppliers. To date, a
This document has been translated

into 35 languages and each
employee receives a copy.
The anti-corruption policy contained
in the Code of Business Ethics
applies to all employees, officers and
directors, Group Executive and
Management Committee members
and its subsidiaries worldwide. Other
policies such as The Way We Buy, a
practical and ethical guide on the
relationships between suppliers and
all employees involved in purchasing
decisions, also addresses these
issues. This document currently exists
in 12 languages.
211
CORPORATE
Implementation
Country Managers are in charge of implementing
LOrals anti-corruption policy. The Groups Chief Ethics
Officer systematically meets with each new Country
Manager in order to raise their awareness of corruption
issues.
The risk of corruption is included in the Group-level risk
assessment: a tool enables Country Managers to assess
their possible local ethical risks (including on corruption)
and to take the necessary corrective action.
LOrals commitment is supported by Human Resources
procedures.Thus, a Obtains results with integrity
competence is now included in the annual appraisal system
for all our employees.
Training courses and communication on Ethics cover

bribery and facilitation payments and also gifts and
entertainment, as well as conflicts of interests. In 2012,
69% of the entities communicated locally on these topics
and 60% included these subjects in their local training
programmes.
Within the framework of LOrals Open Talk policy,
employees are encouraged to express any concerns they
have and a dedicated website provides a secure
mechanism for asking questions or raising concerns
directly with the Groups Chief Ethics Officer.Any
concerns raised in good faith are examined in detail and
appropriate measures are taken, where applicable.
The Groups Internal Control system provides for control
procedures for operational activities and in particular with
regard to separation of tasks.
LOrals Internal Audit teams are particularly vigilant in
this respect. Corruption risks are systematically reviewed
during internal audit assignments, notably through
individual interviews with regard to Ethics.
These interviews include questions specifically
concerning corruption and are conducted separately with
the Country Manager and the administrative and financial
manager. They give rise to an individual report reviewed
and signed by these latter persons.
Within the scope of the legal due diligence reviews
carried out prior to acquisitions, the Groups Legal
Department includes an ethics questionnaire prepared
by the Office of the Chief Ethics Officer.The answers to
this questionnaire are intended to identify, within the
internal control system existing in the target company,
whether corruption risk prevention has been taken into
account.
LOral wants to share its anti-corruption commitment
with its business partners and compliance with the law is
included in the Groups general terms of purchase.
LOral reserves the right to put an end to any
relationships with business partners who fail to comply
with anti-corruption laws.
Measures adopted with regard to

consumer health and safety
Protection of consumer safety is one of LOrals absolute
priorities. The stringent safety tests carried out on products
before they are brought to market ensure that LOral meets
all current safety
rules in the national regulations of all the countries where

the Groups products are marketed. In this respect, long
before the legal requirements were introduced, the Group
had already set up a product safety assessment team in
order to guarantee that products are safe for both
professionals and consumers.
Evaluations by LOrals International Safety Assessment
Department, based on a multidisciplinary scientific
approach, are carried out at all stages of the product life
cycle.
The product safety evaluation is based on a complex
process: evaluation of the safety of each ingredient and
of all finished products on the basis of existing safety
data and the latest medical and scientific knowledge. If
necessary, LOral conducts additional safety studies
subcontracted to qualified laboratories all over the world.
The results of these studies are interpreted by
experienced scientists who are specially trained in safety
assessments.
At the end of the process, a specific safety certificate,
signed by a safety assessment expert, is issued for each
product that LOral places on the market.
Furthermore, LOrals ethical values, rooted in both
scientific rigour and responsiveness to societal concerns,
lead to a pre-emptive approach whereby formulations are
evolved by removing and/or replacing substances that
are the subject of concern.
LOrals added value, in terms of the safety assessment
212
of its ingredients and finished products, lies in its

investment for over twenty years in the development of
predictive methods and tissue engineering. For many
years, LOral has thus been investing in science and
technology to create new evaluation tools which are used
every day by safety assessors.
LOral also works closely with all the international
stakeholders involved in relevant industries in order to
progress the development of alternative multidisciplinary
solutions in the field of safety assessment.
In fact, LOrals products continually evolve as and
when technological innovations occur, but with the
constant desire to guarantee the highest level of safety
for both consumers and professionals.
6.3.5.
OTHER ACTIONS
TAKEN IN FAVOUR OF
HUMAN RIGHTS
LOral became a signatory of the United Nations Global
Compact in 2003, and undertakes to respect and promote
Human Rights. This includes, in particular, the Fundamental
Conventions of the International Labour Organisation (see
6.1.2.7. on page 198).
LOrals Chairman and Chief Executive Officer has

given the Chief Ethics Officer the mission of overseeing
the respect of Human Rights.
The Chief Ethics Officer reports regularly to the
Chairman and Chief Executive Officer. He informs the
Board of Directors and the Executive Committee.

Societal
informati
on
Country Managers are in charge of implementing

the Human Rights policy in their country. The
Groups Chief Ethics Officer meets systematically
with each Country Manager in order to raise their
awareness on Human Rights issues.
Furthermore, in 2012, 92% of the Groups entities

included subjects related to Human Rights in their
local training programmes and 89% communicated
on these topics.
LOral sets out its Human Rights policy in

documents such as The LOral Spirit or the
Code of Business Ethics.
Country Reporting Ethics, an annual reporting

system on ethical issues, covers all the subjects
addressed in the Code of Business Ethics. This
information namely helps to assess the Groups
performance in the application of Human Rights.
In the As an Employer section of The LOral

Spirit, the Group describes its principal
commitments to its staff, namely in terms of
diversity. Its commitments on the abolition of child
labour and forced labour are set out in the As a
Responsible Corporate Citizen section of that
document.
Furthermore, several chapters of the Code of
Business Ethics are devoted to the practical
implementation of respect for Human Rights:
health, safety and security, diversity, bullying and
sexual harassment, respect for privacy, contribution
to the community, and supplier selection and fair
treatment of suppliers.
All new employees receive a copy of the Code of
Business Ethics, which is available in 35 languages
(43 versions) and in Braille in French and English.
This Code of Business Ethics is available on the
www.loreal.com website.
Training sessions and communications on Ethics
also cover Human Rights issues.
Every year, LOral organises an Ethics Day in
order to ensure ongoing internal communication on
this topic. In 2012, each Country Manager
discussed ethics with their employees. Around
22,000 employees took part in this dialogue and
over 2,600 questions were asked worldwide.
At Corporate level, the Office of the Chief Ethics
Officer led 21 training sessions for 529 employees,
representing 1,190 hours of training.
METHODOLOGICAL NOTE
Societal commitment data
scope, indicators, reporting
method and systems
The analysis with regard to supplier and

subcontractor risks is carried out by the Purchasing
Department, namely through social audits (see
section 6.3.3. on page 210).
LOralsOpen Talk policy enables employees to
raise concerns they may have directly with the
Chief Ethics Officer, including those relating to
Human Rights, namely via a secure website. All
concerns are examined in detail and appropriate
mesures are taken, where applicable, in the event
of non-compliance with the Human Rights policy.
The following methods are used to collect data for the defined
scope:
a
certain
amount
of
data
particularly concerning Ethics is
collected by the Ethics Department
using the Country reporting
intranet system, also used to
collect Human Resources data
(see, in this respect, the Human
Resources
data
reporting
methodology
described
on
page199).
the other data are collected from

the
departments
concerned
(Communications
and
Sustainable
Development
Department, Human Resources
Department,
Purchasing
Department,
International
Product
Safety
Assessment
The scope covers, depending on the

indicators, LOral parent company, France
or the Group.The specific scope is
specified for each indicator.
The indicators chosen are those within the

scope of the Grenelle II regulations, with
the aim of data comparability.
An ethical risk assessment and analysis tool

enables Country Managers to assess their possible
local ethical risks (including in the field of Human
Rights) and to take the necessary corrective
action.
Data
Scope of consolidation
Indicators
Within the scope of the legal due diligence reviews

carried out prior to acquisitions, the Groups Legal
Department includes an ethics questionnaire
prepared by the Office of the Chief Ethics Officer.
The answers to this questionnaire are intended to
identify, within the internal control system existing
in the target company, whether the risks of noncompliance with Human Rights (abolition of child
labour and forced labour, etc.) have been taken
into account.
Department and
the Director of
Risk
Management
Compliance).
213
and
CORPORATE
SOCIAL,
ENVIRONMENTAL
AND SOCIETAL
Table of concordance
in respect
of social, environnemental
and societal RESPONSIBILITY
matters
6.4. Table of concordance in respect of

social, environnemental and societal
matters
Page Grenelle II French Decree of April 24th, 2012
Global
GRI Compact
PRINCIPLES
186,
198
Scope of reporting
3.1 to 3.11
Comply or explain
to 199, Data comparability
Principle
3.12
206,
213
Reference to standards
216
Attestation with regard to the exhaustiveness of information
to 217 Opinion with regard to the true and fair view given by the information
3.12
3.12
3.13
SOCIAL INFORMATION
188
194
195
195
197
197
198
Employment
Total workforce
Distribution of employees by gender, by age and by geographic zone
Recruitments
Dismissals
Remuneration and trends
Work organisation
Organisation of working time
Absenteeism
Labour relations
Organisation of the dialogue between employees and management
Situation with regard to collective agreements
Health & Safety
Health and safety conditions at work
Status report on agreements signed with trade union organisations with regard to health
and safety at work
Frequency and severity of accidents at work
Occupational diseases
Training
Training policy implemented
Total number of hours of training
Equality of treatment
Measures taken to promote gender equality
Measures taken in favour of employment and professional insertion of the disabled
Policy to combat discrimination
Promotion & compliance with the provisions of the ILO conventions
Compliance with freedom of association and the right to collective bargaining
Elimination of discrimination in respect of employment and occupation
Elimination of forced or compulsory labour
Effective abolition of child labour
LA1
LA1
LA2
LA2
LA3
LA
LA7
LA4
LA4
#3
LA6 & LA8

LA9
LA7
LA7
# 4-5
LA11
LA10
LA14
LA13
LA13
HR5; LA4 & LA5
HR4; LA13; LA14
HR6; HR7
HR 6
#3
#6
#4
&5
214

Table of concordance in respect of social, environnemental and societal matters
Global
GRI Compact
Page Grenelle II French Decree of April 24th, 2012
ENVIRONMENTAL INFORMATION
200 General environmental policy
Organisation of the Company to take into account environmental issues and,

where applicable, environmental evaluation or certification measures
Training actions and provision of information to employees with regard to environmental protection
The means devoted to prevention of environmental risks and pollution
The amount of the provisions and cover with regard to environmental risks, on condition that this
information is not liable to cause serious harm to the Company in a lawsuit in process
Pollution and waste management
Measures for prevention or reduction of, or to remedy, emissions into the air, water and soil seriously
affecting the environment
Waste prevention, recycling and elimination measures
Taking into account noise pollution and any other form of pollution specific to an activity
Sustainable use of resources
Water consumption and water supply depending on local constraints
Raw material consumption and measures taken to improve efficiency in their use
EN30
201
203
Energy consumption, measures taken to improve energy efficiency and use of renewable energies
Soil use
Climate change
EN28 and EC2 # 7, 8 and 9
EN22, EN23, EN24

EN27 # 7, 8 and 9
EN25
EN8, EN9, EN21
EN1, EN10
EN3, EN4, EN5,
EN6, EN7
# 7, 8 and 9
205
Greenhouse gas emissions

Adaptation to the consequences of climate change
Protection of biodiversity
Measures taken to preserve or develop biodiversity
206
EN16, EN17, EN 18,

EN19, EN20
EN18, EC2 # 7, 8 and 9
EN11 to EN15, EN25 # 7, 8 and 9
SOCIETAL INFORMATION
207
208
210
211
212
Territorial, economic and social impact of the Companys activities

On employment and regional development
EC8, EC9
On neighbouring or local populations
EC1, EC6
Relations maintained with people or organisations who are stakeholders of the Companys activities
Particularly, associations promoting professional insertion, educational establishments, environmental
defence associations, consumer associations and neighbouring populations
The conditions for the dialogue with these people or organisations
Partnership or philanthropy actions
Subcontracting and suppliers
Taking into account social and environmental issues in purchasing policy
EC6, HR2, HR5 to 7
The importance of subcontracting and taking their social and environmental responsibility into account
in relations with suppliers and subcontractors
3.6, 4.14
Fair practices
The actions taken to prevent corruption
SO2 to SO4
The measures taken in favour of consumer health and safety
PR1; PR2
Other actions taken in favour of Human Rights
HR
215
6
# 1, 2
# 10
# 1, 2
CORPORATE
ENVIRONMENTAL
RESPONSIBILITY
Attestation of SOCIAL,
completeness
and limited assuranceAND
report SOCIETAL
of the Statutory
Auditors on selected social,
environmental and other sustainable development information
6.5. Attestation of completeness and limited

assurance report of the Statutory Auditors
on selected social, environmental and other
sustainable development information
Pursuant to your request and in our capacity as Statutory Auditors of LOral, we hereby present you with our attestation of
completeness on the consolidated social, environmental and other sustainable development information present in the Management
Report prepared for the year ended December 31 st, 2012 pursuant to Article L. 225-102-1 of the French Commercial Code (Code du
commerce) as well as our Limited Assurance Report on a selection of such information identified by the sign ( ).
Responsibility of the Company

The Board of Directors is responsible for preparing a Management Report including the consolidated social, environmental and other
sustainable development information provided for in Article R. 225-105-1 of the French Commercial Code (hereinafter the Information),
prepared in accordance with the reporting criteria used by the LOral Group (the Reporting Criteria) and available from the Human
Relations and Environment Executive Management teams.
Independance and Quality Control

Our independence is defined by regulatory texts, the professions Code of Ethics as well as by the provisions set forth in Article L. 82211 of the French Commercial Code. Furthermore, we have set up a quality control system that includes the documented policies and
procedures that aim to ensure compliance with rules of ethics, professional standards and the applicable legal texts and regulations.
Responsibility of the Statutory Auditor

Based on our work, our responsibility is:
to attest that the required Information is presented in the Management Report or, in the event of omission, is explained pursuant to
the third paragraph of Article R. 225-105 of the French Commercial Code and Decree no. 2012-557 of April 24 th, 2012 (Attestation of
completeness);
to express limited assurance on the fact that certain information selected by the LOral Group and identified by the sign ( ) are
presented, fairly, in all material aspects, in accordance with the Reporting Criteria (Limited Assurance Report).
To assist us in conducting our work, we referred to the corporate responsibility experts of our Firms.
1. ATTESTATION OF COMPLETENESS
We conducted the following procedures in accordance with professional standards applicable in France:
we have compared the Information presented in the Management Report with the list set forth in Article R. 225-105-1 of the French
Commercial Code;
we have verified that the Information covered the consolidated scope, i.e., the Company and its subsidiaries within the meaning of
Article L. 233-1 of the French Commercial Code and the companies that it controls within the meaning of Article L. 233-3 of the
French Commercial Code, subject to the limits set forth in the methodological note presented in the section on social, environmental
and other sustainable development information;
in the event of omission of certain consolidated information, we have verified that explanations were provided in accordance with
Decree n 2012-557 of April 24th, 2012.
Based on our work, we attest to the completeness of the required Information in the management report.
This is a free translation into English of the Statutory Auditors report issued in French and is provided solely for the convenience of English speaking readers. This
report should be read in conjunction with, and construed in accordance with, French law and professional auditing standards applicable in France.
216

Attestation of completeness and limited assurance report of the Statutory Auditors on selected social,
environmental and other sustainable development information
2. LIMITED ASSURANCE REPORT ON A SELECTION OF CONSOLIDATED SOCIAL,

ENVIRONMENTAL AND CORPORATE INFORMATION IDENTIFIED BY THE SIGN ( )
Nature and scope of procedures

We conducted our procedures in accordance with ISAE 3000 (International Standard on Assurance Engagements) and professional
guidelines applicable in France.
We have carried out the following work to obtain limited assurance on the fact that the Information selected by the LOral Group and
identified by the sign ( ) does not contain any material anomalies that would call into question its fairness, in all material aspects, in
accordance with the Reporting Criteria. A higher level of assurance would have required more extensive work.
We performed the following procedures:
we assessed the appropriateness of the Reporting Criteria with respect to its relevance, completeness, neutrality, clarity and
reliability, by taking into consideration, when relevant, the sectors best practices;
we have verified the set-up within the LOral Group of a process to collect, compile, process and check the selected information with
regard to its completeness and consistency. We have familiarized ourselves with the internal control and risk management
procedures relating to the compilation of the information. We have conducted interviews with individuals responsible for social,
environmental and other sustainable development reporting;
concerning the selected quantitative information (1):
for the consolidating entity and controlled entities, we have set up analytical procedures and verified, using sampling techniques, the
calculations as well as the consolidation of this information,
at the sites that we have selected based on their activity, their contribution to consolidated indicators, their location and a risk
analysis, we have:
conducted interviews to verify the proper application of procedures and obtained information to perform our verifications,
conducted substantive tests, using sampling techniques, to verify the calculations performed and reconcile data with supporting
evidence.
Conclusion
Based on our work, we did not identify any material anomaly likely to call into question the fact that the information selected by the
LOral Group and identified by the sign ( ) has been presented fairly, in all material aspects, in accordance with the Reporting Criteria.
Deloitte & Associs
David Dupont-Noel
(1)
Eric Dugelay
Grard Morin
Sylvain Lambert
The Information is the following: [The contribution to Group data of the entities selected for our procedures represents 33% of the Finished Goods units produced
by the Group and 22% of total employees.]: Finished goods units produced, Quantity of bulk produced, Volume of total emissions (direct and indirect) of CO 2,
Total energy consumption, Volatile Organic Compounds emissions, Sulphur dioxide emissions, Total waste consumption, Chemical Oxygen Demand (COD) in the
water before and after processing of transportable waste, Waste treatment, Number of hours worked, Conventional frequency rate, Extended frequency rate,
Severity index, MESUR (Managing Effective Safety Using Recognition & Realignment) culture index, Safety culture index (SIO), Total employees, Number of
employees on open-ended and fixed-term employment contracts, Breakdown of employees by gender and by geographical area, Age pyramid by gender,
Average age by geographical area, Breakdown of personnel costs, 2011 World Profit-Sharing 2011 (paid in 2012), Minimum salary, Number of hirings and
dismissals, Absentee rate, Absentee rate for sickness, Employee/social relations, Number of part-time workers by gender, Number of agreements signed in
France, Number of agreements signed in the rest of the world, Number of agreements in force as of 12/31, Number of training hours, Number of social audits in
2012, Number of suppliers having participated in the Carbon Disclosure Project.
217
218
7
STOCK MARKET INFORMATION
AND SHARE CAPITAL

7.1. Information relating
to the Company
220
7.1.1. Legal form
220
7.1.2. Law governing the Issuer
220
7.1.3. Business activity
220
7.1.4. Date of Incorporation and

term of the Company
(Article 5 of the Articles of Association)
220
7.1.5. Purpose of the Company

(extracts from Article 2 of the Articles
of Association)
7.1.6. Company registration number
220
220
7.1.7. Consultation of documents relating

to the Company
220
225
226
7.3.4. Disclosures to the Company of legal

thresholds crossed
226
7.3.5. Shareholders agreements relating to

shares in the Companys share capital
226
7.3.6. Buyback by the Company of its own

shares
227
7.4. Long-Term Incentive Plans* 228

7.4.1. Presentation of the stock option plans
for the purchase or subscription of
shares and plans for the Conditional
Grant of Shares to Employees (ACAs)
228
7.4.2. Stock option plans for the subscription

and purchase of LOral
parent company shares
229
7.1.10. Statutory Distribution of profits

(Article 15 of the Articles of Association) 221
7.4.3. Plans for the Conditional Grant

of Shares (ACAs)
232
7.1.11. Annual General Meetings
221
7.1.12. Statutory share ownership threshold
222
7.5. The LOral share / LOral

share market
235
7.1.8. General Management

(Article 11 of the Articles of Association) 220
7.1.9. Fiscal year (Article 14 of the Articles
of Association)
7.2. Information concerning

the share capital*
7.2.1. Statutory requirements governing
changes in the share capital and
shareholders rights
7.2.2. Issued share capital and authorised
unissued share capital
221
222
7.5.1. The LOral share
235
7.5.2. LOral share market
236
7.6. Information policy

222
222
7.2.3. Changes in the share capital over

the last five years
224
7.3. Shareholder structure*
224
7.3.1. Legal
entities
or
individuals
exercising control over the Company
to
the Companys knowledge
*
7.3.2. Changes in allocation of the

share capital and voting rights
over the last three years
7.3.3. Employee share ownership
240
7.6.1. New modern and complementary

communications media
240
7.6.2. A large number of shareholder events

for a regular and detailed dialogue
241
7.6.3. Financial news releases in 2012
241
224
and Financial Code.
219
STOCK
MARKET
INFORMATION
Information
relating
to the Company AND SHARE CAPITAL
LOral is a French socit anonyme (limited company) listed on the Paris stock
market. This chapter sets out the information relating to its share capital and the
main details of its legal form and its Articles of Association. All the information on
the LOral share and LOral share market are also included in this chapter.
7.1. Information relating to the Company

7.1.1.
LEGAL FORM
products listed above; of all household maintenance products;

of all products and articles relating to feminine and/or child
hygiene and to the embellishment of human beings; the
demonstration and advertising of such products; the
manufacturing of packaging articles;
LOral is incorporated in France as a socit anonyme.
7.1.2. LAW
ISSUER
GOVERNING
THE
the filing and acquisition of all patents, licenses, processes and

manufacturing trademarks, their exploitation, their assignment
and/or their contribution;
all diversification transactions and all commercial, financial,

movable property and/or real property transactions, made in the
Companys interest, under any form whatsoever;
the direct or indirect involvement in all transactions such as

those listed above, in particular by means of the creation of
companies, the contribution to pre-existing companies, the
merger or the alliance with such companies.
French law.
7.1.3.
BUSINESS ACTIVITY
LOral parent company, in addition to its role of strategic, scientific and

industrial coordination of the Group on a global basis, also functions as
a holding company and performs a sales activity that is specific to
France. Most of the subsidiaries have a role of marketing of the
products made in the Groups factories. LOral wholly owns the vast
majority of its subsidiaries. In the other subsidiaries, non-controlling
interests are not material. It also has substantial investments in nonconsolidated companies, details of which are set out on pages 148 to
152 and pages 175 to 178.
7.1.6.
COMPANY
REGISTRATION NUMBER
632 012 100 Paris Trade and Companies Registry.
7.1.4. DATE OF
INCORPORATION AND TERM
OF THE COMPANY (ARTICLE 5
OF THE ARTICLES OF
ASSOCIATION)
The Companys term shall be ninety-nine years, which began to
run on January 1st, 1963 and which shall thus expire on December
31st, 2061, except in the event of early dissolution or of extension,
as provided for in these Articles of Association.
7.1.5.
PURPOSE OF THE COMPANY
(EXTRACTS FROM ARTICLE 2 OF
THE ARTICLES OF ASSOCIATION)
The Companys corporate purpose, both in France and/or at any
other location anywhere throughout the entire world, shall be as
follows:
the manufacturing and the sale of cosmetics products in

general; of all devices intended for the same uses as the
220
7.1.7.
CONSULTATION
OF
DOCUMENTS RELATING TO THE

COMPANY
The Articles of Association, financial statements, reports and
information for shareholders can be consulted at the administrative
headquarters at 41 rue Martre, 92117 Clichy, France, preferably by
appointment. See also the www.loreal-finance.com website.
7.1.8. GENERAL MANAGEMENT

(ARTICLE 11 OF THE ARTICLES
OF ASSOCIATION)
1. In accordance with legal provisions, the General Management
of the Company is assumed, under its responsibility, either by
the Chairman of the Board of Directors, or by another natural
person appointed by the Board of Directors and bearing the
title of Chief Executive Officer.
STOCK MARKET INFORMATION AND SHARE CAPITAL

Company, or that the third party
could not be unaware of this in view
of the circumstances, it being stated
however that the mere publication of
the Articles of Association does not
constitute such proof.
The
choice
between
these two modes of
exercising
General
Management is made by
the Board of Directors
each time a Chairman of
the Board of Directors or
a Chief Executive Officer
is appointed or has his
tenure
renewed.The
Board of Directors must
inform shareholders and
third parties of this choice
in accordance with the
statutory provisions.
4.
In agreement with the Chief

Executive Officer, the Board of
Directors determines the extent and
duration of the powers granted to
the
Deputy
Chief
Executive
Officers.
The choice of the Board of

Directors concerning the
mode of exercise of the
General Management is
made on the basis of a
majority
vote
of
the
Directors
present
or
represented.
Changing
exercise
the
of
Management
2.
3.
mode
the
7.1.9.
not
FISCAL
YEAR (ARTICLE
14 OF THE
ARTICLES OF
ASSOCIATION)
of
General
does
On the proposal of the Chief

Executive Officer, whether this office
is assumed by the Chairman of the
Board of Directors or by another
person, the Board of Directors may
appoint one or more natural persons
in charge of assisting the Chief
Executive Officer, with the title of
Deputy Chief Executive Officer.
Each fiscal year shall have a duration of
involve a modification of the
twelve months, to begin on January 1st
Articles of Association.
and to end on December 31st of each
Depending on the choice

made by the Board of
Directors in accordance
with the provisions of 1
above,
the
General
Management is carried
out
either
by
the
Chairman, or by a natural
person, appointed by the
Board of Directors and
bearing the title of Chief
Executive Officer.
The
Chief
Executive
Officer is granted the
most extensive powers to
act in all circumstances
on behalf of the Company.
He
exercises
these
powers
within
the
limitations of the object of
the Company, and subject
to the powers expressly
granted
by
law
to
Shareholders Meetings.
The
Chief
Executive
Officer represents the
Company in its relations
with third parties. The
Company is bound even
by actions of the Chief
Executive Officer which
are outside the object of
the Company, unless the
Company can prove that
the third party was aware
that the action was
outside the object of the
year.
7.1.10. STATUT
ORY
DISTRIBUTIO
N
OF
PROFITS
(ARTICLE 15
OF
THE ARTICLES OF
ASSOCIATION)
A. From the distributable profits, the
following amounts shall be withheld,
in the following order:
1.
The amount required to pay the

primary
dividend
to
the
shareholders equal to five percent
(5%) of the amounts paid up on the
unredeemed
securities
in
accordance with
Board
of
Directors, shall
have
the
authority
to
resolve
to
withhold
the
amounts that it
deems
appropriate
(and even the
entire amount of
such available
remainder),
either to be
carried forward
to the next fiscal
year, or to be
paid
into
a
prudential
fund or into
one or more
ordinary,
extraordinary or
special reserve
funds.
Such
reserve fund(s),
which shall not
bear
any
interest, may be
distributed
to
the
shareholders, or
allocated
to
complete
the
5%
primary
dividend for the
shareholders, in
the event of
insufficient
results
during
one or more
fiscal years, or
to acquire and
to
cancel
shares in the
Company, or to
redeem
in
whole or in part
such shares.
Informa
tion
relating
to the
Compa
ny
calls
for
funds
,
provi
ded
howe
ver
that
(wher
e the
profit
s for
a
given
year
do
not
allow
such
divide
nd to
be
paid)
the
share
holde
rs
shall
not
be
entitl
ed to
claim
such
divide
nd
from
out of
the
profit
s of
subs
eque
nt
years
.
2.
From
the
availa
ble
remai
nder,
the
Ordin
ary
Gene
ral
Meeti
ng,
upon
a
propo
sal by
the
3.
The remaining
balance (if any)
shall be divided
up among all
the
shareholders,
without
any
discrimination,
and each share
shall entitle its
holder
to
receive
the
same income.
However, any
shareholder
who can prove
at the end of a
financial year,
that
shares
have
been
registered in his
name for at
least two years
and that they
continue to be
registered in his
name at the
date
of
paym
ent of
the
divide
nd
paid
for
such
financ
ial
year,
will
be
entitle
d to a
prefer
ential
divide
nd on
the
share
s that
are
thus
regist
ered,
equal
to
10%
of the
divide
nd
(initial
divide
nd
and
additi
onal
divide
nd)
paid
on
the
other
share
s,
includ
ing in
the
event
of
paym
ent of
the
divide
nd in
new
share
s, the
prefer
ential
divide
nd
thus
paid
being
round
ed
down
to the
neare
st
lower
cent,
if
neces
sary.
Similarly,
any
shareholder
who can prove,
at the end of a
financial year,
that
shares
have
been
registered in his
name for at
least two years
and that they
continue to be
registered in his
name at the
date
of
completion of
an increase in
capital carried
out
through
capitalisation of
reserves, profits
or
share
premiums
by
the distribution
of
bonus
shares, shall be
entitled to an
increase in the
number
of
bonus shares to
be distributed to
him, equal to
10%,
this
number being
rounded down
to the nearest
lower unit in the
event
of
fractional share
rights.
The new shares created in this
manner will be identical, for
the purposes of calculating the
rights to the preferential
dividend and to the increased share
allocations, to the old
which they result.
The number of
shares
eligible
for
these
preferential
dividends
may
not exceed 0.5%
of the share
capital at the
closing date of
the past financial
year, for the
same
shareholder.
B.
The losses (if

any) shall be
charged to the
retained
earnings from
preceding fiscal
years or to the
reserve funds,
and the balance
shall be booked
into a special
carry forward
account.
7 shares from
7.1.11. ANNU
AL
GENERAL
MEETINGS
Annual
General
Meetings
are governed by all

the legal provisions
and regulations laid
down in this
connection.
Since the Annual
General Meeting of
April 29th, 2004,
double voting rights
have been
eliminated.
221
STOCK
MARKET
INFORMATION
AND SHARE CAPITAL
Information
concerning
the share capital
7.1.12.
STATUTORY
SHARE
OWNERSHIP THRESHOLD
Any holder, whether direct or indirect, of a
fraction of the Companys share capital equal
to 1%, or a multiple of this percentage lower
than 5%, is required to inform the Company
within a period of fifteen days in the event
that these thresholds have been passed in
either direction (Article 7, paragraph 2 of the
Articles of Association). This provision of the
Articles of Association supplements the legal
requirements
covering
disclosures
concerning the crossing, upwards or
downwards, of thresholds relating to onetwentieth, one-tenth, three-twentieths, onefifth, one-quarter, three-tenths, one-third, onehalf, two-thirds, eighteen-twentieths or
nineteen-twentieths of share capital or of
voting rights (Article L. 233-7 of the French
Commercial Code).
If not disclosed in accordance with the

conditions stipulated by law or by the Articles
of association, shares exceeding the fraction
which should have been disclosed are
deprived of voting rights at Shareholders
Meetings, in accordance with the conditions
stipulated in the French Commercial Code, if
during a meeting the failure to disclose is
noted, and if one or more shareholders
together holding at least 5% of the share
capital so request during the meeting (Article
7, paragraph 3 of the Articles of Association).
See also the complete text of the

Companys Articles of Association on the
www.loreal-finance.com internet site.
7.2. Information concerning the share

capital
7.2.1.
STATUTO
RY
REQUIREMENT
S GOVERNING
CHANGES IN
THE SHARE
CAPITAL AND
SHAREHOLDE
RS RIGHTS
None.
7.2.2. ISSUED
SHARE
CAPITAL AND
AUTHORISED
UNISSUED
SHARE
CAPITAL
The share capital amounted to
121,762,165.40 as of December 31st,
2012. It was divided into 608,810,827
shares with a par value of 0.20 each, all
of the same class and ranking pari
passu.
At the end of the Board meeting on
February 11th, 2013, after the exercise of
the stock options and the cancellations of
shares, the share capital amounts to
120,862,724.20. It is divided into
604,313,621 shares with a par value of
0.20, all of the same class and carrying
the same rights.
222

Information concerning the share capital
The table set out below summarises (particularly in application of Articles L. 225-129-1 and L. 225-129-2 of the French Commercial
Code) the currently valid authorisations granted to the Board of Directors by the Annual General Meeting of shareholders concerning the
capital, shows the use made of such authorisations over the financial year and presents the authorisations which are to be put to the
vote at the Annual General Meeting on April 26th, 2013.
Nature of
the authorisation
Authorisations in force
Date of
AGM
(resolution
Length
no.) (expiry date)
Authorisations proposed
to the Annual General Meeting
of April 26th, 2013
Use made
Maximum
of the
authorised authorisation Resolution
amount
in 2012
No.
Share capital increases

Capital increase through
April 22nd, 2011
26 months
An increase in
the issue of shares with
(9th) (June 22nd, 2013)
the share capital
maintenance of preferential
to 180,000,000
subscription rights or via
the capitalisation of share
premiums, reserves, profits
or other amounts
Capital increase reserved April 22nd, 2011
26 months 1% of share capital at
for employees
(12th) (June 22nd, 2013) the date of the Annual
None
None
General Meeting
(i.e. a maximum of
6,017,878 shares)
Buyback by the Company

of its own shares
Buyback by the Company April 17th, 2012
ofitsown shares
(9th)
18 months 10% of share capital

(October 17th,
on the date of
2013)
the buybacks
(i.e. 60,881,083 shares
at December 31st, 2012)
Reduction in the share capital

via cancellation of shares
Cancellation of shares
April 17th, 2012
purchased by the Company
(10th) (June 17tth, 2014)
on the date of
within the scope of Article
cancellation per
L. 225-209 of the French
24-month period
Commercial Code
(i.e. 60,881,083 shares
5,077,250 shares
(Capital held by
the Company at
December 31st,
2012: 1.72% of
the share capital)
9th
Length
Maximum
ceiling
26 months
(June 26th,
2015)
An increase in the
share capital to
169,207,813.88
11th 26 months 1% of the share capital

(June 26th,
at the date of the
2015)
General Meeting
(i.e. a maximum of
6,043,136 shares at
February 11th, 2013)
8th

(October
on the date of
26th, 2014)
the buybacks
(i.e. 60,431,362 shares
at February 11th, 2013)
None
at December 31st, 2012)
April 17th, 2012
26 months
500,000 shares
None
purchased by the Company
(10th) (June 17th, 2014)
within the scope of Article
L. 225-208 of the French
Commercial Code
Stock options and free grants
of shares
Allocation of share purchase April 22nd, 2011
26 months 0.6% of share capital
None
or subscription options
(10th) (June 22nd, 2013)
on the date of the
(no discount with regard to
decision to allocate
exercise price)
the options
Free grant of existing shares April 22nd, 2011
26 months 0.6% of share capital on 1,325,050 shares
or shares to be issued to
(11th) (June 22nd, 2013) the date of the decision
employees
to make the grant
7
10th
26 months
0.6% of the share
(June 26th, capital at the date of
2015)
the grant decision
At December 31st, 2012, 20,699,283 share subscription options were allocated. All these options are exercisable on the basis of one
new share per option, and are therefore liable to lead to the creation of the same number of shares. Furthermore, 657,800 conditional
shares had been granted to Group employees. These shares will be created when necessary and, where applicable, by capitalisation of
reserves. Accordingly, the potential share capital of the Company amounts to 126,033,582 divided into 630,167,910 shares with a par
value of 0.20 each.
The Company has not issued any securities which grant indirect entitlement to shares in the capital.
At February 11th, 2013, 20,119,239 stock options were attributed, in light of those exercised since January 1 st, 2013.
At its meeting on February 11th, 2013, the Board of Directors cancelled the 5,077,250 shares bought back in 2012 within the framework
of Article L. 225-209 of the French Commercial Code (10th resolution voted by the Annual General Meeting on April 17th, 2012).
223
STOCK
MARKET
INFORMATION AND SHARE CAPITAL
Shareholder
structure
7.2.3.
Date
12.31.2007
02.13.2008
02.14 to 08.27.2008
08.28.2008
08.29 to 12.31.2008
02.16.2009
02.17 to 12.31.2009
01.01 to 04.26.2010
04.27.2010
04.27 to 12.31.2010
01.01 to 05.30.2011
05.30.2011
05.31 to 12.31.2011
01.01 to 12.31.2012
CHANGES IN THE SHARE CAPITAL OVER THE LAST FIVE YEARS
Nature of the transaction
Amount of
the change in
share capital
Exercise of share subscription options
Conditional grant of shares
-1,437,400.00
6,920.00
-1,682,080.00
600.00
-794,120.00
105,440.00
149,080.00
-100,000.00
354,955.00
233,719.40
80.00
164,500.00
1,165,349
Amount of
the share
Number
capital on of shares
Share completion of created or
premiums the transaction cancelled
Number of
shares on
completion
of the
transaction
123,595,122.00
122,157,722.00
122,164,642.00
120,482,562.00
120,483,162.00
119,689,042.00
119,794,482.00
119,943,562.00
119,843,562.00
120,198,517.00
120,432,236.40
120,432,316.40
120,596,816.40
121,762,165.40
617,975,610
610,788,610
610,823,210
602,412,810
602,415,810
598,445,210
598,972,410
599,717,810
599,217,810
600,992,585
602,161,182
602,161,582
602,984,082
608,810,827
2,087,532.00
185,572.50
31,026,370.50
44,316,558.00
107,450,074.75
71,517,702.03
51,578,602.50
407,590,294.85
-7,187,000
34,600
-8,410,400
3,000
-3,970,600
527,200
745,400
-500,000
1,774,775
1,168,597
400
822,500
5,826,745
For information purposes, the share capital at February 11th, 2013 amounts to 120,862,724.20 divided into 604,313,621 shares with a
par value of 0.20.
7.3. Shareholder structure

Shareholder structure at December 31st, 2012
Employees
0.72%(1)
Individual shareholders
4.99%
International
institutional investors
24.50%
Bettencourt family
30.50%
French
institutional investors
8.27%
Treasury stock
1.72%
(1) In the LOral Company Savings Plan (PEE).
224
Nestl
29.30%
7.3.1.
LEGAL ENTITIES OR
INDIVIDUALS EXERCISING
CONTROL OVER THE COMPANY TO
THE COMPANYS KNOWLEDGE
The Bettencourt family, on the one hand, and Nestl S.A., on the
other hand, are shareholders of the Company and have declared
that they are acting in concert (see the sections on
Changes in allocation of the share capital and voting rights and
shareholders agreements relating to shares in the Companys
share capital).

Shareholder structure
7.3.2. CHANGES IN ALLOCATION OF THE SHARE CAPITAL AND

VOTING RIGHTS OVER THE LAST THREE YEARS
Over the last three years, the allocation of the share capital and the voting rights has changed as follows:
12.31.2012
Bettencourt
family (1) (2)
Nestl S.A. (2)
Company Savings
Plan
Public
Treasury stock
TOTAL
12.31.2011
12.31.2010
Number of
shares
% of
capital
% of
voting
rights (3)
185,661,879
178,381,021
30.50
29.30
30.50
29.30
185,661,879
178,381,021
30.79
29.58
30.79
29.58
185,661,879
178,381,021
30.89
29.68
30.89
29.68
4,379,821
229,933,941
10,454,165
608,810,827
0.72
37.76
1.72
100
0.72
37.76
4,404,950
225,938,573
8,597,659
602,984,082
0.73
37.47
1.43
100
0.73
37.47
4,260,700
221,352,303
11,336,682
600,992,585
0.71
36.83
1.89
100
0.71
36.83
98.28
Number of
shares
% of
capital
% of
voting
rights (3)
Number of
shares
% of
capital
% of
voting
rights (3)
98.57
98.11
(1) Including 185,654,833 LOral shares held in absolute or beneficial ownership by Tthys, a French Socit par actions simplifie (simplified joint- stock
company) of which Mrs. Liliane Bettencourt holds almost all the shares and attached voting rights in beneficial ownership. Mrs. Franoise Bettencourt Meyers
holds 76,441,389 LOral shares in bare ownership, the beneficial ownership of which is held by Tthys of which she is the Chairwoman.
(2)
The Bettencourt family and Nestl S.A. act in concert (see 7.3.5. shareholders agreements relating to shares in the Companys share capital on page 226).
(3)
Calculated in accordance with Article 223-11 of the General Regulation of the Autorit des Marchs Financiers.
To the Companys knowledge, at December 31st, 2012, the

members of the Executive Committee held less than 1% of the
share capital.
The number of shares held by each of the members of the
Board of Directors is set out in paragraph 2.2.1.2. on pages 33
to 45.
The Company is authorised to trade in its own shares on or off
the Stock Exchange in accordance with Articles L. 225-209 et
seq. of the French Commercial Code, within the limits and in
accordance with the purposes defined by the
225
authorisations that are granted to it by its Annual General

Meeting. At December 31st, 2012, the Company held, on this
basis, 10,454,165 of its own shares (1.72% of the share capital),
which, if they were to be valued at their purchase price, would
represent 903.6 million in LOrals parent company accounts.
1,511,160 of these shares were allocated to covering the stock
option plans for the purchase of shares allocated to employees
and corporate officers of Group companies that have not yet
expired and 2,318,600 to a plan for the conditional grant of
shares to employees.
STOCK
MARKET
INFORMATION AND SHARE CAPITAL
Shareholder
structure
elapsed after
Bettencourt.
7.3.3. EMPLOYEE
SHARE
OWNERSHIP
The employees of the Company and its
affiliates held 4,379,821 shares as at
December 31st, 2012, that is 0.72% of the
share capital, through the Company
Savings Plan (PEE).
At that date, this stake in the capital is
held by 9,741 employees participating in
the Group Company Savings Plan.
7.3.4. DISCLOSUR
ES TO THE
COMPANY OF
LEGAL
THRESHOLDS
CROSSED
During 2012, the Company was not
informed of any crossing of the legal
thresholds with regard to the holding of its
shares or voting rights.
7.3.5.
SHAREHOL
DERS
AGREEMENTS
RELATING TO
SHARES IN THE
COMPANYS
SHARE CAPITAL
The Company is not aware of any
shareholders agreements relating to
shares in its share capital other than the
agreement described below.
A memorandum of agreement was signed
on February 3rd, 2004 between Mrs.
Liliane Bettencourt and her family, and
Nestl, providing for the merger of
Gesparal into LOral. It contains the
following clauses:
7.3.5.1.
Clauses
relating
to
the
management
of
the LOral shares

held
Clause limiting the shareholding
The parties agreed not to increase their
shareholdings or their voting rights held in
LOral, either directly or indirectly, in any
manner whatsoever, for a minimum period
of three years as from April 29th, 2004, and
in any case not until six months have
the
death
of
Mrs.
Pre-emption clause
b)
c)
d)
The undertaking to limit the

shareholding and the lock-up clause
will no longer apply in the event of a
takeover bid for LOral shares, as
from the date of publication of the
clearance
decision
(avis
de
recevabilit) and up until the day after
the publication of the notice of results
(avis de rsultat).
In the event of an increase in the
share capital of LOral, the parties
may, provided that the other party
has voted in favour of the capital
increase, acquire shares or subscribe
for new shares, in order to maintain
their holding at the percentage
existing prior to the said transaction.
The parties are free to carry out
transfers of LOral shares, in the
case of individuals, in favour of an
ascendant, descendant or spouse in
the form of a gift, and in the case of
individuals or legal entities, in favour
of any company in which the
individual or legal entity carrying out
the transfer holds over 90% of the
share capital or voting rights.
Lock-up clause
The parties agreed not to transfer any or
all of their LOral shares either directly or
indirectly, for a period of five years as from
April 29th, 2004.
Exceptions to the
undertaking to limit the
shareholding and the
lock-up clause
a)
226
The undertaking to limit the

shareholding does not apply if the
increase in the shareholding results
from a reduction in the number of
LOral shares or voting rights, the
acquisition by the Company of its
own shares, or the suspension or
removal of the voting rights of a
shareholder.
The parties have reciprocally granted

each other a pre-emption right concerning
the LOral shares they hold since the
date of the merger, and those they will
hold after such date.
This pre-emption right will come into force
on expiry of the lock-up clause for a
period of five years; as an exception, it will
come into force before the expiry of the
lock-up period in the event of a takeover
bid for LOral shares for a period
beginning on the day of the clearance
decision and ending the day after the
publication of the notice of results.
No concert party provision

The parties have agreed for a period of
ten years from the effective date of the
merger not to conclude an agreement with
any third party and not to form a concert
party relating to the shares making up the
share capital of LOral.
Breach of such undertaking entitles the
other party to exercise its pre-emption
right with regard to the shareholding of the
party having committed such breach, for a
price per share equal to the average of
the share prices for the last thirty trading
sessions prior to notification of exercise of
the pre-emption right.
7.3.5.2. Board of Directors

The memorandum of agreement did not
provide for any change to the composition
of the Board of Directors as compared to
its composition at the date of signing, but
did stipulate an undertaking by the parties
to vote in favour of the appointment as
Directors of three members proposed by
the other party.
The Bettencourt family and Nestl also
agreed to vote in favour of the appointment
of two Vice-Chairmen of the Board of
Directors, one proposed by the Bettencourt
family, and the other by Nestl.
The parties provided for the creation on

the Board of Directors of LOral of a
committee called the Strategy and
Implementation Committee which has six
members, and is chaired by the Chairman
of the Board of Directors of LOral and
composed of two members proposed by
the Bettencourt family, two members
proposed by Nestl and one other
independent Director. The committee
meets six times a year.

Sha
reh
old
er
stru
ctur
e
7.3.5.3. Term
Unless otherwise stipulated, the
memorandum of agreement will
remain in force for five years from
April 29th, 2004, and in all cases
until a period of six months has
elapsed after the death of Mrs.
Bettencourt.
7.3.5.4. Concerted action

between the parties
The parties declared that they
would act in concert for a period of
five years from April 29th, 2004
onwards.
On April 9th, 2009, the Bettencourt
family and Nestl published the
following press release:
On February 3rd, 2004, the
Bettencourt family and Nestl
signed an agreement organising
their
relationship
and
the
management of their stakes within
the LOral Company.
The agreement is public and
remains unchanged. It foresees the
non-transferability
of
their
respective stakes in the capital of
LOral until April 29th, 2009, the
other clauses (in particular,
limitation on the shareholding, preemption, escrow, prohibition on

constituting a concert party with
any third party, composition of the
Board of Directors and of the
Strategy
and
Implementation
Committee) continue to be effective
until the expiry date mentioned in
the 2004 deed.
The Bettencourt family and Nestl
will continue on acting in concert
with regard to the LOral Company
beyond April 29th, 2009.
7.3.6.
BU
YBACK
BY
THE
COMPAN
Y OF ITS
OWN
SHARES
7.3.6.1.
n
Informatio
concerning
share buybacks
during the 2012
financial year
In 2012, the Company bought back
5,077,250 of its own shares, in
accordance with the authorisation
voted by the Annual General
Meeting of April 17th, 2012.
The table set out below summarises the transactions carried out within this
framework, and the use made of the shares bought back:
Date of authorisation of the Annual

General Meeting
Expiry date of the authorisation
Maximum amount of authorised
buybacks
Maximum purchase price per share

Authorised purposes
Board of Directors meeting that

decided
on the buybacks (maximum amount)
Purpose of buybacks
April 22nd, 2011

(8th resolution)
October 22nd, 2012
10% of capital on the date
of the share buybacks
(i.e.60,298,408shares
at December 31st, 2011), for a
maximum
amount of 7,838.8 million
130
Cancellation
Share purchase options
Free grants of shares
Liquidity and market stabilisation
External growth
None
Not applicable
Period of buybacks made

Number of shares purchased
Average purchase price per share
Use of shares purchased
*
Not applicable
None
None
Not applicable
Shares cancelled by the Board of Directors of February 11th, 2013.
227
STOCK
MARKET
INFORMATION
AND SHARE CAPITAL
Long-Term
Incentive
Plans
7.3.6.2.
Transactio
7.3.6.3. Renewal by the

Annual General
Meeting of the
authorisation given to
the Board to trade in
the Companys shares
ns carried out by
LOral
respect
with
to
its
shares in 2012
Percentage of share capital held by the Company

directly and indirectly at December 31st, 2012
By voting a new resolution, the Annual
General Meeting would be able to provide
Including:
those intended to cover existing share purchase the Board of Directors with the means to
enable it to continue its share buyback
option plans
those intended to cover conditional shares policy.
those intended for cancellation
This authorisation would be given for a
Number of shares cancelled during the last 24 months
Number of shares held in the portfolio at 12.31.2012 maximum period of 18 months as from the
date of the Annual General Meeting and
Net book value of the portfolio at 12.31.2012
the purchase price per share could not
Market portfolio value at 12.31.2012
exceed 170.
The Company would be able to buy its
own shares for the following purposes:
their cancellation;
Total gross transactions

their transfer within the scope of
employee
share
ownership
programmes and their allocation to free
grants of shares for the benefit of
employees and corporate officers of
the Group;
Purchases
Number of shares
Average transaction price
Average exercise price
Amounts
5,077,250
98.15 ***
498.2
million ***
Exercise of stock options for the

purchase
of
shares
granted
to
employees and corporate officers of
Group companies.
The percentage of capital held by the

Company consisting of Treasury stock
intended to be cancelled was reduced to
zero after the cancellation decided by the
Board of Directors on February 11th, 2013.
Before costs.
No use was made of derivatives to make the

share buybacks. There is no open purchase
or sale position at December 31st, 2012.
stabilisation of the share price;
retaining them and subsequently using

them as payment in connection with
external growth operations.
The authorisation would concern up to

10% of the share capital, i.e. for
information purposes 60,431,362 shares,
for a maximum amount of 10.27 billion at
February 11th, 2013, it being specified that
the Company may never at any time hold
over 10% of its own share capital.
These shares could be acquired by any
means, on one or more occasions, on the
stock market or over the counter, including
through purchases of blocks of shares.
7.4. Long-Term Incentive Plans

7.4.1. PRESENTATIO
N OF THE STOCK
OPTION PLANS
FOR THE
PURCHASE OR
SUBSCRIPTION OF
SHARES AND
PLANS FOR THE

CONDITIONAL
GRANT OF
SHARES TO
EMPLOYEES
(ACAs)
Policy
For several years, LOral has set up longterm incentive plans in favour of its
employees and corporate officers in an
international context.
by seeking to foster their loyalty over

time.
It pursues a dual objective:
motivating and associating those who

make big contributions with the future
evolution of the Groups results;
increasing solidarity and helping to

instil a group spirit among its managers
228
Until 2009, LOrals Board of Directors

exclusively granted stock options to the
senior managers and executive officers
whom LOral wished to reward for their
performance and their important role in
business development and in the Groups
current and future projects, wherever they
may be located.

Resources
and
Remuneration
Committee, with regard to the opening of
these plans and the applicable conditions
and rules.
In 2009, LOrals Board of

Directors enlarged its policy by
introducing a mechanism for
the conditional grant of shares
to employees (ACAs).
The objective was:
to provide a long-term
incentive offering greater
motivation to all those who
only received stock options
occasionally or in limited
numbers;
to reach out to a broader

population
of
potential
beneficiaries,
particularly
internationally, in a context
of increased competition
with regard to talents.
In 2010, this policy remained

unchanged, and was applied
to an even larger number of
beneficiaries.
In 2011, LOrals Board of
Directors decided to make
plans for the conditional grant
of shares to employees the
primary tool for its long-term
incentive policy by extending
the grants of such shares to
the Groups main senior
managers who were previously
motivated only through stock
options: thus, except for the
Officer who received stock
options only, the main senior
managers of LOral, including
the members of the Executive
Committee, received a mix of
stock options and conditional
grants of shares in order to
encourage
their
entrepreneurial
spirit
and
reward their medium- and
long-term performance. Other
eligible
employees
are
stimulated
by
conditional
grants of shares only.
In 2012, the Board of
Directors, on the proposal of
the Human Resources and
Remuneration
Committee,
went one step further in this
policy and decided to replace
the grant of stock options by
conditional grants of shares
(ACAs) for all beneficiaries
including the Chairman and
Chief Executive Officer.
The plans are proposed by
General Management to the
Board of Directors which
decides, after receiving the
opinion
of
the
Human
Since 2009, these grants are made after

publication of the financial statements for
the
previous
financial
year,
in
accordance with the AFEP-MEDEF
recommendation.
The decision with regard to each individual
grant is, in every case, contingent on the
quality of the performance rendered at the
time of implementation of the plan with
particular attention being paid to the main
talents for the future. According to the
eligibility criteria linked to the position held
by the beneficiary and the size of the entity
or the country in which the beneficiary
works, in a concern for equity on an
international scale, these grants are made
every year, every two years or every three
years.
The General Management and the Board

of Directors stress the importance that is
given to bringing together the interests of
the beneficiaries of stock options and
conditional grants of shares and those of
the shareholders themselves.
Lon
gTer
m
Inc
enti
ve
Pla
ns
The
employee
s
and
corporate
officers
who are
the
beneficiari
es share
with
the
sharehold
ers
the
same
confidenc
e in the
strong
steady
growth of
the
Company
with
a
medium
and longterm
vision.
This
is
why stock
options
were
granted
for
a
period of
10 years
including
a 5-year
lock-up
period,
and
conditiona
l grants of
shares for
a period of
4
years
followed
by a 2
year
waiting
period for
France
during
which
these
shares
cannot be
sold.
In all, over
3,000
employee
s (i.e. 13%
of
the
senior
managers
throughout
the
world) benefit from
at
least
one
currently
existing
stock option plan or
plan
for
the
conditional grant of
shares.
The
Board
of
Directors draws the
attention
of
the
beneficiaries
of
stock options and
conditional grants of
shares
to
the
regulations in force
concerning persons
holding
inside
information.
The beneficiaries of
stock options and
conditional grants of
shares undertake to
read
the
Stock
Market Code of
Ethics
which
is
attached
to
the
regulations for the
stock option plans or
the plans for the
conditional grant of
shares from which
they benefit and to
comply with the
provisions thereof.
Change in the
number of
beneficiaries of
Stock options
and ACAs
since 2003
557 1,037 1,903 2,177
693
531
774
789
2003 2004 2005 2006

Beneficiaries of ACAs
7.4.2. S
T
O
C
K
O
P
T
I
O
N
P
L
839
2007 2008
195
381
439
434
2009
88
1
2010
Beneficiaries of SO + ACAs
2011 2012
Beneficiaries of SO
P
A
N
T
C
No stock options for the purchase or

subscription of shares
were granted in 2012, as the Board of Directors
decided,
onand
the Remuneration
proposal of Committee,
the Human
Resources
P
U
R
C
H
A
S
E
O
F
to replace the grant

of stock options with
ACAs
for
all
beneficiaries
including
the
Chairman and Chief
Executive Office.
In accordance with
this policy, the Board
of Directors has not
proposed to the
Annual
General
Meeting of April 26th,
2013 to renew the
authorisation of April
22nd, 2011 to grant
stock options for the
subscription
or
purchase of shares.
229
STOCK
MARKET
INFORMATION
AND SHARE CAPITAL
Long-Term
Incentive
Plans
7.4.2.1. Currently existing LOral parent company share purchase or subscription options
(1)
The main features of the plans that existed at December 31st, 2012 are included in the tables set out hereafter:
AGM authorisation date
05.22.2003
05.22.2003
05.22.2003
05.22.2003
05.22.2003
04.25.2006
12.03.2003 (2)
693
03.24.2004
257
12.01.2004
274
06.29.2005
3
11.30.2005 (4)
771
04.25.2006
1
5,000,000
2,000,000
4,000,000
400,000
6,000,000
2,000,000
1,000,000
12.04.2008
12.03.2013
63.02 (S)
71.90 (A)
03.25.2009
03.24.2014
64.69 (S)
1,000,000
12.02.2009
12.01.2014
55.54 (S)
06.30.2010
06.29.2015
60.17 (S)
1,000,000
12.01.2010
11.30.2015
61.37 (S)
62.94 (A)
2,000,000
04.26.2011
04.25.2016
72.60 (S)
2,685,825
1,396,950
1,690,107
1,690,107
2,457,500
2,457,500
200,000
200,000
3,372,575
2,350,160
0
0
705,500
164,000
207,250
396,000
1,608,675
145,893
1,335,250
200,000
2,231,425
2,000,000
AGM authorisation date
04.25.2006
04.24.2007
04.24.2007
04.16.2009
04.22.2011
Date of Board of Directors meeting

Total number of beneficiaries
Total number of shares that may be subscribed or purchased,
Of which may be subscribed or purchased by the corporate
officers (3):
- Mr. Jean-Paul Agon
- Sir Lindsay Owen-Jones
Start date for exercise of the options
Date of expiry
Subscription or purchase price (in euros)
Number of stock options exercised
at 12.31.2012
Of which shares subscribed
Total number of options for subscription or purchase of shares
that have been cancelled or lapsed
Number of option shares remaining to be subscribed
or purchased at year-end
12.01.2006
788
5,500,000
11.30.2007
839
4,000,000
03.25.2009
634
3,650,000
04.27.2010
815
4,200,000
04.22.2011
89
1,470,000
500,000
350,000
400,000
200,000 (5)
12.02.2011
12.01.2016
78.06 (S)
12.01.2012
11.30.2017
91.66 (S)
03.26.2014
03.25.2019
50.11 (S)
04.28.2015
04.27.2020
80.03 (S)
04.23.2016
04.22.2021
83.19 (S)
2,527,250
2,527,250
439,400
439,400
0
0
0
0
0
0
516,250
302,400
174,500
146,000
25,000
2,456,500
3,258,200
3,475,500
4,054,000
1,445,000
Date of Board of Directors meeting

Total number of beneficiaries
Total number of shares that may be
subscribed or purchased,
Of which may be subscribed or purchased
by the corporate officers (3):
- Mr. Jean-Paul Agon
- Sir Lindsay Owen-Jones
Start date for exercise of the options
Date of expiry
Subscription or purchase price (in euros)
Number of stock options exercised
at 12.31.2012
Of which shares subscribed
Total number of options for subscription or
purchase of shares that have been cancelled
or lapsed
Number of option shares remaining to be
subscribed or purchased at year-end
(1) There are no share purchase or subscription option plans at subsidiaries of LOral.
(2) The stock option plan of December 3rd, 2003 is divided into two halves: a share subscription option offer at a price of 63.02 (S) and a share
purchase option offer at a price of 71.90 (A). Each beneficiary received an offer comprising share subscription and purchase options, in equal
parts.
(3) This is the number of stock options granted to the corporate officers during their terms of office within the scope of each of the abovementioned plans. Mr. Jean-Paul Agon has been a corporate officer since April 2006.
(4) The stock option plan of November 30th, 2005 is composed, for 70%, of a share subscription option offer at a price of 61.37 (S) and for 30%, of a
share purchase option offer at a price of 62.94 (A). Each beneficiary received an offer comprising share subscription and purchase options, in the
above proportions. There were no fractional share rights.
These grants of stock options do not have any impact in terms of dilution, inasmuch as the Board of Directors authorised the Company to buy back its
own shares to cancel them.
(5)
The Board of Directors meeting of April 22nd, 2011 allocated 400,000 share subscription options to Mr. Jean-Paul Agon. Mr. Agon waived the right to 200,000
of such options. He therefore benefits from 200,000 stock options under the Plan decided by the Board of Directors at its meeting on April 22 nd, 2011.
There were 22,210,443 outstanding options granted by the Board of Directors within the scope of the authorisations voted by the Annual
General Meetings and not yet exercised at December 31st, 2012, at an average price of 71.90, namely 3.65% of the 608,810,827
shares making up the share capital at such date.
See stock option plan performance conditions on page 130.
230

Long-Term Incentive Plans
7.4.2.2. Stock options to purchase or subscribe for shares granted to employees other
than corporate officers of LOral or exercised by them during the 2012 financial year
Total number
of options
granted/
shares
Weighted
subscribed or average
purchased
price
Options granted
by LOral parent
No stock
company to the
options
(1)
ten employees to
n/a
granted in
whom the largest
2012
number of stock
options was granted
Options held with
regard to LOral
parent company
exercised by the
ten employees (1)
1,279,265 66.22
Plan of
03.26.02
(S)
Plan of
09.04.02
(S)
Plan of
12.03.03
(A)
Plan of
12.03.03
(S)
40,000
55,000
97,500
Plan of
03.24.04
(S)
Plan of
12.01.04
(S)
Plan of
11.30.05
(A)
Plan of
11.30.05
(S)
Plan of
12.01.06
(S)
Plan of
11.30.07
(S)
52,500 215,000 238,000 140,316 240,949 160,000
40,000
who have thus

purchased or
subscribed for
the largest
number of options
(1) Employees other than corporate officers of LOral parent company or employees of companies included in the scope of grant of the stock options.
7.4.2.3. Tables monitoring the performance conditions under the Stock Option plans
Stock Option Plan of 03.25.2009
(Executive Committee)
2010
50% growth in comparable cosmetics sales as compared to the increase

in the cosmetics market
50% operating profit + advertising and promotional expenses
as compared to cosmetic sales

(Executive Committee)

(all beneficiaries)
50% growth in comparable cosmetics sales as compared to that
of a panel of competitors **
50% change in the Groups operating profit
*
*
*
2012
2013
+1.4 point
+0.4 point
+0.9 point*
(+5.6% /+4.2%)
(+5% /+4.6%)
(+5.5% /+4.6%)*
47.05%
47.80%
47.20%
(8,534.3/18,139.1) (9,017.9/18,870.8) (9,815.7/20,811.7)
to come
2011

50% operating profit + advertising and promotional expenses
as compared to cosmetic sales
2011
to come
2012
2013
2014
+0.4 point
+0.9 point*
(+5% /+4.6%)
(+5.5% /+4.6%)*
47.80%
47.20%
(9,017.9/18,870.8) (9,815.7/20,811.7)
to come
to come
to come
to come
2012
2013
2014
2015
+0.6 point ***

(+5.5% /+4.9%) ***
12.30%
(3,292.6/3,697.3)
to come
to come
to come
to come
to come
to come
Evolution of cosmetics market: source LOral (see chapter 1 page 13).

Panel of competitors: Procter & Gamble, Unilever, Este Lauder, Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao, Revlon, Elizabeth Arden.
Provisional information taking into consideration only the data published by the companies of the panel at the time of LOrals Board of
Directors meeting on February 11th, 2013.
No Stock Option Plans after April 22nd, 2011.
231
STOCK
MARKET
INFORMATION
AND SHARE CAPITAL
Long-Term
Incentive
Plans
7.4.3.
PLANS
FOR
THE
CONDITIONAL
GRANT
OF
SHARES (ACAs)
7.4.3.1. Authorisation of
the Ordinary
and
Extraordinary
General
Meeting
of
nd
April
22 ,
2011
The Ordinary and Extraordinary General
Meeting of April 22nd, 2011 gave the Board
of Directors the authorisation to carry out
free grants of existing shares and/or
shares to be issued of the Company to
employees and corporate officers of the
Company and of its French or foreign
affiliates under the conditions of Article L.
225-197-2 of the French Commercial
Code.
This authorisation was granted for a period
of twenty-six months.
The total number of shares that may be
granted may not represent more than
0.6% of the share capital on the date of
the Board of Directors decision.
The free grant of shares is performancerelated.
The mechanism for the Conditional Grant
of Shares to employees complies with the
AFEP-MEDEF
Code
of
Corporate
governance of April 2010 and in particular:
any conditional grants of shares to the

executive officers will be decided by
the
Board
of
Directors
after
assessment of their performance;
the final vesting of all or part of the

shares will be linked to performance
conditions to be met that are set by the
Board;
the executive officers will be obliged to

retain 50% of the shares that are
definitively granted to them at the end of
the vesting period in registered form until
the termination of their duties;
an executive officer may not be

granted any shares at the time of his
departure.
7.4.3.2. Conditional
Grants
of
Shares granted
in the framework
of
the
authorisation of
April 22nd, 2011
(ACAs Plan of April
17th, 2012)
The share capital at April 17th, 2012
consisted of 605,173,747 shares, which
gave the possibility to distribute 2,593,042
shares in light of the 1,038,000 conditional
shares already granted in 2011 within the
scope of the authorisation granted by the
Annual General Meeting on April 22 nd,
2011.
The Board of Directors used this
authorisation at its meeting of April 17 th,
2012, by granting 1,325,050 free shares
to 2,177 beneficiaries, the unit value of
these shares amounting to 77.07 for
French tax and social security residents
and 84.62
Johnson, Henkel, LVMH,

Revlon and Elizabeth Arden,
for non-residents.The value of the shares

here is to be understood as the estimated fair
value for preparation of the consolidated
financial statements of the Company
pursuant to the IFRS.
The Board of Directors granted 50,000

conditional shares (ACAs) to the
Chairman and Chief Executive Officer: the
value of the shares thus granted to the
Chairman and Chief Executive Officer in
2012 represents 3.6% of the value of all
the free shares granted during this
financial year. It should be noted that no
stock options were granted in 2012.
The grant made on April 17th, 2012 is a free
grant of existing shares.
Vesting of the shares is subject to a dual

condition of:
presence: the shares granted will only

finally vest after a period of 4 years at
the end of which the beneficiary must
still be an employee of the Group (save
the exceptions provided for by law or
the Plan regulations);
performance:
232
vesting of all or part of 50% of the

shares granted will depend on the
growth in comparable cosmetics
sales for financial years 2013, 2014
and 2015 as compared to those of a
panel of LOrals biggest direct
competitors consisting of Procter &
Gamble, Unilever, Este Lauder,
Shiseido, Beiersdorf, Johnson &
Kao,
vesting of all or part of 50% of the

shares granted will depend on
growth in the Groups consolidated
operating profit, over the same
period.
The calculation will be made on the basis

of the arithmetical mean of the
performances for the 2013, 2014 and
2015 financial years.
The Human Resources and Remuneration
Committee
is
responsible
for
communicating to the Board of Directors
the level of indicators recorded for the
years to be used for the calculation of the
performance conditions. The Board of
Directors records, at the appropriate time,
the level of performance achieved on
which the number of shares that finally
vests depends.
The data recorded year after year to
determine the levels of performance
achieved are published in the Annual
Financial Report.
The vesting of the first 200 conditional
shares is not subject to fulfilment of the
performance conditions except for the
members of the Executive Committee
including the Chairman and Chief
Executive Officer.
At the end of the vesting period,
beneficiaries who are French residents at
the date of grant of the shares will be
obliged to retain the shares that have
vested for an additional period of 2 years
during which these shares are nontransferable.

Long-Term Incentive Plans
7.4.3.3. Existing Conditional Grants of shares at December 31 st, 2012

Date of authorisation by the
Extraordinary General Meeting
Date of grant by the Board of Directors
Total number of shares conditionally
granted
Of which the ten employees other than
corporate officers granted the largest
number of shares (1)
Number of beneficiaries
Performance conditions:
04.16.2009
04.22.2011
04.22.2011
03.25.2009
04.27.2010
04.22.2011
04.17.2012
270,000
450,000
1,038,000
1,325,050
5,000
752
6,000
1,418
92,000
1,991
185,000
2,177
50% growth in
comparable cosmetics
sales as compared
to that of a panel
of competitors (2)
50% growth in
the LOral Groups
consolidated operating
profit
50% growth in
comparable sales as
compared to growth in
the cosmetics market
50% ratio of operating
profit as compared to
published cosmetic
sales.
Date of final vesting for French tax

residents at the date of grant
Date of final vesting for non-French tax
End of the waiting period for French tax
(1)
(2)
04.24.2007
25% growth in
comparable sales as
compared to growth in
the cosmetics market
75% ratio of operating
profit as compared to
published cosmetic
sales
50% growth in
comparable cosmetics
sales as compared
to that of a panel
of competitors (2)
50% growth in
the LOral Groups
consolidated operating
profit
03.25.2013
04.27.2014
04.22.2015
04.17.2016
03.25.2013
04.27.2014
04.22.2015
04.17.2016
03.25.2015
04.27.2016
04.22.2017
04.17.2018
Employees who are not corporate officers of LOral parent company or employees of companies included within the scope of the grant of shares.
Procter & Gamble, Unilever, Este Lauder, Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao, Revlon, Elizabeth Arden.
7.4.3.4. Shares granted to the ten

employees other than corporate
officers to whom the largest number
of shares have been granted
The total number of shares granted in 2012 to the ten
employees other than corporate officers who received the
largest number of shares amounts to 185,000 shares.
7.4.3.5.
taken into consideration within the scope of the March 25 th, 2009
Plan, namely 2010, 2011 and 2012, exceeded the levels set for
the conditional grant of all the shares (ACAs).
Accordingly, the beneficiaries who meet the conditions under the
Plan on March 25th, 2013, and in particular the condition of
presence in the Company, will receive all the shares that were
granted to them.
For information purposes, no conditional grant of shares (ACAs)
was made to the corporate officers under this Plan.
Shares that have finally vested
within the scope of the March 25th,

2009 Plan
The Board of Directors recorded at its meeting on February 11th,
2013 that the performance levels achieved during the three
years
Table monitoring performance conditions: ACAs Plan of 03.25.2009
2010
50% Growth in comparable cosmetics sales as
compared to the increase in the cosmetics market
50% Ratio of Operating profit for cosmetics versus
published cosmetic sales
*
2011
2012
+1.4 point
+0.4 point
+0.9 point*
(+5.6% /+4.2%)
(+5% /+4.6%)
(+5.5% /+4.6%)*
15.80%
16.50%
16.70%
(2,872.4/18,139.1) (3,104.4/18,870.8) (3,477.1/20,811.9)
Arithmetical mean
of performances
for financial years
2010/2011/2012
+0.90 point
16.30%
233
STOCK
MARKET
INFORMATION
AND SHARE CAPITAL
Long-Term
Incentive
Plans
7.4.3.6. Table monitoring performance conditions for the ACAs plans that are currently in progress
ACAs Plan of 04.27.2010
2011

75% ratio of Operating profit for cosmetics versus published cosmetic sales

50% growth in comparable cosmetics sales as compared to that of a panel
of competitors **
2013
to come
to come
2012
2013
2014
+0.6 point ***

(+5.5% /+4.9%) ***
12.30%
(3,292.6/3,697.3)
to come
to come
to come
to come
Provisional information taking into consideration only the data published by the companies of the panel at the time of LOrals Board of
Directors meeting on February 11th, 2013.

50% growth in comparable cosmetics sales as compared to that of a panel
of competitors *
*
2013
2014
2015
to come
to come
to come
to come
to come
to come
7.4.3.7. Renewal of the authorisation for

the conditional grant of shares submitted to
the Ordinary and Extraordinary General
th
Meeting on April 26 , 2013

The authorisations granted by the Annual General Meeting to the
Board of Directors to grant stock options to purchase and/ or
subscribe for shares and to make free grants of shares to the
Groups employees and certain of its corporate officers are due to
expire in 2013.
th
Further to the decision made by the Board of Directors of April 17 ,

2012, upon the proposal of the Human Resources and
Remuneration Committee, to replace the grant of stock options to
purchase or subscribe for shares with free grants of shares for all
the beneficiaries, including the Chairman and Chief Executive
Officer, the Board of Directors is only asking the Annual General
Meeting to renew the authorisation to make free grants of shares of
the Company (see tenth resolution on pages 250 et seq.).
The main rules would be reapplied and in particular the following
performance conditions which would take into account:
partly the growth in LOrals comparable cosmetics sales as

compared to those of a panel of LOreals biggest direct
competitors;
partly the growth in LOrals consolidated operating profit.
234
2012
+0.4 point
+0.9 point*
(+5% /+4.6%)
(+5.5% /+4.6%)*
16.50%
16.70%
(3,104.4/18,870.8) (3,477.1/20,811.9)
The figures recorded year after year to determine the performance

levels achieved are published in the Annual Financial Report.
The Board of Directors considers that these two criteria, assessed over
a long period of 3 full financial years and applied to several plans, are
complementary, in line with the Groups objectives and suitable to its
specificities and should make it possible to promote balanced,
continuing growth over the long term. They are demanding but remain a
source of motivation for beneficiaries.
In order for all the free shares granted to finally vest for the
beneficiaries at the end of the vesting period pursuant to the
criterion related to sales, LOrals growth must be at least equal to
average growth in sales of the panel of competitors.This panel
currently consists of Procter & Gamble, Unilever, Este Lauder,
Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao,
Revlon, Elizabeth Arden.
No share will finally vest pursuant to the criterion relating to
operating profit, if this profit does not increase in absolute value
over the period.
These performance conditions will apply to all the individual grants
of more than 200 free shares per plan, with the exception of those
for the corporate officers and the Executive Committee members,
to which they will apply in full.

7.5. The LOral share / LOral share market

7.5.1.
7.5.1.3 Dynamic shareholder

return policy
THE LORAL SHARE
7.5.1.1. Information on the LOral

share
4.91(2) net earnings per share.
2.30(3) dividend per share.
Isin code: FR0000120321.
A regular increase in the dividend per share

(in euros):
Loyalty bonus code:
Dividend +10% in 2013: FR0010970285.
Dividend +10% in 2014: FR0011147487.
Dividend
+10%
in
2.3
0(3)
x 3.6
IN 10 YEARS
2015:
2.00
1.80
1.50
FR0011356229. Minimum lot: 1
1.38 1.44
1.18
share.
1.00
Par value: 0.20
0.64 0.73
0.82
Trading on the spot market of the Paris Stock

Exchange. Eligible for the Deferred Settlement
Service (SRD).
2002 2003 2004 2005
Unsponsored American Depositary Receipts are freely

traded in the United States through certain banks
operating in the United States.
2006 2007 2008
Share of profits dedicated to dividends(4) (as

%):
43.9
7.5.1.2. Stock market data

Price at December 31st, 2012
Average of last 30 days closing prices for 2012
% 44.9 % 46.3
104.9036.0 % 36.6 % 36.8 % 38.5 %

104.29
High
106.40
at December 11
Low
79.22
at January 16
Annual share price increase at December 31 st, 2012

LOral
CAC 40
Euronext 100
DJ Euro Stoxx 50
Market capitalisation at December 31st, 2012
At December 31st, 2012, the LOral share weighed:
in the CAC 40
in the Euronext 100
in the DJ Euro Stoxx 50
2009 2010 2011 2012
+29.99%
+15.23%
+14.85%2002 2003
+13.79%
63.86 billion
46.8 %(5)
39.6 % 41.1 % 41.3 %
7
2004 2005
2006 2007 2008 2009 2010 2011 2012
3.66%
3.92%
1.59%
(1)
(2)
Out of the number of shares at December 31st, 2012, i.e. 608,810,827 shares.
Diluted net profit excluding non-recurring items, group share, per share.
(3)
(4)
Dividend proposed to the Annual General Meeting of April 26 th, 2013.

Dividend distribution rate based on net profit excluding non-recurring items diluted, group share, per share. Taking into account Sanofi not
consolidated in this period.
(5)
Based on the dividend proposed to the Annual General Meeting of April 26 th, 2013.
235
STOCK
MARKET
AND SHARE CAPITAL
The LOral
share INFORMATION
/ LOral share market
7.5.2.
LORAL SHARE MARKET
7.5.2.1. Trading volumes and change in the price of the Companys share
According to NYSE-Euronext data, the only stock market for which reliable retrospective statistics could be collected.
Date
High
Price in
Low Average
Average daily
trading volume
( million)
2010
January
February
March
April
May
June
July
August
September
October
November
December
Date
80.22
77.97
80.51
83.76
79.50
84.28
85.00
83.38
84.89
88.00
87.91
86.93
High
75.60
71.90
76.62
76.82
70.90
74.50
77.49
75.03
78.53
80.10
81.66
81.90
77.92
75.53
78.68
80.25
75.18
79.78
81.64
78.48
82.62
83.91
85.34
85.40
Price in
Low Average
61.59
84.15
66.52
97.75
126.83
97.77
85.50
81.90
82.97
74.16
54.33
57.26
Average daily
trading volume
( million)
2012
January
February
March
April
May
June
July
August
September
October
November
December
83.47
86.12
92.53
94.80
93.98
93.27
99.80
102.50
101.15
101.85
105.85
106.40
79.22
80.93
85.27
88.82
88.85
86.80
89.80
95.54
96.17
94.55
95.80
103.20
81.39
83.94
88.87
91.89
91.44
90.24
94.28
100.12
97.84
97.98
100.94
104.86
57.75
73.93
78.27
123.11
77.67
78.67
77.32
63.04
88.43
64.40
57.64
52.32
Average daily
trading volume
Date
High
Price in
Low Average
( million)
2011
January
February
March
April
May
June
July
August
September
October
November
December
Date
86.95
90.00
85.37
86.83
87.48
89.56
91.24
84.95
76.17
81.84
80.32
80.96
High
82.27
82.14
76.64
81.56
84.64
83.58
82.10
71.00
68.83
70.73
74.15
76.73
84.30
86.14
81.33
84.01
85.93
86.23
86.32
78.63
73.27
77.64
77.35
78.97
Price in
Low Average
70.07
93.47
76.43
65.73
93.32
72.33
80.18
102.92
105.28
76.56
71.32
56.07
Average daily
trading volume
( million)
2013
January
February
236
114.50
115.90
103.65
107.55
107.78
111.29
51.95
73.20

Change in the LOral share price compared to the CAC 40 index from January 1 st, 2008 to February 28th, 2013.
L'Oral
CAC 40 rebased on LOral
120
+16.91%
114.55
100
97.98
5,614.08
80
-33.68%
3,723
60
40
20
02/28/2013
12/30/2012
10/31/2012
08/31/2012
06/30/2012
04/29/2012
02/29/2012
10/31/2011
12/30/2011
08/31/2011
06/30/2011
04/29/2011
02/28/2011
12/31/2010
10/29/2010
08/31/2010
06/30/2010
04/30/2010
02/26/2010
12/31/2009
10/30/2009
08/31/2009
06/30/2009
04/30/2009
02/27/2009
12/31/2008
10/31/2008
08/29/2008
06/30/2008
04/30/2008
02/29/2008
12/31/2007
7.5.2.2. Total Shareholder Return

Amongst the various economic and financial indicators used to measure shareholder value, LOral has chosen to apply the criterion of
Total Shareholder Return (TSR). This indicator is a synthetic measurement that takes into account not only the value of the share but
also the dividend income received (excluding tax credits before January 1st, 2005).
01 5-year evolution of a portfolio of approximately 15,000 invested in LOral shares with

reinvestment of coupons
Date of transaction
Nature of transaction
12.31.2007
04.30.2008
Purchase of 153 shares at 97.98

Dividend: 1.38 per share
Reinvestment: purchase of 3 shares at 76.21
Reinvestissement: purchase of 4 shares at 85.79
04.24.2009
05.05.2010
05.04.2011
05.03.2012
TOTAL
TOTAL NET INVESTMENT
Portfolio value at 12.31.2012 (173 shares at 104.90): 18,147.70.
The initial capital has thus been multiplied by 1.21 over 5 years (5-year
inflation rate = 7.7% Source INSEE) and the final capital is 1.19 times the
total net investment.
Investment
Income
()
()
14,990.94
211.14
228.63
224.64
260.08
241.50
307.08
297.00
343.16
338.00
371.36
16,501.25
15,188.97
Number of
shares after the
transaction
153
153
156
156
161
161
165
165
169
169
173
1,312.28
The Total Shareholder Return of the investment is thus 3.65% per year
(assuming that the shares are sold on December 31 st, 2012, excluding tax
on capital gains).
Over the same period, the CAC 40 index fell by - 4.41% per year
(1)
NOTE: Any income tax that may be paid by the investor as a result of the
successive dividend payments is not taken into account.
(1) Reinvested dividends; source: Datastream.
237
STOCK
MARKET
AND SHARE CAPITAL
The LOral
share INFORMATION
/ LOral share market

reinvestment of coupons
Date of transaction
12.31.2002
05.27.2003
Purchase of 207 shares, at 72.55

Dividend: 0.64 per share, excluding tax credit
05.14.2004
05.11.2005
05.10.2006
05.03.2007
04.30.2008
04.24.2009
05.05.2010
05.04.2011
05.03.2012
TOTAL
Portfolio value at 12.31.2012 (252 shares at 104.90): 26,434.80.
The initial capital has thus been multiplied by 1.76 over 10 years
(10-year inflation rate = 18.8% Source INSEE) and the final
capital is 1.71 times the total net investment.
Investment
Income
()
()
Number
of shares after
the transaction
15,017.85
132.48
183.30
153.30
190.95
174.66
226.00
217.00
217.95
259.60
260.01
307.74
381.05
328.32
364.11
352.50
383.85
432.00
514.74
492.00
557.04
18,296.85
15,447.25
207
207
210
210
213
213
217
217
220
220
223
223
228
228
235
235
240
240
246
246
252
2,849.60
The Total Shareholder Return of the investment is thus: 5.59% per

year (assuming that the shares are sold on December 31 st, 2012,
excluding tax on capital gains).
Over the same period, the CAC 40 index increased by +5.44% per
year (1).
NOTE: Any income tax that may be paid by the investor as a result of
the successive dividend payments is not taken into account.
238


reinvestment of coupons and share attribution rights
Date of transaction
12.31.1992
06.25.1993
Purchase of 92 shares at 162.66

Reinvestment: purchase of 1 share at 167.69
Issue of bonus shares (1 for 10)
Compensation for 6 unused share attribution right
at 22.85668 per right
Ten-for-one share split
Reinvestment: purchase of 22 share s at 76.21
06.28.1994
06.28.1995
06.28.1996
07.01.1996
07.31.1996
07.01.1997
06.12.1998
06.15.1999
06.15.2000
07.03.2000
06.08.2001
06.04.2002
05.27.2003
05.14.2004
05.11.2005
05.10.2006
05.03.2007
04.30.2008
04.24.2009
05.05.2010
05.04.2011
05.03.2012
TOTAL
239
Investment
Income
()
()
14,964.72
134.64
167.69
153.12
167.69
174.83
185.84
192.62
260.54
137.14
236.91
226.23
393.93
260.99
473.05
304.59
586.50
370.60
825.00
484.00
547.05
597.78
599.60
713.60
733.20
822.71
827.45
934.80
960.50
1,157.00
1,162.40
1,384.14
1,386.72
1,640.82
1,676.62
1,743.84
1,768.51
1,867.50
1,919.25
2,286.00
2,316.33
2,594.00
2,599.52
34,759.02
16,578.06
18,180.96
Number
of shares after
the transaction
92
92
93
93
94
94
95
95
96
105
105
106
106
107
107
108
108
109
109
110
1,100
1,100
1,107
1,107
1,115
1,115
1,127
1,127
1,140
1,140
1,157
1,157
1,173
1,173
1,189
1,189
1,211
1,211
1,245
1,245
1,270
1,270
1,297
1,297
1,325
STOCK
MARKET
Information
policy INFORMATION AND SHARE CAPITAL
Portfolio value at 12.31.2012

shares at 104.90): 138,992.50.
(1,325
The initial capital has thus been multiplied

by 9.29 over 20 years (20-year inflation
rate = 38.2% Source: INSEE) and the
final capital is 8.38 times the total net
investment.
The Total Shareholder Return of the
investment is thus 11.45% per year
(assuming that the shares are sold on
December 31st, 2012, excluding tax on
capital gains).
7.6.
Information
policy
LOral is pursuing its policy of ongoing
improvement in the quality of its financial
information
and
dialogue
with
its
shareholders and French and international
investors. The objective is not simply to fulfil
statutory obligations, but also to support our
shareholders and investors and to strengthen
the links forged with the Group.
7.6.1.
NEW
MODERN
AND
COMPLEM
ENTARY
COMMUNIC
ATIONS
MEDIA
In
2012,
LOrals
Financial
Communications Department took care to
reinforce and enhance the information
provided to the financial community as a
whole and round out the range of
communication tools proposed:
Extra-financial information: shareholders

and investors expect issuers to give more
sense to financial performance and to the
Companys business activities. For that
reason, extra-financial information is now
provided
to
supplement
financial
information in all our publications: Activity
Reports,
letters
to
shareholders,
newsletters and our shareholders
magazine;
Modern
digital
communications:
Over the same period, the CAC 40 index

increased by + 6.64% per year (1).
NOTE: Any income tax that may be paid by
the investor as a result of the successive
dividend payments is not taken into account.
7.5.2.3. Dividends
The limitation period for dividends is five
years. Any dividends for which payment
has not been requested are paid to the
Caisse des Dpts et Consignations.
Alongside our paper communication
materials, a range of interactive
electronic media have been put in
place to enrich the circulation of our
communications:
1.
The e-newsletter sent to all the

contacts
in
the
Financial
Communications
Department
database at the time of the major
events on our financial calendar:
annual results, Annual General
Meetings, half-year results, etc.,
2.
LOrals shareholders e-magazine,

intended
not
only
for
our
shareholders but also for all those
who are looking for full information on
the life of the Group, offers animated
information, enriched with a large
number of documents, videos,
interviews and testimonials;
year on the www.loreal-finance.com and

www.loreal.com websites and is available
in paper format on request.
In all, LOrals Financial Communications
Department makes a vast array of
communication tools available to the
financial community:
3.
The mobile applications for iPad and

iPhone and their Android version
created in 2012.
The guide describing the 5 reasons to
take part in the LOral adventure, was
published in the autumn of 2011 for the
Actionaria Stock Market fair. This
publication, which has innovative
content and format, is designed to fulfil
our shareholders desire to make more
sense of their investment;
In 2012, LOral published for the first
time a coherent set of 3 essential
documents
presenting
comprehensively all the aspects of its
business: the 2011 Activity Report, the
2011 Registration Document and the
2011 Sustainable Development Report.
In 2013, this set of three documents is

also available online for the 2012 financial
240
the Activity Report;
the Registration Document;
financial news releases;
extra-financial news releases;
letters to shareholders;
e-newsletters;
the shareholders e-magazine;
the mobile applications for iPad and

iPhone and their Android version;
the dedicated
finance.com.
website
www.loreal-
Strongly committed to its communication

policy, LOral offers all shareholders and
investors unrestricted access to these
media or materials. Everyone can access
and download them or can be sent them.

award for Corporate Social and
Shareholder Responsibility by
the Mieux vivre votre argent
magazine in recognition of its
overall vision of shareholder,
social and environmental policy.
7.6.2. A LARGE
NUMBER
OF
SHAREHOL
DER
EVENTS
FOR A
REGULAR
AND
DETAILED
DIALOGUE
As it does every year, the

Financial
Communications
Department organised two major
financial information meetings for
analysts and investors, to which
journalists specialising in the
cosmetics sector are invited. The
presentations of the LOral
Groups financial results and the
business
activities
of
the
Operational
Divisions
are
broadcast live online on the
financial website www.lorealfinance.com, and the information
presented is made available on
this website on the same day,
both for the annual results and
the half-year results;
10 meetings with shareholders

in several large provincial cities
in France and also in foreign
countries, in collaboration with
the French Investment Club
Federation
(Fdration
Franaise
des
Clubs
dInvestissement FFCI), the
Society of Investor Relation
Managers in France (Cercle de
Liaison
des
Informateurs
Financiers en France CLIFF),
shareholder associations and
financial newspapers brought
together over 2,000 participants;
Participation in the Actionaria

Stock Market Fair for the ninth
year
running
offered
an
opportunity for 700 people to
attend a presentation by Mr.
Jean-Paul Agon, Chairman and
Chief Executive Officer. Many
shareholders were also able to
meet representatives of the
LOral Group directly and
obtain information on registering
their shares.
Through all these events, our teams

had the opportunity to meet nearly
6,000 individual shareholders in
2012.
For the fourth year running,

LOral was given the special
on themes such as: the Annual
Informa General
Meeting,
digital
tion
communication, Research and
policy Innovation or overhaul of the
website.
In
2012,
the
Shareholder
Consultation
Committee met 4 times;
On December 10th, 2012, our

Investor Relations Department
received the award for the best
Investor
Relations Manager
(Trophe
du
meilleur
IR)
awarded by the Forum des
Relations Investisseurs for all
categories combined;
One symbol of the loyalty of our

shareholders who accompany the
Groups development over the long
term is the fact that more and more
shareholders are showing an
interest in becoming registered
shareholders.Thanks
to
the
preferential dividend and the
numerous advantages offered by
this method of shareholding,
becoming a registered shareholder
represents a real loyalty bonus
for our shareholders;
Created at the beginning of

2010,
the
Shareholder
Consultation
Committee
consisting of 18 shareholders
(both registered and bearer
shareholders)
who
actively
participate,
through
their
reflections and their work, in
developing and enriching the
Groups financial communication
7.6.3. FINANCIAL
2012
02.13.12
The
Investor
Relations
Department organises numerous
meetings throughout the year
with institutional investors of the
main
international
financial
market places. In 2012, they
thus met nearly 650 investors;
The financial website www.lorealfinance.com, created in 1997 for

the use of international finance
professionals and all LOral
shareholders
was
completed
overhauled in 2012, in particular
with the launch of the abovementioned e-magazine and the
updating of the mobile website in
order to make it more compatible
with the current communication
tools.
Finally, a freephone service is

available to LOral shareholders
calling from France (0 800 66 66
66) or other countries (+33 1 40 14
80 50). An interactive vocal server
gives shareholders round-the-clock
access to information on the share
price and key dates or provides
them with a summary of the latest
press release. The Shareholder
Services Department is also
available on this number during
opening hours.
NEWS
RELEASES
IN
02.13.12
03.02.12
Board of Directors: End of the tenure as Director of Mrs. Liliane Bettenco

Mr. Jean -Victor Meyers
Annual Results 2011: Sustained growth in sales Solid increase in pro
Board of Directors: Tenures as Director proposed to the next Annual G
03.19.12
04.12.12
04.17.12
04.26.12
07.13.12
07.26.12
08.28.12
10.24.12
10.31.12
11.06.12
11.26.12
12.12.12
Annual General Meeting of April 17th, 2012/2011 Registration Documen

First-quarter sales 2012 A promising start to the year
Annual General Meeting of April 17th, 2012
LOral acquires 100% of Cadum
LOral completes the sale of the home care business from the Cadum
First-half results 2012 - Strong sales growth
First-half 2012 results: Strong increase in results
LOral USA signs agreement to acquire Emiliani Enterprises extending its
LOral acquires the Vogue make-up brand in Colombia
Sales at September 30, 2012 - Strong sales growth
LOral signs an agreement to acquire Urban Decay, specialty make-u
Galderma, the world leader exclusively dedicated to dermatology, acqu
241
242
8
8.1. Draft resolutions and Report of
the Board of Directors to the
Annual General Meeting to be
held on April 26th, 2013 (as at
February 11th, 2013)
245
8.1.1. Ordinary Part
245
8.1.2. Extraordinary Part
249
8.2. Statutory Auditors Special

Report on the authorisation
for the free granting of
existing shares and/or shares
to be issued to employees
and corporate officers
of the Company
254
8.3. Statutory
Auditors
Special
Report on the share capital
increase reserved for
employees of the Company
255
This chapter presents the Report of the Board of Directors

on the draft resolutions and the full text of the resolutions which will be
submitted to LOrals Ordinary and Extraordinary General Meeting.
This General Meeting will be held on April 26th,
2013 at the Palais des Congrs, in Paris.
DRAFT AGENDA
Ordinary Part
1.
Approval of the 2012 parent company financial statements
2.
Approval of the 2012 consolidated financial statements
3.
Allocation of the Companys net income for 2012 and declaration of the dividend
4.
Appointment of Ms. Virginie Morgon as Director
5.
Renewal of the tenure as Director of Mrs. Franoise Bettencourt Meyers
6.
Renewal of the tenure as Director of Mr. Peter Brabeck-Letmathe
7.
Renewal of the tenure as Director of Mr. Louis Schweitzer
8.
Authorisation for the Company to buy back its own shares
Extraordinary Part
9.
Delegation of authority to the Board of Directors to increase the share capital either through the issue of ordinary shares with
maintenance of preferential subscription rights, or via the capitalisation of share premiums, reserves, profits or other amounts
10. Authorisation to the Board of Directors to make free grants to employees and corporate officers of existing shares and/or of shares
to be issued entailing waiver by the shareholders of their preferential subscription right
11. Delegation of authority to the Board for the purpose of carrying out a capital increase reserved for employees with cancellation of
the shareholders preferential subscription right
12. Powers for formalities
244

Draft resolutions and Report of the Board of Directors to the Annual General Meeting to be
held on April 26th, 2013 (as at February 11th, 2013)
8.1. Draft resolutions and Report of the Board of

Directors to the Annual General Meeting to be held
on April 26th, 2013 (as at February 11th, 2013)
8.1.1.
ORDINARY PART
Resolutions 1, 2 and 3: Approval of the Company financial statements, allocation of the

Companys net income for 2012 and declaration of the dividend
Statement of reasons
Having reviewed the Reports of the Board of Directors and the
Statutory Auditors, the Annual General Meeting is called on to
approve:
the parent company financial statements, with an income

statement which shows net income of 2,407,976,604.53 for
2012, compared with 2,169,772,192.21 for 2011;
the 2012 consolidated financial statements.
The details of these financial statements are set out in the 2012
Annual Financial Report and the main data included in the file for
calling this Annual General Meeting.
The Board of Directors proposes to the Annual General Meeting:
an ordinary dividend of 2.30 per share, representing an

increase of 15% compared with the dividend for the previous
year;
The rate of distribution of the ordinary dividend (ordinary dividend paid/net income excluding non-recurrent items, Group share, per
share) would be 46.8% and would thus continue to rise:
Year
Rate of distribution
2007
2008
2009
2010
2011
41.1%
41.3%
43.9%
44.9%
46.3%
a preferential dividend of 2.53 per share.

The preferential dividend will be granted to the shares held in
registered form since December 31st, 2010 at the latest, and
which continuously remain in registered form until the dividend
payment date in 2013.The number of shares giving entitlement to
such preferential dividend cannot exceed 0.5% of share capital
for any one shareholder.
First resolution: Approval of the 2012

parent company financial statements
The Annual General Meeting, having reviewed the
reports of the Board of Directors and the Statutory
Auditors, approves the Report of the Board of Directors
and the 2012 parent company financial statements, as
presented and the transactions included in these
financial statements and summarised in these reports,
showing net income of 2,407,976,604.53, compared
with 2,169,772,192.21 for 2011.
If the Annual General Meeting approves this proposal, the ex

dividend date for the dividends (both ordinary and preferential)
will be Tuesday, May 7th, 2013 and the dividends will be paid on
Friday, May 10th, 2013.
The amount of the ordinary dividend and the preferential dividend
is eligible for the tax deduction provided for in Article 158-3-2 of
the French Tax Code.
Second resolution: Approval of

the 2012 consolidated financial
statements
reports of the Board of Directors and the Statutory
Auditors, approves the 2012 consolidated financial
statements.
Third resolution: Allocation of the

Companys net income for 2012 and
declaration of the dividend
The Annual General Meeting, on the proposal of the Board

of Directors, decides to allocate the net income for the 2012
financial year amounting to 2,407,976,604.53, as follows:
No allocation to the legal reserve which already represents over one-tenth of the share capital
Amount allocated to the shareholders as a dividend* (including preferential dividend)
Balance that will be allocated to the Other reserves item
*
including an initial dividend equal to 5% of the amounts paid up on the shares, i.e. the total amount of the share capital.
1,397,400,604.00
1,010,576,000.53
245
ANNUAL
GENERAL
MEETING
Draft resolutions
and Report
of the Board of Directors to the Annual General Meeting to be
This amount is calculated on the basis of the

number of shares forming the capital at February
11th, 2013 and will be adjusted to reflect:
the number of shares issued between February

11th, 2013 and the date of payment of this
dividend following the exercise of stock options
or the final vesting of new free shares granted
and giving entitlement to such dividend;
form until the dividend payment date, it being specified

that the number of shares giving entitlement to such
preferential dividend cannot exceed 0.5% of share
capital for any one shareholder.
The ex dividend date for the dividends (both

ordinary and preferential) will be Tuesday, May 7 th,
2013 and the dividends will be paid on Friday, May
10th, 2013.
the final number of shares eligible for the

preferential dividend, taking into account sales
or transfer to a bearer account between
February 11th, 2013 and the date of payment of
the dividend.
In the event that, at the time of payment of the

dividend, the Company holds treasury shares, the
distributable profit corresponding to the unpaid
dividend due to the holding of such shares, would
be allocated to the Other reserves item.
The Annual General Meeting therefore declares an

ordinary dividend to be paid of 2.30 per share, the
preferential dividend amounting to 2.53 per share.
The preferential dividend will be granted to the shares
It is specified that, as the law currently stands, for

natural persons who have their tax residence in
France, the dividend is liable for personal income
tax on the basis of the progressive scale of tax
rates and is eligible for the tax deduction provided
for in Article 158-3-2 of the French Tax Code.
held in registered form since December 31st, 2010 at

the latest, and which continuously remain in registered
The table set out below gives the amounts of the dividends distributed, that were fully eligible for the tax
deduction provided for in Article 158-3-2 of the French Tax Code, for the last three financial years:
Ordinary dividend per share

Preferential dividend per share*
*
2009
2010
2011
1.50
1.80
2.00
0.20
The preferential dividend was distributed for the first time in 2012 with respect to the 2011 financial year.
Resolutions 4, 5, 6, 7: Tenures as
Directors
The appointment of a new Director is put to the
vote of the Annual General Meeting as well as the
renewal of three Directors whose tenures as
Directors expire at the close of this Annual
General Meeting.
1. LOrals Board of Directors at December 31st,
2012
The Directors of LOral come from different
backgrounds.They complement one another due to
their different professional experience, their skills and
their nationalities. They have good knowledge of the
Company. The Directors are present, active and
closely involved. These are all assets which
contribute to the quality of the Boards deliberations
in the context of the decisions that it is called on to
make.
The Directors have a duty of vigilance and exercise
complete freedom of judgment.This freedom of
judgment enables them in particular to participate, in
complete independence , in the decisions or work of
the Board and its Committees whose remits have
been extended since 2011 (see paragraph 2.2.1.2.
Corporate officers on pages 33 et seq. for more
information).
2. Assessment of the independence of Directors

proposes to the Board of Directors every year to
review on a case-by-case basis the situation of

each of the Directors with regard to their
independence according to the criteria set out
in the AFEP-MEDEF Code.
LOral has a well-balanced Board comprising 14

members at December 31st, 2012: the Chairman and
Chief Executive Officer, Jean-Paul Agon, the Honorary
Chairman, Sir Lindsay Owen-Jones, six Directors
appointed by the majority shareholders, three of whom
are appointed by Mrs. Bettencourts family group and
three by Nestl (the two Vice-Chairmen of the Board
being chosen from among these members) and six
independent Directors: Ms. Annette Roux, Mr. CharlesHenri Filippi, Mr. Xavier Fontanet, Mr. Bernard Kasriel,
Mr. Marc Ladreit de Lacharrire and Mr. Louis
Schweitzer.
The review of the independence of these Directors
246
was made by the Appointments and Governance

Committee at the end of 2012 on the basis, in
particular, of the study of the relations existing
between the Company and the companies in
which the directors have offices. The Directors
have no conflicts of interest.The other corporate
offices and directorships held, their availability,
their personal contributions and their participation
in the work and discussions of the Board and its
Committees in 2012 were taken into consideration
by the Appointments and Governance Committee
to evaluate the composition and modus operandi
of the Board.
3. Appointment of a new Director in 2013
looked at the profile of a possible new Director
who was approved by the Board of Directors. The
proposed appointment of Ms. Virginie Morgon is
submitted to the Annual General Meeting.

Draft resolutions and Report of the Board of Directors to the Annual General Meeting to be
Virginie Morgon (age: 43)

worked for 16 years at
Lazard, in particular as
an investment banker in
New York and London at
the start of her career in
1991 and as a senior
partner in Paris from
2001 to 2007. Virginie
Morgon advised a large
number of French and
international groups on
mergers and acquisitions.
Since 2008 with Eurazeo,
one of the top listed
investment companies in
Europe, she is a member
of the Executive Board
and was appointed as
Chief Investment Officer
in December 2012.
Virginie Morgon is a
Director of Accor and
Edenred* and a member
of their Audit Committees.
Virginie Morgon is a
member of the Board of
Directors of the Womens
Forum for the Economy &
Society.
Virginie
Morgon
has
concrete experience of
the corporate world as an
investor and will provide
LOrals
Board
of
Directors
with
complementary
experience and skills in
this area.
This appointment of Ms.

Virginie Morgon as an
independent Director for a
period of four years would
increase the number of
Directors to 15 and the
number of women on the
Board to 4, thus leading to a
percentage of representation
of women of 26.7% as
opposed to 21.4% in 2012,
and
the
number
of
independent Directors to 7,
thus giving a percentage of
independent Directors of
46.7% as compared with
42.9% in 2012.
4. Renewal of tenures as
Directors in 2013
As the tenures as Directors
of Franoise Bettencourt
Meyers, Peter
BrabeckLetmathe
and
Louis
Schweitzer expire in 2013,
the renewal of their tenures
for a period of four years is
submitted to the Annual
General Meeting.
For information purposes, if
the Annual General Meeting
votes in favour of the
appointment and renewals
proposed to it in 2013, the
expiry dates of the terms of
office of the 15 Directors of
LOral would be as follows:
Directors
2014
Jean-Paul Agon
Franoise Bettencourt Meyers
Peter Brabeck-Letmathe
Paul Bulcke
Charles-Henri Filippi
Xavier Fontanet
Bernard Kasriel
Christiane Kuehne
Marc Ladreit de Lacharrire
Jean-Pierre Meyers
Jean-Victor Meyers
Virginie Morgon
Annette Roux
Louis Schweitzer
Number of renewals per year
Morgon as Director
Fourth
resolution:
Appointment
of Ms. Virginie
The Annual General Meeting,

having reviewed the Report of
the Board of Directors, decides
to appoint Ms. Virginie Morgon
as Director for a period of four
years.
Expiry date
20
Her tenure will expire at

the end of the Annual
General Meeting to be
held in 2017 to review
for
the
previous
financial year.
Fifth resolution:
Renewal of the
tenure as Director
of Mrs. Franoise
Bettencourt
Meyers
The Annual General
Meeting,
having
reviewed the Report of
the Board of Directors,
renews the tenure of
Mrs.
Franoise
Bettencourt Meyers for
a period of four years.
Her tenure will expire at
the end of the Annual
General Meeting to be
held in 2017 to review
for
the
previous
financial year.
Sixth
resolutio
n:
Renewal
of the
tenure as
Director
of Mr.
Peter
BrabeckLetmathe
The Annual
General
Meeting,
having
reviewed
the Report
of
the
Board
of
Directors,
renews the
tenure
of
Mr. Peter
BrabeckLetmathe
for a period
of
four
years.
His tenure
will expire
at the end
of
the
Annual
General
Meeting to
be held in
2017
to
review the
financial
statements
for
the
previous
financial
year.
Seventh resolution: Renewal of the tenure

as Director of Mr. Louis Schweitzer
The Annual
General
Meeting,
having
reviewed
the Report
of
the
Board
of
Directors,
renews the
tenure
of
Mr. Louis
Schweitzer
for a period
of
four
years.
His tenure
will expire
at the end
of
the
Annual
General
Meeting to
be
hel
d
in
20
17
to
*
review the
financial
statements
for
the
previous
financial
year.
Until March 6th, 2013 .
247
ANNUAL
GENERAL
MEETING
Draft resolutions
and Report
of the Board of Directors to the Annual General Meeting to be
Resolution 8: Authorisation for the Company to buy back its own shares
free grants of
It is proposed that you give the Board of
Directors a new authorisation to buy back shares
of the Company.
Pursuant to the authorisation voted by the Annual
General Meeting of April 17 th, 2012 and during the
period from August 30th to December 31st, 2012, the
Board of Directors bought back LOral shares for
an amount of 498 million with a view to their
cancellation. The 5,077,250 shares purchased in
this manner were cancelled by the Board of
Directors on February 11th, 2013.
As the existing authorisation is due to expire in

October 2013, it is proposed that the Annual
General Meeting give the Board a new
authorisation which will enable it to resume its
share buyback policy where applicable,
depending on the opportunities that may arise,
except during periods of public offers with regard
to the Companys capital.
The Company could buy back its own shares
with the aim of:
their cancellation;
Eighth resolution: Authorisation for the

Company to buy back its own shares
Report of the Board of Directors, authorises the
Board of Directors, with the possibility for it to
delegate to the Chairman and Chief Executive
Officer, to purchase shares of the Company, in
accordance with Articles L. 225-209 et seq. of the
French Commercial Code, and subject to the
following conditions:
the purchase price per share may not be greater

than 170;
the number of shares that may be bought by the

Company may not exceed 10% of the number of
shares forming the capital of the Company at
the time the shares are bought back, that is, for
information purposes, as of February 11th, 2013,
60,431,362 shares for a maximum amount of
10.27 billion, it being stipulated that the
Company may at no time hold over 10% of its
own capital.
In the event of any transaction affecting the

Companys capital, the prices and numbers
indicated above will be adjusted where applicable.
The Company may buy its own shares for the
following purposes:
their cancellation by a reduction in capital;
their allocation or sale to employees and

corporate officers of the Company and affiliates,
under the terms and conditions provided for by
French or foreign law, and in particular within
the scope of employee profit sharing schemes,
employee share ownership programmes;
their sale within the scope of employee share

ownership schemes and their allocation to
free grants of shares for the benefit of
employees and corporate officers of the
LOral Group;
market animation of the share;
retaining them and subsequently using them

as payment in connection with external
growth transactions.
The purchase of these shares may be carried out

by any means, on one or more occasions, on or
off the stock markets, including through the
acquisition of blocks of shares.
The authorisation would be granted for a period
of 18 months at a purchase price per share that
may not be greater than 170.The authorisation
would concern no more than 10% of the capital,
namely, for information purposes, 60,431,362
shares for a maximum amount of 10.27 billion
at February 11th, 2013, it being stipulated that the
Company may at no time hold over 10% of its
own capital.
shares or all employee share ownership

programmes as well as carrying out any
transaction to cover the above-mentioned
market animation of the share through a

liquidity agreement entered into with an
investment services provider;
retaining them and subsequently using them as

payment in connection with external growth
transactions.
The purchase of these shares may be carried out

by any means, on one or more occasions, on or off
the stock markets, including through the acquisition
of blocks of shares.
These transactions may be carried out at any time,
in accordance with the regulations in force at the
time of the transactions concerned, except during
periods of public offers with regard to the
Companys capital.
The Annual General Meeting decides that this
authorisation will expire at the end of a period of 18
months following this Annual General Meeting and
renders ineffective as from the date hereof any
prior authorisation for the same purpose.
The Board of Directors will have the possibility of
allocating all the treasury shares currently held by
the Company to any of these objectives under the
conditions provided for in this share buyback
programme. Full powers are granted to the Board
of Directors, with the possibility for it to delegate, for
the implementation of this resolution.
248

LOREAL Document de Reference 2011

Uploaded by

Copyright:

Available Formats

LOREAL Document de Reference 2011

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

LOREAL Document de Reference 2011

Uploaded by

Copyright:

Available Formats

REGISTRATION

5.7. Other information relating to the financial

Information relating to the Company

Key figures and comments

2012 Consolidated financial

2012 Parent company

Compared income statements

8.1. Draft resolutions and Report of the Board of Directors to the

to be held on April 26th, 2013

Detailed chapter contents can be found at the beginning of each chapter.

In application of Article 212-13 of the General Regulation of the Autorit

This label recognises the most

2012 has been another year

REGISTRATION DOCUMENT LORAL 2012

Message from the Chairman and Chief Executive Officer

2012 has been another year of strong performance by LOral.

A very good vintage for innovations

The quality of our results is also underpinned by the very high

and performance of our products that enables us to attract

coverage of the beauty market.

At the Annual General Meeting, the

leading investment companies listed

specialist committees whose remits have been broadened. The

Accelerated international development

Strong value creation

is crucial in the beauty sector, where innovation and adaptation

REGISTRATION DOCUMENTT LORAL 2012

Preparing LOral for

Targeting sustainable, responsible

in 2012, more than 70% of the Groups employees yet again

Confidence in the future

a priority and build growth that is sustainable,

AND OUR MARKET

responsible and inclusive.

while respecting their differences

the industry. Its ability to constantly invent high-quality products

REGISTRATION DOCUMENT LORAL 2012

1.5.2. One step ahead in active

1.3.1. The foundations of

1.5.6. Research in tune with the

1.6.1. From sourcing to delivery, continuous

and optimisation of production

1.6.4. Long-term partnerships with suppliers

1.6.5. LOral and

1.6.6. Strong commitments with regard to

1.6.7. Environmental protection at the heart

1.7. Investment policy

1.8. Risk factors *

1.8.1. Business risks

1.8.2. Legal risks

1.8.3. Industrial and environmental risks

1.8.4. Counterparty risk

1.8.6. Liquidity risk

1.8.7. Financial and market risks

Beauty for all

their personalities, gain self-confidence and open up to others.

the universalisation of beauty its project for the years to come.

LOral, offering beauty for all.

REGISTRATION DOCUMENT LORAL 2012

PRESENTATION OF THE GROUP